sampleID	_EVENT	_INTEGRATION	OS.time	OS	OS.unit	_PATIENT	RFS.time	RFS	RFS.unit	_TIME_TO_EVENT	_TIME_TO_EVENT_UNIT	_cohort	_primary_disease	_primary_site	additional_pharmaceutical_therapy	additional_radiation_therapy	adjacent_hepatic_tissue_inflammation_extent_type	age_at_initial_pathologic_diagnosis	albumin_result_lower_limit	albumin_result_specified_value	albumin_result_upper_limit	bcr_followup_barcode	bcr_patient_barcode	bcr_sample_barcode	bilirubin_lower_limit	bilirubin_upper_limit	cancer_first_degree_relative	child_pugh_classification_grade	creatinine_lower_level	creatinine_upper_limit	creatinine_value_in_mg_dl	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	eastern_cancer_oncology_group	fetoprotein_outcome_lower_limit	fetoprotein_outcome_upper_limit	fetoprotein_outcome_value	fibrosis_ishak_score	followup_case_report_form_submission_reason	form_completion_date	gender	height	hist_hepato_carc_fact	hist_hepato_carcinoma_risk	histological_type	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	initial_weight	inter_norm_ratio_lower_limit	intern_norm_ratio_upper_limit	is_ffpe	lost_follow_up	neoplasm_histologic_grade	new_neoplasm_event_occurrence_anatomic_site	new_neoplasm_event_type	new_neoplasm_occurrence_anatomic_site_text	new_tumor_event_ablation_embo_tx	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	new_tumor_event_liver_transplant	oct_embedded	other_dx	pathologic_M	pathologic_N	pathologic_T	pathologic_stage	pathology_report_file_name	patient_id	person_neoplasm_cancer_status	platelet_result_count	platelet_result_lower_limit	platelet_result_upper_limit	post_op_ablation_embolization_tx	postoperative_rx_tx	prothrombin_time_result_value	radiation_therapy	relative_family_cancer_history	residual_disease_post_new_tumor_event_margin_status	residual_tumor	sample_type	sample_type_id	specimen_collection_method_name	system_version	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	total_bilirubin_upper_limit	tumor_tissue_site	vascular_tumor_cell_type	vial_number	viral_hepatitis_serology	vital_status	weight	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_LIHC_gistic2	_GENOMIC_ID_TCGA_LIHC_gistic2thd	_GENOMIC_ID_TCGA_LIHC_mutation_bcm_gene	_GENOMIC_ID_TCGA_LIHC_miRNA_HiSeq	_GENOMIC_ID_TCGA_LIHC_PDMRNAseq	_GENOMIC_ID_TCGA_LIHC_RPPA	_GENOMIC_ID_TCGA_LIHC_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_LIHC_mutation_bcgsc_gene	_GENOMIC_ID_data/public/TCGA/LIHC/miRNA_HiSeq_gene	_GENOMIC_ID_TCGA_LIHC_PDMRNAseqCNV	_GENOMIC_ID_TCGA_LIHC_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_LIHC_mutation_ucsc_maf_gene	_GENOMIC_ID_TCGA_LIHC_exp_HiSeqV2	_GENOMIC_ID_TCGA_LIHC_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_LIHC_mutation_broad_gene	_GENOMIC_ID_TCGA_LIHC_hMethyl450
TCGA-2V-A95S-01		TCGA-2V-A95S-01			days	TCGA-2V-A95S			days		days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Severe		3.5	4.2	5.2		TCGA-2V-A95S	TCGA-2V-A95S-01A	0	1.5		A	.7	1.2	.6								4	0	8	10793	6 - Established Cirrhosis		2015-6-15	MALE	173	Other	former smoker	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	170	2	3	NO		G3								false	No	MX	NX	T2	Stage II	TCGA-2V-A95S.BE263DC7-2250-42E2-8AD6-D99A6DF679B6.pdf	A95S	WITH TUMOR	107	140	370	NO	NO	2.0	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	2V	.2	Liver	Micro	A		LIVING	78		TCGA-2V-A95S-01A-11D-A36W-01	TCGA-2V-A95S-01A-11D-A36W-01	TCGA-2V-A95S-01A-11D-A36X-10	TCGA-2V-A95S-01	TCGA-2V-A95S-01		53796be6-1c87-448a-9928-3c640e9d3414		TCGA-2V-A95S-01	TCGA-2V-A95S-01	53796be6-1c87-448a-9928-3c640e9d3414		53796be6-1c87-448a-9928-3c640e9d3414	53796be6-1c87-448a-9928-3c640e9d3414		TCGA-2V-A95S-01A-11D-A36Y-05
TCGA-2Y-A9GS-01	1	TCGA-2Y-A9GS-01	724	1	days	TCGA-2Y-A9GS			days	724	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	58	3.5	4	5		TCGA-2Y-A9GS	TCGA-2Y-A9GS-01A	0.2	0.7			0.8	1.5	1.6	-21318	2558	724	0					0	6	74			2014-11-3	MALE	162	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	80	8.3	11.5	NO		G2						YES		true	No	MX	NX	T2	[Discrepancy]	TCGA-2Y-A9GS.DAA3D158-0488-41C9-8B3F-BE6D05E036D8.pdf	A9GS	WITH TUMOR	168	143	382	NO	NO	9.9	NO			R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	2Y	1.3	Liver		A	HCV Genotype|Hepatitis B Surface Antigen|HBV Core Antibody	DECEASED	92	2006	TCGA-2Y-A9GS-01A-12D-A381-01	TCGA-2Y-A9GS-01A-12D-A381-01	TCGA-2Y-A9GS-01A-12D-A382-10	TCGA-2Y-A9GS-01	TCGA-2Y-A9GS-01		7b0d0cd1-3770-4e1c-9a64-93e41825a3b7		TCGA-2Y-A9GS-01	TCGA-2Y-A9GS-01	7b0d0cd1-3770-4e1c-9a64-93e41825a3b7		7b0d0cd1-3770-4e1c-9a64-93e41825a3b7	7b0d0cd1-3770-4e1c-9a64-93e41825a3b7		TCGA-2Y-A9GS-01A-12D-A383-05
TCGA-2Y-A9GT-01	1	TCGA-2Y-A9GT-01	1624	1	days	TCGA-2Y-A9GT			days	1624	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	51	3.5	3.7	5		TCGA-2Y-A9GT		0.2	0.4	1	C	0.8	1.5	0.8	-18768		1624	0				0		7	17			2014-11-3	MALE	182	Alcohol consumption|Hepatitis B|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.3	11.5			G2						YES			No	MX	NX	T1	Stage I		A9GT	WITH TUMOR	187	143	382		NO	9.8	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	2Y	1.3	Liver	None		Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Core Antibody|HBV D	DECEASED	122	2006	TCGA-2Y-A9GT-01A-11D-A381-01	TCGA-2Y-A9GT-01A-11D-A381-01	TCGA-2Y-A9GT-01A-11D-A382-10	TCGA-2Y-A9GT-01	TCGA-2Y-A9GT-01		e1ab65b5-ee17-4e86-93aa-446c8f387ef1		TCGA-2Y-A9GT-01	TCGA-2Y-A9GT-01	e1ab65b5-ee17-4e86-93aa-446c8f387ef1		e1ab65b5-ee17-4e86-93aa-446c8f387ef1	e1ab65b5-ee17-4e86-93aa-446c8f387ef1		TCGA-2Y-A9GT-01A-11D-A383-05
TCGA-2Y-A9GU-01	0	TCGA-2Y-A9GU-01	1939	0	days	TCGA-2Y-A9GU	1939	0	days	1939	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	55	3.5	4.4	5	TCGA-2Y-A9GU-F69082	TCGA-2Y-A9GU	TCGA-2Y-A9GU-01A	0.2	0.3	2		0.8	1.5	0.9	-20187	1752		0	1939			0	0	6	304			2014-12-29	FEMALE	154	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	120	8.3	11.5	NO	NO	G2						NO		true	No	MX	NX	T1	Stage I	TCGA-2Y-A9GU.5585C485-B57A-4CA8-A3E3-F093A7E6AC76.pdf	A9GU	TUMOR FREE	281	143	382	NO	NO	10.8	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	2Y	1.3	Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody	LIVING	78	2009	TCGA-2Y-A9GU-01A-11D-A381-01	TCGA-2Y-A9GU-01A-11D-A381-01	TCGA-2Y-A9GU-01A-11D-A382-10	TCGA-2Y-A9GU-01	TCGA-2Y-A9GU-01		6f3f7f73-b031-424e-ba7c-263f802dd6cf		TCGA-2Y-A9GU-01	TCGA-2Y-A9GU-01	6f3f7f73-b031-424e-ba7c-263f802dd6cf		6f3f7f73-b031-424e-ba7c-263f802dd6cf	6f3f7f73-b031-424e-ba7c-263f802dd6cf		TCGA-2Y-A9GU-01A-11D-A383-05
TCGA-2Y-A9GV-01	1	TCGA-2Y-A9GV-01	2532	1	days	TCGA-2Y-A9GV			days	2532	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				54	3.5	4.2	5		TCGA-2Y-A9GV		0.2	0.3			0.8	1.5	0.6	-20011		2532	0				2		7	6			2014-11-3	FEMALE	167	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.3	11.5			G1						YES			Yes	MX	NX	T1	Stage I		A9GV	WITH TUMOR	370	143	382	NO	YES	9.5	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	2Y	1.3	Liver			Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody	DECEASED	85	2007	TCGA-2Y-A9GV-01A-11D-A381-01	TCGA-2Y-A9GV-01A-11D-A381-01	TCGA-2Y-A9GV-01A-11D-A382-10	TCGA-2Y-A9GV-01	TCGA-2Y-A9GV-01		c0bcdbc7-9bed-49b7-93ca-f82ffc2929a1		TCGA-2Y-A9GV-01	TCGA-2Y-A9GV-01	c0bcdbc7-9bed-49b7-93ca-f82ffc2929a1		c0bcdbc7-9bed-49b7-93ca-f82ffc2929a1	c0bcdbc7-9bed-49b7-93ca-f82ffc2929a1		TCGA-2Y-A9GV-01A-11D-A383-05
TCGA-2Y-A9GW-01	1	TCGA-2Y-A9GW-01	1271	1	days	TCGA-2Y-A9GW			days	1271	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	64	3.5	4.5	5		TCGA-2Y-A9GW	TCGA-2Y-A9GW-01A	0.2	0.6	1		0.8	1.5	1	-23587	2375	1271	0					0	6	2			2014-11-3	MALE	182	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	80	8.3	11.5	NO		G2						YES		true	No	MX	N0	T1	Stage I	TCGA-2Y-A9GW.5846FA3D-E3AD-4530-8A5F-5D90CD17F539.pdf	A9GW	WITH TUMOR	175	143	382	NO	NO	9.7	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	2Y	1.3	Liver		A		DECEASED	139	2007	TCGA-2Y-A9GW-01A-11D-A381-01	TCGA-2Y-A9GW-01A-11D-A381-01	TCGA-2Y-A9GW-01A-11D-A382-10	TCGA-2Y-A9GW-01	TCGA-2Y-A9GW-01		6d979d21-8d92-40aa-a19f-f4a6c55384cf		TCGA-2Y-A9GW-01	TCGA-2Y-A9GW-01	6d979d21-8d92-40aa-a19f-f4a6c55384cf		6d979d21-8d92-40aa-a19f-f4a6c55384cf	6d979d21-8d92-40aa-a19f-f4a6c55384cf		TCGA-2Y-A9GW-01A-11D-A383-05
TCGA-2Y-A9GX-01	0	TCGA-2Y-A9GX-01	2442	0	days	TCGA-2Y-A9GX	2133	1	days	2442	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	68	3.5	4.3	5	TCGA-2Y-A9GX-F69170	TCGA-2Y-A9GX		0.2	0.4			0.8	1.5	0.7	-24963			0	2442		2133	1	0	7	1			2014-12-30	MALE	175	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.3	11.5		NO	G2	Liver	Locoregional Recurrence		No	NO	YES	No		No	MX	NX	T1	Stage I		A9GX	WITH TUMOR	155	143	382	NO	NO	10.3	NO	NO		R1	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	2Y	1.3	Liver			Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	104	2007	TCGA-2Y-A9GX-01A-11D-A381-01	TCGA-2Y-A9GX-01A-11D-A381-01	TCGA-2Y-A9GX-01A-11D-A382-10	TCGA-2Y-A9GX-01	TCGA-2Y-A9GX-01		c4b50fbc-9dbb-4670-88b7-93c77d7d3547		TCGA-2Y-A9GX-01	TCGA-2Y-A9GX-01	c4b50fbc-9dbb-4670-88b7-93c77d7d3547		c4b50fbc-9dbb-4670-88b7-93c77d7d3547	c4b50fbc-9dbb-4670-88b7-93c77d7d3547		TCGA-2Y-A9GX-01A-11D-A383-05
TCGA-2Y-A9GY-01	1	TCGA-2Y-A9GY-01	757	1	days	TCGA-2Y-A9GY			days	757	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	64	3.5	4.2	5		TCGA-2Y-A9GY		0.2	0.4	2		0.8	1.5	0.6	-23435		757	0					0	7	27600			2014-11-3	FEMALE	161	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.3	11.5			G3						YES			No	MX	NX	T2	Stage II		A9GY	WITH TUMOR	207	143	382	NO	NO	9.5	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	2Y	1.3	Liver				DECEASED	92	2007	TCGA-2Y-A9GY-01A-11D-A381-01	TCGA-2Y-A9GY-01A-11D-A381-01	TCGA-2Y-A9GY-01A-11D-A382-10	TCGA-2Y-A9GY-01	TCGA-2Y-A9GY-01		f21c811b-a31a-4b4b-88a0-2488fa59b20d		TCGA-2Y-A9GY-01	TCGA-2Y-A9GY-01	f21c811b-a31a-4b4b-88a0-2488fa59b20d		f21c811b-a31a-4b4b-88a0-2488fa59b20d	f21c811b-a31a-4b4b-88a0-2488fa59b20d		TCGA-2Y-A9GY-01A-11D-A383-05
TCGA-2Y-A9GZ-01	1	TCGA-2Y-A9GZ-01	848	1	days	TCGA-2Y-A9GZ			days	848	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	82	3.5	4.5	5		TCGA-2Y-A9GZ		0.2	0.7	4	A	0.8	1.5	1.1	-30082		848	0					0	7	7			2014-11-3	FEMALE	153	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.3	11.5			G2						YES			No	MX	NX	T2	Stage II		A9GZ	WITH TUMOR	318	143	382	NO	YES	9.9	NO	YES		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	2Y	1.3	Liver			Hepatitis  C Antibody|HBV Core Antibody	DECEASED	51	2007	TCGA-2Y-A9GZ-01A-11D-A38W-01	TCGA-2Y-A9GZ-01A-11D-A38W-01	TCGA-2Y-A9GZ-01A-11D-A38X-10	TCGA-2Y-A9GZ-01	TCGA-2Y-A9GZ-01		b40fc694-28d2-4b49-a5ff-4182156a9654		TCGA-2Y-A9GZ-01	TCGA-2Y-A9GZ-01	b40fc694-28d2-4b49-a5ff-4182156a9654		b40fc694-28d2-4b49-a5ff-4182156a9654	b40fc694-28d2-4b49-a5ff-4182156a9654		TCGA-2Y-A9GZ-01A-11D-A39G-05
TCGA-2Y-A9H0-01	0	TCGA-2Y-A9H0-01	3675	0	days	TCGA-2Y-A9H0	3675	0	days	3675	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	49	3.5	2	5	TCGA-2Y-A9H0-F69171	TCGA-2Y-A9H0	TCGA-2Y-A9H0-01A	0.2	0.8			0.8	1.5	0.8	-18109	3538		0	3675			0	0	8	7598			2014-12-30	MALE	180	Alcohol consumption|Hepatitis B|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	130	8.3	11.5	NO	NO	G1						NO		true	No	M0	N0	T3	Stage IIIA	TCGA-2Y-A9H0.33EB4235-F58D-4AB6-8944-F2B59374A5F0.pdf	A9H0	TUMOR FREE	207	143	382	NO	NO	12.2	NO			R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	2Y	1.3	Liver		A		LIVING	89	2004	TCGA-2Y-A9H0-01A-11D-A381-01	TCGA-2Y-A9H0-01A-11D-A381-01	TCGA-2Y-A9H0-01A-11D-A382-10	TCGA-2Y-A9H0-01	TCGA-2Y-A9H0-01		73769c40-ad9d-4b11-925e-46e3e762d3f4		TCGA-2Y-A9H0-01	TCGA-2Y-A9H0-01	73769c40-ad9d-4b11-925e-46e3e762d3f4		73769c40-ad9d-4b11-925e-46e3e762d3f4	73769c40-ad9d-4b11-925e-46e3e762d3f4		TCGA-2Y-A9H0-01A-11D-A383-05
TCGA-2Y-A9H1-01	1	TCGA-2Y-A9H1-01	1229	1	days	TCGA-2Y-A9H1			days	1229	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				58	3.5	4.4	5		TCGA-2Y-A9H1		0.2	0.5			0.8	1.5	0.9	-21222		1229	0				1	0	7	3	1,2 - Portal Fibrosis		2014-11-3	MALE	171	Alcohol consumption|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.3	11.5			G2						YES			No	MX	NX	T1	Stage I		A9H1	WITH TUMOR	213	143	382	YES	NO	10	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	2Y	1.3	Liver			Hepatitis  C Antibody	DECEASED	89	2010	TCGA-2Y-A9H1-01A-11D-A381-01	TCGA-2Y-A9H1-01A-11D-A381-01	TCGA-2Y-A9H1-01A-11D-A382-10	TCGA-2Y-A9H1-01	TCGA-2Y-A9H1-01		dd08761a-17e5-4d03-820d-2ee5d8d6c2b8		TCGA-2Y-A9H1-01	TCGA-2Y-A9H1-01	dd08761a-17e5-4d03-820d-2ee5d8d6c2b8		dd08761a-17e5-4d03-820d-2ee5d8d6c2b8	dd08761a-17e5-4d03-820d-2ee5d8d6c2b8		TCGA-2Y-A9H1-01A-11D-A383-05
TCGA-2Y-A9H2-01	0	TCGA-2Y-A9H2-01	1731	0	days	TCGA-2Y-A9H2	1731	0	days	1731	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	64	3.5	4.5	5	TCGA-2Y-A9H2-F69173	TCGA-2Y-A9H2	TCGA-2Y-A9H2-01A	0.2	0.4			0.8	1.5	1.4	-23653	1443		0	1731			0	0	7	2			2014-12-30	FEMALE	176	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	80	8.3	11.5	NO	NO	G3						NO		true	No	MX	N0	T1	Stage I	TCGA-2Y-A9H2.4C19CF84-5E30-4854-A084-F6EE53A80543.pdf	A9H2	TUMOR FREE	386	143	382	NO	NO	10.8	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	2Y	1.3	Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody	LIVING	55	2010	TCGA-2Y-A9H2-01A-12D-A381-01	TCGA-2Y-A9H2-01A-12D-A381-01	TCGA-2Y-A9H2-01A-12D-A382-10	TCGA-2Y-A9H2-01	TCGA-2Y-A9H2-01		959e5067-014b-4a33-92d6-6827383efb00		TCGA-2Y-A9H2-01	TCGA-2Y-A9H2-01	959e5067-014b-4a33-92d6-6827383efb00		959e5067-014b-4a33-92d6-6827383efb00	959e5067-014b-4a33-92d6-6827383efb00		TCGA-2Y-A9H2-01A-12D-A383-05
TCGA-2Y-A9H3-01	0	TCGA-2Y-A9H3-01	1516	0	days	TCGA-2Y-A9H3	1516	0	days	1516	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	45	3.5	5.3	5	TCGA-2Y-A9H3-F69086	TCGA-2Y-A9H3		0.2	0.3	3		0.8	1.5	0.9	-16443			0	1516			2	0	7	5640	1,2 - Portal Fibrosis		2014-12-29	MALE	179	Alcohol consumption|Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.3	11.5		NO	G1						NO			No	MX	NX	T2	Stage II		A9H3	TUMOR FREE	245	143	382	[Discrepancy]	NO	10.5	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	2Y	1.3	Liver	Micro		Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	105	2010	TCGA-2Y-A9H3-01A-11D-A381-01	TCGA-2Y-A9H3-01A-11D-A381-01	TCGA-2Y-A9H3-01A-11D-A382-10	TCGA-2Y-A9H3-01	TCGA-2Y-A9H3-01		a9559d4e-1403-4d7f-8638-d74d31dafcd3		TCGA-2Y-A9H3-01	TCGA-2Y-A9H3-01	a9559d4e-1403-4d7f-8638-d74d31dafcd3		a9559d4e-1403-4d7f-8638-d74d31dafcd3	a9559d4e-1403-4d7f-8638-d74d31dafcd3		TCGA-2Y-A9H3-01A-11D-A383-05
TCGA-2Y-A9H4-01	0	TCGA-2Y-A9H4-01	1452	0	days	TCGA-2Y-A9H4	1452	0	days	1452	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				68	3.5	4.6	5	TCGA-2Y-A9H4-F69087	TCGA-2Y-A9H4	TCGA-2Y-A9H4-01A	0.2	0.3	2	A	0.8	1.5	1.2	-25096	1210		0	1452			0	0	7	11			2014-12-29	MALE	167	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	100	8.3	11.5	NO	NO	G2						NO		true	No	MX	N0	T1	Stage I	TCGA-2Y-A9H4.8A93B07B-8DCC-4DF4-B792-212C80E203FB.pdf	A9H4	TUMOR FREE	223	143	382	NO	NO	11	NO	YES		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	2Y	1.3	Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	61	2010	TCGA-2Y-A9H4-01A-11D-A381-01	TCGA-2Y-A9H4-01A-11D-A381-01	TCGA-2Y-A9H4-01A-11D-A382-10	TCGA-2Y-A9H4-01	TCGA-2Y-A9H4-01		5b8cde2d-a8bf-4f84-b4c4-9515a2b97226		TCGA-2Y-A9H4-01	TCGA-2Y-A9H4-01	5b8cde2d-a8bf-4f84-b4c4-9515a2b97226		5b8cde2d-a8bf-4f84-b4c4-9515a2b97226	5b8cde2d-a8bf-4f84-b4c4-9515a2b97226		TCGA-2Y-A9H4-01A-11D-A383-05
TCGA-2Y-A9H5-01	1	TCGA-2Y-A9H5-01	555	1	days	TCGA-2Y-A9H5			days	555	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				59	3.5	4.9	5		TCGA-2Y-A9H5	TCGA-2Y-A9H5-01A	0.2	0.3	2		0.8	1.5	0.6	-21818	1101	555	0					0	7	11700	1,2 - Portal Fibrosis		2014-11-3	FEMALE	157	Alcohol consumption|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	30	8.3	11.5	NO		G3						YES		true	No	MX	N0	T1	Stage I	TCGA-2Y-A9H5.99FC2CC9-19F1-4BCB-81E6-5FED4619B331.pdf	A9H5	WITH TUMOR	204	143	382	NO	NO	10.2	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	2Y	1.3	Liver	None	A	Hepatitis  C Antibody|Hepatitis C Virus R|HCV Genotype	DECEASED	69	2010	TCGA-2Y-A9H5-01A-11D-A381-01	TCGA-2Y-A9H5-01A-11D-A381-01	TCGA-2Y-A9H5-01A-11D-A382-10	TCGA-2Y-A9H5-01	TCGA-2Y-A9H5-01		2599cb92-686e-4939-a97f-c17f2065adcc		TCGA-2Y-A9H5-01	TCGA-2Y-A9H5-01	2599cb92-686e-4939-a97f-c17f2065adcc		2599cb92-686e-4939-a97f-c17f2065adcc	2599cb92-686e-4939-a97f-c17f2065adcc		TCGA-2Y-A9H5-01A-11D-A383-05
TCGA-2Y-A9H6-01	0	TCGA-2Y-A9H6-01	357	0	days	TCGA-2Y-A9H6	357	0	days	357	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	68	3.5	4	5	TCGA-2Y-A9H6-F69088	TCGA-2Y-A9H6	TCGA-2Y-A9H6-01A	0.3	0.3	1		0.8	1.5	1.8	-24982	982		0	357			0	0	7	114			2014-12-29	FEMALE	156	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	100	8.3	11.5	NO	YES	G2						NO		true	Yes	MX	NX	T1	Stage I	TCGA-2Y-A9H6.0B39CB6A-D208-4128-AB46-50C7DB072865.pdf	A9H6		224	143	382	NO	NO	10.5	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	2Y	1.3	Liver	Macro	A		LIVING	99	2011	TCGA-2Y-A9H6-01A-11D-A38W-01	TCGA-2Y-A9H6-01A-11D-A38W-01	TCGA-2Y-A9H6-01A-11D-A38X-10	TCGA-2Y-A9H6-01	TCGA-2Y-A9H6-01		1493a0e1-08ca-4054-b432-f8103e47563c		TCGA-2Y-A9H6-01	TCGA-2Y-A9H6-01	1493a0e1-08ca-4054-b432-f8103e47563c		1493a0e1-08ca-4054-b432-f8103e47563c	1493a0e1-08ca-4054-b432-f8103e47563c		TCGA-2Y-A9H6-01A-11D-A39G-05
TCGA-2Y-A9H7-01	0	TCGA-2Y-A9H7-01	1168	0	days	TCGA-2Y-A9H7	1117	1	days	1168	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	81	3.5	3.4	5	TCGA-2Y-A9H7-F69176	TCGA-2Y-A9H7	TCGA-2Y-A9H7-01A	0.2	0.3		A	0.8	1.5	1.2	-29752	846		0	1168		1117	2	0	7	6	3,4 - Fibrous Speta		2014-12-30	FEMALE	157	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	140	8.3	11.5	NO	NO	G2	Liver	Locoregional Recurrence		Yes	NO	YES	No	true	Yes	MX	N0	T1	Stage I	TCGA-2Y-A9H7.80E07DD4-2925-4F58-B4DA-07041673A13F.pdf	A9H7	WITH TUMOR	165	143	382	[Discrepancy]	NO	10.8	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	2Y	1.3	Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	104	2011	TCGA-2Y-A9H7-01A-11D-A38W-01	TCGA-2Y-A9H7-01A-11D-A38W-01	TCGA-2Y-A9H7-01A-11D-A38X-10	TCGA-2Y-A9H7-01	TCGA-2Y-A9H7-01		185beb02-4b0d-457c-8eee-4e4c51362feb		TCGA-2Y-A9H7-01	TCGA-2Y-A9H7-01	185beb02-4b0d-457c-8eee-4e4c51362feb		185beb02-4b0d-457c-8eee-4e4c51362feb	185beb02-4b0d-457c-8eee-4e4c51362feb		TCGA-2Y-A9H7-01A-11D-A39G-05
TCGA-2Y-A9H8-01	1	TCGA-2Y-A9H8-01	633	1	days	TCGA-2Y-A9H8			days	633	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				85	3.5	4.2	5		TCGA-2Y-A9H8	TCGA-2Y-A9H8-01A	0.2	0.3	2		0.8	1.5	0.6	-31322	792	633	0				2	0	7	234000			2014-11-3	FEMALE	150	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	80	8.3	11.5	NO		G2						YES		true	No	MX	NX	T1	[Discrepancy]	TCGA-2Y-A9H8.61B5E3D4-727D-45ED-BAC3-9125A0E03F40.pdf	A9H8	WITH TUMOR	255	143	382	NO	NO	10.3	NO	YES		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	2Y	1.3	Liver		A	Hepatitis C Virus R|HBV Surface Antibody|HBV D	DECEASED	40	2011	TCGA-2Y-A9H8-01A-11D-A38W-01	TCGA-2Y-A9H8-01A-11D-A38W-01	TCGA-2Y-A9H8-01A-11D-A38X-10	TCGA-2Y-A9H8-01	TCGA-2Y-A9H8-01		327757e4-c3b3-4be0-bdbf-2ad718f92da0		TCGA-2Y-A9H8-01	TCGA-2Y-A9H8-01	327757e4-c3b3-4be0-bdbf-2ad718f92da0		327757e4-c3b3-4be0-bdbf-2ad718f92da0	327757e4-c3b3-4be0-bdbf-2ad718f92da0		TCGA-2Y-A9H8-01A-11D-A39G-05
TCGA-2Y-A9H9-01	0	TCGA-2Y-A9H9-01	697	0	days	TCGA-2Y-A9H9	701	1	days	697	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	70	3.5	4.7	5	TCGA-2Y-A9H9-F69092	TCGA-2Y-A9H9	TCGA-2Y-A9H9-01A	0.2	0.6	2	A	0.8	1.2	0.8	-25670	731		0	697		701	0	0	7	12			2014-12-29	MALE	178	Alcohol consumption|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	120	8.3	11.5	NO	NO	G2	Liver	Intrahepatic Recurrence		No	NO	YES	No	true	No	MX	N0	T1	Stage I	TCGA-2Y-A9H9.36C343AC-443B-4196-8B6D-7D9213F2DAE1.pdf	A9H9	WITH TUMOR	203	143	382	NO	NO	11	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	2Y	1.3	Liver		A		LIVING	88	2011	TCGA-2Y-A9H9-01A-21D-A38W-01	TCGA-2Y-A9H9-01A-21D-A38W-01	TCGA-2Y-A9H9-01A-21D-A38X-10	TCGA-2Y-A9H9-01	TCGA-2Y-A9H9-01		946a3961-1616-4f45-a10a-2c6778491fb9		TCGA-2Y-A9H9-01	TCGA-2Y-A9H9-01	946a3961-1616-4f45-a10a-2c6778491fb9		946a3961-1616-4f45-a10a-2c6778491fb9	946a3961-1616-4f45-a10a-2c6778491fb9		TCGA-2Y-A9H9-01A-21D-A39G-05
TCGA-2Y-A9HA-01	1	TCGA-2Y-A9HA-01	36	1	days	TCGA-2Y-A9HA	36	0	days	36	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	70	3.5	3.5	5		TCGA-2Y-A9HA	TCGA-2Y-A9HA-01A	0.2	0.6		A	0.8	1.5	0.8	-25892	713	36	0				0	0	7	114	3,4 - Fibrous Speta		2014-11-3	MALE	169	Alcohol consumption|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	90	8.3	11.5	NO		G2						NO		true	No	MX	NX	T2	Stage II	TCGA-2Y-A9HA.C07BBEDC-59CE-41B9-9D47-EDFD8AEB26B9.pdf	A9HA	WITH TUMOR	153	143	382	YES	NO	10.6	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	2Y	1.3	Liver		A	Hepatitis  C Antibody	DECEASED	69	2012	TCGA-2Y-A9HA-01A-11D-A38W-01	TCGA-2Y-A9HA-01A-11D-A38W-01	TCGA-2Y-A9HA-01A-11D-A38X-10	TCGA-2Y-A9HA-01	TCGA-2Y-A9HA-01		8a5081d6-358e-4e94-a794-5d9fcdf467fb		TCGA-2Y-A9HA-01	TCGA-2Y-A9HA-01	8a5081d6-358e-4e94-a794-5d9fcdf467fb		8a5081d6-358e-4e94-a794-5d9fcdf467fb	8a5081d6-358e-4e94-a794-5d9fcdf467fb		TCGA-2Y-A9HA-01A-11D-A39G-05
TCGA-2Y-A9HB-01	0	TCGA-2Y-A9HB-01	260	0	days	TCGA-2Y-A9HB	260	0	days	260	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	66	3.5	3.9	5	TCGA-2Y-A9HB-F69098	TCGA-2Y-A9HB		0.2	0.6			0.8	1.5	0.8	-24359			0	260			0	0	7	21			2014-12-29	MALE	167	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.3	11.5		YES	G2						NO			No	MX	NX	T1	Stage I		A9HB	TUMOR FREE	124	143	382	NO	NO	11.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	2Y	1.3	Liver	None		Hepatitis C Virus R|HCV Genotype	LIVING	74	2012	TCGA-2Y-A9HB-01A-11D-A38W-01	TCGA-2Y-A9HB-01A-11D-A38W-01	TCGA-2Y-A9HB-01A-11D-A38X-10	TCGA-2Y-A9HB-01	TCGA-2Y-A9HB-01		fca9f607-7939-4f89-bf60-785f6e848c24		TCGA-2Y-A9HB-01	TCGA-2Y-A9HB-01	fca9f607-7939-4f89-bf60-785f6e848c24		fca9f607-7939-4f89-bf60-785f6e848c24	fca9f607-7939-4f89-bf60-785f6e848c24		TCGA-2Y-A9HB-01A-11D-A39G-05
TCGA-3K-AAZ8-01	0	TCGA-3K-AAZ8-01	396	0	days	TCGA-3K-AAZ8	304	1	days	396	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		65				TCGA-3K-AAZ8-F69330	TCGA-3K-AAZ8									-24046			0	396		304					5 - Nodular Formation and Incomplete Cirrhosis		2015-1-5	MALE	172	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES					NO	G1	Liver	Locoregional Recurrence		No	NO	YES	No		No	MX	NX	T3b	Stage IIIB		AAZ8	WITH TUMOR				NO	YES		NO	NO		RX	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	3K		Liver				LIVING	84	2013	TCGA-3K-AAZ8-01A-12D-A38W-01	TCGA-3K-AAZ8-01A-12D-A38W-01	TCGA-3K-AAZ8-01A-12D-A38X-10	TCGA-3K-AAZ8-01	TCGA-3K-AAZ8-01		ab14829c-defd-41b9-b35d-2876049cb46b		TCGA-3K-AAZ8-01	TCGA-3K-AAZ8-01	ab14829c-defd-41b9-b35d-2876049cb46b		ab14829c-defd-41b9-b35d-2876049cb46b	ab14829c-defd-41b9-b35d-2876049cb46b		TCGA-3K-AAZ8-01A-12D-A39G-05
TCGA-4R-AA8I-01	1	TCGA-4R-AA8I-01	262	1	days	TCGA-4R-AA8I	247	1	days	262	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	66	3.5	3.8	4.8	TCGA-4R-AA8I-F67448	TCGA-4R-AA8I		0.4	1.2		A	0.6	1.3	0.7	-24279		262	0	216		247	1	0	9	5	6 - Established Cirrhosis		2014-11-5	MALE	171	Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.8	1.1		NO	G2	Liver	Locoregional Recurrence			NO	YES	No		Yes	MX	NX	T2	Stage II		AA8I	WITH TUMOR	96	150	450	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	4R	1.5	Liver	Micro		Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	103	2013	TCGA-4R-AA8I-01A-11D-A381-01	TCGA-4R-AA8I-01A-11D-A381-01	TCGA-4R-AA8I-01A-11D-A382-10	TCGA-4R-AA8I-01	TCGA-4R-AA8I-01		da85d30e-2db7-45eb-8a28-6416c0e07b1f		TCGA-4R-AA8I-01	TCGA-4R-AA8I-01	da85d30e-2db7-45eb-8a28-6416c0e07b1f		da85d30e-2db7-45eb-8a28-6416c0e07b1f	da85d30e-2db7-45eb-8a28-6416c0e07b1f		TCGA-4R-AA8I-01A-11D-A383-05
TCGA-5C-A9VG-01	0	TCGA-5C-A9VG-01	328	0	days	TCGA-5C-A9VG	328	0	days	328	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	58				TCGA-5C-A9VG-F68936	TCGA-5C-A9VG					A				-21273			0	328			0						2014-12-23	MALE	170	Other	Worker at steel factory	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES					NO	G2						NO			No	M0	N0	T2	Stage II		A9VG	TUMOR FREE				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	5C		Liver	Micro			LIVING	73	2013	TCGA-5C-A9VG-01A-11D-A36W-01	TCGA-5C-A9VG-01A-11D-A36W-01	TCGA-5C-A9VG-01A-11D-A36X-10	TCGA-5C-A9VG-01	TCGA-5C-A9VG-01		c0c2c272-ac73-445e-85a9-d7ba6ff53391		TCGA-5C-A9VG-01	TCGA-5C-A9VG-01	c0c2c272-ac73-445e-85a9-d7ba6ff53391		c0c2c272-ac73-445e-85a9-d7ba6ff53391	c0c2c272-ac73-445e-85a9-d7ba6ff53391		TCGA-5C-A9VG-01A-11D-A36Y-05
TCGA-5C-A9VH-01	0	TCGA-5C-A9VH-01	322	0	days	TCGA-5C-A9VH	322	0	days	322	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	70				TCGA-5C-A9VH-F68937	TCGA-5C-A9VH	TCGA-5C-A9VH-01A				A				-25608	127		0	322			0						2014-12-23	MALE	165	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	90			NO	NO	G2						NO		true	No	M0	N0	T1	Stage I	TCGA-5C-A9VH.938BCE76-BF7D-4470-A409-805FD012D05D.pdf	A9VH	TUMOR FREE				NO	NO		NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	5C		Liver	None	A		LIVING	69	2013	TCGA-5C-A9VH-01A-11D-A36W-01	TCGA-5C-A9VH-01A-11D-A36W-01	TCGA-5C-A9VH-01A-11D-A36X-10	TCGA-5C-A9VH-01	TCGA-5C-A9VH-01		859c895b-14f8-4155-9b35-bf6e7abb2c5d		TCGA-5C-A9VH-01	TCGA-5C-A9VH-01	859c895b-14f8-4155-9b35-bf6e7abb2c5d		859c895b-14f8-4155-9b35-bf6e7abb2c5d	859c895b-14f8-4155-9b35-bf6e7abb2c5d		TCGA-5C-A9VH-01A-11D-A36Y-05
TCGA-5C-AAPD-01	0	TCGA-5C-AAPD-01	20	0	days	TCGA-5C-AAPD	20	0	days	20	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	61				TCGA-5C-AAPD-F68938	TCGA-5C-AAPD	TCGA-5C-AAPD-01A				A				-22552	55		0	20			1						2014-12-23	MALE	172	Hepatitis B		Hepatocholangiocarcinoma (Mixed)	No	C22.0	8180/3	C22.0	YES	140			NO	NO	G1						NO		true	No	M0	N0	T2	Stage II	TCGA-5C-AAPD.E4DB31C4-89F3-4D8D-A32E-B42C599904E1.pdf	AAPD	TUMOR FREE				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	5C		Liver	None	A	HBV Surface Antibody	LIVING	69	2013	TCGA-5C-AAPD-01A-21D-A38W-01	TCGA-5C-AAPD-01A-21D-A38W-01	TCGA-5C-AAPD-01A-21D-A38X-10	TCGA-5C-AAPD-01	TCGA-5C-AAPD-01		4aced91c-f8c4-4eb7-8911-4924c1ffcd99		TCGA-5C-AAPD-01	TCGA-5C-AAPD-01	4aced91c-f8c4-4eb7-8911-4924c1ffcd99		4aced91c-f8c4-4eb7-8911-4924c1ffcd99	4aced91c-f8c4-4eb7-8911-4924c1ffcd99		TCGA-5C-AAPD-01A-21D-A39G-05
TCGA-5R-AA1C-01	0	TCGA-5R-AA1C-01	520	0	days	TCGA-5R-AA1C	520	0	days	520	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	57	3.2	3.0	4.6	TCGA-5R-AA1C-F72055	TCGA-5R-AA1C	TCGA-5R-AA1C-01A	0	1.8		B	0.5	1.3	1.0	-21073	60		0	520			1	0	15	2	1,2 - Portal Fibrosis		2015-4-6	MALE	174	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	750	11	15	NO	NO	G2						NO		false	No	M0	N0	T2	Stage II	TCGA-5R-AA1C.AF0BACCE-3975-4E9F-9272-404229EC77C9.pdf	AA1C	TUMOR FREE	223000	150000	450000	NO	NO	18	NO	NO		R0	Primary Tumor	01	Extended Lobectomy	7th	YES	NO	5R	1.2	Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	90	2013	TCGA-5R-AA1C-01A-11D-A40Q-01	TCGA-5R-AA1C-01A-11D-A40Q-01	TCGA-5R-AA1C-01A-11D-A40R-10	TCGA-5R-AA1C-01	TCGA-5R-AA1C-01		55844917-3a31-4f8b-a955-14ca0f139368		TCGA-5R-AA1C-01	TCGA-5R-AA1C-01	55844917-3a31-4f8b-a955-14ca0f139368		55844917-3a31-4f8b-a955-14ca0f139368	55844917-3a31-4f8b-a955-14ca0f139368		TCGA-5R-AA1C-01A-11D-A40S-05
TCGA-5R-AA1D-01	0	TCGA-5R-AA1D-01	449	0	days	TCGA-5R-AA1D	449	0	days	449	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	17	3.2	3.3	4.6	TCGA-5R-AA1D-F70155	TCGA-5R-AA1D		0	0.5		B	0.5	1.3	0.7	-6545			0	449			1	0	15	5	0 - No Fibrosis		2015-1-28	FEMALE	161	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		11	15		NO	G3						NO			No	M0	N0	T3a	Stage IIIA		AA1D	TUMOR FREE	333000	150000	450000	NO	NO	19	YES	NO		R0	Primary Tumor	01	Extended Lobectomy	7th	YES	NO	5R	1.2	Liver	Micro		Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	59	2013	TCGA-5R-AA1D-01A-11D-A381-01	TCGA-5R-AA1D-01A-11D-A381-01	TCGA-5R-AA1D-01A-11D-A382-10	TCGA-5R-AA1D-01	TCGA-5R-AA1D-01		cd5cb20c-a12b-44e2-8ebc-874b1296758b		TCGA-5R-AA1D-01	TCGA-5R-AA1D-01	cd5cb20c-a12b-44e2-8ebc-874b1296758b		cd5cb20c-a12b-44e2-8ebc-874b1296758b	cd5cb20c-a12b-44e2-8ebc-874b1296758b		TCGA-5R-AA1D-01A-11D-A383-05
TCGA-5R-AAAM-01	1	TCGA-5R-AAAM-01	46	1	days	TCGA-5R-AAAM	46	0	days	46	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Severe	65	3.2	3.0	4.6		TCGA-5R-AAAM	TCGA-5R-AAAM-01A	0	0.6		A	0.5	1.3	0.7	-24020	35	46	0				1	0	15	32	6 - Established Cirrhosis		2014-11-14	FEMALE	163	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	730	11	15	NO		G2						NO		true	No	M0	N0	T2	Stage II	TCGA-5R-AAAM.B07C5DBA-634E-4028-A32D-61FE7445BDEE.pdf	AAAM	TUMOR FREE	68000	150000	450000	NO	NO		NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	5R	1.2	Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	80	2013	TCGA-5R-AAAM-01A-12D-A40Q-01	TCGA-5R-AAAM-01A-12D-A40Q-01	TCGA-5R-AAAM-01A-12D-A40R-10	TCGA-5R-AAAM-01	TCGA-5R-AAAM-01		9bfa35f8-31cf-4644-b860-b7aba3de3e5d		TCGA-5R-AAAM-01	TCGA-5R-AAAM-01	9bfa35f8-31cf-4644-b860-b7aba3de3e5d		9bfa35f8-31cf-4644-b860-b7aba3de3e5d	9bfa35f8-31cf-4644-b860-b7aba3de3e5d		TCGA-5R-AAAM-01A-12D-A40S-05
TCGA-BC-4072-01	1	TCGA-BC-4072-01	1490	1	days	TCGA-BC-4072	475	1	days	1490	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		74	3.5	4.4	5.0	TCGA-BC-4072-F6875	TCGA-BC-4072	TCGA-BC-4072-01B	0	.5	7		.7	1.1	1	-27162	2256	1490	0			475							2010-12-20	FEMALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	270			NO		G3	Lymph Node(s)	Extrahepatic Recurrence		No	NO	YES		false	No	M0	N0	T3	Stage IIIA	TCGA-BC-4072.CF0E1E81-A89B-4D33-A02E-C77DAE5E8E30.pdf	4072	WITH TUMOR	268	150	440	NO	NO	1	NO	YES		R1	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	BC	1.2	Liver	Macro	B		DECEASED		2005	TCGA-BC-4072-01B-11D-A151-01	TCGA-BC-4072-01B-11D-A151-01		TCGA-BC-4072-01	TCGA-BC-4072-01	6A51966A-B269-41D9-94AF-B46475CDB7A4	091c332c-1596-4db6-88e7-e40ef85f15dd		TCGA-BC-4072-01	TCGA-BC-4072-01	091c332c-1596-4db6-88e7-e40ef85f15dd		091c332c-1596-4db6-88e7-e40ef85f15dd	091c332c-1596-4db6-88e7-e40ef85f15dd		TCGA-BC-4072-01B-11D-A153-05
TCGA-BC-4073-01	0	TCGA-BC-4073-01	849	0	days	TCGA-BC-4073	849	0	days	849	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				73				TCGA-BC-4073-F30829	TCGA-BC-4073	TCGA-BC-4073-01B	0.0	0.7	3		0.7	1.3	1.5	-26795	398		0	849			0					Scheduled Follow-up Submission	2012-4-17	MALE		Hemochromatosis		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	230			NO		G3						NO		true	No	MX	N0	T3	Stage IIIA	TCGA-BC-4073.1C53BF2E-0AA8-477F-8281-63455E0D36E2.pdf	4073	WITH TUMOR	253	150	440	NO	NO	1.0	NO	YES		R1	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	BC	1.2	Liver	Macro	B		LIVING		2009	TCGA-BC-4073-01B-02D-A12Y-01	TCGA-BC-4073-01B-02D-A12Y-01	TCGA-BC-4073-01B-02D-A12Z-10	TCGA-BC-4073-01	TCGA-BC-4073-01		8b3062fd-dd51-4bc0-a858-6783b3b5fe08	TCGA-BC-4073-01B-02D-A12Z-10	TCGA-BC-4073-01	TCGA-BC-4073-01	8b3062fd-dd51-4bc0-a858-6783b3b5fe08	TCGA-BC-4073-01B-02D-A12Z-10	8b3062fd-dd51-4bc0-a858-6783b3b5fe08	8b3062fd-dd51-4bc0-a858-6783b3b5fe08	TCGA-BC-4073-01B-02D-A12Z-10	TCGA-BC-4073-01B-02D-A132-05
TCGA-BC-A10Q-01	1	TCGA-BC-A10Q-01	1135	1	days	TCGA-BC-A10Q	340	1	days	1135	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO		72	3.5	4.1	5.0	TCGA-BC-A10Q-F9852	TCGA-BC-A10Q	TCGA-BC-A10Q-01A		.5	1		0.7	1.1	0.6	-26400	4437	1135	0			340							2011-4-1	FEMALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	340			NO				Intrahepatic Recurrence		No	NO	YES		false	No	MX	NX	T2		TCGA-BC-A10Q.10117C34-85C2-49DE-B2AD-F8D0D4570DA9.pdf	A10Q	WITH TUMOR	287000	150	440	YES	YES	0.9	NO	YES		R1	Primary Tumor	01	Extended Lobectomy	5th	NO	YES	BC		Liver	None	A		DECEASED		1998	TCGA-BC-A10Q-01A-11D-A12Y-01	TCGA-BC-A10Q-01A-11D-A12Y-01	TCGA-BC-A10Q-01A-11D-A12Z-10	TCGA-BC-A10Q-01	TCGA-BC-A10Q-01	A21E10AF-3D45-45A0-B2E4-14BC5FA33FA5	19c97e3d-f5af-4301-92f4-be8ac9e27427	TCGA-BC-A10Q-01A-11D-A12Z-10	TCGA-BC-A10Q-01	TCGA-BC-A10Q-01	19c97e3d-f5af-4301-92f4-be8ac9e27427	TCGA-BC-A10Q-01A-11D-A12Z-10	19c97e3d-f5af-4301-92f4-be8ac9e27427	19c97e3d-f5af-4301-92f4-be8ac9e27427	TCGA-BC-A10Q-01A-11D-A12Z-10	TCGA-BC-A10Q-01A-11D-A132-05
TCGA-BC-A10Q-11	1	TCGA-BC-A10Q-11	1135	1	days	TCGA-BC-A10Q	340	1	days	1135	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO		72	3.5	4.1	5.0	TCGA-BC-A10Q-F9852	TCGA-BC-A10Q	TCGA-BC-A10Q-11A		.5	1		0.7	1.1	0.6	-26400	4437	1135	0			340							2011-4-1	FEMALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	340			NO				Intrahepatic Recurrence		No	NO	YES		false	No	MX	NX	T2			A10Q	WITH TUMOR	287000	150	440	YES	YES	0.9	NO	YES		R1	Solid Tissue Normal	11	Extended Lobectomy	5th	NO	YES	BC		Liver	None	A		DECEASED		1998				TCGA-BC-A10Q-11			469f052a-477e-498a-ba3b-f288dcbc306f		TCGA-BC-A10Q-11		469f052a-477e-498a-ba3b-f288dcbc306f		469f052a-477e-498a-ba3b-f288dcbc306f	469f052a-477e-498a-ba3b-f288dcbc306f		TCGA-BC-A10Q-11A-11D-A132-05
TCGA-BC-A10R-01	1	TCGA-BC-A10R-01	308	1	days	TCGA-BC-A10R	199	1	days	308	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	Mild	66		4.0		TCGA-BC-A10R-F9867	TCGA-BC-A10R	TCGA-BC-A10R-01A			1		0.7	1.1	0.7	-24274	4316	308	0			199				27			2011-4-1	FEMALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	180			NO		G2		Intrahepatic Recurrence		Yes	NO	YES	No	false	No	MX	NX	T3		TCGA-BC-A10R.65BE2C95-CADA-44FC-9313-14529AFF773E.pdf	A10R	WITH TUMOR	209000	150	440	NO	NO	0.9	NO	YES		R0	Primary Tumor	01	Lobectomy	5th	NO	YES	BC		Liver	Micro	A		DECEASED		1999	TCGA-BC-A10R-01A-11D-A12Y-01	TCGA-BC-A10R-01A-11D-A12Y-01	TCGA-BC-A10R-01A-11D-A12Z-10	TCGA-BC-A10R-01	TCGA-BC-A10R-01	E9E08287-5807-4E84-B5A8-59DE0295A4E2	d6cb14d4-1ee1-4d83-ad3f-efa19969c00f	TCGA-BC-A10R-01A-11D-A12Z-10	TCGA-BC-A10R-01	TCGA-BC-A10R-01	d6cb14d4-1ee1-4d83-ad3f-efa19969c00f	TCGA-BC-A10R-01A-11D-A12Z-10	d6cb14d4-1ee1-4d83-ad3f-efa19969c00f	d6cb14d4-1ee1-4d83-ad3f-efa19969c00f	TCGA-BC-A10R-01A-11D-A12Z-10	TCGA-BC-A10R-01A-11D-A132-05
TCGA-BC-A10R-11	1	TCGA-BC-A10R-11	308	1	days	TCGA-BC-A10R	199	1	days	308	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	Mild	66		4.0		TCGA-BC-A10R-F9867	TCGA-BC-A10R	TCGA-BC-A10R-11A			1		0.7	1.1	0.7	-24274	4316	308	0			199				27			2011-4-1	FEMALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1620			NO		G2		Intrahepatic Recurrence		Yes	NO	YES	No	false	No	MX	NX	T3			A10R	WITH TUMOR	209000	150	440	NO	NO	0.9	NO	YES		R0	Solid Tissue Normal	11	Lobectomy	5th	NO	YES	BC		Liver	Micro	A		DECEASED		1999				TCGA-BC-A10R-11			4d49b039-f1fa-4892-8439-4155e72dd7c5		TCGA-BC-A10R-11		4d49b039-f1fa-4892-8439-4155e72dd7c5		4d49b039-f1fa-4892-8439-4155e72dd7c5	4d49b039-f1fa-4892-8439-4155e72dd7c5		TCGA-BC-A10R-11A-11D-A132-05
TCGA-BC-A10S-01	1	TCGA-BC-A10S-01	1423	1	days	TCGA-BC-A10S	1130	1	days	1423	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	81		3.6		TCGA-BC-A10S-F9875	TCGA-BC-A10S	TCGA-BC-A10S-01A		0.6						-29842	4284	1423	0			1130							2011-4-1	MALE		Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	550			NO		G1		Intrahepatic Recurrence		No	NO	YES	No	false	No	MX	NX	T3		TCGA-BC-A10S.A0F69833-CBDD-492D-9564-AE8FB2F9CE3B.pdf	A10S	WITH TUMOR	217000	150	440	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	5th	NO	YES	BC		Liver	Micro	A		DECEASED	74	1999	TCGA-BC-A10S-01A-22D-A12Y-01	TCGA-BC-A10S-01A-22D-A12Y-01		TCGA-BC-A10S-01	TCGA-BC-A10S-01	C13F11E1-2E92-4548-B41E-EA189E440DDE	68f75980-9246-46b2-82d2-41abd9a72998	TCGA-BC-A10S-01A-22D-A12Z-10	TCGA-BC-A10S-01	TCGA-BC-A10S-01	68f75980-9246-46b2-82d2-41abd9a72998	TCGA-BC-A10S-01A-22D-A12Z-10	68f75980-9246-46b2-82d2-41abd9a72998	68f75980-9246-46b2-82d2-41abd9a72998	TCGA-BC-A10S-01A-22D-A12Z-10	TCGA-BC-A10S-01A-22D-A132-05
TCGA-BC-A10S-11	1	TCGA-BC-A10S-11	1423	1	days	TCGA-BC-A10S	1130	1	days	1423	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	81		3.6		TCGA-BC-A10S-F9875	TCGA-BC-A10S	TCGA-BC-A10S-11A		0.6						-29842	4284	1423	0			1130							2011-4-1	MALE		Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	680			NO		G1		Intrahepatic Recurrence		No	NO	YES	No	false	No	MX	NX	T3			A10S	WITH TUMOR	217000	150	440	NO	NO	1.1	NO	NO		R0	Solid Tissue Normal	11	Segmentectomy, Multiple	5th	NO	YES	BC		Liver	Micro	A		DECEASED	74	1999																TCGA-BC-A10S-11A-11D-A132-05
TCGA-BC-A10T-01	1	TCGA-BC-A10T-01	837	1	days	TCGA-BC-A10T	598	1	days	837	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		76		3.0		TCGA-BC-A10T-F9882	TCGA-BC-A10T	TCGA-BC-A10T-01A		0.7					1.2	-27944	3660	837	0			598					1,2 - Portal Fibrosis		2011-4-1	MALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1000			NO		G1	Pulmonary	Extrahepatic Recurrence		No	NO	YES	No	false	No	MX	NX	T4		TCGA-BC-A10T.D8103C33-F303-4D97-81AF-CC3D06E79285.pdf	A10T	WITH TUMOR	450000	150	440	NO	NO	1.1	NO	NO		R1	Primary Tumor	01	Other (specify)	5th	NO	YES	BC		Liver	None	A		DECEASED	86	2000	TCGA-BC-A10T-01A-11D-A12Y-01	TCGA-BC-A10T-01A-11D-A12Y-01	TCGA-BC-A10T-01A-11D-A12Z-10	TCGA-BC-A10T-01	TCGA-BC-A10T-01	52FB12B7-8108-4EE8-AA7A-409225D0702A	a4afd001-11fa-4bce-8766-b60b54566fcd	TCGA-BC-A10T-01A-11D-A12Z-10	TCGA-BC-A10T-01	TCGA-BC-A10T-01	a4afd001-11fa-4bce-8766-b60b54566fcd	TCGA-BC-A10T-01A-11D-A12Z-10	a4afd001-11fa-4bce-8766-b60b54566fcd	a4afd001-11fa-4bce-8766-b60b54566fcd	TCGA-BC-A10T-01A-11D-A12Z-10	TCGA-BC-A10T-01A-11D-A132-05
TCGA-BC-A10T-11	1	TCGA-BC-A10T-11	837	1	days	TCGA-BC-A10T	598	1	days	837	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		76		3.0		TCGA-BC-A10T-F9882	TCGA-BC-A10T	TCGA-BC-A10T-11A		0.7					1.2	-27944	3660	837	0			598					1,2 - Portal Fibrosis		2011-4-1	MALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	480			NO		G1	Pulmonary	Extrahepatic Recurrence		No	NO	YES	No	false	No	MX	NX	T4			A10T	WITH TUMOR	450000	150	440	NO	NO	1.1	NO	NO		R1	Solid Tissue Normal	11	Other (specify)	5th	NO	YES	BC		Liver	None	A		DECEASED	86	2000				TCGA-BC-A10T-11			3497c0d8-c7b0-43ca-92a2-30ea6cd61bde		TCGA-BC-A10T-11		3497c0d8-c7b0-43ca-92a2-30ea6cd61bde		3497c0d8-c7b0-43ca-92a2-30ea6cd61bde	3497c0d8-c7b0-43ca-92a2-30ea6cd61bde		TCGA-BC-A10T-11A-11D-A132-05
TCGA-BC-A10U-01	1	TCGA-BC-A10U-01	837	1	days	TCGA-BC-A10U	586	1	days	837	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		69	3.5	4.3	5.0	TCGA-BC-A10U-F9923	TCGA-BC-A10U	TCGA-BC-A10U-01A	0.0	0.4	4		0.8	1.4	0.9	-25305	3645	837	0			586				38			2011-4-4	MALE		Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	510			NO		G2		Intrahepatic Recurrence		Yes	NO	YES	No	false	No	MX	NX	T2		TCGA-BC-A10U.57EB75F3-6F48-4CFB-86CF-F694C390C86A.pdf	A10U	WITH TUMOR	204000	150	440	NO	NO	1.1	NO	YES		R1	Primary Tumor	01	Lobectomy	5th	NO	YES	BC	1.2	Liver		A		DECEASED		2000	TCGA-BC-A10U-01A-11D-A12Y-01	TCGA-BC-A10U-01A-11D-A12Y-01	TCGA-BC-A10U-01A-11D-A12Z-10	TCGA-BC-A10U-01	TCGA-BC-A10U-01	DFCC1105-AC9E-4DD6-944A-CB6F4FE4EA3C	45684bfb-a8c1-4224-a632-a93aa7f70b47	TCGA-BC-A10U-01A-11D-A12Z-10	TCGA-BC-A10U-01	TCGA-BC-A10U-01	45684bfb-a8c1-4224-a632-a93aa7f70b47	TCGA-BC-A10U-01A-11D-A12Z-10	45684bfb-a8c1-4224-a632-a93aa7f70b47	45684bfb-a8c1-4224-a632-a93aa7f70b47	TCGA-BC-A10U-01A-11D-A12Z-10	TCGA-BC-A10U-01A-11D-A132-05
TCGA-BC-A10U-11	1	TCGA-BC-A10U-11	837	1	days	TCGA-BC-A10U	586	1	days	837	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		69	3.5	4.3	5.0	TCGA-BC-A10U-F9923	TCGA-BC-A10U	TCGA-BC-A10U-11A	0.0	0.4	4		0.8	1.4	0.9	-25305	3645	837	0			586				38			2011-4-4	MALE		Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1130			NO		G2		Intrahepatic Recurrence		Yes	NO	YES	No	false	No	MX	NX	T2			A10U	WITH TUMOR	204000	150	440	NO	NO	1.1	NO	YES		R1	Solid Tissue Normal	11	Lobectomy	5th	NO	YES	BC	1.2	Liver		A		DECEASED		2000				TCGA-BC-A10U-11			1c2972fc-456c-4567-be96-bde9d39a0b76		TCGA-BC-A10U-11		1c2972fc-456c-4567-be96-bde9d39a0b76		1c2972fc-456c-4567-be96-bde9d39a0b76	1c2972fc-456c-4567-be96-bde9d39a0b76		TCGA-BC-A10U-11A-11D-A132-05
TCGA-BC-A10W-01	1	TCGA-BC-A10W-01	91	1	days	TCGA-BC-A10W	91	0	days	91	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				50	3.5	2.8	5.0	TCGA-BC-A10W-F9925	TCGA-BC-A10W	TCGA-BC-A10W-01A	0.0	1.4	1		0.8	1.4	0.8	-18562	3100	91	0							79			2011-4-4	MALE		Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	460			NO		G3		No New Tumor Event				NO		false	No	MX	NX	T4		TCGA-BC-A10W.A7F79765-5038-47AA-87B0-40E2D802E535.pdf	A10W	WITH TUMOR	401	150	440	NO	YES	0.9	NO	YES		R1	Primary Tumor	01	Lobectomy	5th	NO	YES	BC	1.2	Liver		A	Hepatitis B Surface Antigen	DECEASED	71	2002	TCGA-BC-A10W-01A-11D-A12Y-01	TCGA-BC-A10W-01A-11D-A12Y-01	TCGA-BC-A10W-01A-11D-A12Z-10	TCGA-BC-A10W-01	TCGA-BC-A10W-01	2F3ED728-EF5C-4987-A0FA-052947A658D3	affaf79d-f5a4-45a3-9cbf-181c473a8b2a	TCGA-BC-A10W-01A-11D-A12Z-10	TCGA-BC-A10W-01	TCGA-BC-A10W-01	affaf79d-f5a4-45a3-9cbf-181c473a8b2a	TCGA-BC-A10W-01A-11D-A12Z-10	affaf79d-f5a4-45a3-9cbf-181c473a8b2a	affaf79d-f5a4-45a3-9cbf-181c473a8b2a	TCGA-BC-A10W-01A-11D-A12Z-10	TCGA-BC-A10W-01A-11D-A132-05
TCGA-BC-A10W-11	1	TCGA-BC-A10W-11	91	1	days	TCGA-BC-A10W	91	0	days	91	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				50	3.5	2.8	5.0	TCGA-BC-A10W-F9925	TCGA-BC-A10W	TCGA-BC-A10W-11A	0.0	1.4	1		0.8	1.4	0.8	-18562	3100	91	0							79			2011-4-4	MALE		Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	390			NO		G3		No New Tumor Event				NO		false	No	MX	NX	T4			A10W	WITH TUMOR	401	150	440	NO	YES	0.9	NO	YES		R1	Solid Tissue Normal	11	Lobectomy	5th	NO	YES	BC	1.2	Liver		A	Hepatitis B Surface Antigen	DECEASED	71	2002				TCGA-BC-A10W-11			2436079d-3e40-4c50-9f99-85d4a8c2ddac		TCGA-BC-A10W-11		2436079d-3e40-4c50-9f99-85d4a8c2ddac		2436079d-3e40-4c50-9f99-85d4a8c2ddac	2436079d-3e40-4c50-9f99-85d4a8c2ddac		TCGA-BC-A10W-11A-11D-A132-05
TCGA-BC-A10X-01	1	TCGA-BC-A10X-01	770	1	days	TCGA-BC-A10X	770	0	days	770	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	52	3.5	3.6	5.0	TCGA-BC-A10X-F9946	TCGA-BC-A10X	TCGA-BC-A10X-01A	0.0	0.3	2		0.7	1.1	0.7	-19140	3080	770	0							264			2011-4-4	FEMALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	520			NO		G2		No New Tumor Event				NO		false	No	MX	N0	T3a	Stage IIIA	TCGA-BC-A10X.671F5D97-36F3-40BA-9E28-1B65B21EF3D4.pdf	A10X	TUMOR FREE	602	150	440	NO	NO	1.0	NO	YES		R0	Primary Tumor	01	Lobectomy	5th	NO	YES	BC	1.2	Liver	Micro	A		DECEASED	65	2002	TCGA-BC-A10X-01A-11D-A12Y-01	TCGA-BC-A10X-01A-11D-A12Y-01	TCGA-BC-A10X-01A-11D-A12Z-10	TCGA-BC-A10X-01	TCGA-BC-A10X-01	586E5071-D93B-4D0D-B732-999FC8995A4A	92c0e4e0-e7a5-486b-82f9-ba7621a10b83	TCGA-BC-A10X-01A-11D-A12Z-10	TCGA-BC-A10X-01	TCGA-BC-A10X-01	92c0e4e0-e7a5-486b-82f9-ba7621a10b83	TCGA-BC-A10X-01A-11D-A12Z-10	92c0e4e0-e7a5-486b-82f9-ba7621a10b83	92c0e4e0-e7a5-486b-82f9-ba7621a10b83	TCGA-BC-A10X-01A-11D-A12Z-10	TCGA-BC-A10X-01A-11D-A132-05
TCGA-BC-A10X-11	1	TCGA-BC-A10X-11	770	1	days	TCGA-BC-A10X	770	0	days	770	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	52	3.5	3.6	5.0	TCGA-BC-A10X-F9946	TCGA-BC-A10X	TCGA-BC-A10X-11A	0.0	0.3	2		0.7	1.1	0.7	-19140	3080	770	0							264			2011-4-4	FEMALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	430			NO		G2		No New Tumor Event				NO		false	No	MX	N0	T3a	Stage IIIA		A10X	TUMOR FREE	602	150	440	NO	NO	1.0	NO	YES		R0	Solid Tissue Normal	11	Lobectomy	5th	NO	YES	BC	1.2	Liver	Micro	A		DECEASED	65	2002				TCGA-BC-A10X-11			608bf540-a094-441e-9329-9e759ff5d84d		TCGA-BC-A10X-11		608bf540-a094-441e-9329-9e759ff5d84d		608bf540-a094-441e-9329-9e759ff5d84d	608bf540-a094-441e-9329-9e759ff5d84d		TCGA-BC-A10X-11A-11D-A132-05
TCGA-BC-A10Y-01	1	TCGA-BC-A10Y-01	711	1	days	TCGA-BC-A10Y	400	1	days	711	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	76	3.5	4.0	5.0	TCGA-BC-A10Y-F9958	TCGA-BC-A10Y	TCGA-BC-A10Y-01A	0.0	0.5			0.9	1.4	1.0	-28049	2961	711	0			400		0	10	10575			2011-4-4	MALE	175	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	340			NO		G3		Intrahepatic Recurrence		Yes	NO	YES	No	false	No	MX	NX	T4		TCGA-BC-A10Y.20CD1D6D-C4ED-43AD-9FCD-0A683FD96C6E.pdf	A10Y	WITH TUMOR	239	150	440	YES	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	5th	NO	YES	BC	1.2	Liver	Micro	A		DECEASED	77	2002	TCGA-BC-A10Y-01A-11D-A12Y-01	TCGA-BC-A10Y-01A-11D-A12Y-01	TCGA-BC-A10Y-01A-11D-A12Z-10	TCGA-BC-A10Y-01	TCGA-BC-A10Y-01	89EA706C-7252-4E64-9A4E-97F2E6744EE4	dd37c309-81f0-4d3d-863d-a16aa505e346	TCGA-BC-A10Y-01A-11D-A12Z-10	TCGA-BC-A10Y-01	TCGA-BC-A10Y-01	dd37c309-81f0-4d3d-863d-a16aa505e346	TCGA-BC-A10Y-01A-11D-A12Z-10	dd37c309-81f0-4d3d-863d-a16aa505e346	dd37c309-81f0-4d3d-863d-a16aa505e346	TCGA-BC-A10Y-01A-11D-A12Z-10	TCGA-BC-A10Y-01A-11D-A132-05
TCGA-BC-A10Y-11	1	TCGA-BC-A10Y-11	711	1	days	TCGA-BC-A10Y	400	1	days	711	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	76	3.5	4.0	5.0	TCGA-BC-A10Y-F9958	TCGA-BC-A10Y		0.0	0.5			0.9	1.4	1.0	-28049		711	0			400		0	10	10575			2011-4-4	MALE	175	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES						G3		Intrahepatic Recurrence		Yes	NO	YES	No		No	MX	NX	T4			A10Y	WITH TUMOR	239	150	440	YES	NO	1.0	NO	NO		R0	Solid Tissue Normal	11	Lobectomy	5th	NO	YES	BC	1.2	Liver	Micro			DECEASED	77	2002				TCGA-BC-A10Y-11			b8e62048-d0a6-4b0f-8e57-e406b783f698		TCGA-BC-A10Y-11		b8e62048-d0a6-4b0f-8e57-e406b783f698		b8e62048-d0a6-4b0f-8e57-e406b783f698	b8e62048-d0a6-4b0f-8e57-e406b783f698		TCGA-BC-A10Y-11A-11D-A132-05
TCGA-BC-A10Z-01	1	TCGA-BC-A10Z-01	34	1	days	TCGA-BC-A10Z	34	0	days	34	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	62	3.5	3.1	5.0	TCGA-BC-A10Z-F9962	TCGA-BC-A10Z	TCGA-BC-A10Z-01A	0.0	0.6	1		0.7	1.1	1.2	-22913	2652	34	0					0	10	779			2011-4-4	FEMALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	160			NO		G2		No New Tumor Event				NO		false	No	MX	N0	T1	Stage I	TCGA-BC-A10Z.427BA175-823D-4C68-B659-D53CFEB5EA45.pdf	A10Z	TUMOR FREE	260	150	440	NO	NO	0.9	NO	YES		R0	Primary Tumor	01	Extended Lobectomy	6th	NO	YES	BC	1.2	Liver	None	A		DECEASED	79	2003	TCGA-BC-A10Z-01A-11D-A12Y-01	TCGA-BC-A10Z-01A-11D-A12Y-01	TCGA-BC-A10Z-01A-11D-A12Z-10	TCGA-BC-A10Z-01	TCGA-BC-A10Z-01	9E0546BB-8A10-4B59-8083-5CD4F3FD6072	388a996e-0fb1-4274-905d-074ff0058d80	TCGA-BC-A10Z-01A-11D-A12Z-10	TCGA-BC-A10Z-01	TCGA-BC-A10Z-01	388a996e-0fb1-4274-905d-074ff0058d80	TCGA-BC-A10Z-01A-11D-A12Z-10	388a996e-0fb1-4274-905d-074ff0058d80	388a996e-0fb1-4274-905d-074ff0058d80	TCGA-BC-A10Z-01A-11D-A12Z-10	TCGA-BC-A10Z-01A-11D-A132-05
TCGA-BC-A10Z-11	1	TCGA-BC-A10Z-11	34	1	days	TCGA-BC-A10Z	34	0	days	34	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	62	3.5	3.1	5.0	TCGA-BC-A10Z-F9962	TCGA-BC-A10Z	TCGA-BC-A10Z-11A	0.0	0.6	1		0.7	1.1	1.2	-22913	2652	34	0					0	10	779			2011-4-4	FEMALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	160			NO		G2		No New Tumor Event				NO		false	No	MX	N0	T1	Stage I		A10Z	TUMOR FREE	260	150	440	NO	NO	0.9	NO	YES		R0	Solid Tissue Normal	11	Extended Lobectomy	6th	NO	YES	BC	1.2	Liver	None	A		DECEASED	79	2003				TCGA-BC-A10Z-11			07653b81-7194-4348-8ef9-1a7660c95376		TCGA-BC-A10Z-11		07653b81-7194-4348-8ef9-1a7660c95376		07653b81-7194-4348-8ef9-1a7660c95376	07653b81-7194-4348-8ef9-1a7660c95376		TCGA-BC-A10Z-11A-11D-A132-05
TCGA-BC-A110-01	1	TCGA-BC-A110-01	2116	1	days	TCGA-BC-A110	2057	1	days	2116	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		51	3.5	3.7	5.0	TCGA-BC-A110-F9979	TCGA-BC-A110	TCGA-BC-A110-01A	0.0	0.3	2		0.7	1.1	3.5	-18951	2629	2116	0			2057		0	10				2011-4-4	FEMALE	155	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	280			NO		G1	Other, specify	Extrahepatic Recurrence	spleen	No	NO	YES	No	false	Yes	MX	NX	T1		TCGA-BC-A110.DCC8DAE3-E0AF-4B37-8E5F-A2004ACA1F9B.pdf	A110	WITH TUMOR	288	150	440	NO	YES	0.9	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	BC	1.2	Liver	None	A		DECEASED	91	2003	TCGA-BC-A110-01A-11D-A12Y-01	TCGA-BC-A110-01A-11D-A12Y-01	TCGA-BC-A110-01A-11D-A12Z-10	TCGA-BC-A110-01	TCGA-BC-A110-01	202A1EE8-759B-4A19-BC8E-FEDD6EF80192	3f4ab9a7-3a43-4601-a21f-2ee63b10efee	TCGA-BC-A110-01A-11D-A12Z-10	TCGA-BC-A110-01	TCGA-BC-A110-01	3f4ab9a7-3a43-4601-a21f-2ee63b10efee	TCGA-BC-A110-01A-11D-A12Z-10	3f4ab9a7-3a43-4601-a21f-2ee63b10efee	3f4ab9a7-3a43-4601-a21f-2ee63b10efee	TCGA-BC-A110-01A-11D-A12Z-10	TCGA-BC-A110-01A-11D-A132-05
TCGA-BC-A110-11	1	TCGA-BC-A110-11	2116	1	days	TCGA-BC-A110	2057	1	days	2116	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		51	3.5	3.7	5.0	TCGA-BC-A110-F9979	TCGA-BC-A110		0.0	0.3	2		0.7	1.1	3.5	-18951		2116	0			2057		0	10				2011-4-4	FEMALE	155	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES						G1	Other, specify	Extrahepatic Recurrence	spleen	No	NO	YES	No		Yes	MX	NX	T1			A110	WITH TUMOR	288	150	440	NO	YES	0.9	NO	YES		R0	Solid Tissue Normal	11	Segmentectomy, Single	6th	NO	YES	BC	1.2	Liver	None			DECEASED	91	2003				TCGA-BC-A110-11			edcc32ad-1375-4502-822e-defcea52b943		TCGA-BC-A110-11		edcc32ad-1375-4502-822e-defcea52b943		edcc32ad-1375-4502-822e-defcea52b943	edcc32ad-1375-4502-822e-defcea52b943		TCGA-BC-A110-11A-11D-A132-05
TCGA-BC-A112-01	1	TCGA-BC-A112-01	153	1	days	TCGA-BC-A112	153	0	days	153	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				80	3.5	4.1	5.0	TCGA-BC-A112-F9980	TCGA-BC-A112		0.0	0.3			0.7	1.3	2.1	-29511		153	0					0	10	233	0 - No Fibrosis		2011-4-4	MALE	165	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES						G2		No New Tumor Event				NO			Yes	MX	NX	T3			A112	TUMOR FREE	218	150	440	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	BC	1.2	Liver	None			DECEASED	97	2009	TCGA-BC-A112-01A-11D-A12Y-01	TCGA-BC-A112-01A-11D-A12Y-01	TCGA-BC-A112-01A-11D-A12Z-10	TCGA-BC-A112-01	TCGA-BC-A112-01		f2b83833-c94a-4fc1-ae6a-7caf4f3a1353	TCGA-BC-A112-01A-11D-A12Z-10	TCGA-BC-A112-01	TCGA-BC-A112-01	f2b83833-c94a-4fc1-ae6a-7caf4f3a1353	TCGA-BC-A112-01A-11D-A12Z-10	f2b83833-c94a-4fc1-ae6a-7caf4f3a1353	f2b83833-c94a-4fc1-ae6a-7caf4f3a1353	TCGA-BC-A112-01A-11D-A12Z-10	TCGA-BC-A112-01A-11D-A132-05
TCGA-BC-A112-11	1	TCGA-BC-A112-11	153	1	days	TCGA-BC-A112	153	0	days	153	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				80	3.5	4.1	5.0	TCGA-BC-A112-F9980	TCGA-BC-A112	TCGA-BC-A112-11A	0.0	0.3			0.7	1.3	2.1	-29511	538	153	0					0	10	233	0 - No Fibrosis		2011-4-4	MALE	165	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	100			NO		G2		No New Tumor Event				NO		false	Yes	MX	NX	T3			A112	TUMOR FREE	218	150	440	NO	NO	1.1	NO	NO		R0	Solid Tissue Normal	11	Segmentectomy, Multiple	6th	NO	YES	BC	1.2	Liver	None	A		DECEASED	97	2009																TCGA-BC-A112-11A-11D-A132-05
TCGA-BC-A216-01	0	TCGA-BC-A216-01	1351	0	days	TCGA-BC-A216	1351	0	days	1351	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	62	3.5	3.4	5.0	TCGA-BC-A216-F22055	TCGA-BC-A216	TCGA-BC-A216-01A	0.0	0.6	2		0.5	1.5	0.9	-22968	1052		0	1351				0	8	831	0 - No Fibrosis	Scheduled Follow-up Submission	2012-2-23	FEMALE	164	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	100			NO		G2						NO		false	No	M0	NX	T3	Stage IIIA	TCGA-BC-A216.28CDABB8-3172-4676-8F4A-8B91F2B8D85F.pdf	A216	TUMOR FREE	211000	140000	440000	NO	NO	1.4	NO	YES		R0	Primary Tumor	01	Extended Lobectomy	6th	NO	YES	BC	1.5	Liver	None	A		LIVING	151	2008	TCGA-BC-A216-01A-11D-A151-01	TCGA-BC-A216-01A-11D-A151-01	TCGA-BC-A216-01A-11D-A152-10	TCGA-BC-A216-01	TCGA-BC-A216-01	DA2496AC-30CA-4682-BEF4-B37CD691156E	2da5bdd2-23ba-4f3f-93f6-90951a889955	TCGA-BC-A216-01A-11D-A152-10	TCGA-BC-A216-01	TCGA-BC-A216-01	2da5bdd2-23ba-4f3f-93f6-90951a889955	TCGA-BC-A216-01A-11D-A152-10	2da5bdd2-23ba-4f3f-93f6-90951a889955	2da5bdd2-23ba-4f3f-93f6-90951a889955	TCGA-BC-A216-01A-11D-A152-10	TCGA-BC-A216-01A-11D-A153-05
TCGA-BC-A216-11	0	TCGA-BC-A216-11	1351	0	days	TCGA-BC-A216	1351	0	days	1351	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	62	3.5	3.4	5.0	TCGA-BC-A216-F22055	TCGA-BC-A216	TCGA-BC-A216-11A	0.0	0.6	2		0.5	1.5	0.9	-22968	1052		0	1351				0	8	831	0 - No Fibrosis	Scheduled Follow-up Submission	2012-2-23	FEMALE	164	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	120			NO		G2						NO		false	No	M0	NX	T3	Stage IIIA		A216	TUMOR FREE	211000	140000	440000	NO	NO	1.4	NO	YES		R0	Solid Tissue Normal	11	Extended Lobectomy	6th	NO	YES	BC	1.5	Liver	None	A		LIVING	151	2008				TCGA-BC-A216-11			1ec66ae2-e78a-4eb8-891a-7f8b6b061dca		TCGA-BC-A216-11		1ec66ae2-e78a-4eb8-891a-7f8b6b061dca		1ec66ae2-e78a-4eb8-891a-7f8b6b061dca	1ec66ae2-e78a-4eb8-891a-7f8b6b061dca		TCGA-BC-A216-11A-11D-A153-05
TCGA-BC-A217-01	1	TCGA-BC-A217-01	1397	1	days	TCGA-BC-A217	1397	0	days	1397	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	75	3.5	4.4	5.0	TCGA-BC-A217-F70242	TCGA-BC-A217	TCGA-BC-A217-01A	0.0	0.2			0.6	1.0	0.8	-27411	408	1397	0	421				0	10	28	0 - No Fibrosis		2015-2-2	FEMALE	163	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	240			NO	NO	G3						NO		false	No	M0	NX	T2	Stage II	TCGA-BC-A217.FEA652A1-DD1E-4D78-87DF-FC2162267A96.pdf	A217	TUMOR FREE	243000	150000	440000	NO	NO	1.0	NO	NO		R0	Primary Tumor	01		7th	YES	NO	BC	1.2	Liver	Micro	A		DECEASED	81	2010	TCGA-BC-A217-01A-11D-A151-01	TCGA-BC-A217-01A-11D-A151-01	TCGA-BC-A217-01A-11D-A152-10	TCGA-BC-A217-01	TCGA-BC-A217-01	FAB6855B-0EB9-4C94-8D56-C2E357024779	84f24356-27a3-4321-a58d-f1f6b135c954	TCGA-BC-A217-01A-11D-A152-10	TCGA-BC-A217-01	TCGA-BC-A217-01	84f24356-27a3-4321-a58d-f1f6b135c954	TCGA-BC-A217-01A-11D-A152-10	84f24356-27a3-4321-a58d-f1f6b135c954	84f24356-27a3-4321-a58d-f1f6b135c954	TCGA-BC-A217-01A-11D-A152-10	TCGA-BC-A217-01A-11D-A153-05
TCGA-BC-A3KF-01	0	TCGA-BC-A3KF-01	8	0	days	TCGA-BC-A3KF			days	8	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				66				TCGA-BC-A3KF-F38204	TCGA-BC-A3KF	TCGA-BC-A3KF-01A			2		0.6	1.0	0.8	-24328	91		0	8									2012-12-11	FEMALE	173	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	340			NO	YES	G2								false	No	M0	NX	T1	Stage I	TCGA-BC-A3KF.AFBED89A-FA3F-45E9-9824-AEE5F891C5B2.pdf	A3KF	TUMOR FREE	171000	150000	440000			1.0		YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	BC		Liver	None	A		LIVING	58	2011	TCGA-BC-A3KF-01A-11D-A20V-01	TCGA-BC-A3KF-01A-11D-A20V-01	TCGA-BC-A3KF-01A-11D-A20W-10	TCGA-BC-A3KF-01	TCGA-BC-A3KF-01	6563285F-CE8B-40B7-AD37-7F1EC9704D87	82ac64bb-6cca-4f17-942a-3108995245a0	TCGA-BC-A3KF-01A-11D-A20W-10	TCGA-BC-A3KF-01	TCGA-BC-A3KF-01	82ac64bb-6cca-4f17-942a-3108995245a0	TCGA-BC-A3KF-01A-11D-A20W-10	82ac64bb-6cca-4f17-942a-3108995245a0	82ac64bb-6cca-4f17-942a-3108995245a0	TCGA-BC-A3KF-01A-11D-A20W-10	TCGA-BC-A3KF-01A-11D-A20Z-05
TCGA-BC-A3KG-01	0	TCGA-BC-A3KG-01	680	0	days	TCGA-BC-A3KG	209	1	days	680	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES			68	3.5	3.6	5.0	TCGA-BC-A3KG-F38205	TCGA-BC-A3KG	TCGA-BC-A3KG-01A	0.0	0.5			0.6	1.0	0.7	-25061	140		0	680		209		0	10	618			2013-6-27	FEMALE	159	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	790			NO	NO	G3	Liver	Intrahepatic Recurrence			NO	YES	No	false	No	M0	N0	T2	Stage II	TCGA-BC-A3KG.67A81454-06A8-451D-B855-F9D146CC0348.pdf	A3KG	WITH TUMOR	499000	150000	440000	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	BC	1.2	Liver	Micro	A		LIVING	64	2011	TCGA-BC-A3KG-01A-11D-A20V-01	TCGA-BC-A3KG-01A-11D-A20V-01	TCGA-BC-A3KG-01A-11D-A20W-10	TCGA-BC-A3KG-01	TCGA-BC-A3KG-01	96E60A73-A334-453E-BB34-A1A3361E19A1	46deaeee-1e58-4eae-8aaf-94500ec4a6de	TCGA-BC-A3KG-01A-11D-A20W-10	TCGA-BC-A3KG-01	TCGA-BC-A3KG-01	46deaeee-1e58-4eae-8aaf-94500ec4a6de	TCGA-BC-A3KG-01A-11D-A20W-10	46deaeee-1e58-4eae-8aaf-94500ec4a6de	46deaeee-1e58-4eae-8aaf-94500ec4a6de	TCGA-BC-A3KG-01A-11D-A20W-10	TCGA-BC-A3KG-01A-11D-A20Z-05
TCGA-BC-A5W4-01	1	TCGA-BC-A5W4-01	547	1	days	TCGA-BC-A5W4	384	1	days	547	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	69	3.5	4.2	5.0	TCGA-BC-A5W4-F57584	TCGA-BC-A5W4	TCGA-BC-A5W4-01A	0.0	0.6		A	0.70	1.30		-25503	224	547	0	289		384							2014-3-17	MALE	183	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	540	9.9	13.0	NO	NO	G3		Locoregional Recurrence		Yes	NO	YES	No	false	Yes	M0	NX	T3a	Stage IIIA	TCGA-BC-A5W4.6BCF821F-1993-4BA9-A9D2-EB4DEACD402C.pdf	A5W4	TUMOR FREE	102000	150000	440000	NO	NO	12.9	NO	NO		R1	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	BC	1.2	Liver	Micro	A		DECEASED	106	2012	TCGA-BC-A5W4-01A-11D-A28W-01	TCGA-BC-A5W4-01A-11D-A28W-01	TCGA-BC-A5W4-01A-11D-A28X-10	TCGA-BC-A5W4-01	TCGA-BC-A5W4-01	19439DF2-E133-4612-8AB5-F10CBA286F8C	440b70b1-0313-4c54-bfb4-e1f44a336aba	TCGA-BC-A5W4-01A-11D-A28X-10	TCGA-BC-A5W4-01	TCGA-BC-A5W4-01	440b70b1-0313-4c54-bfb4-e1f44a336aba	TCGA-BC-A5W4-01A-11D-A28X-10	440b70b1-0313-4c54-bfb4-e1f44a336aba	440b70b1-0313-4c54-bfb4-e1f44a336aba	TCGA-BC-A5W4-01A-11D-A28X-10	TCGA-BC-A5W4-01A-11D-A28Y-05
TCGA-BC-A69H-01	0	TCGA-BC-A69H-01	444	0	days	TCGA-BC-A69H	444	0	days	444	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	64	3.6	4.3	4.8	TCGA-BC-A69H-F59404	TCGA-BC-A69H	TCGA-BC-A69H-01A	0.0	0.4		A	0.8	1.3	0.8	-23380	94		0	444			1	0		103900			2014-5-12	MALE	173	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	610	9.1	12.0	NO	NO	G3						NO		false	No	M0	NX	T2	Stage II	TCGA-BC-A69H.AE56DFF8-AF71-4217-A491-8F78543E186D.pdf	A69H	TUMOR FREE	194000	140000	440000	NO	NO	10.7	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	BC	1.2	Liver	Micro	A		LIVING	70	2013	TCGA-BC-A69H-01A-11D-A30U-01	TCGA-BC-A69H-01A-11D-A30U-01	TCGA-BC-A69H-01A-11D-A30V-10	TCGA-BC-A69H-01	TCGA-BC-A69H-01	9ECE0636-589F-4452-85F6-FF9EEC933374	d61e6c10-4515-4cd1-9bc7-884db524ebca	TCGA-BC-A69H-01A-11D-A30V-10	TCGA-BC-A69H-01	TCGA-BC-A69H-01	d61e6c10-4515-4cd1-9bc7-884db524ebca	TCGA-BC-A69H-01A-11D-A30V-10	d61e6c10-4515-4cd1-9bc7-884db524ebca	d61e6c10-4515-4cd1-9bc7-884db524ebca	TCGA-BC-A69H-01A-11D-A30V-10	TCGA-BC-A69H-01A-11D-A30Y-05
TCGA-BC-A69I-01	0	TCGA-BC-A69I-01	387	0	days	TCGA-BC-A69I	387	0	days	387	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	69				TCGA-BC-A69I-F59405	TCGA-BC-A69I	TCGA-BC-A69I-01A	0.0	1.2	1		0.7	1.3	1.2	-25370	80		0	387			0	0	10	2			2014-5-12	MALE	180	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	500	9.9	13.0	NO	NO	G1						NO		false	No	M0	N0	T1	Stage I	TCGA-BC-A69I.94F0B317-494A-4467-94A2-5004010E133F.pdf	A69I	TUMOR FREE	171000	150000	440000	NO	NO	10.4	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	BC	1.2	Liver	None	A		LIVING	95	2013	TCGA-BC-A69I-01A-11D-A30U-01	TCGA-BC-A69I-01A-11D-A30U-01		TCGA-BC-A69I-01	TCGA-BC-A69I-01	545DE8B9-4DE8-484B-A8A6-986E674473A6	7f765ffb-6d9d-4cfe-a5b6-8a83d8839d42	TCGA-BC-A69I-01A-11D-A30V-10	TCGA-BC-A69I-01	TCGA-BC-A69I-01	7f765ffb-6d9d-4cfe-a5b6-8a83d8839d42	TCGA-BC-A69I-01A-11D-A30V-10	7f765ffb-6d9d-4cfe-a5b6-8a83d8839d42	7f765ffb-6d9d-4cfe-a5b6-8a83d8839d42	TCGA-BC-A69I-01A-11D-A30V-10	TCGA-BC-A69I-01A-11D-A30Y-05
TCGA-BC-A8YO-01	0	TCGA-BC-A8YO-01	562	0	days	TCGA-BC-A8YO			days	562	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	66	3.5	4.3	5.0	TCGA-BC-A8YO-F70635	TCGA-BC-A8YO	TCGA-BC-A8YO-01A	0.0	0.3	3		0.6	1.0	0.8	-24189	141		0	562									2015-2-26	FEMALE	170	Alcohol consumption|Other	Chronic hepatitis, either viral or autoimmune	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	680			NO	NO	G3						YES		false	No	M0	N0	T4	Stage IIIC	TCGA-BC-A8YO.BF3E21AE-D9DC-4011-908A-32C6C1FE10FB.pdf	A8YO	WITH TUMOR	441000	150000	440000	NO	YES	1.0	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	BC	1.2	Liver	Macro	A		LIVING	74	2013	TCGA-BC-A8YO-01A-11D-A36W-01	TCGA-BC-A8YO-01A-11D-A36W-01	TCGA-BC-A8YO-01A-11D-A36X-10	TCGA-BC-A8YO-01	TCGA-BC-A8YO-01	AC4E92CC-7921-4165-A7A7-30C29F8BB86F	c10552f3-93ad-4f50-a420-3b5277416aef		TCGA-BC-A8YO-01	TCGA-BC-A8YO-01	c10552f3-93ad-4f50-a420-3b5277416aef		c10552f3-93ad-4f50-a420-3b5277416aef	c10552f3-93ad-4f50-a420-3b5277416aef		TCGA-BC-A8YO-01A-11D-A36Y-05
TCGA-BD-A2L6-01	0	TCGA-BD-A2L6-01	1363	0	days	TCGA-BD-A2L6	415	1	days	1363	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	69	3.4	3.7	5.0	TCGA-BD-A2L6-F34562	TCGA-BD-A2L6	TCGA-BD-A2L6-01A	0.3	0.9		A	0.5	1.4	1.2	-25489	148		0	1363		415	1	0	20	53	3,4 - Fibrous Speta		2012-8-23	MALE	168	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	480	0.8	1.2	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	MX	NX	T2		TCGA-BD-A2L6.6E795E68-4CFC-4DC9-A072-9A78C59CE10A.pdf	A2L6	WITH TUMOR	222	156	369	NO	NO	1.0	NO			R0	Primary Tumor	01	Lobectomy	7th	YES	NO	BD	1.5	Liver	Micro	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	110	2011	TCGA-BD-A2L6-01A-11D-A20V-01	TCGA-BD-A2L6-01A-11D-A20V-01	TCGA-BD-A2L6-01A-11D-A20W-10	TCGA-BD-A2L6-01	TCGA-BD-A2L6-01	895D7028-99A7-4CC8-B3E0-A1E4601A4AE2	887e3dc8-2c4b-4b56-b43a-fc2b0ba4e478	TCGA-BD-A2L6-01A-11D-A20W-10	TCGA-BD-A2L6-01	TCGA-BD-A2L6-01	887e3dc8-2c4b-4b56-b43a-fc2b0ba4e478	TCGA-BD-A2L6-01A-11D-A20W-10	887e3dc8-2c4b-4b56-b43a-fc2b0ba4e478	887e3dc8-2c4b-4b56-b43a-fc2b0ba4e478	TCGA-BD-A2L6-01A-11D-A20W-10	TCGA-BD-A2L6-01A-11D-A20Z-05
TCGA-BD-A2L6-11	0	TCGA-BD-A2L6-11	1363	0	days	TCGA-BD-A2L6	415	1	days	1363	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	69	3.4	3.7	5.0	TCGA-BD-A2L6-F34562	TCGA-BD-A2L6	TCGA-BD-A2L6-11A	0.3	0.9		A	0.5	1.4	1.2	-25489	148		0	1363		415	1	0	20	53	3,4 - Fibrous Speta		2012-8-23	MALE	168	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	310	0.8	1.2	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	MX	NX	T2			A2L6	WITH TUMOR	222	156	369	NO	NO	1.0	NO			R0	Solid Tissue Normal	11	Lobectomy	7th	YES	NO	BD	1.5	Liver	Micro	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	110	2011				TCGA-BD-A2L6-11			66811a13-8463-429b-87ae-298455ee961a		TCGA-BD-A2L6-11		66811a13-8463-429b-87ae-298455ee961a		66811a13-8463-429b-87ae-298455ee961a	66811a13-8463-429b-87ae-298455ee961a		TCGA-BD-A2L6-11A-21D-A20Z-05
TCGA-BD-A3EP-01	0	TCGA-BD-A3EP-01	409	0	days	TCGA-BD-A3EP	409	0	days	409	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	75	3.4	3.8	5.0	TCGA-BD-A3EP-F68680	TCGA-BD-A3EP	TCGA-BD-A3EP-01A	0.3	0.6	0	A	0.5	1.4	1.1	-27756	398		0	409			1	0	20	17	1,2 - Portal Fibrosis		2014-12-10	FEMALE	168	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	140	0.8	1.2	NO	YES	G2						NO		true	No	M0	N0	T1	Stage I	TCGA-BD-A3EP.4560D451-6F7E-4F3F-8AF7-F393DB000ABD.pdf	A3EP	TUMOR FREE	333	156	369	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	BD	1.5	Liver	None	A		LIVING	71	2010	TCGA-BD-A3EP-01A-11D-A22E-01	TCGA-BD-A3EP-01A-11D-A22E-01	TCGA-BD-A3EP-01A-11D-A22F-10	TCGA-BD-A3EP-01	TCGA-BD-A3EP-01	3AB8FEB7-1994-4767-8649-B594C45B352F	22142880-0e1a-4e12-98b1-2597e9d14def	TCGA-BD-A3EP-01A-11D-A22F-10	TCGA-BD-A3EP-01	TCGA-BD-A3EP-01	22142880-0e1a-4e12-98b1-2597e9d14def	TCGA-BD-A3EP-01A-11D-A22F-10	22142880-0e1a-4e12-98b1-2597e9d14def	22142880-0e1a-4e12-98b1-2597e9d14def	TCGA-BD-A3EP-01A-11D-A22F-10	TCGA-BD-A3EP-01A-11D-A22H-05
TCGA-BD-A3EP-11	0	TCGA-BD-A3EP-11	409	0	days	TCGA-BD-A3EP	409	0	days	409	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	75	3.4	3.8	5.0	TCGA-BD-A3EP-F68680	TCGA-BD-A3EP	TCGA-BD-A3EP-11A	0.3	0.6	0	A	0.5	1.4	1.1	-27756	398		0	409			1	0	20	17	1,2 - Portal Fibrosis		2014-12-10	FEMALE	168	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	120	0.8	1.2	NO	YES	G2						NO		true	No	M0	N0	T1	Stage I		A3EP	TUMOR FREE	333	156	369	NO	NO	1.0	NO	NO		R0	Solid Tissue Normal	11	Lobectomy	7th	YES	NO	BD	1.5	Liver	None	A		LIVING	71	2010				TCGA-BD-A3EP-11			58067780-a21b-4eeb-b061-caef50ea0650		TCGA-BD-A3EP-11		58067780-a21b-4eeb-b061-caef50ea0650		58067780-a21b-4eeb-b061-caef50ea0650	58067780-a21b-4eeb-b061-caef50ea0650		TCGA-BD-A3EP-11A-12D-A22H-05
TCGA-BD-A3ER-01	0	TCGA-BD-A3ER-01	1115	0	days	TCGA-BD-A3ER	226	1	days	1115	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	62	3.4	3.9	5.0	TCGA-BD-A3ER-F68681	TCGA-BD-A3ER	TCGA-BD-A3ER-01A	0.3	0.7	0	A	0.5	1.4	0.9	-22657	23		0	1115		226	0	0	20	5	6 - Established Cirrhosis		2014-12-10	MALE	188	Hemochromatosis	Alcohol Consumption	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	90	0.8	1.2	NO	NO	G2	Liver	Locoregional Recurrence		Yes	NO	YES	No	true	Yes	MX	NX	T2	Stage II	TCGA-BD-A3ER.2CD158D7-48E7-43D6-8E0F-2D56FC6F5256.pdf	A3ER	WITH TUMOR	208	156	369	NO	NO	1.2	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	BD	1.5	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	111	2011	TCGA-BD-A3ER-01A-11D-A20V-01	TCGA-BD-A3ER-01A-11D-A20V-01	TCGA-BD-A3ER-01A-11D-A20W-10		TCGA-BD-A3ER-01	22616236-E7D6-4905-A80C-4D3776310CCB	459ab827-f9c7-4b30-9b6a-86bee706c6e0	TCGA-BD-A3ER-01A-11D-A20W-10		TCGA-BD-A3ER-01	459ab827-f9c7-4b30-9b6a-86bee706c6e0	TCGA-BD-A3ER-01A-11D-A20W-10	459ab827-f9c7-4b30-9b6a-86bee706c6e0	459ab827-f9c7-4b30-9b6a-86bee706c6e0	TCGA-BD-A3ER-01A-11D-A20W-10	TCGA-BD-A3ER-01A-11D-A20Z-05
TCGA-BW-A5NO-01	0	TCGA-BW-A5NO-01	20	0	days	TCGA-BW-A5NO	20	0	days	20	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				50					TCGA-BW-A5NO	TCGA-BW-A5NO-01A								-18510	840		0	20			1				3,4 - Fibrous Speta		2014-3-26	MALE		Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	110			NO		G2						NO		false	No	MX	NX	T3a	Stage IIIA	TCGA-BW-A5NO.39E090EF-9EA0-4362-BB47-432DE5AA1393.pdf	A5NO	TUMOR FREE				NO	NO		NO			RX	Primary Tumor	01	Lobectomy	7th	YES	NO	BW		Liver	None	A		LIVING		2010	TCGA-BW-A5NO-01A-11D-A27H-01	TCGA-BW-A5NO-01A-11D-A27H-01	TCGA-BW-A5NO-01A-11D-A27I-10	TCGA-BW-A5NO-01	TCGA-BW-A5NO-01	3520231E-6D3B-4514-AA06-E73D1BEAAF53	38bb0662-ec22-4b4f-9264-69957e582b33	TCGA-BW-A5NO-01A-11D-A27I-10	TCGA-BW-A5NO-01	TCGA-BW-A5NO-01	38bb0662-ec22-4b4f-9264-69957e582b33	TCGA-BW-A5NO-01A-11D-A27I-10	38bb0662-ec22-4b4f-9264-69957e582b33	38bb0662-ec22-4b4f-9264-69957e582b33	TCGA-BW-A5NO-01A-11D-A27I-10	TCGA-BW-A5NO-01A-11D-A27W-05
TCGA-BW-A5NP-01		TCGA-BW-A5NP-01			days	TCGA-BW-A5NP			days		days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	26					TCGA-BW-A5NP	TCGA-BW-A5NP-01A								-9809	1057		0	0			2			143684	3,4 - Fibrous Speta		2014-3-26	FEMALE		Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	290			NO		G3						YES		false	No	M1	N0	T2	Stage IV	TCGA-BW-A5NP.D13029B5-B160-48FC-A556-9FBF8CAF4EDB.pdf	A5NP	WITH TUMOR				NO	YES		NO			RX	Primary Tumor	01		7th	YES	NO	BW		Liver	Micro	A		LIVING		2010	TCGA-BW-A5NP-01A-11D-A27H-01	TCGA-BW-A5NP-01A-11D-A27H-01	TCGA-BW-A5NP-01A-11D-A27I-10	TCGA-BW-A5NP-01	TCGA-BW-A5NP-01	E66505C6-DD0D-4EC9-BA9F-21968A5747F6	d2b612ea-bc88-4b16-971d-6f0141bed0b9	TCGA-BW-A5NP-01A-11D-A27I-10	TCGA-BW-A5NP-01	TCGA-BW-A5NP-01	d2b612ea-bc88-4b16-971d-6f0141bed0b9	TCGA-BW-A5NP-01A-11D-A27I-10	d2b612ea-bc88-4b16-971d-6f0141bed0b9	d2b612ea-bc88-4b16-971d-6f0141bed0b9	TCGA-BW-A5NP-01A-11D-A27I-10	TCGA-BW-A5NP-01A-11D-A27W-05
TCGA-BW-A5NQ-01		TCGA-BW-A5NQ-01			days	TCGA-BW-A5NQ			days		days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				63					TCGA-BW-A5NQ	TCGA-BW-A5NQ-01A								-23353	1022		0	0							6 - Established Cirrhosis		2014-3-26	MALE		Alcohol consumption|Other	cirrhosis	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	160			NO		G3								false	Yes	MX	NX	T1	Stage I	TCGA-BW-A5NQ.D56121DE-22A7-44D8-97EF-E33D395ABAF9.pdf	A5NQ	TUMOR FREE										RX	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	BW		Liver	None	A		LIVING		2010	TCGA-BW-A5NQ-01A-11D-A27H-01	TCGA-BW-A5NQ-01A-11D-A27H-01	TCGA-BW-A5NQ-01A-11D-A27I-10	TCGA-BW-A5NQ-01	TCGA-BW-A5NQ-01	48D0CECD-3B95-44BD-A5B0-9F56216B17F3	818ed3ec-2c9c-41cc-8c01-18c9a95e9a02	TCGA-BW-A5NQ-01A-11D-A27I-10	TCGA-BW-A5NQ-01	TCGA-BW-A5NQ-01	818ed3ec-2c9c-41cc-8c01-18c9a95e9a02	TCGA-BW-A5NQ-01A-11D-A27I-10	818ed3ec-2c9c-41cc-8c01-18c9a95e9a02	818ed3ec-2c9c-41cc-8c01-18c9a95e9a02	TCGA-BW-A5NQ-01A-11D-A27I-10	TCGA-BW-A5NQ-01A-11D-A27W-05
TCGA-CC-5258-01	1	TCGA-CC-5258-01	129	1	days	TCGA-CC-5258	129	0	days	129	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				48				TCGA-CC-5258-F20327	TCGA-CC-5258	TCGA-CC-5258-01A								-17586	147	129	0	0			3					Scheduled Follow-up Submission	2012-1-9	MALE				Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1700			NO		G2						NO		true	No	M0	N0	T2	Stage II	TCGA-CC-5258.F63EEB94-37AE-43FC-97B9-8EBF328C2134.pdf	5258	TUMOR FREE				NO	NO		NO	NO		RX	Primary Tumor	01	Other (specify)	6th	YES	NO	CC		Liver	None	A	Hepatitis  C Antibody|HBV Surface Antibody	DECEASED	55	2010	TCGA-CC-5258-01A-01D-A12Y-01	TCGA-CC-5258-01A-01D-A12Y-01	TCGA-CC-5258-01A-01D-A12Z-10	TCGA-CC-5258-01	TCGA-CC-5258-01	3E1812C6-00C2-437C-8BA6-39A2B0C610EC	54315bb5-c78e-4b9c-b9c1-8d0a944a854f	TCGA-CC-5258-01A-01D-A12Z-10	TCGA-CC-5258-01	TCGA-CC-5258-01	54315bb5-c78e-4b9c-b9c1-8d0a944a854f	TCGA-CC-5258-01A-01D-A12Z-10	54315bb5-c78e-4b9c-b9c1-8d0a944a854f	54315bb5-c78e-4b9c-b9c1-8d0a944a854f	TCGA-CC-5258-01A-01D-A12Z-10	TCGA-CC-5258-01A-01D-A132-05
TCGA-CC-5259-01	0	TCGA-CC-5259-01	250	0	days	TCGA-CC-5259	180	1	days	250	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		60				TCGA-CC-5259-F70915	TCGA-CC-5259									-21946			0	250		180							2015-3-10	FEMALE	153	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES					NO	G2	Liver	Locoregional Recurrence		No	NO	YES	No		No	M0	N0	T4	Stage IIIC		5259	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	CC		Liver			Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	49	2010			TCGA-CC-5259-01A-31D-A20W-10	TCGA-CC-5259-01	TCGA-CC-5259-01		e39040d8-cdb2-4ead-9e93-224ba7c37dbc	TCGA-CC-5259-01A-31D-A20W-10	TCGA-CC-5259-01		e39040d8-cdb2-4ead-9e93-224ba7c37dbc	TCGA-CC-5259-01A-31D-A20W-10	e39040d8-cdb2-4ead-9e93-224ba7c37dbc	e39040d8-cdb2-4ead-9e93-224ba7c37dbc	TCGA-CC-5259-01A-31D-A20W-10	TCGA-CC-5259-01A-31D-A20Z-05
TCGA-CC-5260-01	1	TCGA-CC-5260-01	87	1	days	TCGA-CC-5260	87	0	days	87	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				61				TCGA-CC-5260-F20330	TCGA-CC-5260	TCGA-CC-5260-01A								-22345	105	87	0	0								Scheduled Follow-up Submission	2012-1-9	FEMALE	153			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	600			NO		G1						NO		true	No	M0	N0	T4	Stage IIIC	TCGA-CC-5260.2E6A53F8-D019-4B4A-894F-CF21BEE91EDD.pdf	5260	TUMOR FREE				NO	NO		NO	NO		RX	Primary Tumor	01	Other (specify)	7th	YES	NO	CC		Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	46	2010	TCGA-CC-5260-01A-01D-A12Y-01	TCGA-CC-5260-01A-01D-A12Y-01	TCGA-CC-5260-01A-01D-A12Z-10	TCGA-CC-5260-01	TCGA-CC-5260-01	254C5E95-8AE2-44E6-89BF-56DB0E056A71	108f1509-bd7e-4a10-8989-f20f7b45bb09	TCGA-CC-5260-01A-01D-A12Z-10	TCGA-CC-5260-01	TCGA-CC-5260-01	108f1509-bd7e-4a10-8989-f20f7b45bb09	TCGA-CC-5260-01A-01D-A12Z-10	108f1509-bd7e-4a10-8989-f20f7b45bb09	108f1509-bd7e-4a10-8989-f20f7b45bb09	TCGA-CC-5260-01A-01D-A12Z-10	TCGA-CC-5260-01A-01D-A132-05
TCGA-CC-5261-01	1	TCGA-CC-5261-01	97	1	days	TCGA-CC-5261	97	0	days	97	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				44				TCGA-CC-5261-F20332	TCGA-CC-5261	TCGA-CC-5261-01A								-16373	110	97	0	12								Scheduled Follow-up Submission	2012-1-9	MALE	175			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	450			NO		G2						NO		true	No	M0	N0	T2	Stage II	TCGA-CC-5261.30B90892-0231-450E-8A93-28F387047463.pdf	5261	TUMOR FREE				NO	NO		NO			RX	Primary Tumor	01	Other (specify)	7th	YES	NO	CC		Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	58	2010	TCGA-CC-5261-01A-01D-A12Y-01	TCGA-CC-5261-01A-01D-A12Y-01	TCGA-CC-5261-01A-01D-A12Z-10	TCGA-CC-5261-01	TCGA-CC-5261-01	76CB0776-E9E6-475F-9C3D-C8E60205528F	04beffef-0cd3-4935-8f2e-9e11c5638973	TCGA-CC-5261-01A-01D-A12Z-10	TCGA-CC-5261-01	TCGA-CC-5261-01	04beffef-0cd3-4935-8f2e-9e11c5638973	TCGA-CC-5261-01A-01D-A12Z-10	04beffef-0cd3-4935-8f2e-9e11c5638973	04beffef-0cd3-4935-8f2e-9e11c5638973	TCGA-CC-5261-01A-01D-A12Z-10	TCGA-CC-5261-01A-01D-A132-05
TCGA-CC-5262-01	1	TCGA-CC-5262-01	103	1	days	TCGA-CC-5262	103	0	days	103	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				67				TCGA-CC-5262-F20334	TCGA-CC-5262	TCGA-CC-5262-01A								-24787	97	103	0	0								Scheduled Follow-up Submission	2012-1-9	MALE	170	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	800			NO		G1						NO		true	No	M0	N0	T4	Stage IIIC	TCGA-CC-5262.B09509A2-A902-4298-AEDF-66BA21C584BB.pdf	5262	TUMOR FREE				NO	NO		NO	NO			Primary Tumor	01	Other (specify)	7th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	62	2010	TCGA-CC-5262-01A-01D-A12Y-01	TCGA-CC-5262-01A-01D-A12Y-01	TCGA-CC-5262-01A-01D-A12Z-10	TCGA-CC-5262-01	TCGA-CC-5262-01	6AF7DF38-5308-4618-90F5-44A6882CD6DD	5b1b9e38-e00a-462b-976a-c540c13718ca	TCGA-CC-5262-01A-01D-A12Z-10	TCGA-CC-5262-01	TCGA-CC-5262-01	5b1b9e38-e00a-462b-976a-c540c13718ca	TCGA-CC-5262-01A-01D-A12Z-10	5b1b9e38-e00a-462b-976a-c540c13718ca	5b1b9e38-e00a-462b-976a-c540c13718ca	TCGA-CC-5262-01A-01D-A12Z-10	TCGA-CC-5262-01A-01D-A132-05
TCGA-CC-5263-01	1	TCGA-CC-5263-01	129	1	days	TCGA-CC-5263	129	0	days	129	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				35				TCGA-CC-5263-F20328	TCGA-CC-5263	TCGA-CC-5263-01A								-12863	91	129	0									Scheduled Follow-up Submission	2012-1-9	MALE	163	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	900			NO		G1						NO		true	No	M0	N0	T3	Stage IIIA	TCGA-CC-5263.3136CA38-995E-4B6B-97F2-D37AF68EFA4C.pdf	5263	TUMOR FREE				NO	NO		NO	NO		RX	Primary Tumor	01	Other (specify)	6th	YES	NO	CC		Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	59	2010	TCGA-CC-5263-01A-01D-A12Y-01	TCGA-CC-5263-01A-01D-A12Y-01	TCGA-CC-5263-01A-01D-A12Z-10	TCGA-CC-5263-01	TCGA-CC-5263-01	6B4F8CDA-B879-4BF0-9AD5-317CEB6AA090	038e0d7b-8f46-40fb-bfec-74dab7a6fe59	TCGA-CC-5263-01A-01D-A12Z-10	TCGA-CC-5263-01	TCGA-CC-5263-01	038e0d7b-8f46-40fb-bfec-74dab7a6fe59	TCGA-CC-5263-01A-01D-A12Z-10	038e0d7b-8f46-40fb-bfec-74dab7a6fe59	038e0d7b-8f46-40fb-bfec-74dab7a6fe59	TCGA-CC-5263-01A-01D-A12Z-10	TCGA-CC-5263-01A-01D-A132-05
TCGA-CC-5264-01	1	TCGA-CC-5264-01	102	1	days	TCGA-CC-5264	102	0	days	102	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				71				TCGA-CC-5264-F20329	TCGA-CC-5264	TCGA-CC-5264-01A								-25979	84	102	0	0								Scheduled Follow-up Submission	2012-1-9	MALE	160			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	550			NO		G2						NO		true	No	M0	N0	T3	Stage IIIA	TCGA-CC-5264.4D5CD8E8-DAD7-4392-A44C-BBDF3DAD872F.pdf	5264	TUMOR FREE				NO	NO		NO			RX	Primary Tumor	01	Other (specify)	6th	YES	NO	CC		Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	52	2010	TCGA-CC-5264-01A-01D-A12Y-01	TCGA-CC-5264-01A-01D-A12Y-01	TCGA-CC-5264-01A-01D-A12Z-10	TCGA-CC-5264-01	TCGA-CC-5264-01	D7CA2572-EA6A-4E9E-8E11-43FF0976EA17	06a52d13-3cb4-4d5f-94ef-55d980562486	TCGA-CC-5264-01A-01D-A12Z-10	TCGA-CC-5264-01	TCGA-CC-5264-01	06a52d13-3cb4-4d5f-94ef-55d980562486	TCGA-CC-5264-01A-01D-A12Z-10	06a52d13-3cb4-4d5f-94ef-55d980562486	06a52d13-3cb4-4d5f-94ef-55d980562486	TCGA-CC-5264-01A-01D-A12Z-10	TCGA-CC-5264-01A-01D-A132-05
TCGA-CC-A123-01	0	TCGA-CC-A123-01	219	0	days	TCGA-CC-A123	145	1	days	219	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		24				TCGA-CC-A123-F70913	TCGA-CC-A123	TCGA-CC-A123-01A								-9107	49		0	219		145	3						2015-3-10	FEMALE				Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	280			NO	NO	G1	Lung	New Primary Tumor		No	NO	YES		true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A123.65D669CE-291F-489A-9B25-AD619B906900.pdf	A123	WITH TUMOR				NO	NO		NO			RX	Primary Tumor	01	Other (specify)	6th	YES	NO	CC		Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING		2010			TCGA-CC-A123-01A-11D-A12Z-10	TCGA-CC-A123-01	TCGA-CC-A123-01	BB3F83AE-BA9B-44B2-998F-2D184242DD98	3e205fbf-b9e5-470d-9c6f-68ff88640c45	TCGA-CC-A123-01A-11D-A12Z-10	TCGA-CC-A123-01		3e205fbf-b9e5-470d-9c6f-68ff88640c45	TCGA-CC-A123-01A-11D-A12Z-10	3e205fbf-b9e5-470d-9c6f-68ff88640c45	3e205fbf-b9e5-470d-9c6f-68ff88640c45	TCGA-CC-A123-01A-11D-A12Z-10	TCGA-CC-A123-01A-11D-A132-05
TCGA-CC-A1HT-01	1	TCGA-CC-A1HT-01	101	1	days	TCGA-CC-A1HT	101	0	days	101	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				50				TCGA-CC-A1HT-F20333	TCGA-CC-A1HT	TCGA-CC-A1HT-01A								-18553	86	101	0	0			4					Scheduled Follow-up Submission	2012-1-9	MALE	163	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	470			NO		G3						NO		true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A1HT.81F0F911-C2C1-48AD-A67F-FD455503CB46.pdf	A1HT	TUMOR FREE				NO	NO		NO	NO			Primary Tumor	01	Other (specify)	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	54	2010	TCGA-CC-A1HT-01A-11D-A12Y-01	TCGA-CC-A1HT-01A-11D-A12Y-01	TCGA-CC-A1HT-01A-11D-A12Z-10	TCGA-CC-A1HT-01	TCGA-CC-A1HT-01	C7A6791C-7141-42F9-8AFA-5083CCE10124	63a48c81-2b6c-4f68-a76b-69ff2fc449ed	TCGA-CC-A1HT-01A-11D-A12Z-10	TCGA-CC-A1HT-01	TCGA-CC-A1HT-01	63a48c81-2b6c-4f68-a76b-69ff2fc449ed	TCGA-CC-A1HT-01A-11D-A12Z-10	63a48c81-2b6c-4f68-a76b-69ff2fc449ed	63a48c81-2b6c-4f68-a76b-69ff2fc449ed	TCGA-CC-A1HT-01A-11D-A12Z-10	TCGA-CC-A1HT-01A-11D-A132-05
TCGA-CC-A3M9-01	1	TCGA-CC-A3M9-01	300	1	days	TCGA-CC-A3M9	219	1	days	300	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		45				TCGA-CC-A3M9-F70909	TCGA-CC-A3M9	TCGA-CC-A3M9-01A								-16460	226	300	0	3		219	2						2015-3-10	MALE	174	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8173/3	C22.0	YES	200			NO	NO	G3		Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A3M9.9529CF47-D435-4CA9-B8B4-069CA2FCD3CD.pdf	A3M9	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	61	2011	TCGA-CC-A3M9-01A-11D-A20V-01	TCGA-CC-A3M9-01A-11D-A20V-01	TCGA-CC-A3M9-01A-11D-A20W-10	TCGA-CC-A3M9-01	TCGA-CC-A3M9-01	4A85474C-9DD3-4576-BC28-53D26AB6E49B	faec0e24-6bcd-4388-b227-b8d4b73bb110	TCGA-CC-A3M9-01A-11D-A20W-10	TCGA-CC-A3M9-01	TCGA-CC-A3M9-01	faec0e24-6bcd-4388-b227-b8d4b73bb110	TCGA-CC-A3M9-01A-11D-A20W-10	faec0e24-6bcd-4388-b227-b8d4b73bb110	faec0e24-6bcd-4388-b227-b8d4b73bb110	TCGA-CC-A3M9-01A-11D-A20W-10	TCGA-CC-A3M9-01A-11D-A20Z-05
TCGA-CC-A3MA-01	1	TCGA-CC-A3MA-01	303	1	days	TCGA-CC-A3MA	261	1	days	303	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		61				TCGA-CC-A3MA-F70907	TCGA-CC-A3MA	TCGA-CC-A3MA-01A								-22375	177	303	0	2		261	3						2015-3-10	MALE	168	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	530			NO	NO	G2		Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A3MA.B631A61B-4550-47DE-9240-0FCFAEF47BC6.pdf	A3MA	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	66	2011	TCGA-CC-A3MA-01A-11D-A20V-01	TCGA-CC-A3MA-01A-11D-A20V-01	TCGA-CC-A3MA-01A-11D-A20W-10	TCGA-CC-A3MA-01	TCGA-CC-A3MA-01	9DC784BA-8DD4-4B84-9D5B-D0288C2312AE	86cde8fe-ca8b-47f6-b121-df5a05d3ec4c	TCGA-CC-A3MA-01A-11D-A20W-10	TCGA-CC-A3MA-01	TCGA-CC-A3MA-01	86cde8fe-ca8b-47f6-b121-df5a05d3ec4c	TCGA-CC-A3MA-01A-11D-A20W-10	86cde8fe-ca8b-47f6-b121-df5a05d3ec4c	86cde8fe-ca8b-47f6-b121-df5a05d3ec4c	TCGA-CC-A3MA-01A-11D-A20W-10	TCGA-CC-A3MA-01A-11D-A20Z-05
TCGA-CC-A3MB-01	1	TCGA-CC-A3MB-01	315	1	days	TCGA-CC-A3MB	260	1	days	315	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		36				TCGA-CC-A3MB-F70908	TCGA-CC-A3MB	TCGA-CC-A3MB-01A								-13255	205	315	0	3		260	3						2015-3-10	MALE	176	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	460			NO	NO	G1	Lung	New Primary Tumor		No	NO	YES	No	true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A3MB.62A01956-C6F4-4FCB-AC43-052EEC8AE7AE.pdf	A3MB	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	58	2011	TCGA-CC-A3MB-01A-11D-A20V-01	TCGA-CC-A3MB-01A-11D-A20V-01	TCGA-CC-A3MB-01A-11D-A20W-10	TCGA-CC-A3MB-01	TCGA-CC-A3MB-01	7E1DF0FD-6902-42B5-B4CE-BC7D69F5CC3C	97a9402f-537a-4767-bee3-72e1bebcdd97	TCGA-CC-A3MB-01A-11D-A20W-10	TCGA-CC-A3MB-01	TCGA-CC-A3MB-01	97a9402f-537a-4767-bee3-72e1bebcdd97	TCGA-CC-A3MB-01A-11D-A20W-10	97a9402f-537a-4767-bee3-72e1bebcdd97	97a9402f-537a-4767-bee3-72e1bebcdd97	TCGA-CC-A3MB-01A-11D-A20W-10	TCGA-CC-A3MB-01A-11D-A20Z-05
TCGA-CC-A3MC-01	0	TCGA-CC-A3MC-01	363	0	days	TCGA-CC-A3MC	297	1	days	363	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		54				TCGA-CC-A3MC-F70912	TCGA-CC-A3MC	TCGA-CC-A3MC-01A								-20067	268		0	363		297	3						2015-3-10	MALE	163	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	400			NO	NO	G2	Liver	Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A3MC.3D0D4B1A-1340-488C-B231-F18CC1BC3783.pdf	A3MC	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	52	2011	TCGA-CC-A3MC-01A-11D-A22E-01	TCGA-CC-A3MC-01A-11D-A22E-01	TCGA-CC-A3MC-01A-11D-A22F-10	TCGA-CC-A3MC-01	TCGA-CC-A3MC-01	F0DE71AB-1E83-49F4-9335-7601B45D2FE1	19377cf4-aafe-449a-b10b-f637b4eef29f	TCGA-CC-A3MC-01A-11D-A22F-10	TCGA-CC-A3MC-01	TCGA-CC-A3MC-01	19377cf4-aafe-449a-b10b-f637b4eef29f	TCGA-CC-A3MC-01A-11D-A22F-10	19377cf4-aafe-449a-b10b-f637b4eef29f	19377cf4-aafe-449a-b10b-f637b4eef29f	TCGA-CC-A3MC-01A-11D-A22F-10	TCGA-CC-A3MC-01A-11D-A22H-05
TCGA-CC-A5UC-01	1	TCGA-CC-A5UC-01	347	1	days	TCGA-CC-A5UC	312	1	days	347	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		63				TCGA-CC-A5UC-F69917	TCGA-CC-A5UC	TCGA-CC-A5UC-01A								-23156	99	347	0	0		312	2						2015-1-22	MALE	165	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	210			NO	NO	G3	Lung	New Primary Tumor		No	NO	YES	No	true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A5UC.21B4A68D-F76C-49BB-81D7-423E957852E1.pdf	A5UC	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	57	2012	TCGA-CC-A5UC-01A-11D-A28W-01	TCGA-CC-A5UC-01A-11D-A28W-01	TCGA-CC-A5UC-01A-11D-A28X-10	TCGA-CC-A5UC-01	TCGA-CC-A5UC-01	D2A8F8C2-65A2-4CF1-9635-CEB3AC787FFF	04ecdbec-f452-4bff-986c-23b414d92252	TCGA-CC-A5UC-01A-11D-A28X-10	TCGA-CC-A5UC-01	TCGA-CC-A5UC-01	04ecdbec-f452-4bff-986c-23b414d92252	TCGA-CC-A5UC-01A-11D-A28X-10	04ecdbec-f452-4bff-986c-23b414d92252	04ecdbec-f452-4bff-986c-23b414d92252	TCGA-CC-A5UC-01A-11D-A28X-10	TCGA-CC-A5UC-01A-11D-A28Y-05
TCGA-CC-A5UD-01	1	TCGA-CC-A5UD-01	304	1	days	TCGA-CC-A5UD	182	1	days	304	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		45				TCGA-CC-A5UD-F69700	TCGA-CC-A5UD	TCGA-CC-A5UD-01A								-16702	92	304	0	0		182	1						2015-1-16	MALE	170	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	310			NO	NO	G2		Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A5UD.77BF208C-F5ED-4A05-BFDE-36063F43E022.pdf	A5UD	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	62	2012	TCGA-CC-A5UD-01A-11D-A28W-01	TCGA-CC-A5UD-01A-11D-A28W-01	TCGA-CC-A5UD-01A-11D-A28X-10	TCGA-CC-A5UD-01	TCGA-CC-A5UD-01	EDBB5D86-ACB6-4404-993E-CA4B015846B1	cdb1c4a5-5d21-4ab7-aeb3-e65dc5d739c6	TCGA-CC-A5UD-01A-11D-A28X-10	TCGA-CC-A5UD-01	TCGA-CC-A5UD-01	cdb1c4a5-5d21-4ab7-aeb3-e65dc5d739c6	TCGA-CC-A5UD-01A-11D-A28X-10	cdb1c4a5-5d21-4ab7-aeb3-e65dc5d739c6	cdb1c4a5-5d21-4ab7-aeb3-e65dc5d739c6	TCGA-CC-A5UD-01A-11D-A28X-10	TCGA-CC-A5UD-01A-11D-A28Y-05
TCGA-CC-A5UE-01	1	TCGA-CC-A5UE-01	272	1	days	TCGA-CC-A5UE	175	1	days	272	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		48				TCGA-CC-A5UE-F69701	TCGA-CC-A5UE	TCGA-CC-A5UE-01A								-17805	85	272	0	0		175	3						2015-1-16	MALE	175	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	300			NO	NO	G2		Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T4	Stage IIIB	TCGA-CC-A5UE.3D729315-DE44-441D-9CB2-3CFB827C2808.pdf	A5UE	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	65	2012	TCGA-CC-A5UE-01A-11D-A28W-01	TCGA-CC-A5UE-01A-11D-A28W-01	TCGA-CC-A5UE-01A-11D-A28X-10	TCGA-CC-A5UE-01	TCGA-CC-A5UE-01	04DD2C1C-27F8-4CF7-B2E0-28FAF54A3A83	dff668bd-b423-4ab8-961c-93c0bc093763	TCGA-CC-A5UE-01A-11D-A28X-10	TCGA-CC-A5UE-01	TCGA-CC-A5UE-01	dff668bd-b423-4ab8-961c-93c0bc093763	TCGA-CC-A5UE-01A-11D-A28X-10	dff668bd-b423-4ab8-961c-93c0bc093763	dff668bd-b423-4ab8-961c-93c0bc093763	TCGA-CC-A5UE-01A-11D-A28X-10	TCGA-CC-A5UE-01A-11D-A28Y-05
TCGA-CC-A7IE-01	1	TCGA-CC-A7IE-01	217	1	days	TCGA-CC-A7IE	169	1	days	217	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		57				TCGA-CC-A7IE-F69923	TCGA-CC-A7IE									-20985		217	0	0		169	3						2015-1-22	MALE	172	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES					NO	G2	Lung	New Primary Tumor		No	NO	YES	No		No	M0	N0	T3	Stage IIIA		A7IE	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver			Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	62	2012	TCGA-CC-A7IE-01A-21D-A381-01	TCGA-CC-A7IE-01A-21D-A381-01	TCGA-CC-A7IE-01A-21D-A382-10	TCGA-CC-A7IE-01	TCGA-CC-A7IE-01		b4e476f1-17f7-4af3-9076-8bcd783324a7		TCGA-CC-A7IE-01	TCGA-CC-A7IE-01	b4e476f1-17f7-4af3-9076-8bcd783324a7		b4e476f1-17f7-4af3-9076-8bcd783324a7	b4e476f1-17f7-4af3-9076-8bcd783324a7		TCGA-CC-A7IE-01A-21D-A383-05
TCGA-CC-A7IF-01	1	TCGA-CC-A7IF-01	649	1	days	TCGA-CC-A7IF	254	1	days	649	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		59				TCGA-CC-A7IF-F69922	TCGA-CC-A7IF	TCGA-CC-A7IF-01A								-21845	236	649	0	0		254	3						2015-1-22	MALE	169	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	380			NO	NO	G1	Lung	New Primary Tumor		No	NO	YES	No	true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A7IF.4CD1A49C-2243-4F21-BF19-EB6F069D431E.pdf	A7IF	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	58	2013	TCGA-CC-A7IF-01A-11D-A33B-01	TCGA-CC-A7IF-01A-11D-A33B-01	TCGA-CC-A7IF-01A-11D-A33K-10	TCGA-CC-A7IF-01	TCGA-CC-A7IF-01	0CC0E36D-2924-43A0-BE95-40D8B37E6D94	cb8ca883-8695-48c3-9ab4-2f3a84e562ef	TCGA-CC-A7IF-01A-11D-A33K-10	TCGA-CC-A7IF-01	TCGA-CC-A7IF-01	cb8ca883-8695-48c3-9ab4-2f3a84e562ef	TCGA-CC-A7IF-01A-11D-A33K-10	cb8ca883-8695-48c3-9ab4-2f3a84e562ef	cb8ca883-8695-48c3-9ab4-2f3a84e562ef	TCGA-CC-A7IF-01A-11D-A33K-10	TCGA-CC-A7IF-01A-11D-A33L-05
TCGA-CC-A7IG-01	1	TCGA-CC-A7IG-01	299	1	days	TCGA-CC-A7IG	195	1	days	299	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		47				TCGA-CC-A7IG-F69702	TCGA-CC-A7IG	TCGA-CC-A7IG-01A								-17453	239	299	0	0		195	2						2015-1-16	MALE	174	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	210			NO	NO	G2		Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T2	Stage II	TCGA-CC-A7IG.FF015D7F-02CD-485E-83B6-8C533DE83B2A.pdf	A7IG	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	62	2013	TCGA-CC-A7IG-01A-11D-A33B-01	TCGA-CC-A7IG-01A-11D-A33B-01	TCGA-CC-A7IG-01A-11D-A33K-10	TCGA-CC-A7IG-01	TCGA-CC-A7IG-01	7567BCA8-9934-401C-A0C2-F835EB05C5B8	0caa8897-d988-4898-8c6a-c706598b9b94	TCGA-CC-A7IG-01A-11D-A33K-10	TCGA-CC-A7IG-01	TCGA-CC-A7IG-01	0caa8897-d988-4898-8c6a-c706598b9b94	TCGA-CC-A7IG-01A-11D-A33K-10	0caa8897-d988-4898-8c6a-c706598b9b94	0caa8897-d988-4898-8c6a-c706598b9b94	TCGA-CC-A7IG-01A-11D-A33K-10	TCGA-CC-A7IG-01A-11D-A33L-05
TCGA-CC-A7IH-01	0	TCGA-CC-A7IH-01	365	0	days	TCGA-CC-A7IH	365	0	days	365	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				58				TCGA-CC-A7IH-F69920	TCGA-CC-A7IH	TCGA-CC-A7IH-01A								-21381	181		0	365			3						2015-1-22	MALE	175	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	190			NO	NO	G1						NO		true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A7IH.643C84D1-C247-4CA6-84C3-38ED99E886F6.pdf	A7IH	TUMOR FREE				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	56	2013	TCGA-CC-A7IH-01A-11D-A33B-01	TCGA-CC-A7IH-01A-11D-A33B-01	TCGA-CC-A7IH-01A-11D-A33K-10	TCGA-CC-A7IH-01	TCGA-CC-A7IH-01	0012F1FF-DA7A-46FD-895D-6AFE2F19CF89	8d017f32-1008-4312-b94e-a98be428973f	TCGA-CC-A7IH-01A-11D-A33K-10	TCGA-CC-A7IH-01	TCGA-CC-A7IH-01	8d017f32-1008-4312-b94e-a98be428973f	TCGA-CC-A7IH-01A-11D-A33K-10	8d017f32-1008-4312-b94e-a98be428973f	8d017f32-1008-4312-b94e-a98be428973f	TCGA-CC-A7IH-01A-11D-A33K-10	TCGA-CC-A7IH-01A-11D-A33L-05
TCGA-CC-A7II-01	0	TCGA-CC-A7II-01	399	0	days	TCGA-CC-A7II	278	1	days	399	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		54				TCGA-CC-A7II-F69918	TCGA-CC-A7II	TCGA-CC-A7II-01A								-20079	169		0	399		278	2						2015-1-22	MALE	168	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	400			NO	NO	G3		Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A7II.A5E3C73D-B84B-4D1C-858F-4B4392341610.pdf	A7II	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	52	2013	TCGA-CC-A7II-01A-11D-A33B-01	TCGA-CC-A7II-01A-11D-A33B-01	TCGA-CC-A7II-01A-11D-A33K-10	TCGA-CC-A7II-01	TCGA-CC-A7II-01	7BBE03C6-0221-4D78-829D-75FE8E98D5C0	097f54ce-6270-4e1f-bd7a-f55ed185bead	TCGA-CC-A7II-01A-11D-A33K-10	TCGA-CC-A7II-01	TCGA-CC-A7II-01	097f54ce-6270-4e1f-bd7a-f55ed185bead	TCGA-CC-A7II-01A-11D-A33K-10	097f54ce-6270-4e1f-bd7a-f55ed185bead	097f54ce-6270-4e1f-bd7a-f55ed185bead	TCGA-CC-A7II-01A-11D-A33K-10	TCGA-CC-A7II-01A-11D-A33L-05
TCGA-CC-A7IJ-01	0	TCGA-CC-A7IJ-01	382	0	days	TCGA-CC-A7IJ	382	0	days	382	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				56				TCGA-CC-A7IJ-F69704	TCGA-CC-A7IJ	TCGA-CC-A7IJ-01A								-20751	168		0	382			2						2015-1-16	MALE	165	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	270			NO	NO	G3						NO		true	No	M0	N0	T2	Stage II	TCGA-CC-A7IJ.0FF7D013-EAEC-4406-B314-0ECEA7B59E69.pdf	A7IJ	TUMOR FREE				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	54	2013	TCGA-CC-A7IJ-01A-11D-A33P-01	TCGA-CC-A7IJ-01A-11D-A33P-01	TCGA-CC-A7IJ-01A-11D-A33Q-10	TCGA-CC-A7IJ-01	TCGA-CC-A7IJ-01	3C457C98-F4B2-4C93-8127-0CCC18DC0600	96863e50-5c9b-4bee-8870-8c938aa66633	TCGA-CC-A7IJ-01A-11D-A33Q-10	TCGA-CC-A7IJ-01	TCGA-CC-A7IJ-01	96863e50-5c9b-4bee-8870-8c938aa66633	TCGA-CC-A7IJ-01A-11D-A33Q-10	96863e50-5c9b-4bee-8870-8c938aa66633	96863e50-5c9b-4bee-8870-8c938aa66633	TCGA-CC-A7IJ-01A-11D-A33Q-10	TCGA-CC-A7IJ-01A-11D-A341-05
TCGA-CC-A7IK-01	1	TCGA-CC-A7IK-01	262	1	days	TCGA-CC-A7IK	150	1	days	262	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		59				TCGA-CC-A7IK-F69705	TCGA-CC-A7IK	TCGA-CC-A7IK-01A								-21552	163	262	0	0		150	2						2015-1-16	MALE	168	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	470			NO	NO	G3		Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A7IK.6944ABF0-8C64-48D5-920A-6FA6DAC8A57B.pdf	A7IK	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	57	2013	TCGA-CC-A7IK-01A-12D-A33P-01	TCGA-CC-A7IK-01A-12D-A33P-01	TCGA-CC-A7IK-01A-12D-A33Q-10	TCGA-CC-A7IK-01	TCGA-CC-A7IK-01	E37E4FA6-4FFA-439E-9AC5-973B0B09546E	acaa569c-eed9-471d-8eb2-4723eb07c00b	TCGA-CC-A7IK-01A-12D-A33Q-10	TCGA-CC-A7IK-01	TCGA-CC-A7IK-01	acaa569c-eed9-471d-8eb2-4723eb07c00b	TCGA-CC-A7IK-01A-12D-A33Q-10	acaa569c-eed9-471d-8eb2-4723eb07c00b	acaa569c-eed9-471d-8eb2-4723eb07c00b	TCGA-CC-A7IK-01A-12D-A33Q-10	TCGA-CC-A7IK-01A-12D-A341-05
TCGA-CC-A7IL-01	1	TCGA-CC-A7IL-01	278	1	days	TCGA-CC-A7IL	179	1	days	278	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		61				TCGA-CC-A7IL-F69706	TCGA-CC-A7IL	TCGA-CC-A7IL-01A								-22319	161	278	0	0		179	2						2015-1-16	MALE	174	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	230			NO	NO	G1		Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A7IL.2C629C1E-6849-47F6-B9B4-A97BC0453EFF.pdf	A7IL	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	63	2013	TCGA-CC-A7IL-01A-11D-A33P-01	TCGA-CC-A7IL-01A-11D-A33P-01	TCGA-CC-A7IL-01A-11D-A33Q-10	TCGA-CC-A7IL-01	TCGA-CC-A7IL-01	89E30AE9-EC3D-41A9-B00C-AAC64C23348D	e198c43b-5d3f-4fe6-8f3c-09642a2b4995	TCGA-CC-A7IL-01A-11D-A33Q-10	TCGA-CC-A7IL-01	TCGA-CC-A7IL-01	e198c43b-5d3f-4fe6-8f3c-09642a2b4995	TCGA-CC-A7IL-01A-11D-A33Q-10	e198c43b-5d3f-4fe6-8f3c-09642a2b4995	e198c43b-5d3f-4fe6-8f3c-09642a2b4995	TCGA-CC-A7IL-01A-11D-A33Q-10	TCGA-CC-A7IL-01A-11D-A341-05
TCGA-CC-A8HS-01	1	TCGA-CC-A8HS-01	300	1	days	TCGA-CC-A8HS	201	1	days	300	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		18				TCGA-CC-A8HS-F69707	TCGA-CC-A8HS	TCGA-CC-A8HS-01A								-6617	223	300	0	0		201	3						2015-1-16	MALE	172	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	240			NO	NO	G1		Locoregional Recurrence		No	NO	YES	No	true	No	M0	N1	T3	Stage IIIC	TCGA-CC-A8HS.D7967904-FE4B-4BB5-92B2-5354404AC939.pdf	A8HS	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	62	2013			TCGA-CC-A8HS-01A-11D-A35Z-10	TCGA-CC-A8HS-01	TCGA-CC-A8HS-01	5FDE4663-91E1-4017-ABF8-9B5A895A772D	c8c2f5d3-a744-4bff-acdb-ada38d8dd074		TCGA-CC-A8HS-01		c8c2f5d3-a744-4bff-acdb-ada38d8dd074		c8c2f5d3-a744-4bff-acdb-ada38d8dd074	c8c2f5d3-a744-4bff-acdb-ada38d8dd074		TCGA-CC-A8HS-01A-11D-A369-05
TCGA-CC-A8HT-01	1	TCGA-CC-A8HT-01	140	1	days	TCGA-CC-A8HT	83	1	days	140	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		74				TCGA-CC-A8HT-F69842	TCGA-CC-A8HT	TCGA-CC-A8HT-01A								-27334	197	140	0	0		83	4						2015-1-21	MALE	159	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	170			NO	NO	G2		Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A8HT.0D2B4676-F045-4259-A18C-47EA5DF8E7A2.pdf	A8HT	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	48	2013	TCGA-CC-A8HT-01A-11D-A35Y-01	TCGA-CC-A8HT-01A-11D-A35Y-01	TCGA-CC-A8HT-01A-11D-A35Z-10	TCGA-CC-A8HT-01	TCGA-CC-A8HT-01	F16A4EEA-9AE9-4C17-AE6E-4FEA4F3A6611	33b64021-96cf-4916-92db-948b9a767d1b		TCGA-CC-A8HT-01	TCGA-CC-A8HT-01	33b64021-96cf-4916-92db-948b9a767d1b		33b64021-96cf-4916-92db-948b9a767d1b	33b64021-96cf-4916-92db-948b9a767d1b		TCGA-CC-A8HT-01A-11D-A369-05
TCGA-CC-A8HU-01	1	TCGA-CC-A8HU-01	344	1	days	TCGA-CC-A8HU	301	1	days	344	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		39				TCGA-CC-A8HU-F69708	TCGA-CC-A8HU	TCGA-CC-A8HU-01A								-14367	141	344	0	0		301	3						2015-1-16	FEMALE	163	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	360			NO	NO	G3		Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A8HU.CBCE823C-E6F5-4718-97F0-2705BE3C855A.pdf	A8HU	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	42	2013	TCGA-CC-A8HU-01A-11D-A35Y-01	TCGA-CC-A8HU-01A-11D-A35Y-01	TCGA-CC-A8HU-01A-11D-A35Z-10	TCGA-CC-A8HU-01	TCGA-CC-A8HU-01	55506EEF-798F-408E-96D6-E687AB8C340B	81b1e9c2-4184-42bd-86ac-a8452d7ca9ec		TCGA-CC-A8HU-01	TCGA-CC-A8HU-01	81b1e9c2-4184-42bd-86ac-a8452d7ca9ec		81b1e9c2-4184-42bd-86ac-a8452d7ca9ec	81b1e9c2-4184-42bd-86ac-a8452d7ca9ec		TCGA-CC-A8HU-01A-11D-A369-05
TCGA-CC-A8HV-01	1	TCGA-CC-A8HV-01	279	1	days	TCGA-CC-A8HV	149	1	days	279	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO		51				TCGA-CC-A8HV-F69784	TCGA-CC-A8HV	TCGA-CC-A8HV-01A								-18935	140	279	0	0		149	2						2015-1-19	FEMALE	159	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	230			NO	NO	G2		Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T2	Stage II	TCGA-CC-A8HV.8C178CD4-7D29-4584-B41B-BAE67890DBEB.pdf	A8HV	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	51	2013	TCGA-CC-A8HV-01A-11D-A40C-01	TCGA-CC-A8HV-01A-11D-A40C-01	TCGA-CC-A8HV-01A-11D-A35Z-10	TCGA-CC-A8HV-01	TCGA-CC-A8HV-01	B4CB08BD-E5B7-4266-B8DC-AF5DBA49E929	2eabe1cd-7b0a-4a9f-a26b-c43dd0f61e44		TCGA-CC-A8HV-01	TCGA-CC-A8HV-01	2eabe1cd-7b0a-4a9f-a26b-c43dd0f61e44		2eabe1cd-7b0a-4a9f-a26b-c43dd0f61e44	2eabe1cd-7b0a-4a9f-a26b-c43dd0f61e44		TCGA-CC-A8HV-01A-11D-A369-05
TCGA-CC-A9FS-01	0	TCGA-CC-A9FS-01	211	0	days	TCGA-CC-A9FS	109	1	days	211	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		55				TCGA-CC-A9FS-F69914	TCGA-CC-A9FS									-20157			0	211		109	2						2015-1-22	MALE	174	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES					NO	G2	Lung	New Primary Tumor		No	NO	YES	No		No	M0	N0	T2	Stage II		A9FS	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver			Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	72	2013	TCGA-CC-A9FS-01A-11D-A36W-01	TCGA-CC-A9FS-01A-11D-A36W-01	TCGA-CC-A9FS-01A-11D-A36X-10	TCGA-CC-A9FS-01	TCGA-CC-A9FS-01		cebcb67f-7a10-479f-a49a-b60030e0cc11		TCGA-CC-A9FS-01	TCGA-CC-A9FS-01	cebcb67f-7a10-479f-a49a-b60030e0cc11		cebcb67f-7a10-479f-a49a-b60030e0cc11	cebcb67f-7a10-479f-a49a-b60030e0cc11		TCGA-CC-A9FS-01A-11D-A36Y-05
TCGA-CC-A9FU-01		TCGA-CC-A9FU-01			days	TCGA-CC-A9FU			days		days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				52					TCGA-CC-A9FU	TCGA-CC-A9FU-01A								-19326	205		0	0									2014-8-22	FEMALE	153	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	220			NO		G2						NO		true	No	M0	N0	T3a	Stage IIIA	TCGA-CC-A9FU.95F22F75-89A6-4B67-BDF2-A357825453EF.pdf	A9FU	TUMOR FREE								NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	48	2013	TCGA-CC-A9FU-01A-11D-A36W-01	TCGA-CC-A9FU-01A-11D-A36W-01	TCGA-CC-A9FU-01A-11D-A36X-10	TCGA-CC-A9FU-01	TCGA-CC-A9FU-01		654a532f-71be-4ce2-9102-e73dde083ab1		TCGA-CC-A9FU-01	TCGA-CC-A9FU-01	654a532f-71be-4ce2-9102-e73dde083ab1		654a532f-71be-4ce2-9102-e73dde083ab1	654a532f-71be-4ce2-9102-e73dde083ab1		TCGA-CC-A9FU-01A-11D-A36Y-05
TCGA-CC-A9FV-01		TCGA-CC-A9FV-01			days	TCGA-CC-A9FV			days		days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				57					TCGA-CC-A9FV	TCGA-CC-A9FV-01A								-21044	184		0	0									2014-8-22	MALE	165	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	420			NO		G2						NO		true	No	M0	N0	T3	Stage IIIA	TCGA-CC-A9FV.01A31339-0FAD-4D49-ACD1-E357D32C887B.pdf	A9FV	TUMOR FREE								NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	59	2013	TCGA-CC-A9FV-01A-11D-A36W-01	TCGA-CC-A9FV-01A-11D-A36W-01	TCGA-CC-A9FV-01A-11D-A36X-10	TCGA-CC-A9FV-01	TCGA-CC-A9FV-01		6fdf4f1c-5fac-46b4-bb5c-c23dae9bf215		TCGA-CC-A9FV-01	TCGA-CC-A9FV-01	6fdf4f1c-5fac-46b4-bb5c-c23dae9bf215		6fdf4f1c-5fac-46b4-bb5c-c23dae9bf215	6fdf4f1c-5fac-46b4-bb5c-c23dae9bf215		TCGA-CC-A9FV-01A-11D-A36Y-05
TCGA-CC-A9FW-01	0	TCGA-CC-A9FW-01	248	0	days	TCGA-CC-A9FW	153	1	days	248	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		68				TCGA-CC-A9FW-F69912	TCGA-CC-A9FW									-24891			0	248		153	3						2015-1-22	MALE	175	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES					NO	G2		Locoregional Recurrence		No	NO	YES	No		No	M0	N0	T3	Stage IIIA		A9FW	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	6th	YES	NO	CC		Liver			Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	67	2013	TCGA-CC-A9FW-01A-11D-A36W-01	TCGA-CC-A9FW-01A-11D-A36W-01	TCGA-CC-A9FW-01A-11D-A36X-10	TCGA-CC-A9FW-01	TCGA-CC-A9FW-01		c05ba7f7-a80f-4cea-ac20-5935edc5c4d1		TCGA-CC-A9FW-01	TCGA-CC-A9FW-01	c05ba7f7-a80f-4cea-ac20-5935edc5c4d1		c05ba7f7-a80f-4cea-ac20-5935edc5c4d1	c05ba7f7-a80f-4cea-ac20-5935edc5c4d1		TCGA-CC-A9FW-01A-11D-A36Y-05
TCGA-DD-A113-01	0	TCGA-DD-A113-01	2425	0	days	TCGA-DD-A113	1676	1	days	2425	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	55	3.5	4.3	5.0	TCGA-DD-A113-F38777	TCGA-DD-A113	TCGA-DD-A113-01A	0.1	0.5		A	0.7	1.2	0.8	-20188	1650		0	2425	1678	1676	1	0	6	133	0 - No Fibrosis		2012-12-21	FEMALE	154	Other	Smoking	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	110	0.9	1.2	NO	NO	G3	Liver	Intrahepatic Recurrence		Yes	YES	YES	No	false	No	M0	N0	T2	Stage II	TCGA-DD-A113.F0D7BCB4-D3C3-491A-BDE2-8E77E77F1655.pdf	A113	WITH TUMOR	365	150	450	NO	NO	0.9	NO		R0	R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	Micro	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	56	2006	TCGA-DD-A113-01A-11D-A12Y-01	TCGA-DD-A113-01A-11D-A12Y-01	TCGA-DD-A113-01A-11D-A12Z-10	TCGA-DD-A113-01	TCGA-DD-A113-01		32faf34e-96a7-4668-9edb-a9addeceda95	TCGA-DD-A113-01A-11D-A12Z-10	TCGA-DD-A113-01	TCGA-DD-A113-01	32faf34e-96a7-4668-9edb-a9addeceda95	TCGA-DD-A113-01A-11D-A12Z-10	32faf34e-96a7-4668-9edb-a9addeceda95	32faf34e-96a7-4668-9edb-a9addeceda95	TCGA-DD-A113-01A-11D-A12Z-10	TCGA-DD-A113-01A-11D-A132-05
TCGA-DD-A113-11	0	TCGA-DD-A113-11	2425	0	days	TCGA-DD-A113	1676	1	days	2425	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	55	3.5	4.3	5.0	TCGA-DD-A113-F38777	TCGA-DD-A113		0.1	0.5		A	0.7	1.2	0.8	-20188			0	2425	1678	1676	1	0	6	133	0 - No Fibrosis		2012-12-21	FEMALE	154	Other	Smoking	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.9	1.2		NO	G3	Liver	Intrahepatic Recurrence		Yes	YES	YES	No		No	M0	N0	T2	Stage II		A113	WITH TUMOR	365	150	450	NO	NO	0.9	NO		R0	R0	Solid Tissue Normal	11	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	Micro		Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	56	2006				TCGA-DD-A113-11			c6842e1d-4f63-458c-9287-0326c03a69c9		TCGA-DD-A113-11		c6842e1d-4f63-458c-9287-0326c03a69c9		c6842e1d-4f63-458c-9287-0326c03a69c9	c6842e1d-4f63-458c-9287-0326c03a69c9		TCGA-DD-A113-11A-12D-A132-05
TCGA-DD-A114-01	1	TCGA-DD-A114-01	1149	1	days	TCGA-DD-A114	1149	0	days	1149	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	42	3.5	3.5	5.0	TCGA-DD-A114-F38779	TCGA-DD-A114	TCGA-DD-A114-01A	0.1	2.5		A	0.9	1.4	1.2	-15410	2063	1149	0				1	0	6	21	5 - Nodular Formation and Incomplete Cirrhosis		2012-12-21	MALE	173	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	250	0.9	1.2	NO	NO	G3						NO		false	No	M0		T2	Stage II	TCGA-DD-A114.BACAFF9B-FAC1-49A8-8C56-A0A26794AA1E.pdf	A114	TUMOR FREE	185	150	450	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.0	Liver	Micro	A	Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	74	2005	TCGA-DD-A114-01A-11D-A12Y-01	TCGA-DD-A114-01A-11D-A12Y-01	TCGA-DD-A114-01A-11D-A12Z-10	TCGA-DD-A114-01	TCGA-DD-A114-01	63446327-F5E2-4CEA-909A-0E67787B85F0	6cff6851-4d3c-479d-a83a-e579953f6b18	TCGA-DD-A114-01A-11D-A12Z-10	TCGA-DD-A114-01	TCGA-DD-A114-01	6cff6851-4d3c-479d-a83a-e579953f6b18	TCGA-DD-A114-01A-11D-A12Z-10	6cff6851-4d3c-479d-a83a-e579953f6b18	6cff6851-4d3c-479d-a83a-e579953f6b18	TCGA-DD-A114-01A-11D-A12Z-10	TCGA-DD-A114-01A-11D-A132-05
TCGA-DD-A114-11	1	TCGA-DD-A114-11	1149	1	days	TCGA-DD-A114	1149	0	days	1149	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	42	3.5	3.5	5.0	TCGA-DD-A114-F38779	TCGA-DD-A114		0.1	2.5		A	0.9	1.4	1.2	-15410		1149	0				1	0	6	21	5 - Nodular Formation and Incomplete Cirrhosis		2012-12-21	MALE	173	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.9	1.2		NO	G3						NO			No	M0		T2	Stage II		A114	TUMOR FREE	185	150	450	NO	NO	1.0	NO	NO		R0	Solid Tissue Normal	11	Lobectomy	6th	NO	YES	DD	1.0	Liver	Micro		Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	74	2005				TCGA-DD-A114-11			fbeec4cf-0ad3-4e9e-bfc1-d112b1e51b3a		TCGA-DD-A114-11		fbeec4cf-0ad3-4e9e-bfc1-d112b1e51b3a		fbeec4cf-0ad3-4e9e-bfc1-d112b1e51b3a	fbeec4cf-0ad3-4e9e-bfc1-d112b1e51b3a		TCGA-DD-A114-11A-12D-A132-05
TCGA-DD-A115-01	1	TCGA-DD-A115-01	2542	1	days	TCGA-DD-A115	469	1	days	2542	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	53	3.5	4.1	5.0	TCGA-DD-A115-F38780	TCGA-DD-A115	TCGA-DD-A115-01A	0.1	0.6		A	0.1	1.2	1.1	-19697	3198	2542	0			469	0	0	6	10	0 - No Fibrosis		2012-12-21	MALE	168	Alcohol consumption	Smoking	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	230			NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	false	No	M0	N0	T3	Stage IIIA	TCGA-DD-A115.C0EAB9A6-AAA3-48D5-AE3F-A428D828D63C.pdf	A115	WITH TUMOR	337	150	450	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Extended Lobectomy	5th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	79	2002	TCGA-DD-A115-01A-11D-A12Y-01	TCGA-DD-A115-01A-11D-A12Y-01	TCGA-DD-A115-01A-11D-A12Z-10	TCGA-DD-A115-01	TCGA-DD-A115-01	BD79C5A6-BBA6-424B-BFB8-9F4D495E31F4	bb55462c-2475-4a92-98e4-9119b26c0c82	TCGA-DD-A115-01A-11D-A12Z-10	TCGA-DD-A115-01	TCGA-DD-A115-01	bb55462c-2475-4a92-98e4-9119b26c0c82	TCGA-DD-A115-01A-11D-A12Z-10	bb55462c-2475-4a92-98e4-9119b26c0c82	bb55462c-2475-4a92-98e4-9119b26c0c82	TCGA-DD-A115-01A-11D-A12Z-10	TCGA-DD-A115-01A-11D-A132-05
TCGA-DD-A115-11	1	TCGA-DD-A115-11	2542	1	days	TCGA-DD-A115	469	1	days	2542	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	53	3.5	4.1	5.0	TCGA-DD-A115-F38780	TCGA-DD-A115	TCGA-DD-A115-11A	0.1	0.6		A	0.1	1.2	1.1	-19697	3198	2542	0			469	0	0	6	10	0 - No Fibrosis		2012-12-21	MALE	168	Alcohol consumption	Smoking	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	170			NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	false	No	M0	N0	T3	Stage IIIA		A115	WITH TUMOR	337	150	450	NO	NO	1.0	NO	NO		R0	Solid Tissue Normal	11	Extended Lobectomy	5th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	79	2002																TCGA-DD-A115-11A-12D-A132-05
TCGA-DD-A116-01	1	TCGA-DD-A116-01	1622	1	days	TCGA-DD-A116	828	1	days	1622	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	YES		68	3.5	4.1	5.0	TCGA-DD-A116-F38781	TCGA-DD-A116	TCGA-DD-A116-01A	0.1	1.1	0	A	0.8	1.4	1.1	-24934	3208	1622	0		1023	828	1	0	6	24	3,4 - Fibrous Speta		2012-12-21	MALE	175	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	170			NO	NO	G3	Other, specify	Extrahepatic Recurrence	sternum	No	YES	YES	No	false	No	M0	N0	T3	Stage IIIA	TCGA-DD-A116.0914680E-B846-4370-920D-FEB06F609EE5.pdf	A116	TUMOR FREE	157	150	450	NO	NO	1.0	YES	NO	R0	R0	Primary Tumor	01	Segmentectomy, Multiple	5th	NO	YES	DD	1.0	Liver		A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	73	2002	TCGA-DD-A116-01A-11D-A12Y-01	TCGA-DD-A116-01A-11D-A12Y-01	TCGA-DD-A116-01A-11D-A12Z-10	TCGA-DD-A116-01	TCGA-DD-A116-01	A1871661-C3B8-42AA-B48F-765AD96F0ADB	6dcfd83a-74cb-447c-ab0d-40894fa9d359	TCGA-DD-A116-01A-11D-A12Z-10	TCGA-DD-A116-01	TCGA-DD-A116-01	6dcfd83a-74cb-447c-ab0d-40894fa9d359	TCGA-DD-A116-01A-11D-A12Z-10	6dcfd83a-74cb-447c-ab0d-40894fa9d359	6dcfd83a-74cb-447c-ab0d-40894fa9d359	TCGA-DD-A116-01A-11D-A12Z-10	TCGA-DD-A116-01A-11D-A132-05
TCGA-DD-A116-11	1	TCGA-DD-A116-11	1622	1	days	TCGA-DD-A116	828	1	days	1622	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	YES		68	3.5	4.1	5.0	TCGA-DD-A116-F38781	TCGA-DD-A116	TCGA-DD-A116-11A	0.1	1.1	0	A	0.8	1.4	1.1	-24934	3208	1622	0		1023	828	1	0	6	24	3,4 - Fibrous Speta		2012-12-21	MALE	175	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	170			NO	NO	G3	Other, specify	Extrahepatic Recurrence	sternum	No	YES	YES	No	false	No	M0	N0	T3	Stage IIIA		A116	TUMOR FREE	157	150	450	NO	NO	1.0	YES	NO	R0	R0	Solid Tissue Normal	11	Segmentectomy, Multiple	5th	NO	YES	DD	1.0	Liver		A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	73	2002							f099f7fb-f07a-4529-83dc-e7023c52a999				f099f7fb-f07a-4529-83dc-e7023c52a999		f099f7fb-f07a-4529-83dc-e7023c52a999	f099f7fb-f07a-4529-83dc-e7023c52a999		TCGA-DD-A116-11A-11D-A132-05
TCGA-DD-A118-01	0	TCGA-DD-A118-01	3437	0	days	TCGA-DD-A118	658	1	days	3437	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	77	3.4	3.4	4.8	TCGA-DD-A118-F38782	TCGA-DD-A118	TCGA-DD-A118-01A	0.1	0.5		A	0.7	1.2	0.9	-28406	2854		0	3437	659	658	1	0	6	85150	0 - No Fibrosis		2012-12-21	FEMALE	169			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	30			NO	NO	G2	Other, specify	Extrahepatic Recurrence	lateral to the C-loop of the duodenum, anterior to the right  kidney	No	YES	YES	No	false	No	M0	N0	T2	Stage II	TCGA-DD-A118.74D4EB64-F12B-470D-8A7C-EDD24CD1448D.pdf	A118		381	150	450	NO	NO	1.0	NO	NO	R0	R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	75	2003	TCGA-DD-A118-01A-11D-A12Y-01	TCGA-DD-A118-01A-11D-A12Y-01	TCGA-DD-A118-01A-11D-A12Z-10	TCGA-DD-A118-01	TCGA-DD-A118-01	443B7BF5-9A6A-43F6-BCD9-DDF6498FEF31	20d6834b-5766-4f4a-b30d-8c14195ec7ed	TCGA-DD-A118-01A-11D-A12Z-10	TCGA-DD-A118-01	TCGA-DD-A118-01	20d6834b-5766-4f4a-b30d-8c14195ec7ed	TCGA-DD-A118-01A-11D-A12Z-10	20d6834b-5766-4f4a-b30d-8c14195ec7ed	20d6834b-5766-4f4a-b30d-8c14195ec7ed	TCGA-DD-A118-01A-11D-A12Z-10	TCGA-DD-A118-01A-11D-A132-05
TCGA-DD-A118-11	0	TCGA-DD-A118-11	3437	0	days	TCGA-DD-A118	658	1	days	3437	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	77	3.4	3.4	4.8	TCGA-DD-A118-F38782	TCGA-DD-A118	TCGA-DD-A118-11A	0.1	0.5		A	0.7	1.2	0.9	-28406	2854		0	3437	659	658	1	0	6	85150	0 - No Fibrosis		2012-12-21	FEMALE	169			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	60			NO	NO	G2	Other, specify	Extrahepatic Recurrence	lateral to the C-loop of the duodenum, anterior to the right  kidney	No	YES	YES	No	false	No	M0	N0	T2	Stage II		A118		381	150	450	NO	NO	1.0	NO	NO	R0	R0	Solid Tissue Normal	11	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	75	2003				TCGA-DD-A118-11			485b184d-15f1-4858-9e06-330d5258cfff		TCGA-DD-A118-11		485b184d-15f1-4858-9e06-330d5258cfff		485b184d-15f1-4858-9e06-330d5258cfff	485b184d-15f1-4858-9e06-330d5258cfff		TCGA-DD-A118-11A-11D-A132-05
TCGA-DD-A119-01	1	TCGA-DD-A119-01	223	1	days	TCGA-DD-A119			days	223	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	40	3.5	3.9	5.0	TCGA-DD-A119-F38783	TCGA-DD-A119	TCGA-DD-A119-01A	0.1	1.6	2	A	0.9	1.4	1.3	-14613	2738	223	0				1	0	6	1836	0 - No Fibrosis		2012-12-21	MALE	160	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	160			NO	NO	G3								false	No	M1	N0	T3a	Stage IV	TCGA-DD-A119.F8B8C948-933A-4B28-A0D1-98166C9B16EF.pdf	A119		572	150	450			1.0		YES		R2	Primary Tumor	01	Extended Lobectomy	6th	NO	YES	DD	1.0	Liver	Micro	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	58	2003	TCGA-DD-A119-01A-11D-A12Y-01	TCGA-DD-A119-01A-11D-A12Y-01	TCGA-DD-A119-01A-11D-A12Z-10	TCGA-DD-A119-01	TCGA-DD-A119-01	7E545BB7-0EB0-4AC5-AC91-9B50DFA1A13B	3d0d0f6b-4caa-4c53-b971-17466f076e95	TCGA-DD-A119-01A-11D-A12Z-10	TCGA-DD-A119-01	TCGA-DD-A119-01	3d0d0f6b-4caa-4c53-b971-17466f076e95	TCGA-DD-A119-01A-11D-A12Z-10	3d0d0f6b-4caa-4c53-b971-17466f076e95	3d0d0f6b-4caa-4c53-b971-17466f076e95	TCGA-DD-A119-01A-11D-A12Z-10	TCGA-DD-A119-01A-11D-A132-05
TCGA-DD-A119-11	1	TCGA-DD-A119-11	223	1	days	TCGA-DD-A119			days	223	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	40	3.5	3.9	5.0	TCGA-DD-A119-F38783	TCGA-DD-A119		0.1	1.6	2	A	0.9	1.4	1.3	-14613		223	0				1	0	6	1836	0 - No Fibrosis		2012-12-21	MALE	160	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES					NO	G3									No	M1	N0	T3a	Stage IV		A119		572	150	450			1.0		YES		R2	Solid Tissue Normal	11	Extended Lobectomy	6th	NO	YES	DD	1.0	Liver	Micro		Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	58	2003				TCGA-DD-A119-11			d5e600a3-d273-4879-ac33-1a72a02073e5		TCGA-DD-A119-11		d5e600a3-d273-4879-ac33-1a72a02073e5		d5e600a3-d273-4879-ac33-1a72a02073e5	d5e600a3-d273-4879-ac33-1a72a02073e5		TCGA-DD-A119-11A-11D-A132-05
TCGA-DD-A11A-01	0	TCGA-DD-A11A-01	79	0	days	TCGA-DD-A11A			days	79	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	67				TCGA-DD-A11A-F38784	TCGA-DD-A11A	TCGA-DD-A11A-01A	0.1	3.6			0.9	1.4	1.1	-24646	2184		0	79			0	0	6	223	0 - No Fibrosis		2012-12-21	MALE	156	Other	HBcAB total (+), HBsAg (-), HBcIgm Ab (-)	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	260			NO	YES	G3								false	No	M0	N0	T1	Stage I	TCGA-DD-A11A.E1571DB1-B1B2-4B0E-9A0A-01A4470353DF.pdf	A11A		513	150	450			1.0		NO		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Core Antibody	LIVING	67	2004	TCGA-DD-A11A-01A-11D-A12Y-01	TCGA-DD-A11A-01A-11D-A12Y-01	TCGA-DD-A11A-01A-11D-A12Z-10	TCGA-DD-A11A-01	TCGA-DD-A11A-01	789AC9AF-D425-4708-98CF-E6656BE1CCCB	2e96d65b-0247-40fc-a0e3-90fcb6feac3d	TCGA-DD-A11A-01A-11D-A12Z-10	TCGA-DD-A11A-01	TCGA-DD-A11A-01	2e96d65b-0247-40fc-a0e3-90fcb6feac3d	TCGA-DD-A11A-01A-11D-A12Z-10	2e96d65b-0247-40fc-a0e3-90fcb6feac3d	2e96d65b-0247-40fc-a0e3-90fcb6feac3d	TCGA-DD-A11A-01A-11D-A12Z-10	TCGA-DD-A11A-01A-11D-A132-05
TCGA-DD-A11A-11	0	TCGA-DD-A11A-11	79	0	days	TCGA-DD-A11A			days	79	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	67				TCGA-DD-A11A-F38784	TCGA-DD-A11A	TCGA-DD-A11A-11A	0.1	3.6			0.9	1.4	1.1	-24646	2184		0	79			0	0	6	223	0 - No Fibrosis		2012-12-21	MALE	156	Other	HBcAB total (+), HBsAg (-), HBcIgm Ab (-)	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	240			NO	YES	G3								false	No	M0	N0	T1	Stage I		A11A		513	150	450			1.0		NO		R0	Solid Tissue Normal	11	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Core Antibody	LIVING	67	2004				TCGA-DD-A11A-11			1f1a8329-397c-4ec8-a7cc-46ec9c48fa42		TCGA-DD-A11A-11		1f1a8329-397c-4ec8-a7cc-46ec9c48fa42		1f1a8329-397c-4ec8-a7cc-46ec9c48fa42	1f1a8329-397c-4ec8-a7cc-46ec9c48fa42		TCGA-DD-A11A-11A-11D-A132-05
TCGA-DD-A11B-01	1	TCGA-DD-A11B-01	14	1	days	TCGA-DD-A11B	14	0	days	14	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	73	3.5	3.9	5.0	TCGA-DD-A11B-F38785	TCGA-DD-A11B	TCGA-DD-A11B-01A	0.1	1.6		A	0.9	1.4	1.0	-26857	1975	14	0				1	0	6	15	6 - Established Cirrhosis		2012-12-21	MALE	181	Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	280	8.4	12.0	NO	NO	G2						NO		false	No	M0	N0	T1	Stage I	TCGA-DD-A11B.B53C4282-5266-43FE-A958-19097FD20290.pdf	A11B	TUMOR FREE	90	150	450	NO	NO	10.2	NO	NO		RX	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	134	2005	TCGA-DD-A11B-01A-11D-A12Y-01	TCGA-DD-A11B-01A-11D-A12Y-01	TCGA-DD-A11B-01A-11D-A12Z-10	TCGA-DD-A11B-01	TCGA-DD-A11B-01	76061131-4963-4848-8B8D-771C892D21D9	92802474-4e5b-46c9-a000-a4451ad43582	TCGA-DD-A11B-01A-11D-A12Z-10	TCGA-DD-A11B-01	TCGA-DD-A11B-01	92802474-4e5b-46c9-a000-a4451ad43582	TCGA-DD-A11B-01A-11D-A12Z-10	92802474-4e5b-46c9-a000-a4451ad43582	92802474-4e5b-46c9-a000-a4451ad43582	TCGA-DD-A11B-01A-11D-A12Z-10	TCGA-DD-A11B-01A-11D-A132-05
TCGA-DD-A11B-11	1	TCGA-DD-A11B-11	14	1	days	TCGA-DD-A11B	14	0	days	14	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	73	3.5	3.9	5.0	TCGA-DD-A11B-F38785	TCGA-DD-A11B	TCGA-DD-A11B-11A	0.1	1.6		A	0.9	1.4	1.0	-26857	1975	14	0				1	0	6	15	6 - Established Cirrhosis		2012-12-21	MALE	181	Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	320	8.4	12.0	NO	NO	G2						NO		false	No	M0	N0	T1	Stage I		A11B	TUMOR FREE	90	150	450	NO	NO	10.2	NO	NO		RX	Solid Tissue Normal	11	Segmentectomy, Single	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	134	2005				TCGA-DD-A11B-11			5b37433a-6415-497f-bf36-0f0b5c2ad21e		TCGA-DD-A11B-11		5b37433a-6415-497f-bf36-0f0b5c2ad21e		5b37433a-6415-497f-bf36-0f0b5c2ad21e	5b37433a-6415-497f-bf36-0f0b5c2ad21e		TCGA-DD-A11B-11A-11D-A132-05
TCGA-DD-A11C-01	0	TCGA-DD-A11C-01	662	0	days	TCGA-DD-A11C	662	0	days	662	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	69	3.5	3.6	5.0	TCGA-DD-A11C-F38786	TCGA-DD-A11C	TCGA-DD-A11C-01A	0.1	2.3	1	A	0.9	1.4	0.9	-25403	1703		0	662			1	0	6	11	0 - No Fibrosis		2012-12-21	MALE	186			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	220			NO	YES	G3						NO		false	No	M0	N0	T1	Stage I	TCGA-DD-A11C.35CD5B20-BF61-4D28-AC7F-2CDC959382CD.pdf	A11C	TUMOR FREE	391	150	450	NO	NO	1.0	NO	YES		RX	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	123	2006	TCGA-DD-A11C-01A-11D-A12Y-01	TCGA-DD-A11C-01A-11D-A12Y-01	TCGA-DD-A11C-01A-11D-A12Z-10	TCGA-DD-A11C-01	TCGA-DD-A11C-01	76C64559-2722-42D3-9C42-1734DB8DEF08	edc609e1-c791-4d5f-8ca1-272ce9b34289	TCGA-DD-A11C-01A-11D-A12Z-10	TCGA-DD-A11C-01	TCGA-DD-A11C-01	edc609e1-c791-4d5f-8ca1-272ce9b34289	TCGA-DD-A11C-01A-11D-A12Z-10	edc609e1-c791-4d5f-8ca1-272ce9b34289	edc609e1-c791-4d5f-8ca1-272ce9b34289	TCGA-DD-A11C-01A-11D-A12Z-10	TCGA-DD-A11C-01A-11D-A132-05
TCGA-DD-A11C-11	0	TCGA-DD-A11C-11	662	0	days	TCGA-DD-A11C	662	0	days	662	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	69	3.5	3.6	5.0	TCGA-DD-A11C-F38786	TCGA-DD-A11C		0.1	2.3	1	A	0.9	1.4	0.9	-25403			0	662			1	0	6	11	0 - No Fibrosis		2012-12-21	MALE	186			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES					YES	G3						NO			No	M0	N0	T1	Stage I		A11C	TUMOR FREE	391	150	450	NO	NO	1.0	NO	YES		RX	Solid Tissue Normal	11	Lobectomy	6th	NO	YES	DD	1.0	Liver	None		Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	123	2006				TCGA-DD-A11C-11			ba72262f-9361-4d4c-8fa0-cc44e26320f6		TCGA-DD-A11C-11		ba72262f-9361-4d4c-8fa0-cc44e26320f6		ba72262f-9361-4d4c-8fa0-cc44e26320f6	ba72262f-9361-4d4c-8fa0-cc44e26320f6		TCGA-DD-A11C-11A-11D-A132-05
TCGA-DD-A11D-01	1	TCGA-DD-A11D-01	1560	1	days	TCGA-DD-A11D	498	1	days	1560	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	57	3.5	4.5	5.0	TCGA-DD-A11D-F38787	TCGA-DD-A11D	TCGA-DD-A11D-01A	0.1	0.5	2	A	0.6	1.1	1.1	-21003	1731	1560	0			498	1	0	6	8	6 - Established Cirrhosis		2012-12-21	FEMALE	163	Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	300	0.9	1.2	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	false	No	M0	N0	T1	Stage I	TCGA-DD-A11D.8D1A74F7-E6C3-4557-917A-CA7273929ADF.pdf	A11D	WITH TUMOR	249	150	450	NO	NO	0.9	NO	YES		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A		DECEASED	73	2006	TCGA-DD-A11D-01A-11D-A12Y-01	TCGA-DD-A11D-01A-11D-A12Y-01	TCGA-DD-A11D-01A-11D-A12Z-10	TCGA-DD-A11D-01	TCGA-DD-A11D-01	808949E2-ABA5-44F8-A479-D21599DEC5AB	62a6d38d-34a2-4d06-962f-95cc89d582d4	TCGA-DD-A11D-01A-11D-A12Z-10	TCGA-DD-A11D-01	TCGA-DD-A11D-01	62a6d38d-34a2-4d06-962f-95cc89d582d4	TCGA-DD-A11D-01A-11D-A12Z-10	62a6d38d-34a2-4d06-962f-95cc89d582d4	62a6d38d-34a2-4d06-962f-95cc89d582d4	TCGA-DD-A11D-01A-11D-A12Z-10	TCGA-DD-A11D-01A-11D-A132-05
TCGA-DD-A11D-11	1	TCGA-DD-A11D-11	1560	1	days	TCGA-DD-A11D	498	1	days	1560	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	57	3.5	4.5	5.0	TCGA-DD-A11D-F38787	TCGA-DD-A11D	TCGA-DD-A11D-11A	0.1	0.5	2	A	0.6	1.1	1.1	-21003	1731	1560	0			498	1	0	6	8	6 - Established Cirrhosis		2012-12-21	FEMALE	163	Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	240	0.9	1.2	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	false	No	M0	N0	T1	Stage I		A11D	WITH TUMOR	249	150	450	NO	NO	0.9	NO	YES		R0	Solid Tissue Normal	11	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A		DECEASED	73	2006				TCGA-DD-A11D-11			8e70d12c-38fd-4da2-ad1e-b7f860959aa2		TCGA-DD-A11D-11		8e70d12c-38fd-4da2-ad1e-b7f860959aa2		8e70d12c-38fd-4da2-ad1e-b7f860959aa2	8e70d12c-38fd-4da2-ad1e-b7f860959aa2		TCGA-DD-A11D-11A-12D-A132-05
TCGA-DD-A1E9-01	1	TCGA-DD-A1E9-01	2759	1	days	TCGA-DD-A1E9	2759	0	days	2759	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Severe	70	3.5	4.1	5.0	TCGA-DD-A1E9-F42012	TCGA-DD-A1E9	TCGA-DD-A1E9-01A	0.1	13	4	A	0.8	1.3	0.9	-25808	3234	2759	0			720	1	0	6	202	6 - Established Cirrhosis		2013-4-9	MALE	172	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	100	8.4	12.0	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	NO	No	true	No	M0	N0	T1	Stage I	TCGA-DD-A1E9.07CF8AAC-8A8A-4E4C-BBDA-EDCD78608723.pdf	A1E9		110	150	450	NO	NO	10.4	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	5th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	101	2002	TCGA-DD-A1E9-01A-21D-A151-01	TCGA-DD-A1E9-01A-21D-A151-01	TCGA-DD-A1E9-01A-21D-A152-10			D93BA981-49B7-4E84-82FE-5AAF95EAA05C		TCGA-DD-A1E9-01A-21D-A152-10				TCGA-DD-A1E9-01A-21D-A152-10			TCGA-DD-A1E9-01A-21D-A152-10	TCGA-DD-A1E9-01A-21D-A153-05
TCGA-DD-A1E9-11	1	TCGA-DD-A1E9-11	2759	1	days	TCGA-DD-A1E9	2759	0	days	2759	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Severe	70	3.5	4.1	5.0	TCGA-DD-A1E9-F42012	TCGA-DD-A1E9	TCGA-DD-A1E9-11A	0.1	13	4	A	0.8	1.3	0.9	-25808	3234	2759	0			720	1	0	6	202	6 - Established Cirrhosis		2013-4-9	MALE	172	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	120	8.4	12.0	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	NO	No	true	No	M0	N0	T1	Stage I		A1E9		110	150	450	NO	NO	10.4	NO	YES		R0	Solid Tissue Normal	11	Segmentectomy, Multiple	5th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	101	2002																TCGA-DD-A1E9-11A-11D-A153-05
TCGA-DD-A1EA-01	0	TCGA-DD-A1EA-01	2415	0	days	TCGA-DD-A1EA	754	1	days	2415	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	68	3.5	3.3	5.0	TCGA-DD-A1EA-F42204	TCGA-DD-A1EA	TCGA-DD-A1EA-01A	0.1	0.9	1	A	0.8	1.3	1.2	-24925	3298		0	2415		754	0	0	6	3	1,2 - Portal Fibrosis		2013-4-15	MALE	168	Hepatitis B	smoking	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	80	8.3	10.8	NO	NO	G2	Liver	Locoregional Recurrence		Yes	NO	YES	No	true	No	M0	N0	T2	Stage II	TCGA-DD-A1EA.0B2D3D3C-78CC-4DB7-9A8C-92BF05CFB68B.pdf	A1EA	WITH TUMOR	209	150	450	NO	NO	10.2	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	5th	NO	YES	DD	1.0	Liver	Micro	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D	LIVING	94	2002	TCGA-DD-A1EA-01A-11D-A12Y-01	TCGA-DD-A1EA-01A-11D-A12Y-01	TCGA-DD-A1EA-01A-11D-A12Z-10	TCGA-DD-A1EA-01	TCGA-DD-A1EA-01		4e8c2054-b8f7-4754-b42d-4714edcee3c7	TCGA-DD-A1EA-01A-11D-A12Z-10	TCGA-DD-A1EA-01	TCGA-DD-A1EA-01	4e8c2054-b8f7-4754-b42d-4714edcee3c7	TCGA-DD-A1EA-01A-11D-A12Z-10	4e8c2054-b8f7-4754-b42d-4714edcee3c7	4e8c2054-b8f7-4754-b42d-4714edcee3c7	TCGA-DD-A1EA-01A-11D-A12Z-10	TCGA-DD-A1EA-01A-11D-A132-05
TCGA-DD-A1EB-01	0	TCGA-DD-A1EB-01	2017	0	days	TCGA-DD-A1EB	505	1	days	2017	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	72	3.5	3.7	5.0	TCGA-DD-A1EB-F42225	TCGA-DD-A1EB	TCGA-DD-A1EB-01A	0.1	0.3	1	B	0.6	1.1	1.3	-26471	3538		0	2017		505	1	0	6	7	0 - No Fibrosis		2013-4-15	FEMALE	164	Other	smoking	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	180	8.4	12.0	NO	YES	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-A1EB.40ABAF02-60C0-4997-AB0F-2B9A90F1FE3B.pdf	A1EB	TUMOR FREE	204	150	450	NO	NO	8.7	NO	YES		R0	Primary Tumor	01	Lobectomy	5th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	57	2001	TCGA-DD-A1EB-01A-11D-A12Y-01	TCGA-DD-A1EB-01A-11D-A12Y-01	TCGA-DD-A1EB-01A-11D-A12Z-10	TCGA-DD-A1EB-01	TCGA-DD-A1EB-01	17D465CF-A283-416B-B948-91BFE18168C2	bb931f9d-802e-4e02-b503-a637aa369e8b	TCGA-DD-A1EB-01A-11D-A12Z-10	TCGA-DD-A1EB-01	TCGA-DD-A1EB-01	bb931f9d-802e-4e02-b503-a637aa369e8b	TCGA-DD-A1EB-01A-11D-A12Z-10	bb931f9d-802e-4e02-b503-a637aa369e8b	bb931f9d-802e-4e02-b503-a637aa369e8b	TCGA-DD-A1EB-01A-11D-A12Z-10	TCGA-DD-A1EB-01A-11D-A132-05
TCGA-DD-A1EB-11	0	TCGA-DD-A1EB-11	2017	0	days	TCGA-DD-A1EB	505	1	days	2017	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	72	3.5	3.7	5.0	TCGA-DD-A1EB-F42225	TCGA-DD-A1EB		0.1	0.3	1	B	0.6	1.1	1.3	-26471			0	2017		505	1	0	6	7	0 - No Fibrosis		2013-4-15	FEMALE	164	Other	smoking	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.4	12.0		YES	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No		No	M0	N0	T1	Stage I		A1EB	TUMOR FREE	204	150	450	NO	NO	8.7	NO	YES		R0	Solid Tissue Normal	11	Lobectomy	5th	NO	YES	DD	1.0	Liver	None		Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	57	2001				TCGA-DD-A1EB-11			e55a12d6-3ec4-4346-8849-cf7525fff740		TCGA-DD-A1EB-11		e55a12d6-3ec4-4346-8849-cf7525fff740		e55a12d6-3ec4-4346-8849-cf7525fff740	e55a12d6-3ec4-4346-8849-cf7525fff740		TCGA-DD-A1EB-11A-11D-A132-05
TCGA-DD-A1EC-01	0	TCGA-DD-A1EC-01	602	0	days	TCGA-DD-A1EC	299	1	days	602	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	20	3.5	3.2	5.0	TCGA-DD-A1EC-F42201	TCGA-DD-A1EC	TCGA-DD-A1EC-01A	0.1	0.4		A	0.7	1.2	0.8	-7363	2254		0	602		299	1	0	6	2	0 - No Fibrosis		2013-4-15	FEMALE	157			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	110	8.4	12.0	NO	YES	G3	Other, specify	Extrahepatic Recurrence	peritoneal	No	NO	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-A1EC.7CF5361C-34F3-496F-A7FC-AF4E9F2BD859.pdf	A1EC		556	150	450	NO	NO	11.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	None	A		LIVING	50	2004	TCGA-DD-A1EC-01A-21D-A12Y-01	TCGA-DD-A1EC-01A-21D-A12Y-01	TCGA-DD-A1EC-01A-21D-A12Z-10	TCGA-DD-A1EC-01	TCGA-DD-A1EC-01	E364D0C2-AC0F-47AD-A720-ED09E8270F5E	7d73dcf5-7ddc-4df8-82f8-19fbb1f719ed	TCGA-DD-A1EC-01A-21D-A12Z-10	TCGA-DD-A1EC-01	TCGA-DD-A1EC-01	7d73dcf5-7ddc-4df8-82f8-19fbb1f719ed	TCGA-DD-A1EC-01A-21D-A12Z-10	7d73dcf5-7ddc-4df8-82f8-19fbb1f719ed	7d73dcf5-7ddc-4df8-82f8-19fbb1f719ed	TCGA-DD-A1EC-01A-21D-A12Z-10	TCGA-DD-A1EC-01A-21D-A132-05
TCGA-DD-A1EC-11	0	TCGA-DD-A1EC-11	602	0	days	TCGA-DD-A1EC	299	1	days	602	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	20	3.5	3.2	5.0	TCGA-DD-A1EC-F42201	TCGA-DD-A1EC		0.1	0.4		A	0.7	1.2	0.8	-7363			0	602		299	1	0	6	2	0 - No Fibrosis		2013-4-15	FEMALE	157			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.4	12.0		YES	G3	Other, specify	Extrahepatic Recurrence	peritoneal	No	NO	YES	No		No	M0	N0	T1	Stage I		A1EC		556	150	450	NO	NO	11.0	NO	NO		R0	Solid Tissue Normal	11	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	None			LIVING	50	2004				TCGA-DD-A1EC-11			d3041275-6a41-4974-a082-9b261b65c81f		TCGA-DD-A1EC-11		d3041275-6a41-4974-a082-9b261b65c81f		d3041275-6a41-4974-a082-9b261b65c81f	d3041275-6a41-4974-a082-9b261b65c81f		TCGA-DD-A1EC-11A-11D-A132-05
TCGA-DD-A1ED-01	0	TCGA-DD-A1ED-01	2301	0	days	TCGA-DD-A1ED	2301	0	days	2301	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	68	3.5	4.2	5.0	TCGA-DD-A1ED-F42202	TCGA-DD-A1ED	TCGA-DD-A1ED-01A	0.1	0.8		A	0.8	1.3	1.3	-25039	1525		0	2301			1	0	6	3	0 - No Fibrosis		2013-4-15	MALE	168	Alcohol consumption	tattoos	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	60	8.4	12.0	NO	NO	G1						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-A1ED.6C4C27E3-EB96-48E4-BDF8-6E93C1557707.pdf	A1ED	TUMOR FREE	219	150	450	NO	NO	8.9	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	85	2006	TCGA-DD-A1ED-01A-11D-A151-01	TCGA-DD-A1ED-01A-11D-A151-01	TCGA-DD-A1ED-01A-11D-A152-10	TCGA-DD-A1ED-01	TCGA-DD-A1ED-01	37114D9C-9279-40B4-B2CE-513F96895267	24f42719-6ad5-48fb-b27d-5812c3447b46	TCGA-DD-A1ED-01A-11D-A152-10	TCGA-DD-A1ED-01	TCGA-DD-A1ED-01	24f42719-6ad5-48fb-b27d-5812c3447b46	TCGA-DD-A1ED-01A-11D-A152-10	24f42719-6ad5-48fb-b27d-5812c3447b46	24f42719-6ad5-48fb-b27d-5812c3447b46	TCGA-DD-A1ED-01A-11D-A152-10	TCGA-DD-A1ED-01A-11D-A153-05
TCGA-DD-A1ED-11	0	TCGA-DD-A1ED-11	2301	0	days	TCGA-DD-A1ED	2301	0	days	2301	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	68	3.5	4.2	5.0	TCGA-DD-A1ED-F42202	TCGA-DD-A1ED	TCGA-DD-A1ED-11A	0.1	0.8		A	0.8	1.3	1.3	-25039	1525		0	2301			1	0	6	3	0 - No Fibrosis		2013-4-15	MALE	168	Alcohol consumption	tattoos	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	170	8.4	12.0	NO	NO	G1						NO		true	No	M0	N0	T1	Stage I		A1ED	TUMOR FREE	219	150	450	NO	NO	8.9	NO	NO		R0	Solid Tissue Normal	11	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	85	2006																TCGA-DD-A1ED-11A-11D-A153-05
TCGA-DD-A1EE-01	1	TCGA-DD-A1EE-01	349	1	days	TCGA-DD-A1EE	44	1	days	349	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Severe	73	3.5	2.7	5.0	TCGA-DD-A1EE-F42208	TCGA-DD-A1EE	TCGA-DD-A1EE-01A	0.1	0.5		B	0.8	1.3	1.2	-26858	1521	349	0	204		44	2	0	6	3	6 - Established Cirrhosis		2013-4-15	MALE	175	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	110	8.4	12.0	NO	NO	G3	Liver	Intrahepatic Recurrence		No	NO	YES	No	true	No	M0	N0	T3	Stage IIIA	TCGA-DD-A1EE.EC55BB6D-4704-48D6-9C37-E82AADE685F7.pdf	A1EE	WITH TUMOR	208	150	450	NO	NO	14.3	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	77	2006	TCGA-DD-A1EE-01A-11D-A12Y-01	TCGA-DD-A1EE-01A-11D-A12Y-01	TCGA-DD-A1EE-01A-11D-A12Z-10	TCGA-DD-A1EE-01	TCGA-DD-A1EE-01	4D09C18B-8451-4B2D-BB83-7688A4B19389	b5ef133a-86de-4cd1-9ff2-52e6cbbeaae8		TCGA-DD-A1EE-01	TCGA-DD-A1EE-01	b5ef133a-86de-4cd1-9ff2-52e6cbbeaae8		b5ef133a-86de-4cd1-9ff2-52e6cbbeaae8	b5ef133a-86de-4cd1-9ff2-52e6cbbeaae8		TCGA-DD-A1EE-01A-11D-A132-05
TCGA-DD-A1EE-11	1	TCGA-DD-A1EE-11	349	1	days	TCGA-DD-A1EE	44	1	days	349	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Severe	73	3.5	2.7	5.0	TCGA-DD-A1EE-F42208	TCGA-DD-A1EE	TCGA-DD-A1EE-11A	0.1	0.5		B	0.8	1.3	1.2	-26858	1521	349	0	204		44	2	0	6	3	6 - Established Cirrhosis		2013-4-15	MALE	175	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	190	8.4	12.0	NO	NO	G3	Liver	Intrahepatic Recurrence		No	NO	YES	No	true	No	M0	N0	T3	Stage IIIA		A1EE	WITH TUMOR	208	150	450	NO	NO	14.3	NO	NO		R0	Solid Tissue Normal	11	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	77	2006				TCGA-DD-A1EE-11			78eb93c7-0300-4f16-ab32-7489715e3353		TCGA-DD-A1EE-11		78eb93c7-0300-4f16-ab32-7489715e3353		78eb93c7-0300-4f16-ab32-7489715e3353	78eb93c7-0300-4f16-ab32-7489715e3353		TCGA-DD-A1EE-11A-11D-A132-05
TCGA-DD-A1EF-01	1	TCGA-DD-A1EF-01	394	1	days	TCGA-DD-A1EF			days	394	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	57	3.5	4.5	5.0	TCGA-DD-A1EF-F42200	TCGA-DD-A1EF	TCGA-DD-A1EF-01A	0.1	1.0	9	B	0.6	1.1	0.9	-21165	1382	394	0				2	0	6	16211	3,4 - Fibrous Speta		2013-4-15	FEMALE	164	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	190	8.4	12.0	NO	NO	G3								true	No	M0	N0	T1	Stage I	TCGA-DD-A1EF.002B24F9-22DB-4504-A048-BF9790A4837E.pdf	A1EF	WITH TUMOR	337	150	450			8.5		YES		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	81	2007	TCGA-DD-A1EF-01A-11D-A12Y-01	TCGA-DD-A1EF-01A-11D-A12Y-01	TCGA-DD-A1EF-01A-11D-A12Z-10	TCGA-DD-A1EF-01	TCGA-DD-A1EF-01	062D49C8-C170-4837-9CC6-13C6D665122D	5da8b83f-c43b-46c3-9667-022d7e0a6f2b	TCGA-DD-A1EF-01A-11D-A12Z-10	TCGA-DD-A1EF-01	TCGA-DD-A1EF-01	5da8b83f-c43b-46c3-9667-022d7e0a6f2b	TCGA-DD-A1EF-01A-11D-A12Z-10	5da8b83f-c43b-46c3-9667-022d7e0a6f2b	5da8b83f-c43b-46c3-9667-022d7e0a6f2b	TCGA-DD-A1EF-01A-11D-A12Z-10	TCGA-DD-A1EF-01A-11D-A132-05
TCGA-DD-A1EF-11	1	TCGA-DD-A1EF-11	394	1	days	TCGA-DD-A1EF			days	394	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	57	3.5	4.5	5.0	TCGA-DD-A1EF-F42200	TCGA-DD-A1EF	TCGA-DD-A1EF-11A	0.1	1.0	9	B	0.6	1.1	0.9	-21165	1382	394	0				2	0	6	16211	3,4 - Fibrous Speta		2013-4-15	FEMALE	164	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	70	8.4	12.0	NO	NO	G3								true	No	M0	N0	T1	Stage I		A1EF	WITH TUMOR	337	150	450			8.5		YES		R0	Solid Tissue Normal	11	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	81	2007																TCGA-DD-A1EF-11A-11D-A132-05
TCGA-DD-A1EG-01	1	TCGA-DD-A1EG-01	1372	1	days	TCGA-DD-A1EG	875	1	days	1372	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	76	3.5	4.2	5.0	TCGA-DD-A1EG-F42003	TCGA-DD-A1EG		0.1	0.7	1	A	0.8	1.3	0.6	-28108		1372	0		880	875	0	0	6	16	1,2 - Portal Fibrosis		2013-4-9	MALE	168	Alcohol consumption|Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.4	12.0		NO	G3	Liver	Intrahepatic Recurrence		No	YES	YES	No		No	M0	N0	T1	Stage I		A1EG	WITH TUMOR	146	150	450	YES	YES	9.1	NO	YES	R0	R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.0	Liver	None		Hepatitis B Surface Antigen	DECEASED	82	2007	TCGA-DD-A1EG-01A-11D-A20V-01	TCGA-DD-A1EG-01A-11D-A20V-01	TCGA-DD-A1EG-01A-11D-A20W-10	TCGA-DD-A1EG-01	TCGA-DD-A1EG-01		caf05305-45bc-4858-b8b5-21fe37061a5c	TCGA-DD-A1EG-01A-11D-A20W-10	TCGA-DD-A1EG-01	TCGA-DD-A1EG-01	caf05305-45bc-4858-b8b5-21fe37061a5c	TCGA-DD-A1EG-01A-11D-A20W-10	caf05305-45bc-4858-b8b5-21fe37061a5c	caf05305-45bc-4858-b8b5-21fe37061a5c	TCGA-DD-A1EG-01A-11D-A20W-10	TCGA-DD-A1EG-01A-11D-A20Z-05
TCGA-DD-A1EG-11	1	TCGA-DD-A1EG-11	1372	1	days	TCGA-DD-A1EG	875	1	days	1372	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	76	3.5	4.2	5.0	TCGA-DD-A1EG-F42003	TCGA-DD-A1EG		0.1	0.7	1	A	0.8	1.3	0.6	-28108		1372	0		880	875	0	0	6	16	1,2 - Portal Fibrosis		2013-4-9	MALE	168	Alcohol consumption|Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.4	12.0		NO	G3	Liver	Intrahepatic Recurrence		No	YES	YES	No		No	M0	N0	T1	Stage I		A1EG	WITH TUMOR	146	150	450	YES	YES	9.1	NO	YES	R0	R0	Solid Tissue Normal	11	Lobectomy	7th	NO	YES	DD	1.0	Liver	None		Hepatitis B Surface Antigen	DECEASED	82	2007				TCGA-DD-A1EG-11			b80a257d-9c8b-4c49-87bc-30f74ff9cd3e		TCGA-DD-A1EG-11		b80a257d-9c8b-4c49-87bc-30f74ff9cd3e		b80a257d-9c8b-4c49-87bc-30f74ff9cd3e	b80a257d-9c8b-4c49-87bc-30f74ff9cd3e		TCGA-DD-A1EG-11A-11D-A20Z-05
TCGA-DD-A1EH-01	0	TCGA-DD-A1EH-01	1495	0	days	TCGA-DD-A1EH	120	1	days	1495	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	23	3.5	4.7	5.0	TCGA-DD-A1EH-F42567	TCGA-DD-A1EH	TCGA-DD-A1EH-01A	0.1	1.0	1	B	0.8	1.3	1.0	-8499	933		0	1495		120	1	0	6	94340	3,4 - Fibrous Speta		2013-4-24	MALE	179	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	220	9.5	13.8	NO	NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	N0	T3	Stage III	TCGA-DD-A1EH.951E7AFB-F380-4FA8-B213-CB766A60FF5B.pdf	A1EH	WITH TUMOR	212	150	450	YES	YES	10.4	NO	YES		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.0	Liver	Macro	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D	LIVING	70	2008	TCGA-DD-A1EH-01A-11D-A12Y-01	TCGA-DD-A1EH-01A-11D-A12Y-01	TCGA-DD-A1EH-01A-11D-A12Z-10	TCGA-DD-A1EH-01	TCGA-DD-A1EH-01	D64DEA8B-1FBC-463F-B634-BB8AD46FA286	0559ff1c-6aee-491f-9b58-747732a10755	TCGA-DD-A1EH-01A-11D-A12Z-10	TCGA-DD-A1EH-01	TCGA-DD-A1EH-01	0559ff1c-6aee-491f-9b58-747732a10755	TCGA-DD-A1EH-01A-11D-A12Z-10	0559ff1c-6aee-491f-9b58-747732a10755	0559ff1c-6aee-491f-9b58-747732a10755	TCGA-DD-A1EH-01A-11D-A12Z-10	TCGA-DD-A1EH-01A-11D-A132-05
TCGA-DD-A1EH-11	0	TCGA-DD-A1EH-11	1495	0	days	TCGA-DD-A1EH	120	1	days	1495	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	23	3.5	4.7	5.0	TCGA-DD-A1EH-F42567	TCGA-DD-A1EH		0.1	1.0	1	B	0.8	1.3	1.0	-8499			0	1495		120	1	0	6	94340	3,4 - Fibrous Speta		2013-4-24	MALE	179	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		9.5	13.8		NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No		No	M0	N0	T3	Stage III		A1EH	WITH TUMOR	212	150	450	YES	YES	10.4	NO	YES		R0	Solid Tissue Normal	11	Lobectomy	6th	NO	YES	DD	1.0	Liver	Macro		Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D	LIVING	70	2008				TCGA-DD-A1EH-11			ac77b52b-6f6c-41ec-b998-6d23250d0516		TCGA-DD-A1EH-11		ac77b52b-6f6c-41ec-b998-6d23250d0516		ac77b52b-6f6c-41ec-b998-6d23250d0516	ac77b52b-6f6c-41ec-b998-6d23250d0516		TCGA-DD-A1EH-11A-11D-A132-05
TCGA-DD-A1EI-01	0	TCGA-DD-A1EI-01	183	0	days	TCGA-DD-A1EI	183	0	days	183	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	46	3.5	5.1	5.0	TCGA-DD-A1EI-F42222	TCGA-DD-A1EI	TCGA-DD-A1EI-01A	0.1	0.7	0	B	0.8	1.3	0.9	-17097	926		0	183			2	0	6	24	6 - Established Cirrhosis		2013-4-15	MALE	175	Hepatitis B	cirrhosis	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	80	8.3	10.8	NO	YES	G2						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-A1EI.C253EB16-129F-4442-8C88-8A132E610E8C.pdf	A1EI	TUMOR FREE	148	150	450			10.9		NO		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV D	LIVING	69	2008	TCGA-DD-A1EI-01A-11D-A12Y-01	TCGA-DD-A1EI-01A-11D-A12Y-01	TCGA-DD-A1EI-01A-11D-A12Z-10	TCGA-DD-A1EI-01	TCGA-DD-A1EI-01		95cdfdf7-26d2-41b6-bac7-a6305a91ec3c	TCGA-DD-A1EI-01A-11D-A12Z-10	TCGA-DD-A1EI-01	TCGA-DD-A1EI-01	95cdfdf7-26d2-41b6-bac7-a6305a91ec3c	TCGA-DD-A1EI-01A-11D-A12Z-10	95cdfdf7-26d2-41b6-bac7-a6305a91ec3c	95cdfdf7-26d2-41b6-bac7-a6305a91ec3c	TCGA-DD-A1EI-01A-11D-A12Z-10	TCGA-DD-A1EI-01A-11D-A132-05
TCGA-DD-A1EI-11	0	TCGA-DD-A1EI-11	183	0	days	TCGA-DD-A1EI	183	0	days	183	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	46	3.5	5.1	5.0	TCGA-DD-A1EI-F42222	TCGA-DD-A1EI	TCGA-DD-A1EI-11A	0.1	0.7	0	B	0.8	1.3	0.9	-17097	926		0	183			2	0	6	24	6 - Established Cirrhosis		2013-4-15	MALE	175	Hepatitis B	cirrhosis	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	190	8.3	10.8	NO	YES	G2						NO		true	No	M0	N0	T1	Stage I		A1EI	TUMOR FREE	148	150	450			10.9		NO		R0	Solid Tissue Normal	11	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV D	LIVING	69	2008				TCGA-DD-A1EI-11			196f7a32-4d09-4e8b-9aa4-7964baf951d7		TCGA-DD-A1EI-11		196f7a32-4d09-4e8b-9aa4-7964baf951d7		196f7a32-4d09-4e8b-9aa4-7964baf951d7	196f7a32-4d09-4e8b-9aa4-7964baf951d7		TCGA-DD-A1EI-11A-11D-A132-05
TCGA-DD-A1EJ-01	1	TCGA-DD-A1EJ-01	1005	1	days	TCGA-DD-A1EJ	263	1	days	1005	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	Mild	71	3.2	3.5	5.0	TCGA-DD-A1EJ-F42209	TCGA-DD-A1EJ	TCGA-DD-A1EJ-01A	0.1	0.7	1	B	0.6	1.1	0.6	-26009	909	1005	0	887		263	2	0	6	18840	0 - No Fibrosis		2013-4-15	FEMALE	154	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	290	8.3	10.8	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	N1	T1	Stage IIIC	TCGA-DD-A1EJ.A34C7F12-5EB1-4B7C-890C-FD2DFF41E85C.pdf	A1EJ	WITH TUMOR	608	150	450	NO	NO	10.2	NO	YES		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	64	2008	TCGA-DD-A1EJ-01A-11D-A151-01	TCGA-DD-A1EJ-01A-11D-A151-01	TCGA-DD-A1EJ-01A-11D-A152-10	TCGA-DD-A1EJ-01	TCGA-DD-A1EJ-01	ECCFCC47-BC5E-437D-9AD7-BB7E39A6016B	c8b3eddd-f3cf-42eb-bb30-ccc3943eadec	TCGA-DD-A1EJ-01A-11D-A152-10	TCGA-DD-A1EJ-01	TCGA-DD-A1EJ-01	c8b3eddd-f3cf-42eb-bb30-ccc3943eadec	TCGA-DD-A1EJ-01A-11D-A152-10	c8b3eddd-f3cf-42eb-bb30-ccc3943eadec	c8b3eddd-f3cf-42eb-bb30-ccc3943eadec	TCGA-DD-A1EJ-01A-11D-A152-10	TCGA-DD-A1EJ-01A-11D-A153-05
TCGA-DD-A1EJ-11	1	TCGA-DD-A1EJ-11	1005	1	days	TCGA-DD-A1EJ	263	1	days	1005	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	Mild	71	3.2	3.5	5.0	TCGA-DD-A1EJ-F42209	TCGA-DD-A1EJ	TCGA-DD-A1EJ-11A	0.1	0.7	1	B	0.6	1.1	0.6	-26009	909	1005	0	887		263	2	0	6	18840	0 - No Fibrosis		2013-4-15	FEMALE	154	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	130	8.3	10.8	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	N1	T1	Stage IIIC		A1EJ	WITH TUMOR	608	150	450	NO	NO	10.2	NO	YES		R0	Solid Tissue Normal	11	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	64	2008				TCGA-DD-A1EJ-11			8e48cff2-5edd-4ce6-9531-5dc594ae78ff		TCGA-DD-A1EJ-11		8e48cff2-5edd-4ce6-9531-5dc594ae78ff		8e48cff2-5edd-4ce6-9531-5dc594ae78ff	8e48cff2-5edd-4ce6-9531-5dc594ae78ff		TCGA-DD-A1EJ-11A-11D-A153-05
TCGA-DD-A1EK-01	1	TCGA-DD-A1EK-01	558	1	days	TCGA-DD-A1EK	167	1	days	558	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	Mild	64	3.5	4.3	5.0	TCGA-DD-A1EK-F42001	TCGA-DD-A1EK	TCGA-DD-A1EK-01A	0.1	0.5	1	A	0.6	1.1	0.7	-23437	819	558	0			167	0	0	6	19	0 - No Fibrosis		2013-4-9	FEMALE	159	Other	tobacco, birth control bills	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	40	8.3	10.8	NO	NO	G2	Liver	Locoregional Recurrence		Yes	NO	YES	No	true	No	M1	N0	T4	Stage IVB	TCGA-DD-A1EK.AE199A35-2585-4363-8896-9B55B12C1BDF.pdf	A1EK	WITH TUMOR	387	150	450	YES	NO	10.3	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	97	2008	TCGA-DD-A1EK-01A-11D-A20V-01	TCGA-DD-A1EK-01A-11D-A20V-01	TCGA-DD-A1EK-01A-11D-A20W-10	TCGA-DD-A1EK-01	TCGA-DD-A1EK-01		24214ac8-46a2-44c2-9ce8-8514b9c61181	TCGA-DD-A1EK-01A-11D-A20W-10	TCGA-DD-A1EK-01	TCGA-DD-A1EK-01	24214ac8-46a2-44c2-9ce8-8514b9c61181	TCGA-DD-A1EK-01A-11D-A20W-10	24214ac8-46a2-44c2-9ce8-8514b9c61181	24214ac8-46a2-44c2-9ce8-8514b9c61181	TCGA-DD-A1EK-01A-11D-A20W-10	TCGA-DD-A1EK-01A-11D-A20Z-05
TCGA-DD-A1EL-01	1	TCGA-DD-A1EL-01	415	1	days	TCGA-DD-A1EL			days	415	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	23	3.5	4.4	5.0	TCGA-DD-A1EL-F42229	TCGA-DD-A1EL	TCGA-DD-A1EL-01A	0.1	0.5		A	0.8	1.3	1.0	-8573	577	415	0			[Discrepancy]	0	0	6	5	0 - No Fibrosis		2013-4-15	MALE	182	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	130	8.3	10.8	NO	NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	N0	T2	Stage II	TCGA-DD-A1EL.C8A1098A-0717-4801-A3E5-C13C42C65936.pdf	A1EL	WITH TUMOR	153	150	450	YES	NO	10.8	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D	DECEASED	54	2009	TCGA-DD-A1EL-01A-11D-A151-01	TCGA-DD-A1EL-01A-11D-A151-01	TCGA-DD-A1EL-01A-11D-A152-10	TCGA-DD-A1EL-01	TCGA-DD-A1EL-01	2FACE58F-5F20-4DDA-921C-E6DB5744DC09	4e27ce05-b76a-4d5a-b070-78c508f509a3	TCGA-DD-A1EL-01A-11D-A152-10	TCGA-DD-A1EL-01	TCGA-DD-A1EL-01	4e27ce05-b76a-4d5a-b070-78c508f509a3	TCGA-DD-A1EL-01A-11D-A152-10	4e27ce05-b76a-4d5a-b070-78c508f509a3	4e27ce05-b76a-4d5a-b070-78c508f509a3	TCGA-DD-A1EL-01A-11D-A152-10	TCGA-DD-A1EL-01A-11D-A153-05
TCGA-DD-A1EL-11	1	TCGA-DD-A1EL-11	415	1	days	TCGA-DD-A1EL			days	415	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	23	3.5	4.4	5.0	TCGA-DD-A1EL-F42229	TCGA-DD-A1EL		0.1	0.5		A	0.8	1.3	1.0	-8573		415	0			[Discrepancy]	0	0	6	5	0 - No Fibrosis		2013-4-15	MALE	182	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.3	10.8		NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No		No	M0	N0	T2	Stage II		A1EL	WITH TUMOR	153	150	450	YES	NO	10.8	NO	NO		R0	Solid Tissue Normal	11	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	None		Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody|HBV D	DECEASED	54	2009				TCGA-DD-A1EL-11			ddd83e9a-35cb-4539-8141-7557eccd3b34		TCGA-DD-A1EL-11		ddd83e9a-35cb-4539-8141-7557eccd3b34		ddd83e9a-35cb-4539-8141-7557eccd3b34	ddd83e9a-35cb-4539-8141-7557eccd3b34		TCGA-DD-A1EL-11A-11D-A153-05
TCGA-DD-A39V-01	1	TCGA-DD-A39V-01	643	1	days	TCGA-DD-A39V	455	1	days	643	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	YES	None	77	3.5	4.0	5.0	TCGA-DD-A39V-F42707	TCGA-DD-A39V	TCGA-DD-A39V-01A			3	A	0.8	1.2	0.9	-28254	4180	643	0			455	1				0 - No Fibrosis		2013-4-27	MALE	174	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	180	8.4	12.0	NO	NO	G3	Other, specify	Extrahepatic Recurrence	second or third rib posteriorly	No	NO	YES	No	false	No	M0	NX	T2	Stage II	TCGA-DD-A39V.AB7EF7A1-F8F1-404A-BF15-2CC53F63C033.pdf	A39V	WITH TUMOR	193	150	450	NO	NO	11.4	YES	YES		R0	Primary Tumor	01	Lobectomy	5th	NO	YES	DD		Liver	None	A		DECEASED	79	2000	TCGA-DD-A39V-01A-11D-A20V-01	TCGA-DD-A39V-01A-11D-A20V-01	TCGA-DD-A39V-01A-11D-A20W-10	TCGA-DD-A39V-01	TCGA-DD-A39V-01	97B93870-5348-422B-83D9-9A64A2EF3E30	f2a077e8-1dd2-4a7b-b832-0f7367818044	TCGA-DD-A39V-01A-11D-A20W-10	TCGA-DD-A39V-01	TCGA-DD-A39V-01	f2a077e8-1dd2-4a7b-b832-0f7367818044	TCGA-DD-A39V-01A-11D-A20W-10	f2a077e8-1dd2-4a7b-b832-0f7367818044	f2a077e8-1dd2-4a7b-b832-0f7367818044	TCGA-DD-A39V-01A-11D-A20W-10	TCGA-DD-A39V-01A-11D-A20Z-05
TCGA-DD-A39V-11	1	TCGA-DD-A39V-11	643	1	days	TCGA-DD-A39V	455	1	days	643	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	YES	None	77	3.5	4.0	5.0	TCGA-DD-A39V-F42707	TCGA-DD-A39V	TCGA-DD-A39V-11A			3	A	0.8	1.2	0.9	-28254	4180	643	0			455	1				0 - No Fibrosis		2013-4-27	MALE	174	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	140	8.4	12.0	NO	NO	G3	Other, specify	Extrahepatic Recurrence	second or third rib posteriorly	No	NO	YES	No	false	No	M0	NX	T2	Stage II		A39V	WITH TUMOR	193	150	450	NO	NO	11.4	YES	YES		R0	Solid Tissue Normal	11	Lobectomy	5th	NO	YES	DD		Liver	None	A		DECEASED	79	2000				TCGA-DD-A39V-11			9e3df1b0-dba1-4423-976e-99aab5b7d5e2		TCGA-DD-A39V-11		9e3df1b0-dba1-4423-976e-99aab5b7d5e2		9e3df1b0-dba1-4423-976e-99aab5b7d5e2	9e3df1b0-dba1-4423-976e-99aab5b7d5e2		TCGA-DD-A39V-11A-11D-A20Z-05
TCGA-DD-A39W-01	1	TCGA-DD-A39W-01	827	1	days	TCGA-DD-A39W			days	827	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				29				TCGA-DD-A39W-F42705	TCGA-DD-A39W	TCGA-DD-A39W-01A								-10699	6014	827	0										2013-5-8	FEMALE	177	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	180			NO	NO	G2								false	No	M0	N0	T3	Stage III	TCGA-DD-A39W.3EE9248B-64B4-4B76-A427-73C254D6489D.pdf	A39W											R0	Primary Tumor	01	Segmentectomy, Multiple	4th	NO	YES	DD		Liver	None	A		DECEASED	74	1995	TCGA-DD-A39W-01A-11D-A20V-01	TCGA-DD-A39W-01A-11D-A20V-01	TCGA-DD-A39W-01A-11D-A20W-10	TCGA-DD-A39W-01	TCGA-DD-A39W-01	95A7A30E-A9BC-4197-8142-4F4C70B041CE	6f393dc9-7002-4fa7-8d05-c390e95e81e0	TCGA-DD-A39W-01A-11D-A20W-10	TCGA-DD-A39W-01	TCGA-DD-A39W-01	6f393dc9-7002-4fa7-8d05-c390e95e81e0	TCGA-DD-A39W-01A-11D-A20W-10	6f393dc9-7002-4fa7-8d05-c390e95e81e0	6f393dc9-7002-4fa7-8d05-c390e95e81e0	TCGA-DD-A39W-01A-11D-A20W-10	TCGA-DD-A39W-01A-11D-A20Z-05
TCGA-DD-A39W-11	1	TCGA-DD-A39W-11	827	1	days	TCGA-DD-A39W			days	827	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				29				TCGA-DD-A39W-F42705	TCGA-DD-A39W									-10699		827	0										2013-5-8	FEMALE	177	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES					NO	G2									No	M0	N0	T3	Stage III		A39W											R0	Solid Tissue Normal	11	Segmentectomy, Multiple	4th	NO	YES	DD		Liver	None			DECEASED	74	1995				TCGA-DD-A39W-11			e66b878f-0a33-4edf-ba17-e0ec9f41e589		TCGA-DD-A39W-11		e66b878f-0a33-4edf-ba17-e0ec9f41e589		e66b878f-0a33-4edf-ba17-e0ec9f41e589	e66b878f-0a33-4edf-ba17-e0ec9f41e589		TCGA-DD-A39W-11A-11D-A20Z-05
TCGA-DD-A39X-01	1	TCGA-DD-A39X-01	1694	1	days	TCGA-DD-A39X	1032	1	days	1694	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	78	3.5	4.1	5.0	TCGA-DD-A39X-F42568	TCGA-DD-A39X	TCGA-DD-A39X-01A	0.1	0.5	2	A	0.6	0.9	0.9	-28528	4705	1694	0			1032	1	0	6	10	0 - No Fibrosis		2013-4-24	FEMALE	152	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	120	8.4	12.0	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	false	No	M0	NX	T1	Stage I	TCGA-DD-A39X.B9919D23-7D65-4295-84D5-6678B26BEA01.pdf	A39X	WITH TUMOR	180	150	450	YES	NO	9.8	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	5th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody	DECEASED	48	1998	TCGA-DD-A39X-01A-11D-A20V-01	TCGA-DD-A39X-01A-11D-A20V-01	TCGA-DD-A39X-01A-11D-A20W-10	TCGA-DD-A39X-01	TCGA-DD-A39X-01	5D51C3D9-4693-4108-B601-BCC8C59743A5	2a624b0d-4dc2-4c00-8984-b256a69643c7	TCGA-DD-A39X-01A-11D-A20W-10	TCGA-DD-A39X-01	TCGA-DD-A39X-01	2a624b0d-4dc2-4c00-8984-b256a69643c7	TCGA-DD-A39X-01A-11D-A20W-10	2a624b0d-4dc2-4c00-8984-b256a69643c7	2a624b0d-4dc2-4c00-8984-b256a69643c7	TCGA-DD-A39X-01A-11D-A20W-10	TCGA-DD-A39X-01A-11D-A20Z-05
TCGA-DD-A39X-11	1	TCGA-DD-A39X-11	1694	1	days	TCGA-DD-A39X	1032	1	days	1694	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	78	3.5	4.1	5.0	TCGA-DD-A39X-F42568	TCGA-DD-A39X	TCGA-DD-A39X-11A	0.1	0.5	2	A	0.6	0.9	0.9	-28528	4705	1694	0			1032	1	0	6	10	0 - No Fibrosis		2013-4-24	FEMALE	152	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	230	8.4	12.0	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	false	No	M0	NX	T1	Stage I		A39X	WITH TUMOR	180	150	450	YES	NO	9.8	NO	YES		R0	Solid Tissue Normal	11	Segmentectomy, Multiple	5th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody	DECEASED	48	1998				TCGA-DD-A39X-11			9815693f-418d-4517-9a7e-5c708c157b0c		TCGA-DD-A39X-11		9815693f-418d-4517-9a7e-5c708c157b0c		9815693f-418d-4517-9a7e-5c708c157b0c	9815693f-418d-4517-9a7e-5c708c157b0c		TCGA-DD-A39X-11A-11D-A20Z-05
TCGA-DD-A39Y-01	1	TCGA-DD-A39Y-01	171	1	days	TCGA-DD-A39Y	171	0	days	171	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	67	3.5	4.0	5.0	TCGA-DD-A39Y-F42701	TCGA-DD-A39Y	TCGA-DD-A39Y-01A	0.1	1.1		A	1.2	12.0	0.8	-24769	3530	171	0				2	0	6	5600	0 - No Fibrosis		2013-4-27	MALE	176	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	220	8.4	12.0	NO	NO	G3						NO		false	No	M0	NX	T1	Stage I	TCGA-DD-A39Y.2674265B-6B9D-49B3-9BD2-DF4E77AD4B26.pdf	A39Y	TUMOR FREE	243	150	450	NO	NO	10.2	NO	YES		R0	Primary Tumor	01	Extended Lobectomy	5th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	85	2002	TCGA-DD-A39Y-01A-11D-A20V-01	TCGA-DD-A39Y-01A-11D-A20V-01	TCGA-DD-A39Y-01A-11D-A20W-10	TCGA-DD-A39Y-01	TCGA-DD-A39Y-01	2BEF3FF0-41EC-4939-AC16-6E32F2C94D1E	6a169722-0dcb-4df7-82c5-8f8b7a512d32	TCGA-DD-A39Y-01A-11D-A20W-10	TCGA-DD-A39Y-01	TCGA-DD-A39Y-01	6a169722-0dcb-4df7-82c5-8f8b7a512d32	TCGA-DD-A39Y-01A-11D-A20W-10	6a169722-0dcb-4df7-82c5-8f8b7a512d32	6a169722-0dcb-4df7-82c5-8f8b7a512d32	TCGA-DD-A39Y-01A-11D-A20W-10	TCGA-DD-A39Y-01A-11D-A20Z-05
TCGA-DD-A39Z-01	1	TCGA-DD-A39Z-01	601	1	days	TCGA-DD-A39Z			days	601	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				43	3.5	3.1	5.0	TCGA-DD-A39Z-F42006	TCGA-DD-A39Z	TCGA-DD-A39Z-01A	0.1	1.2	1	B	0.6	0.9	0.7	-15930	5728	601	0				2						2013-4-24	FEMALE	165	Alcohol consumption	extensive tobacco history	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	250	8.4	12.0	NO	NO	G2								false	No	M0	NX	T2	Stage II	TCGA-DD-A39Z.1976B0D8-E1F2-468F-9AB0-242E9507AB0D.pdf	A39Z	TUMOR FREE	437	150	450			12.6		YES		R0	Primary Tumor	01	Segmentectomy, Single	4th	NO	YES	DD	1.1	Liver	None	A		DECEASED	61	1996	TCGA-DD-A39Z-01A-11D-A20V-01	TCGA-DD-A39Z-01A-11D-A20V-01	TCGA-DD-A39Z-01A-11D-A20W-10	TCGA-DD-A39Z-01	TCGA-DD-A39Z-01	A17BEA72-BD38-493A-98EA-C7768718E81D	2bbf9181-a71f-4714-b1b5-0d23a47d1306	TCGA-DD-A39Z-01A-11D-A20W-10	TCGA-DD-A39Z-01	TCGA-DD-A39Z-01	2bbf9181-a71f-4714-b1b5-0d23a47d1306	TCGA-DD-A39Z-01A-11D-A20W-10	2bbf9181-a71f-4714-b1b5-0d23a47d1306	2bbf9181-a71f-4714-b1b5-0d23a47d1306	TCGA-DD-A39Z-01A-11D-A20W-10	TCGA-DD-A39Z-01A-11D-A20Z-05
TCGA-DD-A39Z-11	1	TCGA-DD-A39Z-11	601	1	days	TCGA-DD-A39Z			days	601	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				43	3.5	3.1	5.0	TCGA-DD-A39Z-F42006	TCGA-DD-A39Z		0.1	1.2	1	B	0.6	0.9	0.7	-15930		601	0				2						2013-4-24	FEMALE	165	Alcohol consumption	extensive tobacco history	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.4	12.0		NO	G2									No	M0	NX	T2	Stage II		A39Z	TUMOR FREE	437	150	450			12.6		YES		R0	Solid Tissue Normal	11	Segmentectomy, Single	4th	NO	YES	DD	1.1	Liver	None			DECEASED	61	1996				TCGA-DD-A39Z-11			f847f8c8-7a39-4327-ad12-3aac2c331be8		TCGA-DD-A39Z-11		f847f8c8-7a39-4327-ad12-3aac2c331be8		f847f8c8-7a39-4327-ad12-3aac2c331be8	f847f8c8-7a39-4327-ad12-3aac2c331be8		TCGA-DD-A39Z-11A-21D-A20Z-05
TCGA-DD-A3A0-01	1	TCGA-DD-A3A0-01	785	1	days	TCGA-DD-A3A0	359	1	days	785	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	YES	None	70	3.5	3.3	5.0	TCGA-DD-A3A0-F42710	TCGA-DD-A3A0	TCGA-DD-A3A0-01A	0.1	1.4		A	0.8	1.2	2.7	-25889	3586	785	0			359	1	0	6	1	0 - No Fibrosis		2013-4-27	MALE	178	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	220	8.4	12.0	NO	NO	G2		New Primary Tumor		No	NO	YES	No	false	No	M0	NX	T1	Stage I	TCGA-DD-A3A0.C9E146D4-77FF-4877-8DA6-2E5D912F33C6.pdf	A3A0	WITH TUMOR	138	150	450	NO	NO	13.2	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	5th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	88	2001	TCGA-DD-A3A0-01A-11D-A20V-01	TCGA-DD-A3A0-01A-11D-A20V-01	TCGA-DD-A3A0-01A-11D-A20W-10	TCGA-DD-A3A0-01		053627EF-A775-4F28-85F8-CDCFE4DCDDF7		TCGA-DD-A3A0-01A-11D-A20W-10	TCGA-DD-A3A0-01			TCGA-DD-A3A0-01A-11D-A20W-10			TCGA-DD-A3A0-01A-11D-A20W-10	TCGA-DD-A3A0-01A-11D-A20Z-05
TCGA-DD-A3A1-01	1	TCGA-DD-A3A1-01	233	1	days	TCGA-DD-A3A1			days	233	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	65	3.5	3.8	5.0	TCGA-DD-A3A1-F42704	TCGA-DD-A3A1	TCGA-DD-A3A1-01A	0.1	0.8	1	A	0.8	1.2	1.1	-24046	3753	233	0				0	0	6	6	0 - No Fibrosis		2013-4-27	MALE	185	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	240	8.4	12.0	NO	NO	G2								false	No	M0	N0	T3b	Stage IIIA	TCGA-DD-A3A1.EAB38F5C-4399-48DE-A4F5-18B7CB982689.pdf	A3A1	TUMOR FREE	178	150	450	NO	NO	11.2	NO	YES		R0	Primary Tumor	01	Extended Lobectomy	5th	NO	YES	DD	1.1	Liver	Macro	A		DECEASED	78	2001	TCGA-DD-A3A1-01A-11D-A20V-01	TCGA-DD-A3A1-01A-11D-A20V-01	TCGA-DD-A3A1-01A-11D-A20W-10	TCGA-DD-A3A1-01	TCGA-DD-A3A1-01	8F14D825-2D09-4F5C-A2CD-0FAFC2104791	578e5ec2-7091-4f3e-a440-1fcd5585a704	TCGA-DD-A3A1-01A-11D-A20W-10	TCGA-DD-A3A1-01	TCGA-DD-A3A1-01	578e5ec2-7091-4f3e-a440-1fcd5585a704	TCGA-DD-A3A1-01A-11D-A20W-10	578e5ec2-7091-4f3e-a440-1fcd5585a704	578e5ec2-7091-4f3e-a440-1fcd5585a704	TCGA-DD-A3A1-01A-11D-A20W-10	TCGA-DD-A3A1-01A-11D-A20Z-05
TCGA-DD-A3A1-11	1	TCGA-DD-A3A1-11	233	1	days	TCGA-DD-A3A1			days	233	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	65	3.5	3.8	5.0	TCGA-DD-A3A1-F42704	TCGA-DD-A3A1	TCGA-DD-A3A1-11A	0.1	0.8	1	A	0.8	1.2	1.1	-24046	3753	233	0				0	0	6	6	0 - No Fibrosis		2013-4-27	MALE	185	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	180	8.4	12.0	NO	NO	G2								false	No	M0	N0	T3b	Stage IIIA		A3A1	TUMOR FREE	178	150	450	NO	NO	11.2	NO	YES		R0	Solid Tissue Normal	11	Extended Lobectomy	5th	NO	YES	DD	1.1	Liver	Macro	A		DECEASED	78	2001				TCGA-DD-A3A1-11			5573955b-f0ec-4cfe-ad02-4f9f91693770		TCGA-DD-A3A1-11		5573955b-f0ec-4cfe-ad02-4f9f91693770		5573955b-f0ec-4cfe-ad02-4f9f91693770	5573955b-f0ec-4cfe-ad02-4f9f91693770		TCGA-DD-A3A1-11A-11D-A20Z-05
TCGA-DD-A3A2-01	1	TCGA-DD-A3A2-01	2131	1	days	TCGA-DD-A3A2			days	2131	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	76	3.5	4.2	5.0	TCGA-DD-A3A2-F42706	TCGA-DD-A3A2	TCGA-DD-A3A2-01A	0.1	0.5		A	0.6	0.9	0.8	-27930	4962	2131	0				0				0 - No Fibrosis		2013-4-27	FEMALE	178	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	250	8.4	12.0	NO	NO	G1								false	No	M0	N0	T1	Stage I	TCGA-DD-A3A2.91B547FA-DAB2-4B65-9AC4-5151D4524001.pdf	A3A2	TUMOR FREE	326	150	450	NO	NO	8.8	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	5th	NO	YES	DD	1.1	Liver	None	A		DECEASED	85	1998	TCGA-DD-A3A2-01A-11D-A20V-01	TCGA-DD-A3A2-01A-11D-A20V-01	TCGA-DD-A3A2-01A-11D-A20W-10	TCGA-DD-A3A2-01	TCGA-DD-A3A2-01	694C11EB-8C14-41FF-AD29-B0029EE9A218	b532e040-8d89-458b-a13c-3da835918813	TCGA-DD-A3A2-01A-11D-A20W-10	TCGA-DD-A3A2-01	TCGA-DD-A3A2-01	b532e040-8d89-458b-a13c-3da835918813	TCGA-DD-A3A2-01A-11D-A20W-10	b532e040-8d89-458b-a13c-3da835918813	b532e040-8d89-458b-a13c-3da835918813	TCGA-DD-A3A2-01A-11D-A20W-10	TCGA-DD-A3A2-01A-11D-A20Z-05
TCGA-DD-A3A2-11	1	TCGA-DD-A3A2-11	2131	1	days	TCGA-DD-A3A2			days	2131	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	76	3.5	4.2	5.0	TCGA-DD-A3A2-F42706	TCGA-DD-A3A2	TCGA-DD-A3A2-11A	0.1	0.5		A	0.6	0.9	0.8	-27930	4962	2131	0				0				0 - No Fibrosis		2013-4-27	FEMALE	178	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	160	8.4	12.0	NO	NO	G1								false	No	M0	N0	T1	Stage I		A3A2	TUMOR FREE	326	150	450	NO	NO	8.8	NO	NO		R0	Solid Tissue Normal	11	Segmentectomy, Multiple	5th	NO	YES	DD	1.1	Liver	None	A		DECEASED	85	1998				TCGA-DD-A3A2-11			6d9b3d3a-2dd0-477e-aaf2-504ecd6c3de3		TCGA-DD-A3A2-11		6d9b3d3a-2dd0-477e-aaf2-504ecd6c3de3		6d9b3d3a-2dd0-477e-aaf2-504ecd6c3de3	6d9b3d3a-2dd0-477e-aaf2-504ecd6c3de3		TCGA-DD-A3A2-11A-11D-A20Z-05
TCGA-DD-A3A3-01	1	TCGA-DD-A3A3-01	535	1	days	TCGA-DD-A3A3			days	535	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	45				TCGA-DD-A3A3-F42700	TCGA-DD-A3A3	TCGA-DD-A3A3-01A	0.1	0.9		B	0.8	1.2	1.2	-16708	4397	535	0				1	0	6	6	0 - No Fibrosis		2013-4-27	MALE	167	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	250	8.4	12.0	NO	NO	G2								false	No	M0	N0	T1	Stage I	TCGA-DD-A3A3.A37A1F44-D2AD-457C-8292-3E7A6667268D.pdf	A3A3		276	150	450			8.8		NO		R0	Primary Tumor	01	Extended Lobectomy	5th	NO	YES	DD	1.1	Liver	Macro	A		DECEASED	71	1999	TCGA-DD-A3A3-01A-11D-A22E-01	TCGA-DD-A3A3-01A-11D-A22E-01	TCGA-DD-A3A3-01A-11D-A22F-10	TCGA-DD-A3A3-01	TCGA-DD-A3A3-01	12B1E429-5B1A-40A2-BEBD-65CAECD789C3	3d39e165-1def-4a5e-b011-b2ceb033d415	TCGA-DD-A3A3-01A-11D-A22F-10	TCGA-DD-A3A3-01	TCGA-DD-A3A3-01	3d39e165-1def-4a5e-b011-b2ceb033d415	TCGA-DD-A3A3-01A-11D-A22F-10	3d39e165-1def-4a5e-b011-b2ceb033d415	3d39e165-1def-4a5e-b011-b2ceb033d415	TCGA-DD-A3A3-01A-11D-A22F-10	TCGA-DD-A3A3-01A-11D-A22H-05
TCGA-DD-A3A3-11	1	TCGA-DD-A3A3-11	535	1	days	TCGA-DD-A3A3			days	535	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	45				TCGA-DD-A3A3-F42700	TCGA-DD-A3A3	TCGA-DD-A3A3-11A	0.1	0.9		B	0.8	1.2	1.2	-16708	4397	535	0				1	0	6	6	0 - No Fibrosis		2013-4-27	MALE	167	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	190	8.4	12.0	NO	NO	G2								false	No	M0	N0	T1	Stage I		A3A3		276	150	450			8.8		NO		R0	Solid Tissue Normal	11	Extended Lobectomy	5th	NO	YES	DD	1.1	Liver	Macro	A		DECEASED	71	1999				TCGA-DD-A3A3-11			13d4c229-cf05-4fca-a52d-798dc7894ba1		TCGA-DD-A3A3-11		13d4c229-cf05-4fca-a52d-798dc7894ba1		13d4c229-cf05-4fca-a52d-798dc7894ba1	13d4c229-cf05-4fca-a52d-798dc7894ba1		TCGA-DD-A3A3-11A-11D-A22H-05
TCGA-DD-A3A4-01	1	TCGA-DD-A3A4-01	612	1	days	TCGA-DD-A3A4	87	1	days	612	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	37	3.5	3.3	5.0	TCGA-DD-A3A4-F42697	TCGA-DD-A3A4	TCGA-DD-A3A4-01A	0.1	1.0	2	B	0.4	1.2	1.0	-13739	4776	612	0			87	0				0 - No Fibrosis		2013-4-27	MALE	189	Other	Tobacco use	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	160	8.4	12.0	NO	NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	false	No	M0	N0	T3	Stage IIIA	TCGA-DD-A3A4.C755324B-9B82-4319-BDD8-EB8A24107AAC.pdf	A3A4	WITH TUMOR	283	150	450	YES	NO	11.0	NO	YES		R0	Primary Tumor	01	Extended Lobectomy	5th	NO	YES	DD	1.0	Liver	None	A		DECEASED	65	1998	TCGA-DD-A3A4-01A-11D-A22E-01	TCGA-DD-A3A4-01A-11D-A22E-01	TCGA-DD-A3A4-01A-11D-A22F-10	TCGA-DD-A3A4-01	TCGA-DD-A3A4-01	953B1312-01CF-4CB4-8916-F3813C9FE832	3bf58509-d849-492e-85cc-665f1db2ccc7	TCGA-DD-A3A4-01A-11D-A22F-10	TCGA-DD-A3A4-01	TCGA-DD-A3A4-01	3bf58509-d849-492e-85cc-665f1db2ccc7	TCGA-DD-A3A4-01A-11D-A22F-10	3bf58509-d849-492e-85cc-665f1db2ccc7	3bf58509-d849-492e-85cc-665f1db2ccc7	TCGA-DD-A3A4-01A-11D-A22F-10	TCGA-DD-A3A4-01A-11D-A22H-05
TCGA-DD-A3A4-11	1	TCGA-DD-A3A4-11	612	1	days	TCGA-DD-A3A4	87	1	days	612	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	37	3.5	3.3	5.0	TCGA-DD-A3A4-F42697	TCGA-DD-A3A4		0.1	1.0	2	B	0.4	1.2	1.0	-13739		612	0			87	0				0 - No Fibrosis		2013-4-27	MALE	189	Other	Tobacco use	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.4	12.0		NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No		No	M0	N0	T3	Stage IIIA		A3A4	WITH TUMOR	283	150	450	YES	NO	11.0	NO	YES		R0	Solid Tissue Normal	11	Extended Lobectomy	5th	NO	YES	DD	1.0	Liver	None			DECEASED	65	1998				TCGA-DD-A3A4-11			b706b36a-2bcf-405c-aa18-30cbb54fac73		TCGA-DD-A3A4-11		b706b36a-2bcf-405c-aa18-30cbb54fac73		b706b36a-2bcf-405c-aa18-30cbb54fac73	b706b36a-2bcf-405c-aa18-30cbb54fac73		
TCGA-DD-A3A5-01	1	TCGA-DD-A3A5-01	3125	1	days	TCGA-DD-A3A5	84	1	days	3125	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	66	3.5	4.2	5.0	TCGA-DD-A3A5-F42571	TCGA-DD-A3A5	TCGA-DD-A3A5-01A	0.1	0.8		A	0.6	0.9	0.7	-24288	5538	3125	0			84	1	0	6	55	0 - No Fibrosis		2013-4-24	FEMALE	170	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	250	8.4	12.0	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	false	No	M0	N0	T3	Stage III	TCGA-DD-A3A5.646F2FED-EA95-4758-B454-4B0E638553B4.pdf	A3A5	WITH TUMOR	312	150	450	NO	NO	8.7	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	4th	NO	YES	DD	1.1	Liver	None	A		DECEASED	58	1996	TCGA-DD-A3A5-01A-11D-A22E-01	TCGA-DD-A3A5-01A-11D-A22E-01	TCGA-DD-A3A5-01A-11D-A22F-10	TCGA-DD-A3A5-01	TCGA-DD-A3A5-01	EB836FD0-DB80-410C-8C1E-8F713772CE75	a2367aee-0cd5-473e-b799-77970c0ceea3	TCGA-DD-A3A5-01A-11D-A22F-10	TCGA-DD-A3A5-01	TCGA-DD-A3A5-01	a2367aee-0cd5-473e-b799-77970c0ceea3	TCGA-DD-A3A5-01A-11D-A22F-10	a2367aee-0cd5-473e-b799-77970c0ceea3	a2367aee-0cd5-473e-b799-77970c0ceea3	TCGA-DD-A3A5-01A-11D-A22F-10	TCGA-DD-A3A5-01A-11D-A22H-05
TCGA-DD-A3A5-11	1	TCGA-DD-A3A5-11	3125	1	days	TCGA-DD-A3A5	84	1	days	3125	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	66	3.5	4.2	5.0	TCGA-DD-A3A5-F42571	TCGA-DD-A3A5		0.1	0.8		A	0.6	0.9	0.7	-24288		3125	0			84	1	0	6	55	0 - No Fibrosis		2013-4-24	FEMALE	170	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.4	12.0		NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No		No	M0	N0	T3	Stage III		A3A5	WITH TUMOR	312	150	450	NO	NO	8.7	NO	NO		R0	Solid Tissue Normal	11	Segmentectomy, Multiple	4th	NO	YES	DD	1.1	Liver	None			DECEASED	58	1996				TCGA-DD-A3A5-11			dfeaa69b-72ec-4a2e-8f26-7c4d826a1aa0		TCGA-DD-A3A5-11		dfeaa69b-72ec-4a2e-8f26-7c4d826a1aa0		dfeaa69b-72ec-4a2e-8f26-7c4d826a1aa0	dfeaa69b-72ec-4a2e-8f26-7c4d826a1aa0		
TCGA-DD-A3A6-01	1	TCGA-DD-A3A6-01	3258	1	days	TCGA-DD-A3A6	3258	0	days	3258	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	72	3.5	4.3	5.0	TCGA-DD-A3A6-F42703	TCGA-DD-A3A6	TCGA-DD-A3A6-01A	0.1	0.4		A	0.6	0.9	1.0	-26319	5304	3258	0				0				0 - No Fibrosis		2013-4-27	FEMALE	175	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	150	8.4	12.0	NO	NO	G2						NO		false	No	M0	N0	T2	Stage II	TCGA-DD-A3A6.EEA9EFFB-B5F9-42D9-B452-E165E018C33C.pdf	A3A6	TUMOR FREE	4	0	6	NO	NO	9.3	NO	NO		R0	Primary Tumor	01	Extended Lobectomy	4th	NO	YES	DD	1.1	Liver	Micro	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	52	1997	TCGA-DD-A3A6-01A-11D-A22E-01	TCGA-DD-A3A6-01A-11D-A22E-01	TCGA-DD-A3A6-01A-11D-A22F-10	TCGA-DD-A3A6-01	TCGA-DD-A3A6-01	BA568908-D423-4039-87E8-B5597CB65AB9	56e6f602-0afb-434e-b28e-665d923ad781	TCGA-DD-A3A6-01A-11D-A22F-10	TCGA-DD-A3A6-01	TCGA-DD-A3A6-01	56e6f602-0afb-434e-b28e-665d923ad781	TCGA-DD-A3A6-01A-11D-A22F-10	56e6f602-0afb-434e-b28e-665d923ad781	56e6f602-0afb-434e-b28e-665d923ad781	TCGA-DD-A3A6-01A-11D-A22F-10	TCGA-DD-A3A6-01A-11D-A22H-05
TCGA-DD-A3A6-11	1	TCGA-DD-A3A6-11	3258	1	days	TCGA-DD-A3A6	3258	0	days	3258	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	72	3.5	4.3	5.0	TCGA-DD-A3A6-F42703	TCGA-DD-A3A6	TCGA-DD-A3A6-11A	0.1	0.4		A	0.6	0.9	1.0	-26319	5304	3258	0				0				0 - No Fibrosis		2013-4-27	FEMALE	175	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	8.4	12.0	NO	NO	G2						NO		false	No	M0	N0	T2	Stage II		A3A6	TUMOR FREE	4	0	6	NO	NO	9.3	NO	NO		R0	Solid Tissue Normal	11	Extended Lobectomy	4th	NO	YES	DD	1.1	Liver	Micro	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	52	1997				TCGA-DD-A3A6-11			809db606-7929-48aa-ae6b-c2c9597a31c7		TCGA-DD-A3A6-11		809db606-7929-48aa-ae6b-c2c9597a31c7		809db606-7929-48aa-ae6b-c2c9597a31c7	809db606-7929-48aa-ae6b-c2c9597a31c7		
TCGA-DD-A3A7-01	1	TCGA-DD-A3A7-01	419	1	days	TCGA-DD-A3A7	144	1	days	419	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	Mild	67				TCGA-DD-A3A7-F42004	TCGA-DD-A3A7	TCGA-DD-A3A7-01A	0.1	0.8	4		0.8	1.2	1.4	-24599	4772	419	0			144	1	0	6	120	0 - No Fibrosis		2013-4-9	MALE	188	Alcohol consumption|Other	tobacco	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	130	8.4	12.0	NO	NO	G3	Liver	Intrahepatic Recurrence		No	NO	YES	No	false	No	M0	N0	T3b	Stage IIIB	TCGA-DD-A3A7.B520F88D-4004-4DFA-BF8D-7CE96777C5A3.pdf	A3A7	WITH TUMOR	562	150	450	NO	NO	10.6	NO	YES		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.1	Liver	Micro	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	80	1998	TCGA-DD-A3A7-01A-11D-A22E-01	TCGA-DD-A3A7-01A-11D-A22E-01	TCGA-DD-A3A7-01A-11D-A22F-10	TCGA-DD-A3A7-01	TCGA-DD-A3A7-01	DC935FAC-6F3A-4861-A820-4F0A5D7D8CEA	5bd6ca42-16ca-484f-877f-cda4fb3f93a8	TCGA-DD-A3A7-01A-11D-A22F-10	TCGA-DD-A3A7-01	TCGA-DD-A3A7-01	5bd6ca42-16ca-484f-877f-cda4fb3f93a8	TCGA-DD-A3A7-01A-11D-A22F-10	5bd6ca42-16ca-484f-877f-cda4fb3f93a8	5bd6ca42-16ca-484f-877f-cda4fb3f93a8	TCGA-DD-A3A7-01A-11D-A22F-10	TCGA-DD-A3A7-01A-11D-A22H-05
TCGA-DD-A3A8-01	1	TCGA-DD-A3A8-01	11	1	days	TCGA-DD-A3A8	11	0	days	11	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	75				TCGA-DD-A3A8-F42570	TCGA-DD-A3A8	TCGA-DD-A3A8-01A	0.1	1.0	3	A	0.8	1.2	0.9	-27524	3708	11	0				1	0	6	4	0 - No Fibrosis		2013-4-24	MALE	177	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	290			NO	NO	G2						NO		false	Yes	M0	N0	T2	Stage II	TCGA-DD-A3A8.5D143B3D-AC64-4C1C-A276-D12111750C67.pdf	A3A8	TUMOR FREE	251	150	450	NO	NO		NO	YES		R0	Primary Tumor	01	Lobectomy	5th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	99	2001	TCGA-DD-A3A8-01A-11D-A22E-01	TCGA-DD-A3A8-01A-11D-A22E-01	TCGA-DD-A3A8-01A-11D-A22F-10	TCGA-DD-A3A8-01	TCGA-DD-A3A8-01	D0C214D0-9A29-41AE-9FC4-1FE0D7B5428A	41e90e6f-0afe-433e-a13d-cc5fc758c55b	TCGA-DD-A3A8-01A-11D-A22F-10	TCGA-DD-A3A8-01	TCGA-DD-A3A8-01	41e90e6f-0afe-433e-a13d-cc5fc758c55b	TCGA-DD-A3A8-01A-11D-A22F-10	41e90e6f-0afe-433e-a13d-cc5fc758c55b	41e90e6f-0afe-433e-a13d-cc5fc758c55b	TCGA-DD-A3A8-01A-11D-A22F-10	TCGA-DD-A3A8-01A-11D-A22H-05
TCGA-DD-A3A8-11	1	TCGA-DD-A3A8-11	11	1	days	TCGA-DD-A3A8	11	0	days	11	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	75				TCGA-DD-A3A8-F42570	TCGA-DD-A3A8		0.1	1.0	3	A	0.8	1.2	0.9	-27524		11	0				1	0	6	4	0 - No Fibrosis		2013-4-24	MALE	177	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES					NO	G2						NO			Yes	M0	N0	T2	Stage II		A3A8	TUMOR FREE	251	150	450	NO	NO		NO	YES		R0	Solid Tissue Normal	11	Lobectomy	5th	NO	YES	DD	1.0	Liver	None		Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	99	2001				TCGA-DD-A3A8-11			cf95e020-748c-474d-baba-68ca888d2f4f		TCGA-DD-A3A8-11		cf95e020-748c-474d-baba-68ca888d2f4f		cf95e020-748c-474d-baba-68ca888d2f4f	cf95e020-748c-474d-baba-68ca888d2f4f		
TCGA-DD-A3A9-01	1	TCGA-DD-A3A9-01	931	1	days	TCGA-DD-A3A9	289	1	days	931	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	64	3.5	4.0	5.0	TCGA-DD-A3A9-F42709	TCGA-DD-A3A9	TCGA-DD-A3A9-01A	0.1	0.3		A	0.6	0.9	0.9	-23526	3584	931	0			289	1	0	6	19930	0 - No Fibrosis		2013-4-27	FEMALE	168	Other	smoker	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	230	8.4	12.0	NO	NO	G2	Lung	Extrahepatic Recurrence			NO	YES		false	No	M1	N0	T4	Stage IVB	TCGA-DD-A3A9.59B64E76-42CB-421D-B8A7-36F7050BA5E5.pdf	A3A9	WITH TUMOR	317	150	450			9.3		NO		R0	Primary Tumor	01	Lobectomy	5th	NO	YES	DD	1.0	Liver	None	A		DECEASED	62	2001	TCGA-DD-A3A9-01A-11D-A25U-01	TCGA-DD-A3A9-01A-11D-A25U-01	TCGA-DD-A3A9-01A-11D-A25V-10	TCGA-DD-A3A9-01	TCGA-DD-A3A9-01	8021FC77-6677-4784-83FA-19CF2ECBDC1F	e53f26c4-eb37-4a21-823e-98000f26309d	TCGA-DD-A3A9-01A-11D-A25V-10	TCGA-DD-A3A9-01	TCGA-DD-A3A9-01	e53f26c4-eb37-4a21-823e-98000f26309d	TCGA-DD-A3A9-01A-11D-A25V-10	e53f26c4-eb37-4a21-823e-98000f26309d	e53f26c4-eb37-4a21-823e-98000f26309d	TCGA-DD-A3A9-01A-11D-A25V-10	TCGA-DD-A3A9-01A-11D-A264-05
TCGA-DD-A4NA-01	0	TCGA-DD-A4NA-01	1008	0	days	TCGA-DD-A4NA	1008	0	days	1008	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	67				TCGA-DD-A4-F49640	TCGA-DD-A4	TCGA-DD-A4-01A			2		0.6	1.1	0.8	-24603	1198		0	1008			0	0	6	3	5 - Nodular Formation and Incomplete Cirrhosis		2013-10-7	FEMALE	166	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	110	8.3	10.8	NO	YES	G3						NO		true	No	M0	N1	T2	Stage IIIC	TCGA-DD-A4.48C11C04-947E-4954-9687-DF275D897F79.pdf	A4	TUMOR FREE	332	150	450	NO	NO	9.6	NO	YES		R0	Primary Tumor	01	Extended Lobectomy	6th	NO	YES	DD		Liver		A	Hepatitis B Surface Antigen|HBV Surface Antibody	LIVING	93	2009	TCGA-DD-A4NA-01A-11D-A25U-01	TCGA-DD-A4NA-01A-11D-A25U-01	TCGA-DD-A4NA-01A-11D-A25V-10	TCGA-DD-A4NA-01	TCGA-DD-A4NA-01	C7C5E4DB-1B88-4A44-8048-7E87E1540459	59b320d5-a277-4723-b9f0-d1e7fe2a20af	TCGA-DD-A4NA-01A-11D-A25V-10	TCGA-DD-A4NA-01	TCGA-DD-A4NA-01	59b320d5-a277-4723-b9f0-d1e7fe2a20af	TCGA-DD-A4NA-01A-11D-A25V-10	59b320d5-a277-4723-b9f0-d1e7fe2a20af	59b320d5-a277-4723-b9f0-d1e7fe2a20af	TCGA-DD-A4NA-01A-11D-A25V-10	TCGA-DD-A4NA-01A-11D-A264-05
TCGA-DD-A4NB-01	0	TCGA-DD-A4NB-01	989	0	days	TCGA-DD-A4NB	912	1	days	989	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	25				TCGA-DD-A4NB-F59448	TCGA-DD-A4NB	TCGA-DD-A4NB-01A	0.1	1.0	2		0.8	1.3	0.8	-9426	464		0	989	913	912	1	0	6	3			2014-5-13	MALE	185	No History of Primary Risk Factors		Fibrolamellar Carcinoma	No	C22.0	8171/3	C22.0	YES	180	9.5	13.8	NO	NO	G2	Other, specify	Extrahepatic Recurrence	retroperitoneal lymph nodes	No	YES	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-A4NB.963CA9F8-DA47-4E2E-892E-14E7AB0EB76E.pdf	A4NB	TUMOR FREE	296	150	450	NO	NO	13.9	NO	YES	R0	R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	DD	1.0	Liver	None	A		LIVING	69	2011	TCGA-DD-A4NB-01A-12D-A25U-01	TCGA-DD-A4NB-01A-12D-A25U-01	TCGA-DD-A4NB-01A-12D-A25V-10	TCGA-DD-A4NB-01	TCGA-DD-A4NB-01	45787358-74F0-4C4F-85E9-984864B87439	173a2cc4-0d27-4a27-857f-97a0e53fa8d1	TCGA-DD-A4NB-01A-12D-A25V-10	TCGA-DD-A4NB-01	TCGA-DD-A4NB-01	173a2cc4-0d27-4a27-857f-97a0e53fa8d1	TCGA-DD-A4NB-01A-12D-A25V-10	173a2cc4-0d27-4a27-857f-97a0e53fa8d1	173a2cc4-0d27-4a27-857f-97a0e53fa8d1	TCGA-DD-A4NB-01A-12D-A25V-10	TCGA-DD-A4NB-01A-12D-A264-05
TCGA-DD-A4ND-01	0	TCGA-DD-A4ND-01	2746	0	days	TCGA-DD-A4ND	2746	0	days	2746	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	56	3.5	3.9	5	TCGA-DD-A4ND-F43021	TCGA-DD-A4ND	TCGA-DD-A4ND-01A	0.1	0.5	3	A	0.6	1.1	0.7	-20782	2088		0	2746		20	1				0 - No Fibrosis		2014-10-21	FEMALE	162	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	140	8.4	12	NO	NO	G3	Other, specify	New Primary Tumor	stage IV breast carcinoma	No	NO	NO	No	true	Yes	M0	N0	T1	Stage I	TCGA-DD-A4ND.64D878AE-DEEA-4C56-854C-3774038E2914.pdf	A4ND	TUMOR FREE				NO	NO	8.8	NO	YES		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1	Liver	None	A		LIVING	89	2007	TCGA-DD-A4ND-01A-11D-A25U-01	TCGA-DD-A4ND-01A-11D-A25U-01	TCGA-DD-A4ND-01A-11D-A25V-10	TCGA-DD-A4ND-01	TCGA-DD-A4ND-01	BED220BC-C4F4-407D-A237-BB3ADCAB45CB	b3d02a68-fde3-42cd-8ca2-7e3565f85632	TCGA-DD-A4ND-01A-11D-A25V-10	TCGA-DD-A4ND-01	TCGA-DD-A4ND-01	b3d02a68-fde3-42cd-8ca2-7e3565f85632	TCGA-DD-A4ND-01A-11D-A25V-10	b3d02a68-fde3-42cd-8ca2-7e3565f85632	b3d02a68-fde3-42cd-8ca2-7e3565f85632	TCGA-DD-A4ND-01A-11D-A25V-10	TCGA-DD-A4ND-01A-11D-A264-05
TCGA-DD-A4NE-01	1	TCGA-DD-A4NE-01	660	1	days	TCGA-DD-A4NE	190	1	days	660	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	75	3.5	4.2	5.0	TCGA-DD-A4NE-F49644	TCGA-DD-A4NE	TCGA-DD-A4NE-01A	0.1	0.9	3	A	0.6	1.0	0.8	-27549	631	660	0			190	0	0	6	28	0 - No Fibrosis		2013-10-7	FEMALE	170	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	200	8.3	10.8	NO	NO	G3	Liver	Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T3a	Stage IIIA	TCGA-DD-A4NE.8E3E5E19-6A21-44B1-B000-F90EA27F6EE0.pdf	A4NE	WITH TUMOR	348	150	450	NO	NO	10.2	NO	YES		R0	Primary Tumor	01	Extended Lobectomy	7th	NO	YES	DD	1.0	Liver	None	A	Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Core Antibody	DECEASED	79	2011			TCGA-DD-A4NE-01A-11D-A27I-10	TCGA-DD-A4NE-01	TCGA-DD-A4NE-01	A13ADCC3-E48C-4BFA-8AC2-654490756B65	050080ae-44db-4056-8df1-eae4d9014ac9	TCGA-DD-A4NE-01A-11D-A27I-10	TCGA-DD-A4NE-01		050080ae-44db-4056-8df1-eae4d9014ac9	TCGA-DD-A4NE-01A-11D-A27I-10	050080ae-44db-4056-8df1-eae4d9014ac9	050080ae-44db-4056-8df1-eae4d9014ac9	TCGA-DD-A4NE-01A-11D-A27I-10	TCGA-DD-A4NE-01A-11D-A27W-05
TCGA-DD-A4NF-01	0	TCGA-DD-A4NF-01	942	0	days	TCGA-DD-A4NF	656	1	days	942	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	YES	Mild	72	3.5	4	5.0	TCGA-DD-A4NF-F59456	TCGA-DD-A4NF	TCGA-DD-A4NF-01A	0.1	0.5		A	0.8	1.3	0.9	-26330	364		0	942		656	0	0	6	6	6 - Established Cirrhosis		2014-5-13	MALE	173	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	200	9.5	13.8	NO	NO	G2	Bone	Extrahepatic Recurrence		No	NO	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-A4NF.7381633C-866A-4440-93B1-BC7102B59C93.pdf	A4NF	WITH TUMOR	97	150	450	NO	NO	12.7	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.0	Liver	None	A	Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	86	2011	TCGA-DD-A4NF-01A-11D-A27H-01	TCGA-DD-A4NF-01A-11D-A27H-01	TCGA-DD-A4NF-01A-11D-A27I-10	TCGA-DD-A4NF-01	TCGA-DD-A4NF-01	F89D6497-C924-4C3A-953D-6DCA31C8764A	23ac1fcb-a802-468b-8a25-639f2b221aba	TCGA-DD-A4NF-01A-11D-A27I-10	TCGA-DD-A4NF-01	TCGA-DD-A4NF-01	23ac1fcb-a802-468b-8a25-639f2b221aba	TCGA-DD-A4NF-01A-11D-A27I-10	23ac1fcb-a802-468b-8a25-639f2b221aba	23ac1fcb-a802-468b-8a25-639f2b221aba	TCGA-DD-A4NF-01A-11D-A27I-10	TCGA-DD-A4NF-01A-11D-A27W-05
TCGA-DD-A4NG-01	1	TCGA-DD-A4NG-01	802	1	days	TCGA-DD-A4NG	430	1	days	802	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	77	3.5	4.5	5.0	TCGA-DD-A4NG-F49648	TCGA-DD-A4NG	TCGA-DD-A4NG-01A	0.1	0.5	1	A	0.8	1.3	0.9	-28234	629	802	0	445		430	1	0	6	3			2013-10-7	MALE	164	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	280	8.3	10.8	NO	NO	G2	Liver	Locoregional Recurrence			NO	YES	No	true	No	M0	NX	T3a	Stage IIIA	TCGA-DD-A4NG.4E4F148F-7C70-43DE-802E-271078BDFB4F.pdf	A4NG	WITH TUMOR	220	150	450	NO	NO	10.6	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	DD	1.0	Liver	Micro	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	94	2011			TCGA-DD-A4NG-01A-11D-A27I-10	TCGA-DD-A4NG-01	TCGA-DD-A4NG-01	43087284-F231-4802-AA2D-34B8622D1846	0fd0cbba-815e-4087-aa44-39c4b271ff49	TCGA-DD-A4NG-01A-11D-A27I-10	TCGA-DD-A4NG-01		0fd0cbba-815e-4087-aa44-39c4b271ff49	TCGA-DD-A4NG-01A-11D-A27I-10	0fd0cbba-815e-4087-aa44-39c4b271ff49	0fd0cbba-815e-4087-aa44-39c4b271ff49	TCGA-DD-A4NG-01A-11D-A27I-10	TCGA-DD-A4NG-01A-11D-A27W-05
TCGA-DD-A4NH-01	0	TCGA-DD-A4NH-01	917	0	days	TCGA-DD-A4NH	161	1	days	917	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	65	3.5	4.0	5.0	TCGA-DD-A4NH-F59474	TCGA-DD-A4NH	TCGA-DD-A4NH-01A	0.1	0.6	1	A	0.6	1.1	0.8	-23865	335		0	917		161	0	0	6	92889	1,2 - Portal Fibrosis		2014-5-13	FEMALE	157	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	270	9.5	13.8	NO	NO	G3	Lung	Extrahepatic Recurrence		No	NO	YES	No	true	No	M0	N0	T3b	Stage IIIB	TCGA-DD-A4NH.C9179EC7-2990-4581-B652-60289CC895F5.pdf	A4NH	WITH TUMOR	226	150	450	NO	NO	11.8	NO	YES		R0	Primary Tumor	01	Extended Lobectomy	7th	NO	YES	DD	1.0	Liver	Macro	A	Hepatitis B Surface Antigen	LIVING	81	2011	TCGA-DD-A4NH-01A-11D-A27H-01	TCGA-DD-A4NH-01A-11D-A27H-01	TCGA-DD-A4NH-01A-11D-A27I-10	TCGA-DD-A4NH-01	TCGA-DD-A4NH-01	DAC12730-5AF5-47EB-9DC6-008E0D3C2CD6	8d1c5ea4-08dd-4f4f-9876-ca5316e233b5	TCGA-DD-A4NH-01A-11D-A27I-10	TCGA-DD-A4NH-01	TCGA-DD-A4NH-01	8d1c5ea4-08dd-4f4f-9876-ca5316e233b5	TCGA-DD-A4NH-01A-11D-A27I-10	8d1c5ea4-08dd-4f4f-9876-ca5316e233b5	8d1c5ea4-08dd-4f4f-9876-ca5316e233b5	TCGA-DD-A4NH-01A-11D-A27I-10	TCGA-DD-A4NH-01A-11D-A27W-05
TCGA-DD-A4NI-01	0	TCGA-DD-A4NI-01	816	0	days	TCGA-DD-A4NI	816	0	days	816	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				67	3.5	4.4	5.0	TCGA-DD-A4NI-F59476	TCGA-DD-A4NI	TCGA-DD-A4NI-01A	0.1	0.6	6	A	0.8	1.3	1.1	-24516	357		0	816			0	0	6	6	0 - No Fibrosis		2014-5-13	MALE	172	Alcohol consumption|Non-Alcoholic Fatty Liver Disease	tobacco	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	130	9.5	13.8	NO	YES	G2						NO		true	Yes	M0	NX	T2	Stage II	TCGA-DD-A4NI.7D4F801A-187C-4B20-96B3-98313D5252E3.pdf	A4NI	TUMOR FREE	187	150	450	NO	NO	12.4	NO	YES		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	99	2011	TCGA-DD-A4NI-01A-11D-A27H-01	TCGA-DD-A4NI-01A-11D-A27H-01	TCGA-DD-A4NI-01A-11D-A27I-10	TCGA-DD-A4NI-01	TCGA-DD-A4NI-01	C8A5BC94-6611-4B36-918E-0D26304CFCBA	49d9e652-b4e1-4858-b21e-256c17623f50	TCGA-DD-A4NI-01A-11D-A27I-10	TCGA-DD-A4NI-01	TCGA-DD-A4NI-01	49d9e652-b4e1-4858-b21e-256c17623f50	TCGA-DD-A4NI-01A-11D-A27I-10	49d9e652-b4e1-4858-b21e-256c17623f50	49d9e652-b4e1-4858-b21e-256c17623f50	TCGA-DD-A4NI-01A-11D-A27I-10	TCGA-DD-A4NI-01A-11D-A27W-05
TCGA-DD-A4NJ-01	0	TCGA-DD-A4NJ-01	928	0	days	TCGA-DD-A4NJ	549	1	days	928	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	54	3.5	4.7	5.0	TCGA-DD-A4NJ-F59477	TCGA-DD-A4NJ	TCGA-DD-A4NJ-01A	0.1	0.4	1	A	0.6	1.1	0.7	-19964	416		0	928		549	0	0	6	5	1,2 - Portal Fibrosis		2014-5-13	FEMALE	164	Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	140	9.5	13.8	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	N0	T2	Stage II	TCGA-DD-A4NJ.36C3150D-343E-4B3F-A5D7-1AE978246648.pdf	A4NJ	WITH TUMOR	303	150	450	NO	NO	11.5	NO	YES		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	88	2011	TCGA-DD-A4NJ-01A-11D-A27H-01	TCGA-DD-A4NJ-01A-11D-A27H-01	TCGA-DD-A4NJ-01A-11D-A27I-10		TCGA-DD-A4NJ-01	DCF080D8-9F50-4DB3-B327-0C52F23FCE8D	1dc20bf4-f17d-4b26-88c0-86aff9ddfc7a	TCGA-DD-A4NJ-01A-11D-A27I-10		TCGA-DD-A4NJ-01	1dc20bf4-f17d-4b26-88c0-86aff9ddfc7a	TCGA-DD-A4NJ-01A-11D-A27I-10	1dc20bf4-f17d-4b26-88c0-86aff9ddfc7a	1dc20bf4-f17d-4b26-88c0-86aff9ddfc7a	TCGA-DD-A4NJ-01A-11D-A27I-10	TCGA-DD-A4NJ-01A-11D-A27W-05
TCGA-DD-A4NK-01	1	TCGA-DD-A4NK-01	1210	1	days	TCGA-DD-A4NK	89	1	days	1210	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	80	3.5	4.1	5.0	TCGA-DD-A4NK-F49654	TCGA-DD-A4NK	TCGA-DD-A4NK-01A	0.1	0.5	3	A	0.7	1.2	1.1	-29244	3143	1210	0			89	0	0	6	3	0 - No Fibrosis		2013-10-7	FEMALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	130	8.4	12.0	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	N0	T3	Stage IIIA	TCGA-DD-A4NK.0521278C-B2AC-4D7D-BC1F-5003B630808E.pdf	A4NK	WITH TUMOR	372	150	450	YES	NO	8.7	NO	YES		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen	DECEASED	84	2004	TCGA-DD-A4NK-01A-11D-A28W-01	TCGA-DD-A4NK-01A-11D-A28W-01	TCGA-DD-A4NK-01A-11D-A28X-10		TCGA-DD-A4NK-01	65645058-B639-4FBA-9204-6CC07D139290	28e2f8ef-14bf-4965-82a5-1d2e33a19af3	TCGA-DD-A4NK-01A-11D-A28X-10		TCGA-DD-A4NK-01	28e2f8ef-14bf-4965-82a5-1d2e33a19af3	TCGA-DD-A4NK-01A-11D-A28X-10	28e2f8ef-14bf-4965-82a5-1d2e33a19af3	28e2f8ef-14bf-4965-82a5-1d2e33a19af3	TCGA-DD-A4NK-01A-11D-A28X-10	TCGA-DD-A4NK-01A-11D-A28Y-05
TCGA-DD-A4NL-01	0	TCGA-DD-A4NL-01	1711	0	days	TCGA-DD-A4NL	1711	0	days	1711	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	46	3.5	4.4	5.0	TCGA-DD-A4NL-F59645	TCGA-DD-A4NL	TCGA-DD-A4NL-01A	0.1	0.3			0.8	1.3	1.0	-16874	1896		0	1711			1	0	6	2	0 - No Fibrosis		2014-5-17	MALE	173	Alcohol consumption|Other	Tobacco use	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	80			NO	YES	G1						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-A4NL.54C7EDE1-EDBE-44A4-A3BE-FD639D6891DA.pdf	A4NL	TUMOR FREE	266	150	450	NO	NO		NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	113	2007	TCGA-DD-A4NL-01A-11D-A28W-01	TCGA-DD-A4NL-01A-11D-A28W-01	TCGA-DD-A4NL-01A-11D-A28X-10	TCGA-DD-A4NL-01	TCGA-DD-A4NL-01		90779b87-ec28-4c54-b98e-3d70e132b7b3	TCGA-DD-A4NL-01A-11D-A28X-10	TCGA-DD-A4NL-01	TCGA-DD-A4NL-01	90779b87-ec28-4c54-b98e-3d70e132b7b3	TCGA-DD-A4NL-01A-11D-A28X-10	90779b87-ec28-4c54-b98e-3d70e132b7b3	90779b87-ec28-4c54-b98e-3d70e132b7b3	TCGA-DD-A4NL-01A-11D-A28X-10	TCGA-DD-A4NL-01A-11D-A28Y-05
TCGA-DD-A4NN-01	1	TCGA-DD-A4NN-01	899	1	days	TCGA-DD-A4NN	166	1	days	899	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		56	3.5	4.3	5.0	TCGA-DD-A4NN-F49659	TCGA-DD-A4NN	TCGA-DD-A4NN-01A	0.1	0.5	1	A	0.7	1.2	0.9	-20548	3053	899	0			166	0	0	6	4223	0 - No Fibrosis		2013-10-7	FEMALE	163	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	240	8.0	12.0	NO	NO	G3	Lung	Extrahepatic Recurrence		No	NO	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-A4NN.16053CE8-B3B1-4925-AEAA-5B118E1C2E45.pdf	A4NN	WITH TUMOR	307	150	450	NO	NO	8.8	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	None	A		DECEASED	59	2004	TCGA-DD-A4NN-01A-11D-A28W-01	TCGA-DD-A4NN-01A-11D-A28W-01	TCGA-DD-A4NN-01A-11D-A28X-10	TCGA-DD-A4NN-01	TCGA-DD-A4NN-01	9D74528E-5389-4281-B73A-894B9B356E0E	362c086d-ce73-408a-afcf-f129d54af1e9	TCGA-DD-A4NN-01A-11D-A28X-10	TCGA-DD-A4NN-01	TCGA-DD-A4NN-01	362c086d-ce73-408a-afcf-f129d54af1e9	TCGA-DD-A4NN-01A-11D-A28X-10	362c086d-ce73-408a-afcf-f129d54af1e9	362c086d-ce73-408a-afcf-f129d54af1e9	TCGA-DD-A4NN-01A-11D-A28X-10	TCGA-DD-A4NN-01A-11D-A28Y-05
TCGA-DD-A4NO-01	0	TCGA-DD-A4NO-01	2245	0	days	TCGA-DD-A4NO	990	1	days	2245	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	65	3.5	4.5	5.0	TCGA-DD-A4NO-F49662	TCGA-DD-A4NO	TCGA-DD-A4NO-01A	0.1	0.4		A	0.8	1.3	1.6	-24090	1879		0	2245		990	0	0	6	3	0 - No Fibrosis		2013-10-7	MALE	176	Hepatitis C|Other	Tobacco use	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	190	8.4	12.0	NO	NO	G1	Liver	Locoregional Recurrence		Yes	NO	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-A4NO.0B108361-E361-4A8B-9F5C-FC3ACB992DB9.pdf	A4NO	WITH TUMOR	201	150	450	NO	NO	9.9	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	109	2007	TCGA-DD-A4NO-01A-11D-A28W-01	TCGA-DD-A4NO-01A-11D-A28W-01	TCGA-DD-A4NO-01A-11D-A28X-10	TCGA-DD-A4NO-01	TCGA-DD-A4NO-01	4382BDF1-B3AD-44F1-92B0-1C7DC3CD4CE2	830be6d6-82f7-4085-88a4-060f01c267fb	TCGA-DD-A4NO-01A-11D-A28X-10	TCGA-DD-A4NO-01	TCGA-DD-A4NO-01	830be6d6-82f7-4085-88a4-060f01c267fb	TCGA-DD-A4NO-01A-11D-A28X-10	830be6d6-82f7-4085-88a4-060f01c267fb	830be6d6-82f7-4085-88a4-060f01c267fb	TCGA-DD-A4NO-01A-11D-A28X-10	TCGA-DD-A4NO-01A-11D-A28Y-05
TCGA-DD-A4NP-01	0	TCGA-DD-A4NP-01	3308	0	days	TCGA-DD-A4NP	1286	1	days	3308	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	32	3.5	2.4	5.0	TCGA-DD-A4NP-F59646	TCGA-DD-A4NP	TCGA-DD-A4NP-01A	0.1	0.7		B	0.9	1.4	1.9	-11838	2736		0	3308		1286	0	0	6	2	0 - No Fibrosis		2014-5-17	MALE	177	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	160	8.4	12.0	NO	NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-A4NP.6C7AE628-1BC9-453D-A1C2-5F2F63A295FC.pdf	A4NP	TUMOR FREE	348	150	450	NO	NO	8.9	NO	NO		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	79	2005	TCGA-DD-A4NP-01A-11D-A28W-01	TCGA-DD-A4NP-01A-11D-A28W-01	TCGA-DD-A4NP-01A-11D-A28X-10	TCGA-DD-A4NP-01	TCGA-DD-A4NP-01	BCE78D42-7476-4889-B557-651EE0EBACA7	3101309f-f0e5-42d8-88ca-a44d37d240f0	TCGA-DD-A4NP-01A-11D-A28X-10	TCGA-DD-A4NP-01	TCGA-DD-A4NP-01	3101309f-f0e5-42d8-88ca-a44d37d240f0	TCGA-DD-A4NP-01A-11D-A28X-10	3101309f-f0e5-42d8-88ca-a44d37d240f0	3101309f-f0e5-42d8-88ca-a44d37d240f0	TCGA-DD-A4NP-01A-11D-A28X-10	TCGA-DD-A4NP-01A-11D-A28Y-05
TCGA-DD-A4NQ-01	1	TCGA-DD-A4NQ-01	373	1	days	TCGA-DD-A4NQ	126	1	days	373	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	Mild	60	3.5	4.4	5.0	TCGA-DD-A4NQ-F49669	TCGA-DD-A4NQ	TCGA-DD-A4NQ-01A	0.1	0.7	1	A	0.8	1.3	0.8	-22111	2030	373	0			126	0	0	6	141			2013-10-7	MALE	159	Hepatitis B|Other	tobacco	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	120	8.4	12.0	NO	NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	N0	T2	Stage II	TCGA-DD-A4NQ.D79DB738-2DA3-43F6-898C-4A212964FA03.pdf	A4NQ	WITH TUMOR	283	150	450	NO	NO	10.1	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	Macro	A	Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	75	2007	TCGA-DD-A4NQ-01A-21D-A28W-01	TCGA-DD-A4NQ-01A-21D-A28W-01	TCGA-DD-A4NQ-01A-21D-A28X-10	TCGA-DD-A4NQ-01	TCGA-DD-A4NQ-01	A206D8AA-F54A-47BB-B0DA-E8D95F719D63	15a72f2f-83c5-4264-8103-5c3e28445d12	TCGA-DD-A4NQ-01A-21D-A28X-10	TCGA-DD-A4NQ-01	TCGA-DD-A4NQ-01	15a72f2f-83c5-4264-8103-5c3e28445d12	TCGA-DD-A4NQ-01A-21D-A28X-10	15a72f2f-83c5-4264-8103-5c3e28445d12	15a72f2f-83c5-4264-8103-5c3e28445d12	TCGA-DD-A4NQ-01A-21D-A28X-10	TCGA-DD-A4NQ-01A-21D-A28Y-05
TCGA-DD-A4NR-01	1	TCGA-DD-A4NR-01	9	1	days	TCGA-DD-A4NR	9	0	days	9	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				85	3.5	3.1	5.0	TCGA-DD-A4NR-F49670	TCGA-DD-A4NR	TCGA-DD-A4NR-01A	0.1	0.8	1	A	0.7	1.2	1.0	-31386	2652	9	0				0	0	6	40250	6 - Established Cirrhosis		2013-10-7	FEMALE	64	Other	primary biliary cirrhosis	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	240	8.4	12.0	NO	NO	G3						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-A4NR.93133C58-B1BF-4A5C-8EFC-AE17EC6A0B64.pdf	A4NR	TUMOR FREE	239	150	450	NO	NO	9.3	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	54	2005	TCGA-DD-A4NR-01A-11D-A30U-01	TCGA-DD-A4NR-01A-11D-A30U-01	TCGA-DD-A4NR-01A-11D-A30V-10	TCGA-DD-A4NR-01	TCGA-DD-A4NR-01	D99B1488-C4F1-46C5-BCEF-675E8FFB31D1	6af2d20a-bab8-4f0c-ac22-c1454619ef46	TCGA-DD-A4NR-01A-11D-A30V-10	TCGA-DD-A4NR-01	TCGA-DD-A4NR-01	6af2d20a-bab8-4f0c-ac22-c1454619ef46	TCGA-DD-A4NR-01A-11D-A30V-10	6af2d20a-bab8-4f0c-ac22-c1454619ef46	6af2d20a-bab8-4f0c-ac22-c1454619ef46	TCGA-DD-A4NR-01A-11D-A30V-10	TCGA-DD-A4NR-01A-11D-A30Y-05
TCGA-DD-A4NS-01	1	TCGA-DD-A4NS-01	2456	1	days	TCGA-DD-A4NS	893	1	days	2456	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	61				TCGA-DD-A4NS-F49671	TCGA-DD-A4NS	TCGA-DD-A4NS-01A	0.1	0.9	2		0.7	1.2	1.1	-22638	2596	2456	0		913	893	0	0	6	2	0 - No Fibrosis		2013-10-7	FEMALE	167	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	140	8.4	12.0	NO	NO	G2	Bone	Extrahepatic Recurrence		No	YES	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-A4NS.97CA96D5-990E-41F9-949D-CCCCFFB78CBD.pdf	A4NS	WITH TUMOR	270	150	450	NO	NO	8.8	NO	YES		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	58	2005	TCGA-DD-A4NS-01A-11D-A30U-01	TCGA-DD-A4NS-01A-11D-A30U-01	TCGA-DD-A4NS-01A-11D-A30V-10	TCGA-DD-A4NS-01	TCGA-DD-A4NS-01	75C04C4C-1A60-4B07-B987-76598237D3E0	c3b5e80e-398b-4390-ae78-4f2cb9be4497	TCGA-DD-A4NS-01A-11D-A30V-10	TCGA-DD-A4NS-01	TCGA-DD-A4NS-01	c3b5e80e-398b-4390-ae78-4f2cb9be4497	TCGA-DD-A4NS-01A-11D-A30V-10	c3b5e80e-398b-4390-ae78-4f2cb9be4497	c3b5e80e-398b-4390-ae78-4f2cb9be4497	TCGA-DD-A4NS-01A-11D-A30V-10	TCGA-DD-A4NS-01A-11D-A30Y-05
TCGA-DD-A4NV-01	0	TCGA-DD-A4NV-01	2398	0	days	TCGA-DD-A4NV	2398	0	days	2398	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	61	3.5	3.9	5.0	TCGA-DD-A4NV-F59879	TCGA-DD-A4NV		0.1	0.5	1	A	0.8	1.3	0.8	-22438			0	2398			1	0	6	3	0 - No Fibrosis		2014-5-22	MALE	179	Non-Alcoholic Fatty Liver Disease|Other	morbid obesity, tobacco use	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		8.4	12.0		NO	G1						NO			No	M0	N0	T3	Stage IIIA		A4NV	TUMOR FREE	240	150	450	NO	NO	9.0	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	None		Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	129	2007	TCGA-DD-A4NV-01A-11D-A30U-01	TCGA-DD-A4NV-01A-11D-A30U-01	TCGA-DD-A4NV-01A-11D-A30V-10	TCGA-DD-A4NV-01	TCGA-DD-A4NV-01		cabf0153-dac2-48ae-a225-19147772ddfe	TCGA-DD-A4NV-01A-11D-A30V-10	TCGA-DD-A4NV-01	TCGA-DD-A4NV-01	cabf0153-dac2-48ae-a225-19147772ddfe	TCGA-DD-A4NV-01A-11D-A30V-10	cabf0153-dac2-48ae-a225-19147772ddfe	cabf0153-dac2-48ae-a225-19147772ddfe	TCGA-DD-A4NV-01A-11D-A30V-10	TCGA-DD-A4NV-01A-11D-A30Y-05
TCGA-DD-A73A-01	0	TCGA-DD-A73A-01	728	0	days	TCGA-DD-A73A	728	0	days	728	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	71	3.5	4.4	5.0	TCGA-DD-A73A-F66593	TCGA-DD-A73A		0.1	1.2		A	0.8	1.3	1.4	-26136			0	728			1	0	6	4	3,4 - Fibrous Speta		2014-10-21	MALE	174	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		9.5	13.8		NO	G2						NO			No	M0	N0	T1	Stage I		A73A	TUMOR FREE	89	150	450	NO	NO	12.8	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.0	Liver	None		Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	102	2012	TCGA-DD-A73A-01A-12D-A32F-01	TCGA-DD-A73A-01A-12D-A32F-01	TCGA-DD-A73A-01A-12D-A32G-10	TCGA-DD-A73A-01	TCGA-DD-A73A-01		b2ae2c3b-87c2-47e1-9d66-ae23a3f83919	TCGA-DD-A73A-01A-12D-A32G-10	TCGA-DD-A73A-01	TCGA-DD-A73A-01	b2ae2c3b-87c2-47e1-9d66-ae23a3f83919	TCGA-DD-A73A-01A-12D-A32G-10	b2ae2c3b-87c2-47e1-9d66-ae23a3f83919	b2ae2c3b-87c2-47e1-9d66-ae23a3f83919	TCGA-DD-A73A-01A-12D-A32G-10	TCGA-DD-A73A-01A-12D-A32R-05
TCGA-DD-A73B-01	1	TCGA-DD-A73B-01	283	1	days	TCGA-DD-A73B			days	283	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				72	3.5	3.5	5.0		TCGA-DD-A73B	TCGA-DD-A73B-01A	0.1	2.1	1	B	0.6	1.1	0.9	-26390	345	283	0				0	0	6	30	6 - Established Cirrhosis		2013-9-30	FEMALE	154	Alpha-1 Antitrypsin Deficiency|Other	Gilberts syndrome.	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	150	0.8	1.2	NO		G2						YES		false	No	M0	N0	T1	Stage I	TCGA-DD-A73B.B1C57A75-7C86-49D9-B143-09E60824F508.pdf	A73B	WITH TUMOR	88	150	450	NO	NO	1.1	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen	DECEASED	74	2012	TCGA-DD-A73B-01A-12D-A32F-01	TCGA-DD-A73B-01A-12D-A32F-01	TCGA-DD-A73B-01A-12D-A32G-10	TCGA-DD-A73B-01	TCGA-DD-A73B-01	9C91FA76-A8F5-499C-9D32-2D8B107013D7	4ed5467c-be43-4125-a6c4-7b7aad6ea5f6	TCGA-DD-A73B-01A-12D-A32G-10	TCGA-DD-A73B-01	TCGA-DD-A73B-01	4ed5467c-be43-4125-a6c4-7b7aad6ea5f6	TCGA-DD-A73B-01A-12D-A32G-10	4ed5467c-be43-4125-a6c4-7b7aad6ea5f6	4ed5467c-be43-4125-a6c4-7b7aad6ea5f6	TCGA-DD-A73B-01A-12D-A32G-10	TCGA-DD-A73B-01A-12D-A32R-05
TCGA-DD-A73C-01	0	TCGA-DD-A73C-01	701	0	days	TCGA-DD-A73C	566	1	days	701	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	65	3.5	4.9	5.0	TCGA-DD-A73C-F66595	TCGA-DD-A73C	TCGA-DD-A73C-01A	0.1	0.7	1	A	0.6	1.1	0.8	-23782	288		0	701		566	0	0	6	3	0 - No Fibrosis		2014-10-21	FEMALE	159	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	160	9.5	13.8	NO	NO	G1	Liver	Locoregional Recurrence		No		YES	No	false	No	M0	N0	T3a	Stage IIIA	TCGA-DD-A73C.FE051CD7-9C34-4A45-934C-DD8BB00C717A.pdf	A73C	WITH TUMOR	247	150	450	NO	NO	11.7	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	49	2012	TCGA-DD-A73C-01A-12D-A33B-01	TCGA-DD-A73C-01A-12D-A33B-01	TCGA-DD-A73C-01A-12D-A33K-10	TCGA-DD-A73C-01	TCGA-DD-A73C-01	35C56771-BADA-4231-99BB-BA79C363A7B6	b518428e-84c5-4dbe-a608-c7d55e35067a	TCGA-DD-A73C-01A-12D-A33K-10	TCGA-DD-A73C-01	TCGA-DD-A73C-01	b518428e-84c5-4dbe-a608-c7d55e35067a	TCGA-DD-A73C-01A-12D-A33K-10	b518428e-84c5-4dbe-a608-c7d55e35067a	b518428e-84c5-4dbe-a608-c7d55e35067a	TCGA-DD-A73C-01A-12D-A33K-10	TCGA-DD-A73C-01A-12D-A33L-05
TCGA-DD-A73D-01	0	TCGA-DD-A73D-01	693	0	days	TCGA-DD-A73D	592	1	days	693	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	68	3.5	4.5	5.0	TCGA-DD-A73D-F66596	TCGA-DD-A73D	TCGA-DD-A73D-01A	0.1	0.3	1	A	0.6	1.1	0.8	-24941	313		0	693		592	0	0	6	4	6 - Established Cirrhosis		2014-10-21	FEMALE	170	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	250	9.5	13.8	NO	NO	G1	Liver	Intrahepatic Recurrence		Yes		YES	No	false	No	MX	NX	T2	Stage II	TCGA-DD-A73D.6C9BA4B3-78FD-4D16-A420-5C98BCEFD55D.pdf	A73D	WITH TUMOR	214	150	450	NO	NO	12.5	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.0	Liver	Micro	A	Hepatitis C Virus R|Hepatitis B Surface Antigen	LIVING	102	2012	TCGA-DD-A73D-01A-12D-A32F-01	TCGA-DD-A73D-01A-12D-A32F-01	TCGA-DD-A73D-01A-12D-A32G-10	TCGA-DD-A73D-01	TCGA-DD-A73D-01	E2A3DCDC-788C-4A4E-BA7B-4E77BA910ED6	3470b46c-4f18-47fe-a18f-f98c97e8996a	TCGA-DD-A73D-01A-12D-A32G-10	TCGA-DD-A73D-01	TCGA-DD-A73D-01	3470b46c-4f18-47fe-a18f-f98c97e8996a	TCGA-DD-A73D-01A-12D-A32G-10	3470b46c-4f18-47fe-a18f-f98c97e8996a	3470b46c-4f18-47fe-a18f-f98c97e8996a	TCGA-DD-A73D-01A-12D-A32G-10	TCGA-DD-A73D-01A-12D-A32R-05
TCGA-DD-A73E-01	0	TCGA-DD-A73E-01	44	0	days	TCGA-DD-A73E	44	0	days	44	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	66	3.5	4.7	5.0	TCGA-DD-A73E-F66598	TCGA-DD-A73E	TCGA-DD-A73E-01A	0.1	0.4	2	A	0.8	1.3	1.2	-24377	336		0	44			0	0	6	1	0 - No Fibrosis		2014-10-21	MALE	172	Alcohol consumption|Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	170	9.5	13.8	NO	YES	G1						NO		false	No	M0	N0	T1	Stage I	TCGA-DD-A73E.10881D8D-1C62-4F3D-ACF6-36AD1F23B0A9.pdf	A73E	TUMOR FREE	190	150	450	NO	NO	11.5	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody	LIVING	108	2012	TCGA-DD-A73E-01A-12D-A32F-01	TCGA-DD-A73E-01A-12D-A32F-01	TCGA-DD-A73E-01A-12D-A32G-10	TCGA-DD-A73E-01	TCGA-DD-A73E-01	3E71F43C-97E0-417A-855A-8280181B8197	c5adfcce-a4a4-47bc-8b9e-7e81819b80a1	TCGA-DD-A73E-01A-12D-A32G-10	TCGA-DD-A73E-01	TCGA-DD-A73E-01	c5adfcce-a4a4-47bc-8b9e-7e81819b80a1	TCGA-DD-A73E-01A-12D-A32G-10	c5adfcce-a4a4-47bc-8b9e-7e81819b80a1	c5adfcce-a4a4-47bc-8b9e-7e81819b80a1	TCGA-DD-A73E-01A-12D-A32G-10	TCGA-DD-A73E-01A-12D-A32R-05
TCGA-DD-A73F-01	0	TCGA-DD-A73F-01	1085	0	days	TCGA-DD-A73F	1085	0	days	1085	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	77	3.5	4.6	5.0	TCGA-DD-A73F-F71152	TCGA-DD-A73F	TCGA-DD-A73F-01A	0.1	0.5	1	A	0.6	1.1	1.0	-28234	975		0	1085			1	0	6	283	0 - No Fibrosis		2015-3-18	FEMALE	164	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	250	9.5	13.8	NO	YES	G1						NO		false	No	M0	N0	T1	Stage I	TCGA-DD-A73F.2FCC867C-91AD-40B3-8046-FFB84BDD2EA7.pdf	A73F	TUMOR FREE	243	150	450	NO	NO	10.9	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	DD	1.0	Liver	None	A		LIVING	69	2010	TCGA-DD-A73F-01A-11D-A32F-01	TCGA-DD-A73F-01A-11D-A32F-01	TCGA-DD-A73F-01A-11D-A32G-10	TCGA-DD-A73F-01	TCGA-DD-A73F-01	D6B6C02A-C3BB-400A-91F6-ACA8D71A8E25	ea6f7f61-d66c-47c9-a67a-e0d65af36815	TCGA-DD-A73F-01A-11D-A32G-10	TCGA-DD-A73F-01	TCGA-DD-A73F-01	ea6f7f61-d66c-47c9-a67a-e0d65af36815	TCGA-DD-A73F-01A-11D-A32G-10	ea6f7f61-d66c-47c9-a67a-e0d65af36815	ea6f7f61-d66c-47c9-a67a-e0d65af36815	TCGA-DD-A73F-01A-11D-A32G-10	TCGA-DD-A73F-01A-11D-A32R-05
TCGA-DD-A73G-01	0	TCGA-DD-A73G-01	3478	0	days	TCGA-DD-A73G	3478	0	days	3478	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	73	3.5	3.2	5.0	TCGA-DD-A73G-F66600	TCGA-DD-A73G	TCGA-DD-A73G-01A	0.1	0.5	1	A	0.7	1.2	0.7	-26949	3045		0	3478			0	0	6	2035400	0 - No Fibrosis		2014-10-21	FEMALE	155	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	240	8.4	12.0	NO	NO	G3						NO		false	No	M0	N0	T1	Stage I	TCGA-DD-A73G.C7A70BE1-34F6-4500-8C6C-A0D4FBBBD251.pdf	A73G	TUMOR FREE	460	150	450	NO	NO	11.7	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	44	2005	TCGA-DD-A73G-01A-22D-A32F-01	TCGA-DD-A73G-01A-22D-A32F-01	TCGA-DD-A73G-01A-22D-A32G-10	TCGA-DD-A73G-01	TCGA-DD-A73G-01	77B45158-4306-4D86-9FE3-E1068745AC41	b44b63e6-5163-4df8-b82b-80401b703167	TCGA-DD-A73G-01A-22D-A32G-10	TCGA-DD-A73G-01	TCGA-DD-A73G-01	b44b63e6-5163-4df8-b82b-80401b703167	TCGA-DD-A73G-01A-22D-A32G-10	b44b63e6-5163-4df8-b82b-80401b703167	b44b63e6-5163-4df8-b82b-80401b703167	TCGA-DD-A73G-01A-22D-A32G-10	TCGA-DD-A73G-01A-22D-A32R-05
TCGA-DD-AA3A-01	1	TCGA-DD-AA3A-01	410	1	days	TCGA-DD-AA3A			days	410	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	81	3.5	4.9	5.0		TCGA-DD-AA3A	TCGA-DD-AA3A-01A	0.1	0.8	1	A	0.6	1.1	0.7	-29712	1559	410	0				1	0	8	1	0 - No Fibrosis		2014-5-27	FEMALE	151	No History of Primary Risk Factors		Hepatocholangiocarcinoma (Mixed)	No	C22.0	8180/3	C22.0	YES	100	0.9	1.2	NO		G4								true	No	MX	N0	T1	Stage I	TCGA-DD-AA3A.F1055545-91C4-4397-BD34-FE995A3E9B05.pdf	AA3A	TUMOR FREE	256	150	450	NO	NO	1.1	NO	YES		R0	Primary Tumor	01	Extended Lobectomy	6th	NO	YES	DD	1.0	Liver	None	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	DECEASED	60	2009	TCGA-DD-AA3A-01A-11D-A36W-01	TCGA-DD-AA3A-01A-11D-A36W-01	TCGA-DD-AA3A-01A-11D-A36X-10	TCGA-DD-AA3A-01	TCGA-DD-AA3A-01	8AB78FE1-CF2C-4A91-A1BE-4C038A0E2A8E	99fb714e-01a3-4aa0-8792-39df3be95a1d		TCGA-DD-AA3A-01	TCGA-DD-AA3A-01	99fb714e-01a3-4aa0-8792-39df3be95a1d		99fb714e-01a3-4aa0-8792-39df3be95a1d	99fb714e-01a3-4aa0-8792-39df3be95a1d		TCGA-DD-AA3A-01A-11D-A36Y-05
TCGA-DD-AAC8-01	1	TCGA-DD-AAC8-01	16	1	days	TCGA-DD-AAC8	16	0	days	16	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	72	3.8	4.3	5.3		TCGA-DD-AAC8	TCGA-DD-AAC8-01A	0.2	0.6		A	0.7	1.5	1.1	-26322	2080	16	0				0	0	8	1	1,2 - Portal Fibrosis		2014-6-28	MALE	156	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	570	1.0	1.0	NO		G3						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AAC8.2751F570-A1CE-4F6A-98CD-56C8B31AB0FF.pdf	AAC8	TUMOR FREE	177	130	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.2	Liver	Micro	A		DECEASED	57	2008	TCGA-DD-AAC8-01A-11D-A40Q-01	TCGA-DD-AAC8-01A-11D-A40Q-01	TCGA-DD-AAC8-01A-11D-A40R-10	TCGA-DD-AAC8-01	TCGA-DD-AAC8-01		3c6ca697-64ab-43d8-99ab-10ecbc0e8313		TCGA-DD-AAC8-01	TCGA-DD-AAC8-01	3c6ca697-64ab-43d8-99ab-10ecbc0e8313		3c6ca697-64ab-43d8-99ab-10ecbc0e8313	3c6ca697-64ab-43d8-99ab-10ecbc0e8313		TCGA-DD-AAC8-01A-11D-A40S-05
TCGA-DD-AAC9-01	0	TCGA-DD-AAC9-01	347	0	days	TCGA-DD-AAC9	347	0	days	347	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	51	3.8	4.2	5.3	TCGA-DD-AAC9-F68363	TCGA-DD-AAC9	TCGA-DD-AAC9-01A	0.2	0.7		A	0.7	1.5	1.3	-18911	2069		0	347			0	0	8	5	6 - Established Cirrhosis		2014-11-17	MALE	174	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	130	1.0	1.0	NO	YES	G2						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AAC9.A993CEA3-6AA2-4CE7-A9EC-8318B1377E99.pdf	AAC9	TUMOR FREE	149	130	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.2	Liver	None	A		LIVING	81	2008	TCGA-DD-AAC9-01A-11D-A40Q-01	TCGA-DD-AAC9-01A-11D-A40Q-01	TCGA-DD-AAC9-01A-11D-A40R-10	TCGA-DD-AAC9-01	TCGA-DD-AAC9-01		49d7b78f-7841-4969-b063-5bc57099283c		TCGA-DD-AAC9-01	TCGA-DD-AAC9-01	49d7b78f-7841-4969-b063-5bc57099283c		49d7b78f-7841-4969-b063-5bc57099283c	49d7b78f-7841-4969-b063-5bc57099283c		TCGA-DD-AAC9-01A-11D-A40S-05
TCGA-DD-AACA-01	0	TCGA-DD-AACA-01	2301	0	days	TCGA-DD-AACA	776	1	days	2301	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	65	3.8	3.7	5.3	TCGA-DD-AACA-F68364	TCGA-DD-AACA	TCGA-DD-AACA-01A	0.2	0.7		A	0.7	1.5	1.2	-23973	2057		0	2301	797	776	0	0	8	7	6 - Established Cirrhosis		2014-11-17	MALE	165	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	120	1.0	1.0	NO	NO	G3	Liver	Locoregional Recurrence		No	YES	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-AACA.6600D758-13D7-4925-BC34-F2A90EE0CFE5.pdf	AACA	WITH TUMOR	136	130	400	NO	NO	0.9	NO	NO	R0	R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.2	Liver	None	A		LIVING	70	2008	TCGA-DD-AACA-01A-11D-A40Q-01	TCGA-DD-AACA-01A-11D-A40Q-01	TCGA-DD-AACA-01A-11D-A40R-10	TCGA-DD-AACA-01	TCGA-DD-AACA-01		57f193de-ae4f-4ac9-aab2-a5e275b3501e		TCGA-DD-AACA-01	TCGA-DD-AACA-01	57f193de-ae4f-4ac9-aab2-a5e275b3501e		57f193de-ae4f-4ac9-aab2-a5e275b3501e	57f193de-ae4f-4ac9-aab2-a5e275b3501e		TCGA-DD-AACA-01A-11D-A40S-05
TCGA-DD-AACA-02	0	TCGA-DD-AACA-02	2301	0	days	TCGA-DD-AACA	776	1	days	2301	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	65	3.8	3.7	5.3	TCGA-DD-AACA-F68364	TCGA-DD-AACA	TCGA-DD-AACA-02A	0.2	0.7		A	0.7	1.5	1.2	-23973	2057		0	2301	797	776	0	0	8	7	6 - Established Cirrhosis		2014-11-17	MALE	165	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	1.0	1.0	NO	NO	G3	Liver	Locoregional Recurrence		No	YES	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-AACA.C4260237-1E27-45C7-ADE8-41939D1324A8.pdf	AACA	WITH TUMOR	136	130	400	NO	NO	0.9	NO	NO	R0	R0	Recurrent Tumor	02	Segmentectomy, Single	6th	NO	YES	DD	1.2	Liver	None	A		LIVING	70	2008				TCGA-DD-AACA-02			3f1addce-3a5a-4b68-ae77-df6191c9ba57,b1bab5f2-614b-436b-b53f-b2910b70c487		TCGA-DD-AACA-02		3f1addce-3a5a-4b68-ae77-df6191c9ba57,b1bab5f2-614b-436b-b53f-b2910b70c487		3f1addce-3a5a-4b68-ae77-df6191c9ba57,b1bab5f2-614b-436b-b53f-b2910b70c487	3f1addce-3a5a-4b68-ae77-df6191c9ba57,b1bab5f2-614b-436b-b53f-b2910b70c487		TCGA-DD-AACA-02A-11D-A40S-05,TCGA-DD-AACA-02B-11D-A40S-05
TCGA-DD-AACB-01	0	TCGA-DD-AACB-01	2324	0	days	TCGA-DD-AACB	2324	0	days	2324	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	74	3.8	4.1	5.3	TCGA-DD-AACB-F68365	TCGA-DD-AACB	TCGA-DD-AACB-01A	0.2	0.8		A	0.7	1.5	1.1	-27103	2045		0	2324			0	0	8	1902	6 - Established Cirrhosis		2014-11-17	FEMALE	156	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	410	1.0	1.0	NO	NO	G3						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AACB.40E83F82-43B5-426D-A120-2F2F597332C6.pdf	AACB	TUMOR FREE	179	130	400	NO	NO	0.8	NO	NO		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.2	Liver	Micro	A		LIVING	72	2008	TCGA-DD-AACB-01A-11D-A40Q-01	TCGA-DD-AACB-01A-11D-A40Q-01	TCGA-DD-AACB-01A-11D-A40R-10	TCGA-DD-AACB-01	TCGA-DD-AACB-01		09c2a2ad-2174-4ebc-b356-628af5e05799		TCGA-DD-AACB-01	TCGA-DD-AACB-01	09c2a2ad-2174-4ebc-b356-628af5e05799		09c2a2ad-2174-4ebc-b356-628af5e05799	09c2a2ad-2174-4ebc-b356-628af5e05799		TCGA-DD-AACB-01A-11D-A40S-05
TCGA-DD-AACC-01	1	TCGA-DD-AACC-01	1685	1	days	TCGA-DD-AACC			days	1685	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	61	3.8	3.9	5.3		TCGA-DD-AACC		0.2	0.5		A	0.7	1.5	1.3	-22499		1685	0				0	0	8	24	6 - Established Cirrhosis		2014-6-28	MALE	165	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8180/3	C22.0	YES		1.0	1.0			G2						YES			No	M0	N0	T1	Stage I		AACC	WITH TUMOR	208	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.2	Liver	None			DECEASED	61	2008	TCGA-DD-AACC-01A-11D-A40Q-01	TCGA-DD-AACC-01A-11D-A40Q-01	TCGA-DD-AACC-01A-11D-A40R-10	TCGA-DD-AACC-01	TCGA-DD-AACC-01		bffa7652-8069-4a46-9796-26be43eb1d54		TCGA-DD-AACC-01	TCGA-DD-AACC-01	bffa7652-8069-4a46-9796-26be43eb1d54		bffa7652-8069-4a46-9796-26be43eb1d54	bffa7652-8069-4a46-9796-26be43eb1d54		TCGA-DD-AACC-01A-11D-A40S-05
TCGA-DD-AACD-01	1	TCGA-DD-AACD-01	381	1	days	TCGA-DD-AACD			days	381	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	48	3.8	3.9	5.3		TCGA-DD-AACD	TCGA-DD-AACD-01A	0.2	0.3	3	A	0.7	1.5	1.0	-17828	2015	381	0				1	0	8	2	1,2 - Portal Fibrosis		2014-6-28	MALE	182	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	230	1.0	1.0	NO		G4						YES		true	No	M0	N0	T1	Stage I	TCGA-DD-AACD.0494EF97-6D76-4DC7-8642-880C889C2C24.pdf	AACD	WITH TUMOR	268	130	400	NO	NO	6.9	NO	YES		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.2	Liver	Micro	A		DECEASED	66	2008	TCGA-DD-AACD-01A-11D-A40Q-01	TCGA-DD-AACD-01A-11D-A40Q-01	TCGA-DD-AACD-01A-11D-A40R-10	TCGA-DD-AACD-01	TCGA-DD-AACD-01		84d26646-771b-4d61-95a1-61c695c9f6fc		TCGA-DD-AACD-01	TCGA-DD-AACD-01	84d26646-771b-4d61-95a1-61c695c9f6fc		84d26646-771b-4d61-95a1-61c695c9f6fc	84d26646-771b-4d61-95a1-61c695c9f6fc		TCGA-DD-AACD-01A-11D-A40S-05
TCGA-DD-AACE-01	0	TCGA-DD-AACE-01	2184	0	days	TCGA-DD-AACE	1279	1	days	2184	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	62	3.8	4.4	5.3	TCGA-DD-AACE-F68366	TCGA-DD-AACE	TCGA-DD-AACE-01A	0.2	0.9		A	0.7	1.5	1.2	-22727	1973		0	2184		1279	0	0	8	2	6 - Established Cirrhosis		2014-12-30	MALE	162	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	170	1.0	1.0	NO	NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-AACE.63AE7F04-F180-486A-89FB-6E509AF91E0B.pdf	AACE	TUMOR FREE	175	130	400	[Discrepancy]	NO	0.9	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.2	Liver	None	A		LIVING	62	2008	TCGA-DD-AACE-01A-11D-A40Q-01	TCGA-DD-AACE-01A-11D-A40Q-01	TCGA-DD-AACE-01A-11D-A40R-10	TCGA-DD-AACE-01	TCGA-DD-AACE-01		087f71fd-fbd5-47c6-92ed-23286b2ed945		TCGA-DD-AACE-01	TCGA-DD-AACE-01	087f71fd-fbd5-47c6-92ed-23286b2ed945		087f71fd-fbd5-47c6-92ed-23286b2ed945	087f71fd-fbd5-47c6-92ed-23286b2ed945		TCGA-DD-AACE-01A-11D-A40S-05
TCGA-DD-AACF-01	1	TCGA-DD-AACF-01	365	1	days	TCGA-DD-AACF			days	365	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	68	3.8	3.5	5.3		TCGA-DD-AACF		0.2	0.5		A	0.7	1.5	1.1	-25172		365	0				0	0	8	16	6 - Established Cirrhosis		2014-6-28	MALE	168	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0			G3						YES			No	M0	N0	T1	Stage I		AACF	WITH TUMOR	99	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.2	Liver	None			DECEASED	60	2008	TCGA-DD-AACF-01A-11D-A40Q-01	TCGA-DD-AACF-01A-11D-A40Q-01	TCGA-DD-AACF-01A-11D-A40R-10	TCGA-DD-AACF-01	TCGA-DD-AACF-01		be1c653d-1f9a-41fd-b53c-024216355721		TCGA-DD-AACF-01	TCGA-DD-AACF-01	be1c653d-1f9a-41fd-b53c-024216355721		be1c653d-1f9a-41fd-b53c-024216355721	be1c653d-1f9a-41fd-b53c-024216355721		TCGA-DD-AACF-01A-11D-A40S-05
TCGA-DD-AACG-01	1	TCGA-DD-AACG-01	469	1	days	TCGA-DD-AACG			days	469	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	52	3.8	3.6	5.3		TCGA-DD-AACG	TCGA-DD-AACG-01A	0.2	1.0		A	0.7	1.5	1.5	-19174	1931	469	0				0	0	8	11718	6 - Established Cirrhosis		2014-6-28	MALE	168	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	280	1.0	1.0	NO		G4						YES		true	No	M0	N0	T2	Stage II	TCGA-DD-AACG.8B0FA2B9-F484-4D9C-AFAE-BDD90DA6A7A8.pdf	AACG	WITH TUMOR	196	130	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.2	Liver	Micro	A		DECEASED	65	2008	TCGA-DD-AACG-01A-11D-A40Q-01	TCGA-DD-AACG-01A-11D-A40Q-01	TCGA-DD-AACG-01A-11D-A40R-10	TCGA-DD-AACG-01	TCGA-DD-AACG-01		73815125-e38b-4244-99f0-e630c6ea5fff		TCGA-DD-AACG-01	TCGA-DD-AACG-01	73815125-e38b-4244-99f0-e630c6ea5fff		73815125-e38b-4244-99f0-e630c6ea5fff	73815125-e38b-4244-99f0-e630c6ea5fff		TCGA-DD-AACG-01A-11D-A40S-05
TCGA-DD-AACH-01	1	TCGA-DD-AACH-01	195	1	days	TCGA-DD-AACH			days	195	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	69	3.8	4.3	5.3		TCGA-DD-AACH		0.2	1.5		A	0.7	15	1.2	-25544		195	0				0	0	8	7	6 - Established Cirrhosis		2014-6-28	MALE	160	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0			G3						YES			No	M0	N0	T2	Stage II		AACH	TUMOR FREE	290	130	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.2	Liver	Micro			DECEASED	53	2008	TCGA-DD-AACH-01A-11D-A40Q-01	TCGA-DD-AACH-01A-11D-A40Q-01	TCGA-DD-AACH-01A-11D-A40R-10	TCGA-DD-AACH-01	TCGA-DD-AACH-01		e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed		TCGA-DD-AACH-01	TCGA-DD-AACH-01	e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed		e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed	e23ff6ac-2fdf-4838-aaa3-27e012bbf6ed		TCGA-DD-AACH-01A-11D-A40S-05
TCGA-DD-AACI-01	0	TCGA-DD-AACI-01	1618	0	days	TCGA-DD-AACI	1432	1	days	1618	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	69	3.8	3.6	5.3	TCGA-DD-AACI-F68367	TCGA-DD-AACI	TCGA-DD-AACI-01A	0.2	0.5		A	0.7	1.5	1.0	-25236	1870		0	1618		1432	1	0	8	1	5 - Nodular Formation and Incomplete Cirrhosis		2014-11-17	MALE	155			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	320	1.0	1.0	NO	NO	G3	Liver	Intrahepatic Recurrence		No	NO	YES	No	true	No	M0	N0	T2	Stage II	TCGA-DD-AACI.54CDEB1D-8CF9-4723-9A7D-CD9DFEDFD659.pdf	AACI	WITH TUMOR	106	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.2	Liver	None	A		LIVING	48	2008	TCGA-DD-AACI-01A-11D-A40Q-01	TCGA-DD-AACI-01A-11D-A40Q-01	TCGA-DD-AACI-01A-11D-A40R-10	TCGA-DD-AACI-01	TCGA-DD-AACI-01		6cf6f149-a805-4f83-90cc-a3cf6eee7317		TCGA-DD-AACI-01	TCGA-DD-AACI-01	6cf6f149-a805-4f83-90cc-a3cf6eee7317		6cf6f149-a805-4f83-90cc-a3cf6eee7317	6cf6f149-a805-4f83-90cc-a3cf6eee7317		TCGA-DD-AACI-01A-11D-A40S-05
TCGA-DD-AACJ-01	0	TCGA-DD-AACJ-01	2102	0	days	TCGA-DD-AACJ	100	1	days	2102	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		75	3.8	3.6	5.3	TCGA-DD-AACJ-F68368	TCGA-DD-AACJ	TCGA-DD-AACJ-01A	0.2	1.0		A	0.7	1.5	1.0	-27528	1835		0	2102		100	2	0	8	25			2014-11-17	MALE	159			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	380	1.0	1.0	NO	NO	G2	Liver	Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T2	Stage II	TCGA-DD-AACJ.2CD482F0-0882-4A61-9B40-1D7B3DBC625E.pdf	AACJ	WITH TUMOR	213	130	400	NO	NO	0.8	NO	NO		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.2	Liver	Micro	A		LIVING	73	2008	TCGA-DD-AACJ-01A-11D-A40Q-01	TCGA-DD-AACJ-01A-11D-A40Q-01	TCGA-DD-AACJ-01A-11D-A40R-10	TCGA-DD-AACJ-01	TCGA-DD-AACJ-01		9db8d89d-ef37-49a5-81ed-3ae95aa3c920		TCGA-DD-AACJ-01	TCGA-DD-AACJ-01	9db8d89d-ef37-49a5-81ed-3ae95aa3c920		9db8d89d-ef37-49a5-81ed-3ae95aa3c920	9db8d89d-ef37-49a5-81ed-3ae95aa3c920		TCGA-DD-AACJ-01A-11D-A40S-05
TCGA-DD-AACK-01	0	TCGA-DD-AACK-01	9	0	days	TCGA-DD-AACK	9	0	days	9	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	70	3.8	4.6	5.3	TCGA-DD-AACK-F68369	TCGA-DD-AACK	TCGA-DD-AACK-01A	0.2	0.9		A	0.7	1.5	1.3	-25796	1828		0	9			2	0	8	5	6 - Established Cirrhosis		2014-11-17	MALE	172	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	140	1.0	1.0	NO	YES	G2						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AACK.B41B7C44-ED04-46EB-AD41-271456ECA762.pdf	AACK	TUMOR FREE	98	130	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.2	Liver	Micro	A		LIVING	68	2008	TCGA-DD-AACK-01A-11D-A40Q-01	TCGA-DD-AACK-01A-11D-A40Q-01	TCGA-DD-AACK-01A-11D-A40R-10	TCGA-DD-AACK-01	TCGA-DD-AACK-01		1eb7d71a-045d-4c79-8375-100de27caafd		TCGA-DD-AACK-01	TCGA-DD-AACK-01	1eb7d71a-045d-4c79-8375-100de27caafd		1eb7d71a-045d-4c79-8375-100de27caafd	1eb7d71a-045d-4c79-8375-100de27caafd		TCGA-DD-AACK-01A-11D-A40S-05
TCGA-DD-AACL-01	1	TCGA-DD-AACL-01	107	1	days	TCGA-DD-AACL			days	107	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				66	3.8	3.3	5.3	TCGA-DD-AACL-F68370	TCGA-DD-AACL		0.2	0.7		A	0.7	1.5	1.0	-24355		107	0	58			1	0	8	1368			2014-11-17	FEMALE	150	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3									No	M0	N0	T1	Stage I		AACL		99	130	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.2	Liver	None			DECEASED	69	2008	TCGA-DD-AACL-01A-11D-A40Q-01	TCGA-DD-AACL-01A-11D-A40Q-01	TCGA-DD-AACL-01A-11D-A40R-10	TCGA-DD-AACL-01	TCGA-DD-AACL-01		ece2a45a-7c07-44a2-baca-4a62aa38592f		TCGA-DD-AACL-01	TCGA-DD-AACL-01	ece2a45a-7c07-44a2-baca-4a62aa38592f		ece2a45a-7c07-44a2-baca-4a62aa38592f	ece2a45a-7c07-44a2-baca-4a62aa38592f		TCGA-DD-AACL-01A-11D-A40S-05
TCGA-DD-AACM-01	0	TCGA-DD-AACM-01	1769	0	days	TCGA-DD-AACM	1097	1	days	1769	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	48	3.8	4.2	5.3	TCGA-DD-AACM-F68371	TCGA-DD-AACM		0.2	1.6		A	0.7	1.5	1.2	-17590			0	1769	1126	1097	0	0	8	2	3,4 - Fibrous Speta		2014-11-17	MALE	177	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3	Lung	Extrahepatic Recurrence		No	YES	YES	No		No	M0	N0	T2	Stage II		AACM	WITH TUMOR	113	130	400	NO	NO	0.9	NO	NO	R0	R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.2	Liver	None			LIVING	68	2009	TCGA-DD-AACM-01A-11D-A40Q-01	TCGA-DD-AACM-01A-11D-A40Q-01	TCGA-DD-AACM-01A-11D-A40R-10	TCGA-DD-AACM-01					TCGA-DD-AACM-01							TCGA-DD-AACM-01A-11D-A40S-05
TCGA-DD-AACN-01	0	TCGA-DD-AACN-01	1302	0	days	TCGA-DD-AACN	357	1	days	1302	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		32	3.8	3.9	5.3	TCGA-DD-AACN-F68372	TCGA-DD-AACN		0.2	2.2		A	0.7	1.5	1.5	-12007			0	1302		357	0	0	9	699			2014-11-17	MALE	171	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No		No	M0	N0	T1	Stage I		AACN	WITH TUMOR	185	130	400	YES	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.2	Liver	None			LIVING	70	2009	TCGA-DD-AACN-01A-11D-A40Q-01	TCGA-DD-AACN-01A-11D-A40Q-01	TCGA-DD-AACN-01A-11D-A40R-10	TCGA-DD-AACN-01	TCGA-DD-AACN-01		d3633d63-7cbe-4014-b051-211240a29ac8		TCGA-DD-AACN-01	TCGA-DD-AACN-01	d3633d63-7cbe-4014-b051-211240a29ac8		d3633d63-7cbe-4014-b051-211240a29ac8	d3633d63-7cbe-4014-b051-211240a29ac8		TCGA-DD-AACN-01A-11D-A40S-05
TCGA-DD-AACO-01	0	TCGA-DD-AACO-01	1876	0	days	TCGA-DD-AACO	479	1	days	1876	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	40	3.8	3.7	5.3	TCGA-DD-AACO-F68373	TCGA-DD-AACO	TCGA-DD-AACO-01A	0.2	0.6		A	0.7	1.5	1.4	-14796	1637		0	1876		479	0	0	9	5	6 - Established Cirrhosis		2014-11-17	MALE	164	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	110	1.0	1.0	NO	NO	G3	Liver	Intrahepatic Recurrence		No	NO	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-AACO.B5BE83AC-C974-422B-91E7-A69057BA26C9.pdf	AACO	WITH TUMOR	88	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.2	Liver	None	A		LIVING	43	2009	TCGA-DD-AACO-01A-11D-A40Q-01	TCGA-DD-AACO-01A-11D-A40Q-01	TCGA-DD-AACO-01A-11D-A40R-10	TCGA-DD-AACO-01	TCGA-DD-AACO-01		032ec32d-66ca-4792-9132-2e61d918c3c2		TCGA-DD-AACO-01	TCGA-DD-AACO-01	032ec32d-66ca-4792-9132-2e61d918c3c2		032ec32d-66ca-4792-9132-2e61d918c3c2	032ec32d-66ca-4792-9132-2e61d918c3c2		TCGA-DD-AACO-01A-11D-A40S-05
TCGA-DD-AACP-01	0	TCGA-DD-AACP-01	415	0	days	TCGA-DD-AACP	415	0	days	415	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	64	3.8	4.1	5.3	TCGA-DD-AACP-F68374	TCGA-DD-AACP	TCGA-DD-AACP-01A	0.2	1.1		A	0.7	1.5	1.1	-23728	1625		0	415			0	0	8	227			2014-11-17	MALE	155	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	1.0	1.0	NO	NO	G3						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AACP.7FDD120A-A5AD-4209-B167-34BA2289A784.pdf	AACP		151	130	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.2	Liver	None	A		LIVING	62	2009	TCGA-DD-AACP-01A-11D-A40Q-01	TCGA-DD-AACP-01A-11D-A40Q-01	TCGA-DD-AACP-01A-11D-A40R-10	TCGA-DD-AACP-01	TCGA-DD-AACP-01		6aafc1f6-257e-4105-b032-457bcc52dc1b		TCGA-DD-AACP-01	TCGA-DD-AACP-01	6aafc1f6-257e-4105-b032-457bcc52dc1b		6aafc1f6-257e-4105-b032-457bcc52dc1b	6aafc1f6-257e-4105-b032-457bcc52dc1b		TCGA-DD-AACP-01A-11D-A40S-05
TCGA-DD-AACQ-01	1	TCGA-DD-AACQ-01	432	1	days	TCGA-DD-AACQ	105	1	days	432	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		50	3.8	4.2	5.3	TCGA-DD-AACQ-F68375	TCGA-DD-AACQ	TCGA-DD-AACQ-01A	0.2	0.8		A	0.7	1.5	1.3	-18429	1665	432	0	429		105	0	0	8	7			2014-11-17	MALE	169	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	40	1.0	1.0	NO	NO	G3	Liver	Locoregional Recurrence		Yes	NO	YES	No	true	No	M0	N0	T2	Stage II	TCGA-DD-AACQ.3BBE2BEA-D346-4EA8-82CB-9305EC49A331.pdf	AACQ	WITH TUMOR	157	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	DD	1.2	Liver	None	A		DECEASED	64	2009	TCGA-DD-AACQ-01A-11D-A40Q-01	TCGA-DD-AACQ-01A-11D-A40Q-01	TCGA-DD-AACQ-01A-11D-A40R-10	TCGA-DD-AACQ-01	TCGA-DD-AACQ-01		3e6d35a3-3a10-4629-a316-8df8cc951678		TCGA-DD-AACQ-01	TCGA-DD-AACQ-01	3e6d35a3-3a10-4629-a316-8df8cc951678		3e6d35a3-3a10-4629-a316-8df8cc951678	3e6d35a3-3a10-4629-a316-8df8cc951678		TCGA-DD-AACQ-01A-11D-A40S-05
TCGA-DD-AACS-01	0	TCGA-DD-AACS-01	1804	0	days	TCGA-DD-AACS	1804	0	days	1804	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				39	3.8	4.3	5.3	TCGA-DD-AACS-F68376	TCGA-DD-AACS	TCGA-DD-AACS-01A	0.2	1.0		A	0.7	1.5	1.1	-14473	1532		0	1804			0	0	8	1			2014-11-17	MALE	172	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	1.0	1.0	NO	NO	G3						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AACS.EA952B6F-851C-4675-A933-80325945E7EC.pdf	AACS	TUMOR FREE	223	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.2	Liver	None	A		LIVING	80	2009	TCGA-DD-AACS-01A-11D-A40Q-01	TCGA-DD-AACS-01A-11D-A40Q-01	TCGA-DD-AACS-01A-11D-A40R-10	TCGA-DD-AACS-01	TCGA-DD-AACS-01		078cb900-3686-4894-9e1f-cc4bb1e39eae		TCGA-DD-AACS-01	TCGA-DD-AACS-01	078cb900-3686-4894-9e1f-cc4bb1e39eae		078cb900-3686-4894-9e1f-cc4bb1e39eae	078cb900-3686-4894-9e1f-cc4bb1e39eae		TCGA-DD-AACS-01A-11D-A40S-05
TCGA-DD-AACT-01	0	TCGA-DD-AACT-01	1562	0	days	TCGA-DD-AACT	1562	0	days	1562	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	69	3.8	4.4	5.3	TCGA-DD-AACT-F68377	TCGA-DD-AACT	TCGA-DD-AACT-01A	0.2	0.8		A	0.7	1.5	0.7	-25292	1317		0	1562			0	0	8	4			2014-11-17	FEMALE	158	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	60	1.0	1.0	NO	NO	G2						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AACT.0A9193A6-4600-44F8-88AD-264F8F2D7B4E.pdf	AACT	TUMOR FREE	213	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	62	2010	TCGA-DD-AACT-01A-11D-A40Q-01	TCGA-DD-AACT-01A-11D-A40Q-01	TCGA-DD-AACT-01A-11D-A40R-10	TCGA-DD-AACT-01	TCGA-DD-AACT-01		0e370e53-c3cc-4191-a6f5-68c932ee7641		TCGA-DD-AACT-01	TCGA-DD-AACT-01	0e370e53-c3cc-4191-a6f5-68c932ee7641		0e370e53-c3cc-4191-a6f5-68c932ee7641	0e370e53-c3cc-4191-a6f5-68c932ee7641		TCGA-DD-AACT-01A-11D-A40S-05
TCGA-DD-AACU-01	0	TCGA-DD-AACU-01	1567	0	days	TCGA-DD-AACU	1567	0	days	1567	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				59	3.8	4.4	5.3	TCGA-DD-AACU-F68378	TCGA-DD-AACU	TCGA-DD-AACU-01A	0.2	0.3		A	0.7	1.5	1.1	-21606	1272		0	1567			0	0	8	22			2014-11-17	MALE	166	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	40	1.0	1.0	NO	NO	G3						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AACU.3CA9651B-35BE-4D1E-9C91-BF3029931F32.pdf	AACU	TUMOR FREE	166	130	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	67	2010	TCGA-DD-AACU-01A-11D-A40Q-01	TCGA-DD-AACU-01A-11D-A40Q-01	TCGA-DD-AACU-01A-11D-A40R-10	TCGA-DD-AACU-01	TCGA-DD-AACU-01		3fea9924-e623-43ef-a003-0821bf2e3013		TCGA-DD-AACU-01	TCGA-DD-AACU-01	3fea9924-e623-43ef-a003-0821bf2e3013		3fea9924-e623-43ef-a003-0821bf2e3013	3fea9924-e623-43ef-a003-0821bf2e3013		TCGA-DD-AACU-01A-11D-A40S-05
TCGA-DD-AACV-01	0	TCGA-DD-AACV-01	1531	0	days	TCGA-DD-AACV	344	1	days	1531	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		53	3.8	4.3	5.3	TCGA-DD-AACV-F68379	TCGA-DD-AACV		0.2	0.6		A	0.7	1.5	1.2	-19660			0	1531		344	0	0	8	9			2014-11-17	MALE	169	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No		No	M0	N0	T1	Stage I		AACV	WITH TUMOR	164	130	400	YES	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.2	Liver	Micro			LIVING	70	2010	TCGA-DD-AACV-01A-11D-A40Q-01	TCGA-DD-AACV-01A-11D-A40Q-01	TCGA-DD-AACV-01A-11D-A40R-10	TCGA-DD-AACV-01	TCGA-DD-AACV-01		cd9bf80a-84dc-4ffa-8b82-6d298d9931e7		TCGA-DD-AACV-01	TCGA-DD-AACV-01	cd9bf80a-84dc-4ffa-8b82-6d298d9931e7		cd9bf80a-84dc-4ffa-8b82-6d298d9931e7	cd9bf80a-84dc-4ffa-8b82-6d298d9931e7		TCGA-DD-AACV-01A-11D-A40S-05
TCGA-DD-AACW-01	0	TCGA-DD-AACW-01	1424	0	days	TCGA-DD-AACW	1424	0	days	1424	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				43	3.8	4.0	5.3	TCGA-DD-AACW-F68380	TCGA-DD-AACW	TCGA-DD-AACW-01A	0.2	0.6		A	0.7	1.5	1.0	-15872	1184		0	1424			0	0	8	1726			2014-11-17	MALE	166	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	40	1.0	1.0	NO	NO	G3						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AACW.04474C44-102B-4514-BC48-468B9ED478A2.pdf	AACW	TUMOR FREE	137	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	65	2010	TCGA-DD-AACW-01A-11D-A40Q-01	TCGA-DD-AACW-01A-11D-A40Q-01	TCGA-DD-AACW-01A-11D-A40R-10	TCGA-DD-AACW-01	TCGA-DD-AACW-01		6dd11614-cfb8-46ae-ad65-75fb407306e4		TCGA-DD-AACW-01	TCGA-DD-AACW-01	6dd11614-cfb8-46ae-ad65-75fb407306e4		6dd11614-cfb8-46ae-ad65-75fb407306e4	6dd11614-cfb8-46ae-ad65-75fb407306e4		TCGA-DD-AACW-01A-11D-A40S-05
TCGA-DD-AACX-01	0	TCGA-DD-AACX-01	170	0	days	TCGA-DD-AACX	42	1	days	170	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	Mild	66	3.8	4.2	5.3	TCGA-DD-AACX-F68381	TCGA-DD-AACX		0.2	0.5		A	0.7	1.5	0.8	-24329			0	170		42	1	0	8	3	3,4 - Fibrous Speta		2014-11-17	MALE	155	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3	Other, specify	Extrahepatic Recurrence	lymph node	No	NO	YES	No		No	M0	N0	T2	Stage II		AACX	WITH TUMOR	179	130	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None			LIVING	53	2010	TCGA-DD-AACX-01A-11D-A40Q-01	TCGA-DD-AACX-01A-11D-A40Q-01	TCGA-DD-AACX-01A-11D-A40R-10	TCGA-DD-AACX-01	TCGA-DD-AACX-01		be86bc67-ccbb-4565-adc3-4577b8067a33		TCGA-DD-AACX-01	TCGA-DD-AACX-01	be86bc67-ccbb-4565-adc3-4577b8067a33		be86bc67-ccbb-4565-adc3-4577b8067a33	be86bc67-ccbb-4565-adc3-4577b8067a33		TCGA-DD-AACX-01A-11D-A40S-05
TCGA-DD-AACY-01	0	TCGA-DD-AACY-01	1450	0	days	TCGA-DD-AACY	776	1	days	1450	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	61	3.8	3.1	5.3	TCGA-DD-AACY-F68382	TCGA-DD-AACY		0.2	1.3		A	0.7	1.5	0.6	-22332			0	1450		776	0	0	8	290	3,4 - Fibrous Speta		2014-11-17	MALE	162	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3	Liver	Intrahepatic Recurrence		No	NO	YES	No		No	M0	N0	T1	Stage I		AACY	WITH TUMOR	114	130	400	YES	NO	1.1	NO	NO		R0	Primary Tumor	01	Extended Lobectomy	7th	NO	YES	DD	1.2	Liver	None			LIVING	62	2010	TCGA-DD-AACY-01A-11D-A40Q-01	TCGA-DD-AACY-01A-11D-A40Q-01	TCGA-DD-AACY-01A-11D-A40R-10	TCGA-DD-AACY-01	TCGA-DD-AACY-01		c9dcf079-d32b-47d6-807f-988628c13c92		TCGA-DD-AACY-01	TCGA-DD-AACY-01	c9dcf079-d32b-47d6-807f-988628c13c92		c9dcf079-d32b-47d6-807f-988628c13c92	c9dcf079-d32b-47d6-807f-988628c13c92		TCGA-DD-AACY-01A-11D-A40S-05
TCGA-DD-AACZ-01	1	TCGA-DD-AACZ-01	171	1	days	TCGA-DD-AACZ			days	171	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				63	3.8	4.5	5.3		TCGA-DD-AACZ		0.2	0.4		A	0.7	1.5	0.6	-23230		171	0				1	0	8	25			2014-6-29	FEMALE	149			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0			G4						YES			No	M0	N0	T1	Stage I		AACZ	TUMOR FREE	412	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Extended Lobectomy	7th	NO	YES	DD	1.2	Liver	Macro			DECEASED	52	2010	TCGA-DD-AACZ-01A-11D-A40Q-01	TCGA-DD-AACZ-01A-11D-A40Q-01	TCGA-DD-AACZ-01A-11D-A40R-10	TCGA-DD-AACZ-01	TCGA-DD-AACZ-01		c037b79c-c02f-474e-be9d-6c9ca4cfd633		TCGA-DD-AACZ-01	TCGA-DD-AACZ-01	c037b79c-c02f-474e-be9d-6c9ca4cfd633		c037b79c-c02f-474e-be9d-6c9ca4cfd633	c037b79c-c02f-474e-be9d-6c9ca4cfd633		TCGA-DD-AACZ-01A-11D-A40S-05
TCGA-DD-AAD0-01	0	TCGA-DD-AAD0-01	137	0	days	TCGA-DD-AAD0	47	1	days	137	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	73	3.8	3.4	5.3	TCGA-DD-AAD0-F68383	TCGA-DD-AAD0		0.2	0.8		A	0.7	1.5	0.5	-26781			0	137		47	0	0	8	4			2014-11-17	FEMALE	150	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		YES	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No		No	M0	N0	T1	Stage I		AAD0	WITH TUMOR	86	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None			LIVING	54	2010	TCGA-DD-AAD0-01A-11D-A40Q-01	TCGA-DD-AAD0-01A-11D-A40Q-01	TCGA-DD-AAD0-01A-11D-A40R-10	TCGA-DD-AAD0-01	TCGA-DD-AAD0-01		d9971596-7f19-4d41-ad23-688e1051c85c		TCGA-DD-AAD0-01	TCGA-DD-AAD0-01	d9971596-7f19-4d41-ad23-688e1051c85c		d9971596-7f19-4d41-ad23-688e1051c85c	d9971596-7f19-4d41-ad23-688e1051c85c		TCGA-DD-AAD0-01A-11D-A40S-05
TCGA-DD-AAD1-01	0	TCGA-DD-AAD1-01	564	0	days	TCGA-DD-AAD1	127	1	days	564	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		51	3.8	4.5	5.3	TCGA-DD-AAD1-F68384	TCGA-DD-AAD1		0.2	0.6		A	0.7	1.5	0.5	-18794			0	564		127	1	0	8	451			2014-12-21	FEMALE	161	Hepatitis B|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G4	Liver	Intrahepatic Recurrence		Yes	NO	YES	No		No	M0	N0	T1	Stage I		AAD1	WITH TUMOR	157	130	400	NO	NO	0.9	NO	NO		R1	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.2	Liver	None			LIVING	44	2010	TCGA-DD-AAD1-01A-11D-A40Q-01	TCGA-DD-AAD1-01A-11D-A40Q-01	TCGA-DD-AAD1-01A-11D-A40R-10	TCGA-DD-AAD1-01	TCGA-DD-AAD1-01		d416dda9-edc6-4dae-b563-23a546e70b8a		TCGA-DD-AAD1-01	TCGA-DD-AAD1-01	d416dda9-edc6-4dae-b563-23a546e70b8a		d416dda9-edc6-4dae-b563-23a546e70b8a	d416dda9-edc6-4dae-b563-23a546e70b8a		TCGA-DD-AAD1-01A-11D-A40S-05
TCGA-DD-AAD2-01	0	TCGA-DD-AAD2-01	658	0	days	TCGA-DD-AAD2	658	0	days	658	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	66	3.8	3.5	5.3	TCGA-DD-AAD2-F68385	TCGA-DD-AAD2	TCGA-DD-AAD2-01A	0.2	0.3		A	0.7	1.5	0.8	-24221	1105		0	658			0	0	8	25	1,2 - Portal Fibrosis		2014-11-17	MALE	156	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	30	1.0	1.0	NO	YES	G2						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AAD2.3F50DE59-F830-4D51-90C6-7B275AF0876F.pdf	AAD2	TUMOR FREE	172	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	Micro	A		LIVING	52	2010	TCGA-DD-AAD2-01A-11D-A40Q-01	TCGA-DD-AAD2-01A-11D-A40Q-01	TCGA-DD-AAD2-01A-11D-A40R-10	TCGA-DD-AAD2-01	TCGA-DD-AAD2-01		2c10e17e-58c2-445c-9306-ca22625bdc38		TCGA-DD-AAD2-01	TCGA-DD-AAD2-01	2c10e17e-58c2-445c-9306-ca22625bdc38		2c10e17e-58c2-445c-9306-ca22625bdc38	2c10e17e-58c2-445c-9306-ca22625bdc38		TCGA-DD-AAD2-01A-11D-A40S-05
TCGA-DD-AAD3-01	0	TCGA-DD-AAD3-01	1295	0	days	TCGA-DD-AAD3	1295	0	days	1295	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	43	3.8	3.9	5.3	TCGA-DD-AAD3-F68386	TCGA-DD-AAD3	TCGA-DD-AAD3-01A	0.2	0.4		A	0.7	1.5	0.8	-15706	1072		0	1295			0				1,2 - Portal Fibrosis		2014-11-17	MALE	178	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	1.0	1.0	NO	NO	G2						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AAD3.03056B3E-B81F-44C0-B21E-6C850D67DB43.pdf	AAD3	TUMOR FREE	181	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	77	2011	TCGA-DD-AAD3-01A-11D-A40Q-01	TCGA-DD-AAD3-01A-11D-A40Q-01	TCGA-DD-AAD3-01A-11D-A40R-10	TCGA-DD-AAD3-01	TCGA-DD-AAD3-01		9aa788e8-ff29-49a1-bec4-282c728de83e		TCGA-DD-AAD3-01	TCGA-DD-AAD3-01	9aa788e8-ff29-49a1-bec4-282c728de83e		9aa788e8-ff29-49a1-bec4-282c728de83e	9aa788e8-ff29-49a1-bec4-282c728de83e		TCGA-DD-AAD3-01A-11D-A40S-05
TCGA-DD-AAD5-01	0	TCGA-DD-AAD5-01	1345	0	days	TCGA-DD-AAD5	130	1	days	1345	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	54	3.8	3.7	5.3	TCGA-DD-AAD5-F68387	TCGA-DD-AAD5	TCGA-DD-AAD5-01A	0.2	0.6		A	0.7	1.5	0.6	-19748	1058		0	1345		130	0	0	8	73	3,4 - Fibrous Speta		2014-11-17	MALE	170	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	70	1.0	1.0	NO	NO	G3	Liver	Intrahepatic Recurrence		No	NO	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-AAD5.7F74E08A-C14B-413E-9D75-FCDBFC2F67C5.pdf	AAD5	WITH TUMOR	349	130	400	NO	NO	1.2	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	70	2011	TCGA-DD-AAD5-01A-11D-A40Q-01	TCGA-DD-AAD5-01A-11D-A40Q-01	TCGA-DD-AAD5-01A-11D-A40R-10	TCGA-DD-AAD5-01	TCGA-DD-AAD5-01		6b62b19f-8a09-4042-83e9-f86399aac7d1		TCGA-DD-AAD5-01	TCGA-DD-AAD5-01	6b62b19f-8a09-4042-83e9-f86399aac7d1		6b62b19f-8a09-4042-83e9-f86399aac7d1	6b62b19f-8a09-4042-83e9-f86399aac7d1		TCGA-DD-AAD5-01A-11D-A40S-05
TCGA-DD-AAD6-01	0	TCGA-DD-AAD6-01	672	0	days	TCGA-DD-AAD6	50	1	days	672	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		66	3.8	2.7	5.3	TCGA-DD-AAD6-F68388	TCGA-DD-AAD6	TCGA-DD-AAD6-01A	0.2	0.6		A	0.7	1.5	1.1	-24185	1035		0	672		50	1						2014-11-17	MALE	167	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	70	1.0	1.0	NO	NO	G3	Liver	Locoregional Recurrence		Yes	NO	YES	No	true	No	M0	N0	T3a	Stage IIIA	TCGA-DD-AAD6.B246AEB4-8035-4114-9F1E-3E076809A896.pdf	AAD6	TUMOR FREE	185	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	93	2011	TCGA-DD-AAD6-01A-11D-A40Q-01	TCGA-DD-AAD6-01A-11D-A40Q-01	TCGA-DD-AAD6-01A-11D-A40R-10	TCGA-DD-AAD6-01	TCGA-DD-AAD6-01		14edee70-32c0-41f3-a8f1-1b641ab548cb		TCGA-DD-AAD6-01	TCGA-DD-AAD6-01	14edee70-32c0-41f3-a8f1-1b641ab548cb		14edee70-32c0-41f3-a8f1-1b641ab548cb	14edee70-32c0-41f3-a8f1-1b641ab548cb		TCGA-DD-AAD6-01A-11D-A40S-05
TCGA-DD-AAD8-01	0	TCGA-DD-AAD8-01	1219	0	days	TCGA-DD-AAD8	1219	0	days	1219	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	73	3.8	4.3	5.3	TCGA-DD-AAD8-F68389	TCGA-DD-AAD8	TCGA-DD-AAD8-01A	0.2	0.3		A	0.7	1.5	0.6	-26781	981		0	1219			0	0	8	4	1,2 - Portal Fibrosis		2014-11-17	FEMALE	152	Hepatitis B|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	30	1.0	1.0	NO	NO	G2						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AAD8.5536ED7C-6CC3-442D-A8FD-5EE91C98F358.pdf	AAD8	TUMOR FREE	130	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	57	2011	TCGA-DD-AAD8-01A-11D-A40Q-01	TCGA-DD-AAD8-01A-11D-A40Q-01	TCGA-DD-AAD8-01A-11D-A40R-10	TCGA-DD-AAD8-01	TCGA-DD-AAD8-01		6c2960e2-ad7a-4c08-a453-1bf747483d42		TCGA-DD-AAD8-01	TCGA-DD-AAD8-01	6c2960e2-ad7a-4c08-a453-1bf747483d42		6c2960e2-ad7a-4c08-a453-1bf747483d42	6c2960e2-ad7a-4c08-a453-1bf747483d42		TCGA-DD-AAD8-01A-11D-A40S-05
TCGA-DD-AADA-01	0	TCGA-DD-AADA-01	1233	0	days	TCGA-DD-AADA	1233	0	days	1233	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				66	3.8	4.1	5.3	TCGA-DD-AADA-F68390	TCGA-DD-AADA	TCGA-DD-AADA-01A	0.2	0.5		A	0.7	1.5	0.6	-24288	959		0	1233			0	0	8	8698			2014-11-17	FEMALE	147	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	40	1.0	1.0	NO	NO	G3						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AADA.624DA15E-ADC6-4F09-9DCB-3B4C42F3B453.pdf	AADA	TUMOR FREE	173	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.2	Liver	Macro	A		LIVING	59	2011	TCGA-DD-AADA-01A-11D-A40Q-01	TCGA-DD-AADA-01A-11D-A40Q-01	TCGA-DD-AADA-01A-11D-A40R-10	TCGA-DD-AADA-01	TCGA-DD-AADA-01		392aa482-9a49-403c-817e-7b429e1d82f9		TCGA-DD-AADA-01	TCGA-DD-AADA-01	392aa482-9a49-403c-817e-7b429e1d82f9		392aa482-9a49-403c-817e-7b429e1d82f9	392aa482-9a49-403c-817e-7b429e1d82f9		TCGA-DD-AADA-01A-11D-A40S-05
TCGA-DD-AADB-01	0	TCGA-DD-AADB-01	1242	0	days	TCGA-DD-AADB	1242	0	days	1242	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				51	3.8	4.5	5.3	TCGA-DD-AADB-F68391	TCGA-DD-AADB	TCGA-DD-AADB-01A	0.2	1.5		A	0.7	1.5	0.8	-18728	946		0	1242			0	0	8	419			2014-11-17	MALE	165	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	1.0	1.0	NO	NO	G4						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AADB.3963D999-C204-45C2-8515-B922BEBA7C9D.pdf	AADB	TUMOR FREE	180	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	68	2011	TCGA-DD-AADB-01A-11D-A40Q-01	TCGA-DD-AADB-01A-11D-A40Q-01	TCGA-DD-AADB-01A-11D-A40R-10	TCGA-DD-AADB-01	TCGA-DD-AADB-01		89ad7202-565f-4459-a1ca-946dd27d07b7		TCGA-DD-AADB-01	TCGA-DD-AADB-01	89ad7202-565f-4459-a1ca-946dd27d07b7		89ad7202-565f-4459-a1ca-946dd27d07b7	89ad7202-565f-4459-a1ca-946dd27d07b7		TCGA-DD-AADB-01A-11D-A40S-05
TCGA-DD-AADC-01	1	TCGA-DD-AADC-01	425	1	days	TCGA-DD-AADC			days	425	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				53	3.8	3.8	5.3		TCGA-DD-AADC	TCGA-DD-AADC-01A	0.2	0.7		A	0.7	1.5	0.8	-19527	945	425	0				0	0	8	36			2014-7-7	MALE	176	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	40	1.0	1.0	NO		G3						YES		true	No	M0	N0	T1	Stage I	TCGA-DD-AADC.2A33A2FB-4491-43AA-8C6D-8173FB1D2179.pdf	AADC	WITH TUMOR	212	130	400	NO	NO	1.2	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	DD	1.2	Liver	Macro	A		DECEASED	81	2011	TCGA-DD-AADC-01A-11D-A40Q-01	TCGA-DD-AADC-01A-11D-A40Q-01	TCGA-DD-AADC-01A-11D-A40R-10	TCGA-DD-AADC-01	TCGA-DD-AADC-01		577cf129-d44e-4dda-bc23-bcbe2c55cfcc		TCGA-DD-AADC-01	TCGA-DD-AADC-01	577cf129-d44e-4dda-bc23-bcbe2c55cfcc		577cf129-d44e-4dda-bc23-bcbe2c55cfcc	577cf129-d44e-4dda-bc23-bcbe2c55cfcc		TCGA-DD-AADC-01A-11D-A40S-05
TCGA-DD-AADD-01	0	TCGA-DD-AADD-01	1231	0	days	TCGA-DD-AADD	1231	0	days	1231	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				51	3.8	4.1	5.3	TCGA-DD-AADD-F68392	TCGA-DD-AADD	TCGA-DD-AADD-01A	0.2	0.4		A	0.7	1.5	0.9	-18752	931		0	1231			1	0	8	9804			2014-11-17	MALE	168	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	30	1.0	1.0	NO	NO	G4						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AADD.DCDE4D46-AB4E-4C21-9F01-35A304FFF8D5.pdf	AADD	TUMOR FREE	299	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	68	2011	TCGA-DD-AADD-01A-11D-A40Q-01	TCGA-DD-AADD-01A-11D-A40Q-01	TCGA-DD-AADD-01A-11D-A40R-10	TCGA-DD-AADD-01	TCGA-DD-AADD-01		439c718c-5d13-4516-9343-0a0b8c5869c4		TCGA-DD-AADD-01	TCGA-DD-AADD-01	439c718c-5d13-4516-9343-0a0b8c5869c4		439c718c-5d13-4516-9343-0a0b8c5869c4	439c718c-5d13-4516-9343-0a0b8c5869c4		TCGA-DD-AADD-01A-11D-A40S-05
TCGA-DD-AADE-01	0	TCGA-DD-AADE-01	1202	0	days	TCGA-DD-AADE	168	1	days	1202	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	50	3.8	3.9	5.3	TCGA-DD-AADE-F68393	TCGA-DD-AADE		0.2	0.5		A	0.7	1.5	1.1	-18482			0	1202		168	0	0	8	7	3,4 - Fibrous Speta		2014-11-17	MALE	166	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G4	Liver	Intrahepatic Recurrence		Yes	NO	YES	No		No	M0	N0	T1	Stage I		AADE	WITH TUMOR	148	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	Micro			LIVING	63	2011	TCGA-DD-AADE-01A-11D-A40Q-01	TCGA-DD-AADE-01A-11D-A40Q-01	TCGA-DD-AADE-01A-11D-A40R-10	TCGA-DD-AADE-01					TCGA-DD-AADE-01							TCGA-DD-AADE-01A-11D-A40S-05
TCGA-DD-AADF-01	1	TCGA-DD-AADF-01	115	1	days	TCGA-DD-AADF	115	0	days	115	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				64	3.8	3.5	5.3		TCGA-DD-AADF	TCGA-DD-AADF-01A	0.2	1.1		A	0.7	1.5	0.6	-23614	865	115	0				1	0	8	725			2014-7-7	FEMALE	145	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	30	1.0	1.0	NO		G4						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AADF.046D3A59-FFB8-40B1-8ED2-6853F42CF611.pdf	AADF	TUMOR FREE	174	130	400	NO	NO	1.2	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	DD	1.2	Liver	None	A		DECEASED	55	2011	TCGA-DD-AADF-01A-11D-A40Q-01	TCGA-DD-AADF-01A-11D-A40Q-01	TCGA-DD-AADF-01A-11D-A40R-10	TCGA-DD-AADF-01	TCGA-DD-AADF-01		3213d854-0c94-4958-94e6-d3ada06b0ed2		TCGA-DD-AADF-01	TCGA-DD-AADF-01	3213d854-0c94-4958-94e6-d3ada06b0ed2		3213d854-0c94-4958-94e6-d3ada06b0ed2	3213d854-0c94-4958-94e6-d3ada06b0ed2		TCGA-DD-AADF-01A-11D-A40S-05
TCGA-DD-AADG-01	0	TCGA-DD-AADG-01	1145	0	days	TCGA-DD-AADG	270	1	days	1145	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	70	3.8	4.2	5.3	TCGA-DD-AADG-F68394	TCGA-DD-AADG	TCGA-DD-AADG-01A	0.2	0.9		A	0.7	1.5	1.0	-25887	862		0	1145	386	270	0	0	8	2256	3,4 - Fibrous Speta		2014-11-17	MALE	160	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	80	1.0	1.0	NO	NO	G3	Liver	Intrahepatic Recurrence		No	YES	YES	No	true	No	M0	N0	T3a	Stage IIIA	TCGA-DD-AADG.E6130559-E3EA-4010-9031-071D55816383.pdf	AADG	TUMOR FREE	170	130	400	NO	NO	1.0	NO	NO	R0	R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	61	2011	TCGA-DD-AADG-01A-11D-A40Q-01	TCGA-DD-AADG-01A-11D-A40Q-01	TCGA-DD-AADG-01A-11D-A40R-10	TCGA-DD-AADG-01	TCGA-DD-AADG-01		8f27c933-b86c-4d95-8d17-75f0861ecc10		TCGA-DD-AADG-01	TCGA-DD-AADG-01	8f27c933-b86c-4d95-8d17-75f0861ecc10		8f27c933-b86c-4d95-8d17-75f0861ecc10	8f27c933-b86c-4d95-8d17-75f0861ecc10		TCGA-DD-AADG-01A-11D-A40S-05
TCGA-DD-AADI-01	0	TCGA-DD-AADI-01	1085	0	days	TCGA-DD-AADI	1085	0	days	1085	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				43	3.8	3.8	5.3	TCGA-DD-AADI-F68395	TCGA-DD-AADI		0.2	0.5		A	0.7	1.5	0.8	-15928			0	1085			0	0	8	27			2014-11-17	FEMALE	165	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3						NO			No	M0	N0	T1	Stage I		AADI	TUMOR FREE	141	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.2	Liver	None			LIVING	64	2011	TCGA-DD-AADI-01A-11D-A40Q-01	TCGA-DD-AADI-01A-11D-A40Q-01	TCGA-DD-AADI-01A-11D-A40R-10	TCGA-DD-AADI-01	TCGA-DD-AADI-01		e4311714-b7a4-47b2-81a2-bddd0775f1e6		TCGA-DD-AADI-01	TCGA-DD-AADI-01	e4311714-b7a4-47b2-81a2-bddd0775f1e6		e4311714-b7a4-47b2-81a2-bddd0775f1e6	e4311714-b7a4-47b2-81a2-bddd0775f1e6		TCGA-DD-AADI-01A-11D-A40S-05
TCGA-DD-AADJ-01	0	TCGA-DD-AADJ-01	1066	0	days	TCGA-DD-AADJ	1066	0	days	1066	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				70	3.8	4.2	5.3	TCGA-DD-AADJ-F68396	TCGA-DD-AADJ		0.2	0.6		A	0.7	1.5	0.6	-25863			0	1066			0	0	8	708			2014-11-17	FEMALE	154			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3						NO			No	M0	N0	T1	Stage I		AADJ	TUMOR FREE	203	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None			LIVING	59	2011	TCGA-DD-AADJ-01A-11D-A40Q-01	TCGA-DD-AADJ-01A-11D-A40Q-01	TCGA-DD-AADJ-01A-11D-A40R-10	TCGA-DD-AADJ-01	TCGA-DD-AADJ-01		d3582fe8-0633-449d-969d-8e0e4c06bfd8		TCGA-DD-AADJ-01	TCGA-DD-AADJ-01	d3582fe8-0633-449d-969d-8e0e4c06bfd8		d3582fe8-0633-449d-969d-8e0e4c06bfd8	d3582fe8-0633-449d-969d-8e0e4c06bfd8		TCGA-DD-AADJ-01A-11D-A40S-05
TCGA-DD-AADK-01	0	TCGA-DD-AADK-01	1049	0	days	TCGA-DD-AADK	1049	0	days	1049	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	68	3.8	4.4	5.3	TCGA-DD-AADK-F68397	TCGA-DD-AADK		0.2	0.5		A	0.7	1.5	1.2	-25046			0	1049			0	0	8	236	6 - Established Cirrhosis		2014-11-17	FEMALE	150	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3						NO			No	M0	N0	T2	Stage II		AADK	TUMOR FREE	197	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	DD	1.2	Liver	Micro			LIVING	51	2011	TCGA-DD-AADK-01A-11D-A40Q-01	TCGA-DD-AADK-01A-11D-A40Q-01	TCGA-DD-AADK-01A-11D-A40R-10	TCGA-DD-AADK-01	TCGA-DD-AADK-01		b57c62f8-10b1-47cc-af66-9ba1d281661f		TCGA-DD-AADK-01	TCGA-DD-AADK-01	b57c62f8-10b1-47cc-af66-9ba1d281661f		b57c62f8-10b1-47cc-af66-9ba1d281661f	b57c62f8-10b1-47cc-af66-9ba1d281661f		TCGA-DD-AADK-01A-11D-A40S-05
TCGA-DD-AADL-01	0	TCGA-DD-AADL-01	636	0	days	TCGA-DD-AADL	636	0	days	636	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				58	3.8	3.5	5.3	TCGA-DD-AADL-F68398	TCGA-DD-AADL	TCGA-DD-AADL-01A	0.2	0.5	2	A	0.7	1.5	0.5	-21512	720		0	636			0	0	8	14			2014-11-17	MALE	159	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	1.0	1.0	NO	NO	G4						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AADL.248AF6DC-85A7-4334-B282-B7B0102C4596.pdf	AADL	TUMOR FREE	204	130	400	NO	NO	0.9	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.2	Liver	Micro	A		LIVING	53	2012	TCGA-DD-AADL-01A-11D-A40Q-01	TCGA-DD-AADL-01A-11D-A40Q-01	TCGA-DD-AADL-01A-11D-A40R-10	TCGA-DD-AADL-01	TCGA-DD-AADL-01		5381c623-bc22-4f71-8ce1-4f8a4d354826		TCGA-DD-AADL-01	TCGA-DD-AADL-01	5381c623-bc22-4f71-8ce1-4f8a4d354826		5381c623-bc22-4f71-8ce1-4f8a4d354826	5381c623-bc22-4f71-8ce1-4f8a4d354826		TCGA-DD-AADL-01A-11D-A40S-05
TCGA-DD-AADM-01	1	TCGA-DD-AADM-01	12	1	days	TCGA-DD-AADM	12	0	days	12	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				58	3.8	4.1	5.3		TCGA-DD-AADM	TCGA-DD-AADM-01A	0.2	0.5		A	0.7	1.5	0.8	-21349	704	12	0				0	0	8	112			2014-7-7	MALE	159	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	1.0	1.0	NO		G3						NO		true	No	M0	N0	T2	Stage II	TCGA-DD-AADM.36839A87-47E6-4E63-8683-A1549549AECE.pdf	AADM	TUMOR FREE	126	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	DD	1.2	Liver	None	A		DECEASED	55	2012	TCGA-DD-AADM-01A-11D-A40Q-01	TCGA-DD-AADM-01A-11D-A40Q-01	TCGA-DD-AADM-01A-11D-A40R-10	TCGA-DD-AADM-01	TCGA-DD-AADM-01		377c868a-4176-4c2b-b1bb-9f97b8d85739		TCGA-DD-AADM-01	TCGA-DD-AADM-01	377c868a-4176-4c2b-b1bb-9f97b8d85739		377c868a-4176-4c2b-b1bb-9f97b8d85739	377c868a-4176-4c2b-b1bb-9f97b8d85739		TCGA-DD-AADM-01A-11D-A40S-05
TCGA-DD-AADN-01	0	TCGA-DD-AADN-01	898	0	days	TCGA-DD-AADN	898	0	days	898	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				59	3.8	3.5	5.3	TCGA-DD-AADN-F68400	TCGA-DD-AADN	TCGA-DD-AADN-01A	0.2	1.1		A	0.7	1.5	0.8	-21632	602		0	898			0	0	8	151367			2014-11-17	MALE	160	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	70	1.0	1.0	NO	NO	G4						NO		true	No	MX	NX	T1	Stage I	TCGA-DD-AADN.043E7A50-2122-42D4-BB6F-9AAC61FE8CBE.pdf	AADN	TUMOR FREE	176	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	Micro	A		LIVING	62	2012	TCGA-DD-AADN-01A-11D-A40Q-01	TCGA-DD-AADN-01A-11D-A40Q-01	TCGA-DD-AADN-01A-11D-A40R-10	TCGA-DD-AADN-01	TCGA-DD-AADN-01		972a081e-7a07-4b85-93d9-b58ad38229f7		TCGA-DD-AADN-01	TCGA-DD-AADN-01	972a081e-7a07-4b85-93d9-b58ad38229f7		972a081e-7a07-4b85-93d9-b58ad38229f7	972a081e-7a07-4b85-93d9-b58ad38229f7		TCGA-DD-AADN-01A-11D-A40S-05
TCGA-DD-AADO-01	0	TCGA-DD-AADO-01	453	0	days	TCGA-DD-AADO	453	0	days	453	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				55	3.8	4.5	5.3	TCGA-DD-AADO-F68401	TCGA-DD-AADO		0.2	0.4		A	0.7	1.5	0.6	-20139			0	453			0	0	8	176037			2014-11-17	MALE	168	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3						NO			No	M0	N0	T1	Stage I		AADO	TUMOR FREE	180	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	Micro			LIVING	58	2013	TCGA-DD-AADO-01A-11D-A40Q-01	TCGA-DD-AADO-01A-11D-A40Q-01	TCGA-DD-AADO-01A-11D-A40R-10	TCGA-DD-AADO-01	TCGA-DD-AADO-01		dc8b6cb8-c320-4f72-8e12-0177cecffc87		TCGA-DD-AADO-01	TCGA-DD-AADO-01	dc8b6cb8-c320-4f72-8e12-0177cecffc87		dc8b6cb8-c320-4f72-8e12-0177cecffc87	dc8b6cb8-c320-4f72-8e12-0177cecffc87		TCGA-DD-AADO-01A-11D-A40S-05
TCGA-DD-AADP-01	0	TCGA-DD-AADP-01	458	0	days	TCGA-DD-AADP	458	0	days	458	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				45	3.8	3.7	5.3	TCGA-DD-AADP-F68402	TCGA-DD-AADP	TCGA-DD-AADP-01A	0.2	0.6		A	0.7	1.5	0.5	-16760	161		0	458			0	0	8	9			2014-11-17	MALE	167	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	1.0	1.0	NO	NO	G3						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AADP.11B44F97-2332-4CB7-B57C-063B1C6127EF.pdf	AADP	TUMOR FREE	102	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	Micro	A		LIVING	67	2013	TCGA-DD-AADP-01A-11D-A38W-01	TCGA-DD-AADP-01A-11D-A38W-01	TCGA-DD-AADP-01A-11D-A38X-10	TCGA-DD-AADP-01	TCGA-DD-AADP-01		6b57a5b6-2306-493a-aecf-0de8d2f098a8		TCGA-DD-AADP-01	TCGA-DD-AADP-01	6b57a5b6-2306-493a-aecf-0de8d2f098a8		6b57a5b6-2306-493a-aecf-0de8d2f098a8	6b57a5b6-2306-493a-aecf-0de8d2f098a8		TCGA-DD-AADP-01A-11D-A39G-05
TCGA-DD-AADQ-01	0	TCGA-DD-AADQ-01	436	0	days	TCGA-DD-AADQ	436	0	days	436	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				59	3.8	4.4	5.3	TCGA-DD-AADQ-F68403	TCGA-DD-AADQ		0.2	0.3		A	0.7	1.5	0.7	-21756			0	436			0	0	8	7			2014-11-17	MALE	165	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3						NO			No	M0	N0	T2	Stage II		AADQ	TUMOR FREE	163	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None			LIVING	64	2013	TCGA-DD-AADQ-01A-11D-A40Q-01	TCGA-DD-AADQ-01A-11D-A40Q-01	TCGA-DD-AADQ-01A-11D-A40R-10	TCGA-DD-AADQ-01	TCGA-DD-AADQ-01		c623f952-e487-4d8d-a5c3-eef8bac53a05		TCGA-DD-AADQ-01	TCGA-DD-AADQ-01	c623f952-e487-4d8d-a5c3-eef8bac53a05		c623f952-e487-4d8d-a5c3-eef8bac53a05	c623f952-e487-4d8d-a5c3-eef8bac53a05		TCGA-DD-AADQ-01A-11D-A40S-05
TCGA-DD-AADR-01	0	TCGA-DD-AADR-01	2028	0	days	TCGA-DD-AADR	2028	1	days	2028	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	58	3.8	4.4	5.3	TCGA-DD-AADR-F68404	TCGA-DD-AADR		0.2	0.9		A	0.7	1.5	1.0	-21217			0	2028		2028	0	0	8	3	6 - Established Cirrhosis		2014-11-17	MALE	170	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3	Liver	Intrahepatic Recurrence		No	NO	YES	No		No	M0	N0	T1	Stage I		AADR	TUMOR FREE	75	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.2	Liver	None			LIVING	75	2009	TCGA-DD-AADR-01A-11D-A40Q-01	TCGA-DD-AADR-01A-11D-A40Q-01	TCGA-DD-AADR-01A-11D-A40R-10	TCGA-DD-AADR-01	TCGA-DD-AADR-01		fcea51b1-3899-4c1d-bcc1-b0fbefe01661		TCGA-DD-AADR-01	TCGA-DD-AADR-01	fcea51b1-3899-4c1d-bcc1-b0fbefe01661		fcea51b1-3899-4c1d-bcc1-b0fbefe01661	fcea51b1-3899-4c1d-bcc1-b0fbefe01661		TCGA-DD-AADR-01A-11D-A40S-05
TCGA-DD-AADS-01	0	TCGA-DD-AADS-01	474	0	days	TCGA-DD-AADS	474	0	days	474	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				63	3.8	3.7	5.3	TCGA-DD-AADS-F68405	TCGA-DD-AADS		0.2	0.7	1	A	0.7	1.5	0.9	-23227			0	474			0	0	8	11			2014-11-17	MALE	164	Alcohol consumption|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G2						NO			No	M0	N0	T1	Stage I		AADS	TUMOR FREE	120	130	400	NO	NO	1.2	NO	YES		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None			LIVING	53	2013	TCGA-DD-AADS-01A-11D-A40Q-01	TCGA-DD-AADS-01A-11D-A40Q-01	TCGA-DD-AADS-01A-11D-A40R-10	TCGA-DD-AADS-01	TCGA-DD-AADS-01		b05b2c69-27f3-46db-891a-9d2f8b0d8b97		TCGA-DD-AADS-01	TCGA-DD-AADS-01	b05b2c69-27f3-46db-891a-9d2f8b0d8b97		b05b2c69-27f3-46db-891a-9d2f8b0d8b97	b05b2c69-27f3-46db-891a-9d2f8b0d8b97		TCGA-DD-AADS-01A-11D-A40S-05
TCGA-DD-AADU-01	0	TCGA-DD-AADU-01	554	0	days	TCGA-DD-AADU	554	0	days	554	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	60	3.8	4.3	5.3	TCGA-DD-AADU-F68406	TCGA-DD-AADU		0.2	1.8		A	0.7	1.5	0.8	-21940			0	554			0	0	8	52	3,4 - Fibrous Speta		2014-11-17	MALE	166	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3						NO			No	M0	N0	T2	Stage II		AADU	TUMOR FREE	223	130	400	NO	NO	1.0	NO	YES		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	Micro			LIVING	73	2013	TCGA-DD-AADU-01A-11D-A40Q-01	TCGA-DD-AADU-01A-11D-A40Q-01	TCGA-DD-AADU-01A-11D-A40R-10	TCGA-DD-AADU-01	TCGA-DD-AADU-01		e0178b54-86f9-45e7-949d-2c4132ac9822		TCGA-DD-AADU-01	TCGA-DD-AADU-01	e0178b54-86f9-45e7-949d-2c4132ac9822		e0178b54-86f9-45e7-949d-2c4132ac9822	e0178b54-86f9-45e7-949d-2c4132ac9822		TCGA-DD-AADU-01A-11D-A40S-05
TCGA-DD-AADV-01	0	TCGA-DD-AADV-01	574	0	days	TCGA-DD-AADV	574	0	days	574	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	50	3.8	3.8	5.3	TCGA-DD-AADV-F68407	TCGA-DD-AADV	TCGA-DD-AADV-01A	0.2	0.8		A	0.7	1.5	0.9	-18300	286		0	574			0	0	8	11	6 - Established Cirrhosis		2014-11-17	MALE	176	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	1.0	1.0	NO	NO	G3						NO		true	Yes	M0	N0	T1	Stage I	TCGA-DD-AADV.750CC634-8874-488C-B20D-6B636978156A.pdf	AADV	TUMOR FREE	187	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	64	2013	TCGA-DD-AADV-01A-11D-A38W-01	TCGA-DD-AADV-01A-11D-A38W-01	TCGA-DD-AADV-01A-11D-A38X-10	TCGA-DD-AADV-01	TCGA-DD-AADV-01		31ca8dd5-ebff-496f-b9ea-e62a96449238		TCGA-DD-AADV-01	TCGA-DD-AADV-01	31ca8dd5-ebff-496f-b9ea-e62a96449238		31ca8dd5-ebff-496f-b9ea-e62a96449238	31ca8dd5-ebff-496f-b9ea-e62a96449238		TCGA-DD-AADV-01A-11D-A39G-05
TCGA-DD-AADW-01	0	TCGA-DD-AADW-01	587	0	days	TCGA-DD-AADW	386	1	days	587	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	YES	None	48	3.8	4.3	4.3	TCGA-DD-AADW-F68408	TCGA-DD-AADW	TCGA-DD-AADW-01A	0.2	1.0		A	0.7	1.5	0.8	-17781	287		0	587		386	1	0	8	250	6 - Established Cirrhosis		2014-11-17	MALE	163	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	30	1.0	1.0	NO	NO	G3	Liver	Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-AADW.18DA1A83-81E4-462C-AA58-FBB1298F86F9.pdf	AADW	TUMOR FREE	102	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	49	2013	TCGA-DD-AADW-01A-11D-A38W-01	TCGA-DD-AADW-01A-11D-A38W-01	TCGA-DD-AADW-01A-11D-A38X-10	TCGA-DD-AADW-01	TCGA-DD-AADW-01		64842a3f-2584-4d55-9e6c-bb976485476a		TCGA-DD-AADW-01	TCGA-DD-AADW-01	64842a3f-2584-4d55-9e6c-bb976485476a		64842a3f-2584-4d55-9e6c-bb976485476a	64842a3f-2584-4d55-9e6c-bb976485476a		TCGA-DD-AADW-01A-11D-A39G-05
TCGA-DD-AADY-01	0	TCGA-DD-AADY-01	555	0	days	TCGA-DD-AADY	555	0	days	555	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	55	3.8	3.5	5.3	TCGA-DD-AADY-F68409	TCGA-DD-AADY		0.2	0.8		A	0.7	1.5	0.6	-20233			0	555			0	0	8	9	6 - Established Cirrhosis		2014-11-17	FEMALE	161	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G2						NO			No	M0	N0	T1	Stage I		AADY	TUMOR FREE	159	130	400	NO	NO	1.3	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None			LIVING	55	2013	TCGA-DD-AADY-01A-11D-A40Q-01	TCGA-DD-AADY-01A-11D-A40Q-01	TCGA-DD-AADY-01A-11D-A40R-10	TCGA-DD-AADY-01	TCGA-DD-AADY-01		a7a49062-5a0f-4a5f-bcac-9673538f975d		TCGA-DD-AADY-01	TCGA-DD-AADY-01	a7a49062-5a0f-4a5f-bcac-9673538f975d		a7a49062-5a0f-4a5f-bcac-9673538f975d	a7a49062-5a0f-4a5f-bcac-9673538f975d		TCGA-DD-AADY-01A-11D-A40S-05
TCGA-DD-AAE0-01	0	TCGA-DD-AAE0-01	555	0	days	TCGA-DD-AAE0	555	0	days	555	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	45	3.8	4.8	5.3	TCGA-DD-AAE0-F68410	TCGA-DD-AAE0	TCGA-DD-AAE0-01A	0.2	0.9		A	0.7	1.5	0.5	-16732	314		0	555			0	0	8	8751	3,4 - Fibrous Speta		2014-11-17	FEMALE	159	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	40	1.0	1.0	NO	NO	G4						NO		true	No	M0	N0	T3a	Stage IIIA	TCGA-DD-AAE0.C8EB705D-E9F9-4101-9B7F-EE4968CA5781.pdf	AAE0	TUMOR FREE	226	130	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	56	2013	TCGA-DD-AAE0-01A-11D-A40Q-01	TCGA-DD-AAE0-01A-11D-A40Q-01	TCGA-DD-AAE0-01A-11D-A40R-10	TCGA-DD-AAE0-01	TCGA-DD-AAE0-01		848b19c6-7761-48b9-9f22-ab31d5aadba1		TCGA-DD-AAE0-01	TCGA-DD-AAE0-01	848b19c6-7761-48b9-9f22-ab31d5aadba1		848b19c6-7761-48b9-9f22-ab31d5aadba1	848b19c6-7761-48b9-9f22-ab31d5aadba1		TCGA-DD-AAE0-01A-11D-A40S-05
TCGA-DD-AAE1-01	0	TCGA-DD-AAE1-01	552	0	days	TCGA-DD-AAE1	552	0	days	552	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	52	3.8	4.1	5.3	TCGA-DD-AAE1-F68411	TCGA-DD-AAE1		0.2	0.4		A	0.7	1.5	0.8	-19073			0	552			0	0	8	2693	6 - Established Cirrhosis		2014-11-17	MALE	169	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3						NO			No	M0	N0	T1	Stage I		AAE1	TUMOR FREE	102	130	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None			LIVING	62	2013	TCGA-DD-AAE1-01A-11D-A40Q-01	TCGA-DD-AAE1-01A-11D-A40Q-01	TCGA-DD-AAE1-01A-11D-A40R-10	TCGA-DD-AAE1-01	TCGA-DD-AAE1-01		ba7eaaac-b25a-4f83-b8f8-885b172ac44c		TCGA-DD-AAE1-01	TCGA-DD-AAE1-01	ba7eaaac-b25a-4f83-b8f8-885b172ac44c		ba7eaaac-b25a-4f83-b8f8-885b172ac44c	ba7eaaac-b25a-4f83-b8f8-885b172ac44c		TCGA-DD-AAE1-01A-11D-A40S-05
TCGA-DD-AAE2-01	0	TCGA-DD-AAE2-01	638	0	days	TCGA-DD-AAE2	638	0	days	638	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	51	3.8	4.4	5.3	TCGA-DD-AAE2-F68412	TCGA-DD-AAE2	TCGA-DD-AAE2-01A	0.2	0.4		A	0.7	1.5	0.8	-18695	337		0	638			0	0	8	41	6 - Established Cirrhosis		2014-11-17	MALE	174	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	1.0	1.0	NO	NO	G3						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AAE2.C70F898B-E3C1-42C1-BF50-38E126A5B708.pdf	AAE2	TUMOR FREE	238	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	82	2013	TCGA-DD-AAE2-01A-11D-A40Q-01	TCGA-DD-AAE2-01A-11D-A40Q-01	TCGA-DD-AAE2-01A-11D-A40R-10	TCGA-DD-AAE2-01	TCGA-DD-AAE2-01		1ee97326-1e6c-4c92-ab9f-c4eb6aeb5c46		TCGA-DD-AAE2-01	TCGA-DD-AAE2-01	1ee97326-1e6c-4c92-ab9f-c4eb6aeb5c46		1ee97326-1e6c-4c92-ab9f-c4eb6aeb5c46	1ee97326-1e6c-4c92-ab9f-c4eb6aeb5c46		TCGA-DD-AAE2-01A-11D-A40S-05
TCGA-DD-AAE3-01	0	TCGA-DD-AAE3-01	566	0	days	TCGA-DD-AAE3	566	0	days	566	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	50	3.8	4.7	5.3	TCGA-DD-AAE3-F68413	TCGA-DD-AAE3	TCGA-DD-AAE3-01A	0.2	1.1		A	0.7	1.5	0.8	-18271	342		0	566			0	0	8	2	1,2 - Portal Fibrosis		2014-11-17	MALE	165	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	30	1.0	1.0	NO	NO	G2						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AAE3.FED7CE87-1B13-4035-A76B-CEC1045B93C4.pdf	AAE3	TUMOR FREE	180	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	73	2013	TCGA-DD-AAE3-01A-11D-A40Q-01	TCGA-DD-AAE3-01A-11D-A40Q-01	TCGA-DD-AAE3-01A-11D-A40R-10	TCGA-DD-AAE3-01	TCGA-DD-AAE3-01		5b1caa21-6281-47b4-b11f-fbe5458f1ffb		TCGA-DD-AAE3-01	TCGA-DD-AAE3-01	5b1caa21-6281-47b4-b11f-fbe5458f1ffb		5b1caa21-6281-47b4-b11f-fbe5458f1ffb	5b1caa21-6281-47b4-b11f-fbe5458f1ffb		TCGA-DD-AAE3-01A-11D-A40S-05
TCGA-DD-AAE4-01	0	TCGA-DD-AAE4-01	608	0	days	TCGA-DD-AAE4	111	1	days	608	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	49	3.8	4.0	5.3	TCGA-DD-AAE4-F68414	TCGA-DD-AAE4		0.2	0.8		A	0.7	1.5	0.5	-18009			0	608		111	0	0	8	7	6 - Established Cirrhosis		2014-11-17	FEMALE	157	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G1	Liver	Locoregional Recurrence		Yes	NO	YES	No		No	M0	N0	T1	Stage I		AAE4	WITH TUMOR	113	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None			LIVING	62	2013	TCGA-DD-AAE4-01A-11D-A40Q-01	TCGA-DD-AAE4-01A-11D-A40Q-01	TCGA-DD-AAE4-01A-11D-A40R-10	TCGA-DD-AAE4-01	TCGA-DD-AAE4-01		e1aa2737-5bf3-4348-b3bf-07d881e71e6e		TCGA-DD-AAE4-01	TCGA-DD-AAE4-01	e1aa2737-5bf3-4348-b3bf-07d881e71e6e		e1aa2737-5bf3-4348-b3bf-07d881e71e6e	e1aa2737-5bf3-4348-b3bf-07d881e71e6e		TCGA-DD-AAE4-01A-11D-A40S-05
TCGA-DD-AAE6-01	0	TCGA-DD-AAE6-01	141	0	days	TCGA-DD-AAE6	105	1	days	141	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	59	3.8	4.4	5.3	TCGA-DD-AAE6-F68416	TCGA-DD-AAE6	TCGA-DD-AAE6-01A	0.2	0.9		A	0.7	1.5	0.8	-21764	399		0	141		105	0	0	8	113	6 - Established Cirrhosis		2014-11-17	FEMALE	159			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	80	1.0	1.0	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-AAE6.1B3F62E9-8E87-43FA-AEA8-00C89D678F8F.pdf	AAE6	WITH TUMOR	209	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	Micro	A		LIVING	46	2012	TCGA-DD-AAE6-01A-11D-A40Q-01	TCGA-DD-AAE6-01A-11D-A40Q-01	TCGA-DD-AAE6-01A-11D-A40R-10	TCGA-DD-AAE6-01	TCGA-DD-AAE6-01		8d639a44-445c-440c-8452-bafba2df33fc		TCGA-DD-AAE6-01	TCGA-DD-AAE6-01	8d639a44-445c-440c-8452-bafba2df33fc		8d639a44-445c-440c-8452-bafba2df33fc	8d639a44-445c-440c-8452-bafba2df33fc		TCGA-DD-AAE6-01A-11D-A40S-05
TCGA-DD-AAE7-01	0	TCGA-DD-AAE7-01	644	0	days	TCGA-DD-AAE7	644	0	days	644	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Severe	72	3.8	4.7	5.3	TCGA-DD-AAE7-F68418	TCGA-DD-AAE7	TCGA-DD-AAE7-01A	0.2	1.1		A	0.7	1.5	0.9	-26568	410		0	644			0	0	8	1	3,4 - Fibrous Speta		2014-11-17	MALE	172	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	1.0	1.0	NO	NO	G2						NO		true	Yes	M0	N0	T1	Stage I	TCGA-DD-AAE7.1861F2A9-334D-4C4E-A7D0-D010712D6096.pdf	AAE7	TUMOR FREE	188	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	74	2012	TCGA-DD-AAE7-01A-11D-A40Q-01	TCGA-DD-AAE7-01A-11D-A40Q-01	TCGA-DD-AAE7-01A-11D-A40R-10	TCGA-DD-AAE7-01	TCGA-DD-AAE7-01		2c7587fc-5549-4888-abe9-b989e216e9c4		TCGA-DD-AAE7-01	TCGA-DD-AAE7-01	2c7587fc-5549-4888-abe9-b989e216e9c4		2c7587fc-5549-4888-abe9-b989e216e9c4	2c7587fc-5549-4888-abe9-b989e216e9c4		TCGA-DD-AAE7-01A-11D-A40S-05
TCGA-DD-AAE8-01	0	TCGA-DD-AAE8-01	664	0	days	TCGA-DD-AAE8	113	1	days	664	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		45	3.8	4.3	5.3	TCGA-DD-AAE8-F68419	TCGA-DD-AAE8		0.2	3.0		A	0.7	1.5	0.6	-16549			0	664		113	0	0	8	3	6 - Established Cirrhosis		2014-11-17	MALE	170	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No		Yes	M0	N0	T1	Stage I		AAE8	TUMOR FREE	125	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None			LIVING	78	2012	TCGA-DD-AAE8-01A-11D-A40Q-01	TCGA-DD-AAE8-01A-11D-A40Q-01	TCGA-DD-AAE8-01A-11D-A40R-10	TCGA-DD-AAE8-01					TCGA-DD-AAE8-01							TCGA-DD-AAE8-01A-11D-A40S-05
TCGA-DD-AAE9-01	0	TCGA-DD-AAE9-01	722	0	days	TCGA-DD-AAE9	722	0	days	722	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	69	3.8	4.1	5.3	TCGA-DD-AAE9-F68857	TCGA-DD-AAE9	TCGA-DD-AAE9-01A	0.2	0.7		A	0.7	1.5	0.9	-25451	419		0	722			0	0	8	3	1,2 - Portal Fibrosis		2014-12-21	MALE	165	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	40	1.0	1.0	NO	NO	G3						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AAE9.64700E97-F031-49DE-83F0-8CCDBDEE23AF.pdf	AAE9	TUMOR FREE	138	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	63	2012	TCGA-DD-AAE9-01A-11D-A40Q-01	TCGA-DD-AAE9-01A-11D-A40Q-01	TCGA-DD-AAE9-01A-11D-A40R-10	TCGA-DD-AAE9-01	TCGA-DD-AAE9-01		134b8660-251e-428f-9057-b385b122c5ec		TCGA-DD-AAE9-01	TCGA-DD-AAE9-01	134b8660-251e-428f-9057-b385b122c5ec		134b8660-251e-428f-9057-b385b122c5ec	134b8660-251e-428f-9057-b385b122c5ec		TCGA-DD-AAE9-01A-11D-A40S-05
TCGA-DD-AAEA-01	0	TCGA-DD-AAEA-01	575	0	days	TCGA-DD-AAEA	575	0	days	575	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				65	3.8	4.5	5.3	TCGA-DD-AAEA-F68421	TCGA-DD-AAEA		0.2	0.6		A	0.7	1.5	0.9	-24027			0	575			0	0	8	2	1,2 - Portal Fibrosis		2014-11-17	MALE	163	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3						NO			Yes	M0	N0	T1	Stage I		AAEA	TUMOR FREE	255	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.2	Liver	None			LIVING	66	2012	TCGA-DD-AAEA-01A-11D-A40Q-01	TCGA-DD-AAEA-01A-11D-A40Q-01	TCGA-DD-AAEA-01A-11D-A40R-10	TCGA-DD-AAEA-01	TCGA-DD-AAEA-01		c23a2426-2763-4088-b85b-e9cfcfc7959d		TCGA-DD-AAEA-01	TCGA-DD-AAEA-01	c23a2426-2763-4088-b85b-e9cfcfc7959d		c23a2426-2763-4088-b85b-e9cfcfc7959d	c23a2426-2763-4088-b85b-e9cfcfc7959d		TCGA-DD-AAEA-01A-11D-A40S-05
TCGA-DD-AAEB-01	0	TCGA-DD-AAEB-01	478	0	days	TCGA-DD-AAEB	478	0	days	478	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				60	3.8	4.1	5.3	TCGA-DD-AAEB-F68423	TCGA-DD-AAEB	TCGA-DD-AAEB-01A	0.2	0.3		A	0.7	1.5	0.6	-22121	468		0	478			1	0	8	1			2014-11-17	MALE	161	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	70	1.0	1.0	NO	NO	G2						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AAEB.E991576A-60BD-4C11-9B4E-EA43F19D06C3.pdf	AAEB	TUMOR FREE	270	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	75	2012	TCGA-DD-AAEB-01A-11D-A40Q-01	TCGA-DD-AAEB-01A-11D-A40Q-01	TCGA-DD-AAEB-01A-11D-A40R-10	TCGA-DD-AAEB-01	TCGA-DD-AAEB-01		34dd06ab-c00e-4e24-8c92-eae9c430216a		TCGA-DD-AAEB-01	TCGA-DD-AAEB-01	34dd06ab-c00e-4e24-8c92-eae9c430216a		34dd06ab-c00e-4e24-8c92-eae9c430216a	34dd06ab-c00e-4e24-8c92-eae9c430216a		TCGA-DD-AAEB-01A-11D-A40S-05
TCGA-DD-AAED-01	0	TCGA-DD-AAED-01	763	0	days	TCGA-DD-AAED	198	1	days	763	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	51	3.8	4.0	5.3	TCGA-DD-AAED-F68424	TCGA-DD-AAED		0.2	0.6		A	0.7	1.5	0.5	-18722			0	763		198	0	0	8	2405	1,2 - Portal Fibrosis		2014-11-17	MALE	166	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No		No	M0	N0	T1	Stage I		AAED	WITH TUMOR	211	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None			LIVING	69	2012	TCGA-DD-AAED-01A-12D-A40Q-01	TCGA-DD-AAED-01A-12D-A40Q-01	TCGA-DD-AAED-01A-12D-A40R-10	TCGA-DD-AAED-01	TCGA-DD-AAED-01		ccf74279-b0d5-45ca-9a90-fd7d3d2fa630		TCGA-DD-AAED-01	TCGA-DD-AAED-01	ccf74279-b0d5-45ca-9a90-fd7d3d2fa630		ccf74279-b0d5-45ca-9a90-fd7d3d2fa630	ccf74279-b0d5-45ca-9a90-fd7d3d2fa630		TCGA-DD-AAED-01A-12D-A40S-05
TCGA-DD-AAEE-01	0	TCGA-DD-AAEE-01	810	0	days	TCGA-DD-AAEE	224	1	days	810	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	55	3.8	4.7	5.3	TCGA-DD-AAEE-F68427	TCGA-DD-AAEE	TCGA-DD-AAEE-01A	0.2	0.8		A	0.7	1.5	0.9	-20396	509		0	810	298	224	0	0	8	3	6 - Established Cirrhosis		2014-11-17	MALE	160	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	40	1.0	1.0	NO	NO	G4	Liver	Intrahepatic Recurrence		Yes	YES	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-AAEE.D857BF5A-E2C6-4A6E-88CA-E8707E6FF3D9.pdf	AAEE	WITH TUMOR	221	130	400	NO	NO	1.0	NO	NO	RX	R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	58	2012	TCGA-DD-AAEE-01A-11D-A40Q-01	TCGA-DD-AAEE-01A-11D-A40Q-01	TCGA-DD-AAEE-01A-11D-A40R-10	TCGA-DD-AAEE-01	TCGA-DD-AAEE-01		6624447f-0954-4488-b8f7-2e73162ef22b		TCGA-DD-AAEE-01	TCGA-DD-AAEE-01	6624447f-0954-4488-b8f7-2e73162ef22b		6624447f-0954-4488-b8f7-2e73162ef22b	6624447f-0954-4488-b8f7-2e73162ef22b		TCGA-DD-AAEE-01A-11D-A40S-05
TCGA-DD-AAEG-01	0	TCGA-DD-AAEG-01	719	0	days	TCGA-DD-AAEG	719	0	days	719	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	59	3.8	3.0	5.3	TCGA-DD-AAEG-F68430	TCGA-DD-AAEG	TCGA-DD-AAEG-01A	0.2	0.6		A	0.7	1.5	0.6	-21853	529		0	719			0	0	8	1	6 - Established Cirrhosis		2014-11-17	FEMALE	149	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	1.0	1.0	NO	NO	G3						NO		true	Yes	M0	N0	T1	Stage I	TCGA-DD-AAEG.B48B65B0-92F9-4B49-B8A8-563EA5AF70F1.pdf	AAEG	TUMOR FREE	69	130	400	NO	NO	1.3	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	40	2012	TCGA-DD-AAEG-01A-11D-A38W-01	TCGA-DD-AAEG-01A-11D-A38W-01	TCGA-DD-AAEG-01A-11D-A38X-10	TCGA-DD-AAEG-01	TCGA-DD-AAEG-01		700bf3b6-dff8-4de7-877f-1c742620f896		TCGA-DD-AAEG-01	TCGA-DD-AAEG-01	700bf3b6-dff8-4de7-877f-1c742620f896		700bf3b6-dff8-4de7-877f-1c742620f896	700bf3b6-dff8-4de7-877f-1c742620f896		TCGA-DD-AAEG-01A-11D-A39G-05
TCGA-DD-AAEH-01	0	TCGA-DD-AAEH-01	784	0	days	TCGA-DD-AAEH	644	1	days	784	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	73	3.8	2.9	5.3	TCGA-DD-AAEH-F68431	TCGA-DD-AAEH	TCGA-DD-AAEH-01A	0.2	0.9		A	0.7	1.5	0.6	-26894	553		0	784	660	644	2				1,2 - Portal Fibrosis		2014-11-17	MALE	163			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	10	1.0	1.0	NO	NO	G2	Bone	Extrahepatic Recurrence		No	YES	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-AAEH.D6F3E1F8-27F3-47F9-88CC-F4145C983073.pdf	AAEH	TUMOR FREE	223	130	400	NO	NO	1.1	NO	NO	RX	R0	Primary Tumor	01	Lobectomy	7th	NO	YES	DD	1.2	Liver	Micro	A		LIVING	62	2012	TCGA-DD-AAEH-01A-11D-A40Q-01	TCGA-DD-AAEH-01A-11D-A40Q-01	TCGA-DD-AAEH-01A-11D-A40R-10	TCGA-DD-AAEH-01	TCGA-DD-AAEH-01		5be075bb-9fa0-4821-8e61-672f28e2b833		TCGA-DD-AAEH-01	TCGA-DD-AAEH-01	5be075bb-9fa0-4821-8e61-672f28e2b833		5be075bb-9fa0-4821-8e61-672f28e2b833	5be075bb-9fa0-4821-8e61-672f28e2b833		TCGA-DD-AAEH-01A-11D-A40S-05
TCGA-DD-AAEI-01	0	TCGA-DD-AAEI-01	1531	0	days	TCGA-DD-AAEI	491	1	days	1531	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	YES	None	72	3.8	3.6	5.3	TCGA-DD-AAEI-F68433	TCGA-DD-AAEI		0.2	0.5		A	0.7	1.5	0.9	-26465			0	1531		491	0	0	8	24	6 - Established Cirrhosis		2014-11-17	MALE	166	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.0	1.0		NO	G2	Bone	Extrahepatic Recurrence		No	NO	YES	No		No	M0	N0	T1	Stage I		AAEI	WITH TUMOR	161	130	400	YES	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	DD	1.2	Liver	None			LIVING	79	2010	TCGA-DD-AAEI-01A-11D-A40Q-01	TCGA-DD-AAEI-01A-11D-A40Q-01	TCGA-DD-AAEI-01A-11D-A40R-10	TCGA-DD-AAEI-01	TCGA-DD-AAEI-01		ab0da649-e0c0-497a-a20b-4d1a618dba72		TCGA-DD-AAEI-01	TCGA-DD-AAEI-01	ab0da649-e0c0-497a-a20b-4d1a618dba72		ab0da649-e0c0-497a-a20b-4d1a618dba72	ab0da649-e0c0-497a-a20b-4d1a618dba72		TCGA-DD-AAEI-01A-11D-A40S-05
TCGA-DD-AAEK-01	0	TCGA-DD-AAEK-01	1067	0	days	TCGA-DD-AAEK	1067	0	days	1067	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	51	3.8	4.1	5.3	TCGA-DD-AAEK-F68434	TCGA-DD-AAEK	TCGA-DD-AAEK-01A	0.2	1.0		A	0.7	1.5	0.7	-18757	1162		0	1067			0	0	8	5166	6 - Established Cirrhosis		2014-11-17	MALE	169	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	10	1.0	1.0	NO	YES	G3						NO		true	No	M0	N0	T2	Stage II	TCGA-DD-AAEK.C174382E-E3FB-456E-B5B7-1949B3086967.pdf	AAEK	TUMOR FREE	202	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	DD	1.2	Liver	None	A		LIVING	64	2010	TCGA-DD-AAEK-01A-11D-A40Q-01	TCGA-DD-AAEK-01A-11D-A40Q-01	TCGA-DD-AAEK-01A-11D-A40R-10	TCGA-DD-AAEK-01	TCGA-DD-AAEK-01		099fe601-12b3-4e3d-8d01-322ef9ac9e5a		TCGA-DD-AAEK-01	TCGA-DD-AAEK-01	099fe601-12b3-4e3d-8d01-322ef9ac9e5a		099fe601-12b3-4e3d-8d01-322ef9ac9e5a	099fe601-12b3-4e3d-8d01-322ef9ac9e5a		TCGA-DD-AAEK-01A-11D-A40S-05
TCGA-DD-AAVP-01	0	TCGA-DD-AAVP-01	2752	0	days	TCGA-DD-AAVP	903	1	days	2752	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Severe	48	3.3	4.3	5.0	TCGA-DD-AAVP-F67571	TCGA-DD-AAVP	TCGA-DD-AAVP-01A	0.2	1.1	1	A	0.7	1.4	1.2	-17833	2467		0	2752		903	0	0	15	2	6 - Established Cirrhosis		2014-11-6	MALE	167	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	100	0.8	1.2	NO	NO	G1	Liver	Locoregional Recurrence		Yes	NO	YES	Yes	true	No	M0	N0	T1	Stage I	TCGA-DD-AAVP.E930F87E-767F-4413-909E-97F7ABAD3D51.pdf	AAVP	TUMOR FREE	189	130	400	YES	NO	1	NO	YES	RX	R0	Primary Tumor	01	Extended Lobectomy	6th	NO	YES	DD	1.2	Liver	None	A		LIVING	62	2007	TCGA-DD-AAVP-01A-11D-A40Q-01	TCGA-DD-AAVP-01A-11D-A40Q-01	TCGA-DD-AAVP-01A-11D-A40R-10	TCGA-DD-AAVP-01	TCGA-DD-AAVP-01		6c3a4f09-1862-4fed-9977-759ec00a5aeb		TCGA-DD-AAVP-01	TCGA-DD-AAVP-01	6c3a4f09-1862-4fed-9977-759ec00a5aeb		6c3a4f09-1862-4fed-9977-759ec00a5aeb	6c3a4f09-1862-4fed-9977-759ec00a5aeb		TCGA-DD-AAVP-01A-11D-A40S-05
TCGA-DD-AAVQ-01	0	TCGA-DD-AAVQ-01	2728	0	days	TCGA-DD-AAVQ	1509	1	days	2728	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Severe	38	3.3	3.0	5.2	TCGA-DD-AAVQ-F67572	TCGA-DD-AAVQ		0.2	1.0		A	0.7	1.4	1.1	-13911			0	2728		1509	1	0	15	1456	6 - Established Cirrhosis		2014-11-6	MALE	171	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.8	1.2		NO	G2	Liver	Locoregional Recurrence		Yes	NO	YES	Yes		No	M0	N0	T1	Stage I		AAVQ	TUMOR FREE	128	130	400	YES	NO	1.2	NO	NO	RX	R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.2	Liver	None			LIVING	72	2007	TCGA-DD-AAVQ-01A-11D-A40Q-01	TCGA-DD-AAVQ-01A-11D-A40Q-01	TCGA-DD-AAVQ-01A-11D-A40R-10	TCGA-DD-AAVQ-01	TCGA-DD-AAVQ-01		d01e30b3-9f94-47f6-8a4e-0b4f84ad5eb2		TCGA-DD-AAVQ-01	TCGA-DD-AAVQ-01	d01e30b3-9f94-47f6-8a4e-0b4f84ad5eb2		d01e30b3-9f94-47f6-8a4e-0b4f84ad5eb2	d01e30b3-9f94-47f6-8a4e-0b4f84ad5eb2		TCGA-DD-AAVQ-01A-11D-A40S-05
TCGA-DD-AAVR-01	0	TCGA-DD-AAVR-01	2513	0	days	TCGA-DD-AAVR	2513	0	days	2513	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	44	3.3	3.6	5.2	TCGA-DD-AAVR-F67574	TCGA-DD-AAVR		0.2	1.2	1	A	0.0	1.4	1.1	-16157			0	2513			1	0	15	36	6 - Established Cirrhosis		2014-11-6	MALE	165	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.8	1.2		NO	G2						NO			No	M0	N0	T1	Stage I		AAVR	TUMOR FREE	174	130	400	NO	NO	1.0	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.2	Liver	None			LIVING	69	2007	TCGA-DD-AAVR-01A-11D-A40Q-01	TCGA-DD-AAVR-01A-11D-A40Q-01	TCGA-DD-AAVR-01A-11D-A40R-10	TCGA-DD-AAVR-01	TCGA-DD-AAVR-01		c0c50e3a-973e-429d-b93f-dd7ff2aebbcc		TCGA-DD-AAVR-01	TCGA-DD-AAVR-01	c0c50e3a-973e-429d-b93f-dd7ff2aebbcc		c0c50e3a-973e-429d-b93f-dd7ff2aebbcc	c0c50e3a-973e-429d-b93f-dd7ff2aebbcc		TCGA-DD-AAVR-01A-11D-A40S-05
TCGA-DD-AAVS-01	0	TCGA-DD-AAVS-01	1823	0	days	TCGA-DD-AAVS	1823	0	days	1823	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	56	3.3	3.0	5.2	TCGA-DD-AAVS-F67576	TCGA-DD-AAVS		0.2	1.0		A	0	1.4	1.0	-20586			0	1823			1	0	15	50149	3,4 - Fibrous Speta		2014-11-6	MALE	169	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.8	1.2		NO	G2						NO			No	M0	N0	T1	Stage I		AAVS	TUMOR FREE	281	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.2	Liver	None			LIVING	72	2007	TCGA-DD-AAVS-01A-11D-A40Q-01	TCGA-DD-AAVS-01A-11D-A40Q-01	TCGA-DD-AAVS-01A-11D-A40R-10	TCGA-DD-AAVS-01	TCGA-DD-AAVS-01		b510c5b5-c31a-4d90-9674-994fd9c50ff1		TCGA-DD-AAVS-01	TCGA-DD-AAVS-01	b510c5b5-c31a-4d90-9674-994fd9c50ff1		b510c5b5-c31a-4d90-9674-994fd9c50ff1	b510c5b5-c31a-4d90-9674-994fd9c50ff1		TCGA-DD-AAVS-01A-11D-A40S-05
TCGA-DD-AAVU-01	0	TCGA-DD-AAVU-01	2202	0	days	TCGA-DD-AAVU	1630	1	days	2202	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	46	3.3	4.6	5.2	TCGA-DD-AAVU-F67577	TCGA-DD-AAVU		0.2	0.6		A	0	1.4	1.2	-16889			0	2202		1630	1	0	15	2	3,4 - Fibrous Speta		2014-11-6	MALE	160	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.8	1.2		NO	G2	Liver	Intrahepatic Recurrence		No	NO	YES	Yes		No	M0	N0	T2	Stage II		AAVU	TUMOR FREE	166	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.2	Liver	Micro			LIVING	88	2008	TCGA-DD-AAVU-01A-11D-A40Q-01	TCGA-DD-AAVU-01A-11D-A40Q-01	TCGA-DD-AAVU-01A-11D-A40R-10	TCGA-DD-AAVU-01	TCGA-DD-AAVU-01		ef6ecdbb-20df-4c7b-bb47-5f14af908008		TCGA-DD-AAVU-01	TCGA-DD-AAVU-01	ef6ecdbb-20df-4c7b-bb47-5f14af908008		ef6ecdbb-20df-4c7b-bb47-5f14af908008	ef6ecdbb-20df-4c7b-bb47-5f14af908008		TCGA-DD-AAVU-01A-11D-A40S-05
TCGA-DD-AAVV-01	0	TCGA-DD-AAVV-01	2455	0	days	TCGA-DD-AAVV	2455	0	days	2455	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	56	3.3	4.6	5.2	TCGA-DD-AAVV-F68858	TCGA-DD-AAVV	TCGA-DD-AAVV-01A	0.2	0.9		A	0	1.4	1.3	-20751	2513		0	2455			1	0	15	7	3,4 - Fibrous Speta		2014-12-21	MALE	158	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	70	0.8	1.2	NO	YES	G3						NO		true	No	M0	N0	T2	Stage II	TCGA-DD-AAVV.5F24D049-6BE5-403B-9E5A-399921814C68.pdf	AAVV	TUMOR FREE	244	130	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.2	Liver	Micro	A		LIVING	71	2007	TCGA-DD-AAVV-01A-11D-A40Q-01	TCGA-DD-AAVV-01A-11D-A40Q-01	TCGA-DD-AAVV-01A-11D-A40R-10	TCGA-DD-AAVV-01	TCGA-DD-AAVV-01		45baf47b-b48d-44b4-b97d-1e2955a91f1c		TCGA-DD-AAVV-01	TCGA-DD-AAVV-01	45baf47b-b48d-44b4-b97d-1e2955a91f1c		45baf47b-b48d-44b4-b97d-1e2955a91f1c	45baf47b-b48d-44b4-b97d-1e2955a91f1c		TCGA-DD-AAVV-01A-11D-A40S-05
TCGA-DD-AAVW-01	0	TCGA-DD-AAVW-01	2317	0	days	TCGA-DD-AAVW	2317	0	days	2317	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	35	3.3	4.6	5.2	TCGA-DD-AAVW-F67582	TCGA-DD-AAVW	TCGA-DD-AAVW-01A	0.2	1.4		A	0.7	1.4	1.1	-12986	2156		0	2317			0	0	15	927	6 - Established Cirrhosis		2014-11-6	MALE	162	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	0.8	1.2	NO	NO	G2						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AAVW.922707E9-9F68-458F-B1FC-E95CA2876420.pdf	AAVW	TUMOR FREE	212	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.2	Liver	None	A		LIVING	62	2008	TCGA-DD-AAVW-01A-11D-A40Q-01	TCGA-DD-AAVW-01A-11D-A40Q-01	TCGA-DD-AAVW-01A-11D-A40R-10	TCGA-DD-AAVW-01	TCGA-DD-AAVW-01		931985c4-6972-4fa5-9890-ba58b4ab3b6a		TCGA-DD-AAVW-01	TCGA-DD-AAVW-01	931985c4-6972-4fa5-9890-ba58b4ab3b6a		931985c4-6972-4fa5-9890-ba58b4ab3b6a	931985c4-6972-4fa5-9890-ba58b4ab3b6a		TCGA-DD-AAVW-01A-11D-A40S-05
TCGA-DD-AAVX-01	0	TCGA-DD-AAVX-01	1570	0	days	TCGA-DD-AAVX	393	1	days	1570	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	Severe	38	3.3	3.9	5.2	TCGA-DD-AAVX-F67583	TCGA-DD-AAVX	TCGA-DD-AAVX-01A	0.2	1.1	2	A	0.7	1.4	1.0	-14016	2039		0	1570		393	0	0	15	1	6 - Established Cirrhosis		2014-12-30	MALE	178	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	50	0.8	1.2	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	N0	T2	Stage II	TCGA-DD-AAVX.C62E123A-5AFC-47FA-AE6A-E16C22ACD374.pdf	AAVX	WITH TUMOR	186	130	400	YES	YES	1.0	YES	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.2	Liver	Micro	A		LIVING	65	2008	TCGA-DD-AAVX-01A-11D-A40Q-01	TCGA-DD-AAVX-01A-11D-A40Q-01	TCGA-DD-AAVX-01A-11D-A40R-10	TCGA-DD-AAVX-01	TCGA-DD-AAVX-01		7ac6a0a3-3c2a-4e47-a248-690ac73d4593		TCGA-DD-AAVX-01	TCGA-DD-AAVX-01	7ac6a0a3-3c2a-4e47-a248-690ac73d4593		7ac6a0a3-3c2a-4e47-a248-690ac73d4593	7ac6a0a3-3c2a-4e47-a248-690ac73d4593		TCGA-DD-AAVX-01A-11D-A40S-05
TCGA-DD-AAVY-01	0	TCGA-DD-AAVY-01	1970	0	days	TCGA-DD-AAVY	1970	0	days	1970	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	56	3.3	3.0	5.2	TCGA-DD-AAVY-F67586	TCGA-DD-AAVY	TCGA-DD-AAVY-01A	0.2	1.0	2	A	0.7	1.4	1.2	-20709	1826		0	1970			0	0	15	11	0 - No Fibrosis		2014-11-6	MALE	161	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	40	0.8	1.2	NO	NO	G2						NO		true	No	M0	N0	T3	Stage IIIA	TCGA-DD-AAVY.ADDCC231-66AE-4136-AAEC-DCA3DA1C4159.pdf	AAVY	TUMOR FREE	210	130	400	NO	NO	1.0	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.2	Liver	Micro	A		LIVING	63	2009	TCGA-DD-AAVY-01A-11D-A40Q-01	TCGA-DD-AAVY-01A-11D-A40Q-01	TCGA-DD-AAVY-01A-11D-A40R-10	TCGA-DD-AAVY-01	TCGA-DD-AAVY-01		1e91fe2c-87a8-44b1-ba40-f8d92d470a40		TCGA-DD-AAVY-01	TCGA-DD-AAVY-01	1e91fe2c-87a8-44b1-ba40-f8d92d470a40		1e91fe2c-87a8-44b1-ba40-f8d92d470a40	1e91fe2c-87a8-44b1-ba40-f8d92d470a40		TCGA-DD-AAVY-01A-11D-A40S-05
TCGA-DD-AAVZ-01	0	TCGA-DD-AAVZ-01	1900	0	days	TCGA-DD-AAVZ	1900	0	days	1900	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	38	3.3	3.8	5.2	TCGA-DD-AAVZ-F67588	TCGA-DD-AAVZ		0.2	1.0	1	A	0.7	1.4	1.2	-14005			0	1900			0	0	15	945	6 - Established Cirrhosis		2014-11-6	MALE	171	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.8	1.2		NO	G2						NO			No	M0	N0	T1	Stage I		AAVZ	TUMOR FREE	98	130	400	NO	NO	1.2	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.2	Liver	None			LIVING	62	2009	TCGA-DD-AAVZ-01A-11D-A40Q-01	TCGA-DD-AAVZ-01A-11D-A40Q-01	TCGA-DD-AAVZ-01A-11D-A40R-10	TCGA-DD-AAVZ-01	TCGA-DD-AAVZ-01		ab1ad0d6-3d4e-463c-9ff2-c355602506c5		TCGA-DD-AAVZ-01	TCGA-DD-AAVZ-01	ab1ad0d6-3d4e-463c-9ff2-c355602506c5		ab1ad0d6-3d4e-463c-9ff2-c355602506c5	ab1ad0d6-3d4e-463c-9ff2-c355602506c5		TCGA-DD-AAVZ-01A-11D-A40S-05
TCGA-DD-AAW0-01	0	TCGA-DD-AAW0-01	2015	0	days	TCGA-DD-AAW0	2015	0	days	2015	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	54	3.3	4.6	5.2	TCGA-DD-AAW0-F67590	TCGA-DD-AAW0	TCGA-DD-AAW0-01A	0.2	0.2		A	0.7	1.4	1.3	-19981	1737		0	2015			0	0	15	3	3,4 - Fibrous Speta		2014-11-6	MALE	172	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	70	0.8	1.2	NO	NO	G2						NO		true	No	M0	N0	T1	Stage I	TCGA-DD-AAW0.75F8B93A-4839-4A9B-92CD-98147D025D31.pdf	AAW0	TUMOR FREE	183	130	400	NO	NO	1.0	NO	YES		R0	Primary Tumor	01	Total Hepatectomy with Transplant	6th	NO	YES	DD	1.2	Liver	None	A		LIVING	75	2009	TCGA-DD-AAW0-01A-11D-A40Q-01	TCGA-DD-AAW0-01A-11D-A40Q-01	TCGA-DD-AAW0-01A-11D-A40R-10	TCGA-DD-AAW0-01	TCGA-DD-AAW0-01		7095ba1c-4133-4612-86bf-c3b4dea188ba		TCGA-DD-AAW0-01	TCGA-DD-AAW0-01	7095ba1c-4133-4612-86bf-c3b4dea188ba		7095ba1c-4133-4612-86bf-c3b4dea188ba	7095ba1c-4133-4612-86bf-c3b4dea188ba		TCGA-DD-AAW0-01A-11D-A40S-05
TCGA-DD-AAW1-01	0	TCGA-DD-AAW1-01	1989	0	days	TCGA-DD-AAW1	1989	0	days	1989	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Severe	55	3.3	4.0	5.3	TCGA-DD-AAW1-F67591	TCGA-DD-AAW1	TCGA-DD-AAW1-01A	0.2	0.7		A	0.7	1.4	1.2	-20288	1703		0	1989			0	0	15	4	6 - Established Cirrhosis		2014-11-6	MALE	167	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	40	0.8	1.2	NO	NO	G2						NO		true	No	M0	N0	T3	Stage IIIA	TCGA-DD-AAW1.3ED5891B-FD39-4F88-94AA-D040867A51B5.pdf	AAW1	TUMOR FREE	126	130	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.2	Liver	Micro	A		LIVING	60	2009	TCGA-DD-AAW1-01A-11D-A40O-01	TCGA-DD-AAW1-01A-11D-A40O-01	TCGA-DD-AAW1-01A-11D-A40P-10	TCGA-DD-AAW1-01	TCGA-DD-AAW1-01		898a30f1-75df-4503-a586-c2cb43fe1db9		TCGA-DD-AAW1-01	TCGA-DD-AAW1-01	898a30f1-75df-4503-a586-c2cb43fe1db9		898a30f1-75df-4503-a586-c2cb43fe1db9	898a30f1-75df-4503-a586-c2cb43fe1db9		TCGA-DD-AAW1-01A-11D-A40X-05
TCGA-DD-AAW2-01	0	TCGA-DD-AAW2-01	1855	0	days	TCGA-DD-AAW2	391	1	days	1855	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	69	3.3	4.0	5.2	TCGA-DD-AAW2-F67592	TCGA-DD-AAW2	TCGA-DD-AAW2-01A	0.2	0.4	1	A	0.7	1.4	1.1	-25420	1575		0	1855		391	1	0	15	3	6 - Established Cirrhosis		2014-12-30	MALE	156	Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	70	0.8	1.2	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	N0	T1	Stage I	TCGA-DD-AAW2.74C2D5FA-1FDF-424A-BEE2-DE602A4F6DA7.pdf	AAW2	WITH TUMOR	164	130	400	[Discrepancy]	YES	1.0	[Discrepancy]	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	DD	1.2	Liver	None	A		LIVING	50	2009	TCGA-DD-AAW2-01A-11D-A40O-01	TCGA-DD-AAW2-01A-11D-A40O-01	TCGA-DD-AAW2-01A-11D-A40P-10	TCGA-DD-AAW2-01	TCGA-DD-AAW2-01		3c1b3db3-89b5-479d-8ddf-4765b46934f4		TCGA-DD-AAW2-01	TCGA-DD-AAW2-01	3c1b3db3-89b5-479d-8ddf-4765b46934f4		3c1b3db3-89b5-479d-8ddf-4765b46934f4	3c1b3db3-89b5-479d-8ddf-4765b46934f4		TCGA-DD-AAW2-01A-11D-A40X-05
TCGA-DD-AAW3-01	0	TCGA-DD-AAW3-01	1633	0	days	TCGA-DD-AAW3	1633	0	days	1633	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	69	3.3	4.1	5.2	TCGA-DD-AAW3-F67593	TCGA-DD-AAW3		0.2	0.6	1		0.0	1.4	1.0	-25254			0	1633			0	0	15	3	0 - No Fibrosis		2014-11-6	MALE	162	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES					NO	G2						NO			No	M0	N0	T1	Stage I		AAW3	TUMOR FREE	241	130	400	NO	NO		NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	DD	1.2	Liver	None			LIVING	64	2009	TCGA-DD-AAW3-01A-11D-A40O-01	TCGA-DD-AAW3-01A-11D-A40O-01	TCGA-DD-AAW3-01A-11D-A40P-10	TCGA-DD-AAW3-01	TCGA-DD-AAW3-01		e08177f4-46ff-4f46-94bc-e58870fdfc23		TCGA-DD-AAW3-01	TCGA-DD-AAW3-01	e08177f4-46ff-4f46-94bc-e58870fdfc23		e08177f4-46ff-4f46-94bc-e58870fdfc23	e08177f4-46ff-4f46-94bc-e58870fdfc23		TCGA-DD-AAW3-01A-11D-A40X-05
TCGA-ED-A459-01	0	TCGA-ED-A459-01	910	0	days	TCGA-ED-A459	910	0	days	910	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				47	3800	5200	5100	TCGA-ED-A459-F68559	TCGA-ED-A459	TCGA-ED-A459-01A	.3	1.4			.7	1.1	1.1	-17402	87		0	910				0	20	267			2014-11-26	MALE	167			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1800	.9	1.3	NO	NO	G2						NO		true	No	M0	N0	T2	Stage II	TCGA-ED-A459.289EC60C-0AAB-4E61-A8AB-A199D4663AE6.pdf	A459	TUMOR FREE	200	150	400	NO	YES	.9	YES	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED	1.2	Liver	Micro	A	Hepatitis B Surface Antigen	LIVING	51	2012	TCGA-ED-A459-01A-11D-A25U-01	TCGA-ED-A459-01A-11D-A25U-01	TCGA-ED-A459-01A-11D-A25V-10	TCGA-ED-A459-01	TCGA-ED-A459-01	1FC886B4-8512-4C36-A4AE-280B704566C4	31c9c8be-6cde-4db6-b9fd-6173b41bedc8	TCGA-ED-A459-01A-11D-A25V-10	TCGA-ED-A459-01	TCGA-ED-A459-01	31c9c8be-6cde-4db6-b9fd-6173b41bedc8	TCGA-ED-A459-01A-11D-A25V-10	31c9c8be-6cde-4db6-b9fd-6173b41bedc8	31c9c8be-6cde-4db6-b9fd-6173b41bedc8	TCGA-ED-A459-01A-11D-A25V-10	TCGA-ED-A459-01A-11D-A264-05
TCGA-ED-A4XI-01	0	TCGA-ED-A4XI-01	819	0	days	TCGA-ED-A4XI	819	0	days	819	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	58	3.8	2.9	5.1	TCGA-ED-A4XI-F68085	TCGA-ED-A4XI	TCGA-ED-A4XI-01A	0.1	1.3			4.1	5.9	54	-21497	70		0	819				0	20	573			2014-11-13	MALE	170	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	2000	0.3	1.3	NO	NO	G3						NO		true	No	M0	N0	T2	Stage II	TCGA-ED-A4XI.40130FAC-455F-49B7-A97E-CFFED2202925.pdf	A4XI	TUMOR FREE	276	150	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED	1.3	Liver	Micro	A	Hepatitis B Surface Antigen	LIVING	55	2012	TCGA-ED-A4XI-01A-11D-A25U-01	TCGA-ED-A4XI-01A-11D-A25U-01	TCGA-ED-A4XI-01A-11D-A25V-10	TCGA-ED-A4XI-01	TCGA-ED-A4XI-01	DEFFD9B3-D2EB-424A-A537-732A89EA4EC0	0baf2ded-0f46-4e37-83ae-9e0b99af41c9	TCGA-ED-A4XI-01A-11D-A25V-10	TCGA-ED-A4XI-01	TCGA-ED-A4XI-01	0baf2ded-0f46-4e37-83ae-9e0b99af41c9	TCGA-ED-A4XI-01A-11D-A25V-10	0baf2ded-0f46-4e37-83ae-9e0b99af41c9	0baf2ded-0f46-4e37-83ae-9e0b99af41c9	TCGA-ED-A4XI-01A-11D-A25V-10	TCGA-ED-A4XI-01A-11D-A264-05
TCGA-ED-A5KG-01	0	TCGA-ED-A5KG-01	854	0	days	TCGA-ED-A5KG	854	0	days	854	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Severe	60	3.8	6.0	5.1	TCGA-ED-A5KG-F56100	TCGA-ED-A5KG	TCGA-ED-A5KG-01A	0.1	0.4			4.1	5.8	3.9	-22258	112		0	854		110		0	20	3177			2015-3-30	FEMALE	160	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1810	0.3	1.3	NO	NO	G2	Other, specify	New Primary Tumor	Kidney	No	NO	NO	No	true	No	M0	N0	T2	Stage II	TCGA-ED-A5KG.87394A2B-7AF7-49E0-9ED0-6FFCC899EC38.pdf	A5KG	WITH TUMOR	147	150	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED	1.3	Liver	Micro	A	Hepatitis B Surface Antigen	LIVING	61	2012	TCGA-ED-A5KG-01A-11D-A27H-01	TCGA-ED-A5KG-01A-11D-A27H-01	TCGA-ED-A5KG-01A-11D-A27I-10	TCGA-ED-A5KG-01	TCGA-ED-A5KG-01	ED389F30-65B0-49AA-B262-4F4DA5FE2B78	658b2281-9818-48dc-846d-8cad2bae42f0	TCGA-ED-A5KG-01A-11D-A27I-10	TCGA-ED-A5KG-01	TCGA-ED-A5KG-01	658b2281-9818-48dc-846d-8cad2bae42f0	TCGA-ED-A5KG-01A-11D-A27I-10	658b2281-9818-48dc-846d-8cad2bae42f0	658b2281-9818-48dc-846d-8cad2bae42f0	TCGA-ED-A5KG-01A-11D-A27I-10	TCGA-ED-A5KG-01A-11D-A27W-05
TCGA-ED-A627-01	0	TCGA-ED-A627-01	423	0	days	TCGA-ED-A627	423	0	days	423	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				74				TCGA-ED-A627-F55716	TCGA-ED-A627	TCGA-ED-A627-01A								-27303	157		0	423			2						2014-1-14	MALE	176	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1140			NO	NO	G2						NO		true	No	M0	NX	T1	Stage I	TCGA-ED-A627.104D5D1C-E6E3-4806-9E6C-4C949865F713.pdf	A627	TUMOR FREE				NO	NO		NO			R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	74	2012	TCGA-ED-A627-01A-12D-A30U-01	TCGA-ED-A627-01A-12D-A30U-01	TCGA-ED-A627-01A-12D-A30V-10	TCGA-ED-A627-01	TCGA-ED-A627-01	6DC93090-A39B-4360-9B6D-46E0F2888801	bd4be8e6-c06f-493f-84f4-e434be3a24d4	TCGA-ED-A627-01A-12D-A30V-10	TCGA-ED-A627-01	TCGA-ED-A627-01	bd4be8e6-c06f-493f-84f4-e434be3a24d4	TCGA-ED-A627-01A-12D-A30V-10	bd4be8e6-c06f-493f-84f4-e434be3a24d4	bd4be8e6-c06f-493f-84f4-e434be3a24d4	TCGA-ED-A627-01A-12D-A30V-10	TCGA-ED-A627-01A-12D-A30Y-05
TCGA-ED-A66X-01	0	TCGA-ED-A66X-01	406	0	days	TCGA-ED-A66X	124	1	days	406	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO		Mild	35	3.8	4.7	5.1	TCGA-ED-A66X-F56838	TCGA-ED-A66X	TCGA-ED-A66X-01A	0.1	9			4.1	5.6	4.5	-12947	89		0	406	124	124		0	20	5840			2014-2-24	MALE	170	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	2190	0.3	1.3	NO	NO	G3	Liver	Intrahepatic Recurrence		No	YES	YES	No	true	No	M0	N0	T3a	Stage IIIA	TCGA-ED-A66X.F83A9A75-387A-4A66-9817-084A8E633E37.pdf	A66X	TUMOR FREE	268	150	400	NO	NO	1	NO	NO	R0	R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED	1.3	Liver	Micro	A	Hepatitis B Surface Antigen	LIVING	61	2013	TCGA-ED-A66X-01A-11D-A30U-01	TCGA-ED-A66X-01A-11D-A30U-01	TCGA-ED-A66X-01A-11D-A30V-10	TCGA-ED-A66X-01	TCGA-ED-A66X-01	3C51801A-12EB-499D-8D7B-05DDE844A1C5	9c49cf78-bf9b-4562-a8c1-9e8e4203b548	TCGA-ED-A66X-01A-11D-A30V-10	TCGA-ED-A66X-01	TCGA-ED-A66X-01	9c49cf78-bf9b-4562-a8c1-9e8e4203b548	TCGA-ED-A66X-01A-11D-A30V-10	9c49cf78-bf9b-4562-a8c1-9e8e4203b548	9c49cf78-bf9b-4562-a8c1-9e8e4203b548	TCGA-ED-A66X-01A-11D-A30V-10	TCGA-ED-A66X-01A-11D-A30Y-05
TCGA-ED-A66Y-01	1	TCGA-ED-A66Y-01	296	1	days	TCGA-ED-A66Y	296	0	days	296	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	51	3.8	6	5.1	TCGA-ED-A66Y-F56839	TCGA-ED-A66Y	TCGA-ED-A66Y-01A	0.1	1			4.1	5.9	4.4	-18797	75	296	0	7				0	20	12100			2014-2-24	FEMALE	160	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1670	0.3	1.3	NO	NO	G3						NO		true	No	M0	N0	T3a	Stage IIIA	TCGA-ED-A66Y.14F29317-F7B9-49D4-B215-EF489A4283CA.pdf	A66Y	TUMOR FREE	289	150	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED	1.3	Liver	Micro	A	Hepatitis B Surface Antigen	DECEASED	59	2013	TCGA-ED-A66Y-01A-11D-A30U-01	TCGA-ED-A66Y-01A-11D-A30U-01	TCGA-ED-A66Y-01A-11D-A30V-10	TCGA-ED-A66Y-01	TCGA-ED-A66Y-01	098B1DB6-9847-438F-9541-0FD535A43F1E	920735ec-0932-408d-8132-8a30ba8aa160	TCGA-ED-A66Y-01A-11D-A30V-10	TCGA-ED-A66Y-01	TCGA-ED-A66Y-01	920735ec-0932-408d-8132-8a30ba8aa160	TCGA-ED-A66Y-01A-11D-A30V-10	920735ec-0932-408d-8132-8a30ba8aa160	920735ec-0932-408d-8132-8a30ba8aa160	TCGA-ED-A66Y-01A-11D-A30V-10	TCGA-ED-A66Y-01A-11D-A30Y-05
TCGA-ED-A7PX-01	0	TCGA-ED-A7PX-01	6	0	days	TCGA-ED-A7PX	6	0	days	6	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	48				TCGA-ED-A7PX-F62650	TCGA-ED-A7PX	TCGA-ED-A7PX-01A	0.1	0.9			4.1	5.8	17.0	-17638	86		0	6				0	20	24			2014-9-30	FEMALE	161	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	830			NO	YES	G3						NO		true	No	M0	NX	T2	Stage II	TCGA-ED-A7PX.AF42396C-2DC9-4885-B7B1-D59BA1D2949A.pdf	A7PX	TUMOR FREE	239	150	400	NO			NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED	1.3	Liver	Micro	A	Hepatitis B Surface Antigen	LIVING	43	2013	TCGA-ED-A7PX-01A-51D-A34Y-01	TCGA-ED-A7PX-01A-51D-A34Y-01	TCGA-ED-A7PX-01A-51D-A34Z-10	TCGA-ED-A7PX-01	TCGA-ED-A7PX-01	DC921D8F-D56C-4CAB-B842-6FA7E8164347	cb358266-8d3e-4089-88f1-25e8eaaf6d7c	TCGA-ED-A7PX-01A-51D-A34Z-10	TCGA-ED-A7PX-01	TCGA-ED-A7PX-01	cb358266-8d3e-4089-88f1-25e8eaaf6d7c	TCGA-ED-A7PX-01A-51D-A34Z-10	cb358266-8d3e-4089-88f1-25e8eaaf6d7c	cb358266-8d3e-4089-88f1-25e8eaaf6d7c	TCGA-ED-A7PX-01A-51D-A34Z-10	TCGA-ED-A7PX-01A-51D-A356-05
TCGA-ED-A7PY-01	0	TCGA-ED-A7PY-01	390	0	days	TCGA-ED-A7PY	390	0	days	390	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	20				TCGA-ED-A7PY-F62651	TCGA-ED-A7PY	TCGA-ED-A7PY-01A	0.1	0.6			4.0	5.8	3.9	-7556	83		0	390				0	20	2			2014-7-23	FEMALE	156	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1380	0.3	1.3	NO	NO	G3						NO		true	No	M0	NX	T2	Stage II	TCGA-ED-A7PY.B6D3F89E-C1A5-445A-B9BD-047B2FB92E4C.pdf	A7PY	TUMOR FREE	282	150	400	YES	NO	0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED	1.3	Liver	Micro	A	Hepatitis B Surface Antigen	LIVING	40	2013	TCGA-ED-A7PY-01A-11D-A33P-01	TCGA-ED-A7PY-01A-11D-A33P-01	TCGA-ED-A7PY-01A-11D-A33Q-10	TCGA-ED-A7PY-01	TCGA-ED-A7PY-01	D734D536-23CF-4054-A46E-4B6E29E72204	9800881e-b8ee-4e3f-83fc-f5d7d6b31259	TCGA-ED-A7PY-01A-11D-A33Q-10	TCGA-ED-A7PY-01	TCGA-ED-A7PY-01	9800881e-b8ee-4e3f-83fc-f5d7d6b31259	TCGA-ED-A7PY-01A-11D-A33Q-10	9800881e-b8ee-4e3f-83fc-f5d7d6b31259	9800881e-b8ee-4e3f-83fc-f5d7d6b31259	TCGA-ED-A7PY-01A-11D-A33Q-10	TCGA-ED-A7PY-01A-11D-A341-05
TCGA-ED-A7PZ-01	0	TCGA-ED-A7PZ-01	6	0	days	TCGA-ED-A7PZ	6	0	days	6	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	61	3.8	4.2	5.1	TCGA-ED-A7PZ-F62652	TCGA-ED-A7PZ	TCGA-ED-A7PZ-01A	0.1	0.9			4.0	5.8	7.0	-22601	78		0	6				0	20	2			2014-9-30	MALE	159	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1350	0.3	1.3	NO	YES	G2						NO		true	No	M0	NX	T2	Stage II	TCGA-ED-A7PZ.85F0B753-BB67-4836-92DC-81F602C0CC8C.pdf	A7PZ	TUMOR FREE	289	150	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED	1.3	Liver	Micro	A	Hepatitis B Surface Antigen	LIVING	50	2013	TCGA-ED-A7PZ-01A-11D-A33P-01	TCGA-ED-A7PZ-01A-11D-A33P-01	TCGA-ED-A7PZ-01A-11D-A33Q-10	TCGA-ED-A7PZ-01	TCGA-ED-A7PZ-01	B3158C1C-6EBD-44FB-B18D-EC780AF191AE	847c0750-c025-4c3d-be34-3721eff0b1b7	TCGA-ED-A7PZ-01A-11D-A33Q-10	TCGA-ED-A7PZ-01	TCGA-ED-A7PZ-01	847c0750-c025-4c3d-be34-3721eff0b1b7	TCGA-ED-A7PZ-01A-11D-A33Q-10	847c0750-c025-4c3d-be34-3721eff0b1b7	847c0750-c025-4c3d-be34-3721eff0b1b7	TCGA-ED-A7PZ-01A-11D-A33Q-10	TCGA-ED-A7PZ-01A-11D-A341-05
TCGA-ED-A7XO-01	0	TCGA-ED-A7XO-01	427	0	days	TCGA-ED-A7XO	262	1	days	427	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver		NO	Mild	29	3.8	4.2	5.1	TCGA-ED-A7XO-F65727	TCGA-ED-A7XO	TCGA-ED-A7XO-01A	0.1	0.6			4.1	5.9	4.9	-10828	77		0	427		262		0		4			2014-10-8	MALE	175	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1430			NO	NO	G2	Liver	Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T3a	Stage IIIA	TCGA-ED-A7XO.3FC3BB34-8E4A-4422-BFEF-58B15947F032.pdf	A7XO	WITH TUMOR				NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED	1.3	Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	64	2013	TCGA-ED-A7XO-01A-11D-A34Y-01	TCGA-ED-A7XO-01A-11D-A34Y-01	TCGA-ED-A7XO-01A-11D-A34Z-10	TCGA-ED-A7XO-01	TCGA-ED-A7XO-01	8AB5B223-7E37-42E0-AFF5-5FAA283348E6	22e11be6-f4ce-47a6-8c50-5eb957834906	TCGA-ED-A7XO-01A-11D-A34Z-10	TCGA-ED-A7XO-01	TCGA-ED-A7XO-01	22e11be6-f4ce-47a6-8c50-5eb957834906	TCGA-ED-A7XO-01A-11D-A34Z-10	22e11be6-f4ce-47a6-8c50-5eb957834906	22e11be6-f4ce-47a6-8c50-5eb957834906	TCGA-ED-A7XO-01A-11D-A34Z-10	TCGA-ED-A7XO-01A-11D-A356-05
TCGA-ED-A7XP-01	0	TCGA-ED-A7XP-01	400	0	days	TCGA-ED-A7XP	187	1	days	400	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	53	3.8	6.9	5.1	TCGA-ED-A7XP-F65353	TCGA-ED-A7XP	TCGA-ED-A7XP-01A	0.1	0.1			4.1	5.9	4.8	-19504	62		0	400		187		0	20	18			2014-9-22	FEMALE	157	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	780	0.3	1.3	NO	NO	G3	Liver	Locoregional Recurrence		Yes	NO	YES	No	true	No	M0	N0	T2	Stage II	TCGA-ED-A7XP.70432A18-BDAF-465D-9311-66E37E3F941E.pdf	A7XP	WITH TUMOR	108	150	400	NO	NO	1	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED	1.3	Liver	Micro	A	Hepatitis B Surface Antigen	LIVING	54	2013	TCGA-ED-A7XP-01A-11D-A34Y-01	TCGA-ED-A7XP-01A-11D-A34Y-01	TCGA-ED-A7XP-01A-11D-A34Z-10	TCGA-ED-A7XP-01	TCGA-ED-A7XP-01	61951975-5873-4365-B1DB-F64554C07D3A	932e8866-4903-4541-a239-8318abbca064	TCGA-ED-A7XP-01A-11D-A34Z-10	TCGA-ED-A7XP-01	TCGA-ED-A7XP-01	932e8866-4903-4541-a239-8318abbca064	TCGA-ED-A7XP-01A-11D-A34Z-10	932e8866-4903-4541-a239-8318abbca064	932e8866-4903-4541-a239-8318abbca064	TCGA-ED-A7XP-01A-11D-A34Z-10	TCGA-ED-A7XP-01A-11D-A356-05
TCGA-ED-A82E-01	0	TCGA-ED-A82E-01	408	0	days	TCGA-ED-A82E	408	0	days	408	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	60	3.8	4.3	5.1	TCGA-ED-A82E-F65333	TCGA-ED-A82E	TCGA-ED-A82E-01A	0.1	0.4			4.1	5.8	2.8	-22234	78		0	408				0	20	4			2014-9-22	FEMALE	150	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1320	0.3	1.3	NO	NO	G2						NO		true	No	M0	N0	T3a	Stage IIIA	TCGA-ED-A82E.2FE90807-3C01-4956-B565-A5A18A08C93C.pdf	A82E	TUMOR FREE	261	150	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED	1.3	Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	44	2013	TCGA-ED-A82E-01A-11D-A34Y-01	TCGA-ED-A82E-01A-11D-A34Y-01	TCGA-ED-A82E-01A-11D-A34Z-10	TCGA-ED-A82E-01	TCGA-ED-A82E-01	9BE4B145-9FD9-4A59-A317-9A969CF1A280	443ec308-d974-4e36-96f4-b7c0101bf5d5	TCGA-ED-A82E-01A-11D-A34Z-10	TCGA-ED-A82E-01	TCGA-ED-A82E-01	443ec308-d974-4e36-96f4-b7c0101bf5d5	TCGA-ED-A82E-01A-11D-A34Z-10	443ec308-d974-4e36-96f4-b7c0101bf5d5	443ec308-d974-4e36-96f4-b7c0101bf5d5	TCGA-ED-A82E-01A-11D-A34Z-10	TCGA-ED-A82E-01A-11D-A356-05
TCGA-ED-A8O5-01	0	TCGA-ED-A8O5-01	406	0	days	TCGA-ED-A8O5	406	0	days	406	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	59	3.8	4.2	5.1	TCGA-ED-A8O5-F67146	TCGA-ED-A8O5	TCGA-ED-A8O5-01A	0.1	0.4			4.1	5.8	3.4	-21648	100		0	406				0	20	498			2014-10-31	FEMALE	165	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	950	0.3	1.3	NO	NO	G3						NO		true	No	M0	N0	T3a	Stage IIIA	TCGA-ED-A8O5.6C198F5C-9B63-45D9-A83D-4CFEC01DDC8C.pdf	A8O5	TUMOR FREE	171	150	400	NO	NO	1.3	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED	1.3	Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	63	2013	TCGA-ED-A8O5-01A-11D-A35Y-01	TCGA-ED-A8O5-01A-11D-A35Y-01	TCGA-ED-A8O5-01A-11D-A35Z-10	TCGA-ED-A8O5-01	TCGA-ED-A8O5-01	92E61221-9B0A-411F-BA5F-B923CA216B07	0636fc10-cfb4-427b-b3fc-cd9d7c0c7db6		TCGA-ED-A8O5-01	TCGA-ED-A8O5-01	0636fc10-cfb4-427b-b3fc-cd9d7c0c7db6		0636fc10-cfb4-427b-b3fc-cd9d7c0c7db6	0636fc10-cfb4-427b-b3fc-cd9d7c0c7db6		TCGA-ED-A8O5-01A-11D-A369-05
TCGA-ED-A8O6-01	1	TCGA-ED-A8O6-01	56	1	days	TCGA-ED-A8O6	56	0	days	56	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	50	3.8	2.8	5.1	TCGA-ED-A8O6-F68512	TCGA-ED-A8O6	TCGA-ED-A8O6-01A	0.1	2.3			4.1	5.8	2.8	-18572	97	56	0	6				0	20	3000			2014-11-21	FEMALE	165	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1030	0.3	1.3	NO	NO	G3						NO		true	No	M0	N0	T3a	Stage IIIA	TCGA-ED-A8O6.0ABB9050-0248-42F0-AFEB-98FA5CE2DD55.pdf	A8O6	TUMOR FREE		150	400	NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED	1.3	Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED	45	2013	TCGA-ED-A8O6-01A-11D-A35Y-01	TCGA-ED-A8O6-01A-11D-A35Y-01	TCGA-ED-A8O6-01A-11D-A35Z-10	TCGA-ED-A8O6-01	TCGA-ED-A8O6-01	C22BF46A-9552-41FD-A467-E6DB6A14831B	7de41172-ca92-4cb9-b7de-b92fbeb5b3ef		TCGA-ED-A8O6-01	TCGA-ED-A8O6-01	7de41172-ca92-4cb9-b7de-b92fbeb5b3ef		7de41172-ca92-4cb9-b7de-b92fbeb5b3ef	7de41172-ca92-4cb9-b7de-b92fbeb5b3ef		TCGA-ED-A8O6-01A-11D-A369-05
TCGA-ED-A97K-01	0	TCGA-ED-A97K-01	6	0	days	TCGA-ED-A97K	6	0	days	6	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	54	3.8	8	5.1	TCGA-ED-A97K-F68560	TCGA-ED-A97K	TCGA-ED-A97K-01A	0.1	1.0			4.0	5.8	4.6	-20073	92		0	6				0	20	3			2014-12-2	MALE	170	Alcohol consumption		Hepatocholangiocarcinoma (Mixed)	No	C22.0	8180/3	C22.0	YES	1650	0.3	1.3	NO	YES	G2						NO		true	No	M0	N0	T3a	Stage IIIA	TCGA-ED-A97K.518E0619-1C4F-475C-904E-009300CF1768.pdf	A97K	TUMOR FREE	264	150	400	NO		0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	ED	1.3	Liver	Micro	A	Hepatitis B Surface Antigen	LIVING	64	2013	TCGA-ED-A97K-01A-21D-A381-01	TCGA-ED-A97K-01A-21D-A381-01	TCGA-ED-A97K-01A-21D-A382-10	TCGA-ED-A97K-01	TCGA-ED-A97K-01		169bde29-467d-44b1-9260-6dc8cfb1e207		TCGA-ED-A97K-01	TCGA-ED-A97K-01	169bde29-467d-44b1-9260-6dc8cfb1e207		169bde29-467d-44b1-9260-6dc8cfb1e207	169bde29-467d-44b1-9260-6dc8cfb1e207		TCGA-ED-A97K-01A-21D-A383-05
TCGA-EP-A12J-01	0	TCGA-EP-A12J-01	570	0	days	TCGA-EP-A12J	570	0	days	570	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				62	3.8	4.2	5.1	TCGA-EP-A12J-F40456	TCGA-EP-A12J	TCGA-EP-A12J-01A	0.2	0.4	1	B	0.7	1.3	0.8	-22997	59		0	570									2013-2-20	MALE	173	Hepatitis C	Sarcoidosis	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	300			NO	NO	G1						NO		false	No	MX	NX	T1	Stage I	TCGA-EP-A12J.CC7D4052-0068-425B-A5C3-873059716D44.pdf	A12J	TUMOR FREE	187	150	400	NO	NO	1.1	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	EP	1.0	Liver	None	A		LIVING		2010	TCGA-EP-A12J-01A-11D-A12Y-01	TCGA-EP-A12J-01A-11D-A12Y-01	TCGA-EP-A12J-01A-11D-A12Z-10	TCGA-EP-A12J-01	TCGA-EP-A12J-01	DAC6BB4F-6DDB-4478-A92E-C46567F9B24F	5453b1a0-b5c0-4d85-95b4-4591fdf05874	TCGA-EP-A12J-01A-11D-A12Z-10	TCGA-EP-A12J-01	TCGA-EP-A12J-01	5453b1a0-b5c0-4d85-95b4-4591fdf05874	TCGA-EP-A12J-01A-11D-A12Z-10	5453b1a0-b5c0-4d85-95b4-4591fdf05874	5453b1a0-b5c0-4d85-95b4-4591fdf05874	TCGA-EP-A12J-01A-11D-A12Z-10	TCGA-EP-A12J-01A-11D-A132-05
TCGA-EP-A12J-11	0	TCGA-EP-A12J-11	570	0	days	TCGA-EP-A12J	570	0	days	570	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				62	3.8	4.2	5.1	TCGA-EP-A12J-F40456	TCGA-EP-A12J	TCGA-EP-A12J-11A	0.2	0.4	1	B	0.7	1.3	0.8	-22997	59		0	570									2013-2-20	MALE	173	Hepatitis C	Sarcoidosis	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	410			NO	NO	G1						NO		false	No	MX	NX	T1	Stage I		A12J	TUMOR FREE	187	150	400	NO	NO	1.1	NO	YES		R0	Solid Tissue Normal	11	Segmentectomy, Single	7th	YES	NO	EP	1.0	Liver	None	A		LIVING		2010				TCGA-EP-A12J-11			5a1a1f96-bf4f-415d-b2a2-4481a72914cf		TCGA-EP-A12J-11		5a1a1f96-bf4f-415d-b2a2-4481a72914cf		5a1a1f96-bf4f-415d-b2a2-4481a72914cf	5a1a1f96-bf4f-415d-b2a2-4481a72914cf		TCGA-EP-A12J-11A-11D-A132-05
TCGA-EP-A26S-01	0	TCGA-EP-A26S-01	608	0	days	TCGA-EP-A26S	608	0	days	608	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	70	3.8	3.5	5.1	TCGA-EP-A26S-F39041	TCGA-EP-A26S	TCGA-EP-A26S-01A	0.2	0.4						-25677	91		0	608			1	0			0 - No Fibrosis		2013-1-9	MALE	168	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	520	9.5	12.5	NO	NO	G2						NO		false	No	MX	N0	T1	Stage I	TCGA-EP-A26S.078A6815-B1E3-47F5-A49B-C06B7D47F5E8.pdf	A26S	TUMOR FREE	234	140	415	NO	NO	12.9	NO	NO			Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	EP	1.0	Liver	None	A		LIVING	41	2011	TCGA-EP-A26S-01A-11D-A16U-01	TCGA-EP-A26S-01A-11D-A16U-01	TCGA-EP-A26S-01A-11D-A16V-10	TCGA-EP-A26S-01	TCGA-EP-A26S-01	98FBF2C6-DB11-4522-BD97-FC1C9546023D	7e6e755a-5503-4729-a3f4-249183687647	TCGA-EP-A26S-01A-11D-A16V-10	TCGA-EP-A26S-01	TCGA-EP-A26S-01	7e6e755a-5503-4729-a3f4-249183687647	TCGA-EP-A26S-01A-11D-A16V-10	7e6e755a-5503-4729-a3f4-249183687647	7e6e755a-5503-4729-a3f4-249183687647	TCGA-EP-A26S-01A-11D-A16V-10	TCGA-EP-A26S-01A-11D-A16X-05
TCGA-EP-A26S-11	0	TCGA-EP-A26S-11	608	0	days	TCGA-EP-A26S	608	0	days	608	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	70	3.8	3.5	5.1	TCGA-EP-A26S-F39041	TCGA-EP-A26S	TCGA-EP-A26S-11A	0.2	0.4						-25677	91		0	608			1	0			0 - No Fibrosis		2013-1-9	MALE	168	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1140	9.5	12.5	NO	NO	G2						NO		false	No	MX	N0	T1	Stage I		A26S	TUMOR FREE	234	140	415	NO	NO	12.9	NO	NO			Solid Tissue Normal	11	Segmentectomy, Single	7th	YES	NO	EP	1.0	Liver	None	A		LIVING	41	2011				TCGA-EP-A26S-11			3e1411dc-8c6d-4a87-bb4f-44ef5ff8761b		TCGA-EP-A26S-11		3e1411dc-8c6d-4a87-bb4f-44ef5ff8761b		3e1411dc-8c6d-4a87-bb4f-44ef5ff8761b	3e1411dc-8c6d-4a87-bb4f-44ef5ff8761b		TCGA-EP-A26S-11A-12D-A16X-05
TCGA-EP-A2KA-01	1	TCGA-EP-A2KA-01	627	1	days	TCGA-EP-A2KA	433	1	days	627	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	YES		52				TCGA-EP-A2KA-F41362	TCGA-EP-A2KA	TCGA-EP-A2KA-01A			2			1.0	0.7	-19214	106	627	0	111	433	433	0	0		13	1,2 - Portal Fibrosis		2013-3-15	FEMALE	178	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	400			NO	NO	G3	Brain	Extrahepatic Recurrence		No	YES	YES	No	false	No	MX	NX	T3a	Stage IIIA	TCGA-EP-A2KA.CCEFF8C5-E949-4F3F-93DA-67ECF5503C1C.pdf	A2KA	WITH TUMOR	435	140	415	NO	NO		NO	YES		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	EP		Liver		A		DECEASED		2011	TCGA-EP-A2KA-01A-11D-A182-01	TCGA-EP-A2KA-01A-11D-A182-01	TCGA-EP-A2KA-01A-11D-A183-10	TCGA-EP-A2KA-01	TCGA-EP-A2KA-01	CF4018AA-83D5-4E96-B473-BAACD5D686FA	e41bb478-2e81-4ce3-a0c7-e5412ea80490	TCGA-EP-A2KA-01A-11D-A183-10	TCGA-EP-A2KA-01	TCGA-EP-A2KA-01	e41bb478-2e81-4ce3-a0c7-e5412ea80490	TCGA-EP-A2KA-01A-11D-A183-10	e41bb478-2e81-4ce3-a0c7-e5412ea80490	e41bb478-2e81-4ce3-a0c7-e5412ea80490	TCGA-EP-A2KA-01A-11D-A183-10	TCGA-EP-A2KA-01A-11D-A17Z-05
TCGA-EP-A2KB-01	1	TCGA-EP-A2KB-01	596	1	days	TCGA-EP-A2KB	161	1	days	596	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		46	3.8	3.8	5.1	TCGA-EP-A2KB-F41390	TCGA-EP-A2KB	TCGA-EP-A2KB-01A	0.2	1.4		A		1.0		-16835	50	596	0	60		161	1	0	9	2128			2013-3-18	FEMALE	165	Hepatitis C	Cirrhosis, Alcohol abuse	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1210			NO	NO	G2	Liver	Locoregional Recurrence		Yes	NO	YES	No	false	No	MX	NX	T1	Stage I	TCGA-EP-A2KB.DF650AE0-E9E8-48A7-8D39-88A3F7EC2AC7.pdf	A2KB	WITH TUMOR	133	140	415	NO	NO	1.4	NO	NO		R0	Primary Tumor	01	Other (specify)	7th	YES	NO	EP	1.0	Liver	None	A		DECEASED	81	2011	TCGA-EP-A2KB-01A-11D-A182-01	TCGA-EP-A2KB-01A-11D-A182-01	TCGA-EP-A2KB-01A-11D-A183-10	TCGA-EP-A2KB-01	TCGA-EP-A2KB-01	0C00E15C-9E8B-4BAA-9A46-4BA04403456A	0b233eab-4541-4b62-b9ae-baebf672403e	TCGA-EP-A2KB-01A-11D-A183-10	TCGA-EP-A2KB-01	TCGA-EP-A2KB-01	0b233eab-4541-4b62-b9ae-baebf672403e	TCGA-EP-A2KB-01A-11D-A183-10	0b233eab-4541-4b62-b9ae-baebf672403e	0b233eab-4541-4b62-b9ae-baebf672403e	TCGA-EP-A2KB-01A-11D-A183-10	TCGA-EP-A2KB-01A-11D-A17Z-05
TCGA-EP-A2KC-01	1	TCGA-EP-A2KC-01	19	1	days	TCGA-EP-A2KC	19	0	days	19	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				62	3.6	3.1	4.8	TCGA-EP-A2KC-F17206	TCGA-EP-A2KC	TCGA-EP-A2KC-01A				A				-22677	30	19	0				0	0		43			2011-10-5	MALE	171	Hepatitis C	Liver Cirrhosis, Moderate alcohol use on weekends	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	260	0.8	1.2	NO		G3						NO		false	No	MX	NX	T1	Stage I	TCGA-EP-A2KC.F45A4E99-3856-4455-BF21-B767A0A4FA82.pdf	A2KC	TUMOR FREE	193	140	415	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	EP		Liver	None	A		DECEASED		2011	TCGA-EP-A2KC-01A-11D-A20V-01	TCGA-EP-A2KC-01A-11D-A20V-01	TCGA-EP-A2KC-01A-11D-A20W-10	TCGA-EP-A2KC-01	TCGA-EP-A2KC-01	5D6AB371-9255-4290-A182-CF58291CB2F7	43426760-46b7-422e-ab1b-d29d6c2ee21e	TCGA-EP-A2KC-01A-11D-A20W-10	TCGA-EP-A2KC-01	TCGA-EP-A2KC-01	43426760-46b7-422e-ab1b-d29d6c2ee21e	TCGA-EP-A2KC-01A-11D-A20W-10	43426760-46b7-422e-ab1b-d29d6c2ee21e	43426760-46b7-422e-ab1b-d29d6c2ee21e	TCGA-EP-A2KC-01A-11D-A20W-10	TCGA-EP-A2KC-01A-11D-A20Z-05
TCGA-EP-A3JL-01	0	TCGA-EP-A3JL-01	303	0	days	TCGA-EP-A3JL	303	0	days	303	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				76	3.2	4.1	4.8	TCGA-EP-A3JL-F37140	TCGA-EP-A3JL	TCGA-EP-A3JL-01A	0	0.6		A	0.60	1.10		-27886	22		0	303			0	0	9	13			2012-11-27	MALE	168	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	570	0.9	1.10	NO	NO	G2						NO		false	Yes	MX	NX	T1	Stage I	TCGA-EP-A3JL.B277ACF9-B233-474B-975A-52FDE44F27E3.pdf	A3JL	TUMOR FREE	149	130	386	NO	NO		NO	NO			Primary Tumor	01	Other (specify)	7th	YES	NO	EP	1.2	Liver	None	A		LIVING	73	2011	TCGA-EP-A3JL-01A-11D-A20V-01	TCGA-EP-A3JL-01A-11D-A20V-01	TCGA-EP-A3JL-01A-11D-A20W-10	TCGA-EP-A3JL-01	TCGA-EP-A3JL-01	7032F53E-C4EE-4462-819B-D9AE04F88821	0b20024b-a8dd-4683-9a3b-00fe4cb14f71	TCGA-EP-A3JL-01A-11D-A20W-10	TCGA-EP-A3JL-01	TCGA-EP-A3JL-01	0b20024b-a8dd-4683-9a3b-00fe4cb14f71	TCGA-EP-A3JL-01A-11D-A20W-10	0b20024b-a8dd-4683-9a3b-00fe4cb14f71	0b20024b-a8dd-4683-9a3b-00fe4cb14f71	TCGA-EP-A3JL-01A-11D-A20W-10	TCGA-EP-A3JL-01A-11D-A20Z-05
TCGA-EP-A3RK-01	0	TCGA-EP-A3RK-01	363	0	days	TCGA-EP-A3RK	320	1	days	363	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES			73	3.5	4.3	4.8	TCGA-EP-A3RK-F40454	TCGA-EP-A3RK	TCGA-EP-A3RK-01A	0.0	0.6		A				-26985	14		0	363		320	0	0		7	1,2 - Portal Fibrosis		2013-2-20	MALE	178	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1040	0.9	1.2	NO	NO	G2	Liver	Locoregional Recurrence			NO	YES	No	false	No	MX	NX	T3a	Stage IIIA	TCGA-EP-A3RK.49F4E752-EFBE-458F-85C0-1B81B9506D91.pdf	A3RK	WITH TUMOR	234	140	415	NO	NO	1.1	NO	NO			Primary Tumor	01	Other (specify)	7th	YES	NO	EP	1.2	Liver		A		LIVING	101	2012	TCGA-EP-A3RK-01A-11D-A22E-01	TCGA-EP-A3RK-01A-11D-A22E-01	TCGA-EP-A3RK-01A-11D-A22F-10	TCGA-EP-A3RK-01	TCGA-EP-A3RK-01	EC810F3B-2F51-41DC-9A52-4605BE1BA1B4	2412baac-c345-465e-9c6e-bd17d3797129	TCGA-EP-A3RK-01A-11D-A22F-10	TCGA-EP-A3RK-01	TCGA-EP-A3RK-01	2412baac-c345-465e-9c6e-bd17d3797129	TCGA-EP-A3RK-01A-11D-A22F-10	2412baac-c345-465e-9c6e-bd17d3797129	2412baac-c345-465e-9c6e-bd17d3797129	TCGA-EP-A3RK-01A-11D-A22F-10	TCGA-EP-A3RK-01A-11D-A22H-05
TCGA-EP-A3RK-11	0	TCGA-EP-A3RK-11	363	0	days	TCGA-EP-A3RK	320	1	days	363	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES			73	3.5	4.3	4.8	TCGA-EP-A3RK-F40454	TCGA-EP-A3RK		0.0	0.6		A				-26985			0	363		320	0	0		7	1,2 - Portal Fibrosis		2013-2-20	MALE	178	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.9	1.2		NO	G2	Liver	Locoregional Recurrence			NO	YES	No		No	MX	NX	T3a	Stage IIIA		A3RK	WITH TUMOR	234	140	415	NO	NO	1.1	NO	NO			Solid Tissue Normal	11	Other (specify)	7th	YES	NO	EP	1.2	Liver				LIVING	101	2012				TCGA-EP-A3RK-11			ce3a2fa7-905e-491d-ade0-c8d5712c4afa		TCGA-EP-A3RK-11		ce3a2fa7-905e-491d-ade0-c8d5712c4afa		ce3a2fa7-905e-491d-ade0-c8d5712c4afa	ce3a2fa7-905e-491d-ade0-c8d5712c4afa		
TCGA-ES-A2HS-01	1	TCGA-ES-A2HS-01	688	1	days	TCGA-ES-A2HS			days	688	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	80	3.5	3.8	5.0		TCGA-ES-A2HS	TCGA-ES-A2HS-01A	0	1.9	0	A	0.8	1.2	0.6	-29268	1113	688	0				1	0	8	1	0 - No Fibrosis		2011-9-28	MALE	180	No History of Primary Risk Factors	No	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	320	0.8	1.2	NO		G2								true	Yes	MX	NX	T1	Stage I	TCGA-ES-A2HS.53AB28EC-71C0-4AF0-93DA-FE72CD7FE19B.pdf	A2HS	TUMOR FREE	119	150	450			1.3		NO		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	ES	1.0	Liver	None	A		DECEASED	97	2008	TCGA-ES-A2HS-01A-11D-A182-01	TCGA-ES-A2HS-01A-11D-A182-01	TCGA-ES-A2HS-01A-11D-A183-10	TCGA-ES-A2HS-01	TCGA-ES-A2HS-01	4ADDC326-6E3D-420E-86B8-22FCD02FF7C7	e642839c-9891-4ff0-93c4-556d81572af9	TCGA-ES-A2HS-01A-11D-A183-10	TCGA-ES-A2HS-01	TCGA-ES-A2HS-01	e642839c-9891-4ff0-93c4-556d81572af9	TCGA-ES-A2HS-01A-11D-A183-10	e642839c-9891-4ff0-93c4-556d81572af9	e642839c-9891-4ff0-93c4-556d81572af9	TCGA-ES-A2HS-01A-11D-A183-10	TCGA-ES-A2HS-01A-11D-A17Z-05
TCGA-ES-A2HS-11	1	TCGA-ES-A2HS-11	688	1	days	TCGA-ES-A2HS			days	688	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	80	3.5	3.8	5.0		TCGA-ES-A2HS	TCGA-ES-A2HS-11A	0	1.9	0	A	0.8	1.2	0.6	-29268	1113	688	0				1	0	8	1	0 - No Fibrosis		2011-9-28	MALE	180	No History of Primary Risk Factors	No	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	230	0.8	1.2	NO		G2								true	Yes	MX	NX	T1	Stage I		A2HS	TUMOR FREE	119	150	450			1.3		NO		R0	Solid Tissue Normal	11	Segmentectomy, Single	6th	NO	YES	ES	1.0	Liver	None	A		DECEASED	97	2008																TCGA-ES-A2HS-11A-11D-A17Z-05
TCGA-ES-A2HT-01	1	TCGA-ES-A2HT-01	438	1	days	TCGA-ES-A2HT			days	438	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	54	3.5	4.1	5.0		TCGA-ES-A2HT	TCGA-ES-A2HT-01A	0	0.6	0	A	0.8	1.2	0.7	-20023	1392	438	0				1	0	10	4	0 - No Fibrosis		2011-9-30	MALE	174	Hepatitis C	no	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	340	0.3	1.1	NO		G2								true	No	MX	NX	T1	Stage I	TCGA-ES-A2HT.FF97C711-0686-480B-BC53-3CADCAA4C4C1.pdf	A2HT	TUMOR FREE	135	150	450			1.1		NO		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	ES	1.0	Liver	None	A		DECEASED	80	2007	TCGA-ES-A2HT-01A-12D-A182-01	TCGA-ES-A2HT-01A-12D-A182-01	TCGA-ES-A2HT-01A-12D-A183-10	TCGA-ES-A2HT-01	TCGA-ES-A2HT-01	2BB535EF-7136-49C8-AFF4-3045F4E37B8C	e5e12896-2cf3-4d5d-8f79-00cd964fc132	TCGA-ES-A2HT-01A-12D-A183-10	TCGA-ES-A2HT-01	TCGA-ES-A2HT-01	e5e12896-2cf3-4d5d-8f79-00cd964fc132	TCGA-ES-A2HT-01A-12D-A183-10	e5e12896-2cf3-4d5d-8f79-00cd964fc132	e5e12896-2cf3-4d5d-8f79-00cd964fc132	TCGA-ES-A2HT-01A-12D-A183-10	TCGA-ES-A2HT-01A-12D-A17Z-05
TCGA-ES-A2HT-11	1	TCGA-ES-A2HT-11	438	1	days	TCGA-ES-A2HT			days	438	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	54	3.5	4.1	5.0		TCGA-ES-A2HT		0	0.6	0	A	0.8	1.2	0.7	-20023		438	0				1	0	10	4	0 - No Fibrosis		2011-9-30	MALE	174	Hepatitis C	no	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.3	1.1			G2									No	MX	NX	T1	Stage I		A2HT	TUMOR FREE	135	150	450			1.1		NO		R0	Solid Tissue Normal	11	Segmentectomy, Multiple	6th	NO	YES	ES	1.0	Liver	None			DECEASED	80	2007				TCGA-ES-A2HT-11			d5e3a3be-c4d9-41de-a39c-ae7aad3f3826		TCGA-ES-A2HT-11		d5e3a3be-c4d9-41de-a39c-ae7aad3f3826		d5e3a3be-c4d9-41de-a39c-ae7aad3f3826	d5e3a3be-c4d9-41de-a39c-ae7aad3f3826		TCGA-ES-A2HT-11A-11D-A17Z-05
TCGA-FV-A23B-01	1	TCGA-FV-A23B-01	1852	1	days	TCGA-FV-A23B	1453	1	days	1852	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		70				TCGA-FV-A23B-F45565	TCGA-FV-A23B	TCGA-FV-A23B-01A								-25788	2030	1852	0	987		1453							2013-7-17	FEMALE		Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	110			NO	NO		Liver	Locoregional Recurrence		Yes	NO	YES	No	false	No	M0	N0	T2	Stage II	TCGA-FV-A23B.82010944-23DA-4FC5-934B-05AB3C238467.pdf	A23B	WITH TUMOR				NO	NO		NO			R0	Primary Tumor	01	Other (specify)	6th	NO	YES	FV		Liver		A		DECEASED		2005	TCGA-FV-A23B-01A-11D-A16U-01	TCGA-FV-A23B-01A-11D-A16U-01	TCGA-FV-A23B-01A-11D-A16V-10	TCGA-FV-A23B-01	TCGA-FV-A23B-01	C7818FEE-D630-4B0A-824A-6423A2251C05	5343646d-bb46-4acc-9361-7432813a886f	TCGA-FV-A23B-01A-11D-A16V-10	TCGA-FV-A23B-01	TCGA-FV-A23B-01	5343646d-bb46-4acc-9361-7432813a886f	TCGA-FV-A23B-01A-11D-A16V-10	5343646d-bb46-4acc-9361-7432813a886f	5343646d-bb46-4acc-9361-7432813a886f	TCGA-FV-A23B-01A-11D-A16V-10	TCGA-FV-A23B-01A-11D-A16X-05
TCGA-FV-A23B-11	1	TCGA-FV-A23B-11	1852	1	days	TCGA-FV-A23B	1453	1	days	1852	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		70				TCGA-FV-A23B-F45565	TCGA-FV-A23B									-25788		1852	0	987		1453							2013-7-17	FEMALE		Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES					NO		Liver	Locoregional Recurrence		Yes	NO	YES	No		No	M0	N0	T2	Stage II		A23B	WITH TUMOR				NO	NO		NO			R0	Solid Tissue Normal	11	Other (specify)	6th	NO	YES	FV		Liver				DECEASED		2005				TCGA-FV-A23B-11			a3eef529-ed7d-438c-b0be-ce569a846a8f		TCGA-FV-A23B-11		a3eef529-ed7d-438c-b0be-ce569a846a8f		a3eef529-ed7d-438c-b0be-ce569a846a8f	a3eef529-ed7d-438c-b0be-ce569a846a8f		TCGA-FV-A23B-11A-11D-A16X-05
TCGA-FV-A2QQ-01	0	TCGA-FV-A2QQ-01	729	0	days	TCGA-FV-A2QQ	729	0	days	729	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				80				TCGA-FV-A2QQ-F57856	TCGA-FV-A2QQ	TCGA-FV-A2QQ-01A								-29354	71		0	729									2014-3-27	MALE		Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	150			NO	NO	G2						NO		false	No	MX	N0	T1	Stage I	TCGA-FV-A2QQ.350B10AF-C17B-41DA-BB21-A672DBB683B2.pdf	A2QQ	TUMOR FREE				NO	NO		NO			R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	FV		Liver	None	A		LIVING		2011	TCGA-FV-A2QQ-01A-11D-A22E-01	TCGA-FV-A2QQ-01A-11D-A22E-01	TCGA-FV-A2QQ-01A-11D-A22F-10	TCGA-FV-A2QQ-01	TCGA-FV-A2QQ-01	2B60F8A5-1528-4569-9B3E-40B28A275302	9ac9a050-720a-45bc-94d4-87802c8f0aba	TCGA-FV-A2QQ-01A-11D-A22F-10	TCGA-FV-A2QQ-01	TCGA-FV-A2QQ-01	9ac9a050-720a-45bc-94d4-87802c8f0aba	TCGA-FV-A2QQ-01A-11D-A22F-10	9ac9a050-720a-45bc-94d4-87802c8f0aba	9ac9a050-720a-45bc-94d4-87802c8f0aba	TCGA-FV-A2QQ-01A-11D-A22F-10	TCGA-FV-A2QQ-01A-11D-A22H-05
TCGA-FV-A2QR-01	1	TCGA-FV-A2QR-01	581	1	days	TCGA-FV-A2QR	561	1	days	581	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		75				TCGA-FV-A2QR-F42770	TCGA-FV-A2QR	TCGA-FV-A2QR-01A			1						1764	581	0			561							2013-4-30	MALE		Other	Male, IDDM for 30+years	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	100			NO	NO	G1		Extrahepatic Recurrence		No	NO	YES	No	false	No	M0	N0	T1	Stage I	TCGA-FV-A2QR.DE38B13D-FD4D-4077-ADBE-D034C2F5F003.pdf	A2QR	WITH TUMOR				NO	NO		NO	YES		RX	Primary Tumor	01	Lobectomy	6th	NO	YES	FV		Liver		A		DECEASED		2006	TCGA-FV-A2QR-01A-11D-A20V-01	TCGA-FV-A2QR-01A-11D-A20V-01	TCGA-FV-A2QR-01A-11D-A20W-10	TCGA-FV-A2QR-01	TCGA-FV-A2QR-01	3F858642-BFA2-4D05-B9CB-2233AFE9C0A3	4850e928-80c5-4ad3-9291-2e9d80fde8c6	TCGA-FV-A2QR-01A-11D-A20W-10	TCGA-FV-A2QR-01	TCGA-FV-A2QR-01	4850e928-80c5-4ad3-9291-2e9d80fde8c6	TCGA-FV-A2QR-01A-11D-A20W-10	4850e928-80c5-4ad3-9291-2e9d80fde8c6	4850e928-80c5-4ad3-9291-2e9d80fde8c6	TCGA-FV-A2QR-01A-11D-A20W-10	TCGA-FV-A2QR-01A-11D-A20Z-05
TCGA-FV-A2QR-11	1	TCGA-FV-A2QR-11	581	1	days	TCGA-FV-A2QR	561	1	days	581	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		75				TCGA-FV-A2QR-F42770	TCGA-FV-A2QR	TCGA-FV-A2QR-11A			1						1764	581	0			561							2013-4-30	MALE		Other	Male, IDDM for 30+years	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	30			NO	NO	G1		Extrahepatic Recurrence		No	NO	YES	No	false	No	M0	N0	T1	Stage I		A2QR	WITH TUMOR				NO	NO		NO	YES		RX	Solid Tissue Normal	11	Lobectomy	6th	NO	YES	FV		Liver		A		DECEASED		2006				TCGA-FV-A2QR-11			6fca2b4e-2aa2-42bb-9991-b0a69e6155cd		TCGA-FV-A2QR-11		6fca2b4e-2aa2-42bb-9991-b0a69e6155cd		6fca2b4e-2aa2-42bb-9991-b0a69e6155cd	6fca2b4e-2aa2-42bb-9991-b0a69e6155cd		TCGA-FV-A2QR-11A-11D-A20Z-05
TCGA-FV-A3I0-01	0	TCGA-FV-A3I0-01	848	0	days	TCGA-FV-A3I0	159	1	days	848	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO		76		4.40		TCGA-FV-A3I0-F57854	TCGA-FV-A3I0	TCGA-FV-A3I0-01A		0.4						-28101	70		0	848		159							2014-3-27	FEMALE		No History of Primary Risk Factors		Hepatocholangiocarcinoma (Mixed)	No	C22.0	8171/3	C22.0	YES	190			NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	false	No	M0	NX	T2	Stage II	TCGA-FV-A3I0.B4DB59E9-FFBB-4716-9235-90A1DF17455B.pdf	A3I0	WITH TUMOR				NO	NO		NO			R0	Primary Tumor	01	Lobectomy	7th	YES	NO	FV		Liver	Micro	A		LIVING		2011	TCGA-FV-A3I0-01A-11D-A22E-01	TCGA-FV-A3I0-01A-11D-A22E-01	TCGA-FV-A3I0-01A-11D-A22F-10	TCGA-FV-A3I0-01	TCGA-FV-A3I0-01		51d59e9b-2f54-4a54-b5f5-81376be2eb82	TCGA-FV-A3I0-01A-11D-A22F-10	TCGA-FV-A3I0-01	TCGA-FV-A3I0-01	51d59e9b-2f54-4a54-b5f5-81376be2eb82	TCGA-FV-A3I0-01A-11D-A22F-10	51d59e9b-2f54-4a54-b5f5-81376be2eb82	51d59e9b-2f54-4a54-b5f5-81376be2eb82	TCGA-FV-A3I0-01A-11D-A22F-10	TCGA-FV-A3I0-01A-11D-A22H-05
TCGA-FV-A3I0-11	0	TCGA-FV-A3I0-11	848	0	days	TCGA-FV-A3I0	159	1	days	848	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO		76		4.40		TCGA-FV-A3I0-F57854	TCGA-FV-A3I0	TCGA-FV-A3I0-11A		0.4						-28101	70		0	848		159							2014-3-27	FEMALE		No History of Primary Risk Factors		Hepatocholangiocarcinoma (Mixed)	No	C22.0	8171/3	C22.0	YES	40			NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	false	No	M0	NX	T2	Stage II		A3I0	WITH TUMOR				NO	NO		NO			R0	Solid Tissue Normal	11	Lobectomy	7th	YES	NO	FV		Liver	Micro	A		LIVING		2011				TCGA-FV-A3I0-11			07401514-29ef-43a8-8a7f-a4e147852470		TCGA-FV-A3I0-11		07401514-29ef-43a8-8a7f-a4e147852470		07401514-29ef-43a8-8a7f-a4e147852470	07401514-29ef-43a8-8a7f-a4e147852470		
TCGA-FV-A3I1-01	1	TCGA-FV-A3I1-01	247	1	days	TCGA-FV-A3I1	247	0	days	247	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				81				TCGA-FV-A3I1-F42771	TCGA-FV-A3I1	TCGA-FV-A3I1-01A									76	247	0	0							0 - No Fibrosis		2013-4-30	FEMALE		Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	70			NO	NO	G2						NO		false	Yes	MX	N0	T2	Stage II	TCGA-FV-A3I1.B40A8E73-2904-4C68-B2AD-6FC27211654B.pdf	A3I1	TUMOR FREE				NO	NO		NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	FV		Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody	DECEASED		2011	TCGA-FV-A3I1-01A-11D-A22E-01	TCGA-FV-A3I1-01A-11D-A22E-01	TCGA-FV-A3I1-01A-11D-A22F-10	TCGA-FV-A3I1-01	TCGA-FV-A3I1-01		1cc4f319-fc1d-46bb-9fbb-469d66bd23f2	TCGA-FV-A3I1-01A-11D-A22F-10	TCGA-FV-A3I1-01	TCGA-FV-A3I1-01	1cc4f319-fc1d-46bb-9fbb-469d66bd23f2	TCGA-FV-A3I1-01A-11D-A22F-10	1cc4f319-fc1d-46bb-9fbb-469d66bd23f2	1cc4f319-fc1d-46bb-9fbb-469d66bd23f2	TCGA-FV-A3I1-01A-11D-A22F-10	TCGA-FV-A3I1-01A-11D-A22H-05
TCGA-FV-A3I1-11	1	TCGA-FV-A3I1-11	247	1	days	TCGA-FV-A3I1	247	0	days	247	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				81				TCGA-FV-A3I1-F42771	TCGA-FV-A3I1	TCGA-FV-A3I1-11A									76	247	0	0							0 - No Fibrosis		2013-4-30	FEMALE		Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	70			NO	NO	G2						NO		false	Yes	MX	N0	T2	Stage II		A3I1	TUMOR FREE				NO	NO		NO	NO		R0	Solid Tissue Normal	11	Segmentectomy, Multiple	7th	YES	NO	FV		Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody	DECEASED		2011				TCGA-FV-A3I1-11			61fcdecf-52ca-465a-b8f1-262b6540117f		TCGA-FV-A3I1-11		61fcdecf-52ca-465a-b8f1-262b6540117f		61fcdecf-52ca-465a-b8f1-262b6540117f	61fcdecf-52ca-465a-b8f1-262b6540117f		
TCGA-FV-A3R2-01	1	TCGA-FV-A3R2-01	194	1	days	TCGA-FV-A3R2	194	0	days	194	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				75				TCGA-FV-A3R2-F47054	TCGA-FV-A3R2	TCGA-FV-A3R2-01A			4					-27530	2555	194	0										2013-8-21	MALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	120			NO	NO							NO		true	Yes	MX	NX	T1	Stage I	TCGA-FV-A3R2.6F330991-CD7E-4387-AFE8-B9C6C8D98396.pdf	A3R2	TUMOR FREE				NO	YES		NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	FV		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody	DECEASED	75	2005	TCGA-FV-A3R2-01A-11D-A22E-01	TCGA-FV-A3R2-01A-11D-A22E-01	TCGA-FV-A3R2-01A-11D-A22F-10		TCGA-FV-A3R2-01	92F08485-2808-4F9B-8F1F-A893D3CF6FD3	4cda696b-42da-43fd-9f6f-95dfc748a0ca	TCGA-FV-A3R2-01A-11D-A22F-10		TCGA-FV-A3R2-01	4cda696b-42da-43fd-9f6f-95dfc748a0ca	TCGA-FV-A3R2-01A-11D-A22F-10	4cda696b-42da-43fd-9f6f-95dfc748a0ca	4cda696b-42da-43fd-9f6f-95dfc748a0ca	TCGA-FV-A3R2-01A-11D-A22F-10	TCGA-FV-A3R2-01A-11D-A22H-05
TCGA-FV-A3R2-11	1	TCGA-FV-A3R2-11	194	1	days	TCGA-FV-A3R2	194	0	days	194	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				75				TCGA-FV-A3R2-F47054	TCGA-FV-A3R2	TCGA-FV-A3R2-11A			4					-27530	2555	194	0										2013-8-21	MALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	80			NO	NO							NO		true	Yes	MX	NX	T1	Stage I		A3R2	TUMOR FREE				NO	YES		NO	YES		R0	Solid Tissue Normal	11	Segmentectomy, Multiple	6th	NO	YES	FV		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody	DECEASED	75	2005				TCGA-FV-A3R2-11			92462e76-eed1-4eab-8c38-4cf9897be417		TCGA-FV-A3R2-11		92462e76-eed1-4eab-8c38-4cf9897be417		92462e76-eed1-4eab-8c38-4cf9897be417	92462e76-eed1-4eab-8c38-4cf9897be417		
TCGA-FV-A3R3-01	1	TCGA-FV-A3R3-01	366	1	days	TCGA-FV-A3R3	366	0	days	366	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				38	3.4	2.0	5.0	TCGA-FV-A3R3-F64062	TCGA-FV-A3R3	TCGA-FV-A3R3-01A	0.0	0.4			0.6	1.3	1.3	-14231	28	366	0	4			1						2014-8-25	FEMALE	161	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	90	9.5	11.9	NO	NO	G2						NO		true	No	MX	NX	T1	Stage I	TCGA-FV-A3R3.FF0E1601-BC87-4E61-95BE-1776C9F85002.pdf	A3R3	TUMOR FREE	323	150	450	NO	NO	10.7	NO	NO		R0	Primary Tumor	01	Other (specify)	7th	YES	NO	FV	1.0	Liver	None	A		DECEASED	97	2012	TCGA-FV-A3R3-01A-11D-A22E-01	TCGA-FV-A3R3-01A-11D-A22E-01	TCGA-FV-A3R3-01A-11D-A22F-10		TCGA-FV-A3R3-01	91FC95B8-388B-4B2F-B3BC-0F1B5783E815	db848332-4ee8-4f22-b6c9-b2634bd35918	TCGA-FV-A3R3-01A-11D-A22F-10		TCGA-FV-A3R3-01	db848332-4ee8-4f22-b6c9-b2634bd35918	TCGA-FV-A3R3-01A-11D-A22F-10	db848332-4ee8-4f22-b6c9-b2634bd35918	db848332-4ee8-4f22-b6c9-b2634bd35918	TCGA-FV-A3R3-01A-11D-A22F-10	TCGA-FV-A3R3-01A-11D-A22H-05
TCGA-FV-A495-01	0	TCGA-FV-A495-01	1	0	days	TCGA-FV-A495	1	0	days	1	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	51	3.8	4.0	5.0		TCGA-FV-A495	TCGA-FV-A495-01A	0.3	1.0	1		0.6	1.1	1.0	-18740	56		0	1				0	8	39	3,4 - Fibrous Speta		2013-2-21	FEMALE	172	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	70			NO		G2						NO		false	No	M0	NX	T2	Stage II	TCGA-FV-A495.99D80D8A-88F7-445D-9B87-9B4B96C3C010.pdf	A495	TUMOR FREE	258	140	440					YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	FV	1.9	Liver	None	A		LIVING	70	2012	TCGA-FV-A495-01A-11D-A25U-01	TCGA-FV-A495-01A-11D-A25U-01	TCGA-FV-A495-01A-11D-A25V-10	TCGA-FV-A495-01	TCGA-FV-A495-01		6a2cafbb-2824-4727-b950-0c2bdcf26358	TCGA-FV-A495-01A-11D-A25V-10	TCGA-FV-A495-01	TCGA-FV-A495-01	6a2cafbb-2824-4727-b950-0c2bdcf26358	TCGA-FV-A495-01A-11D-A25V-10	6a2cafbb-2824-4727-b950-0c2bdcf26358	6a2cafbb-2824-4727-b950-0c2bdcf26358	TCGA-FV-A495-01A-11D-A25V-10	TCGA-FV-A495-01A-11D-A264-05
TCGA-FV-A496-01	0	TCGA-FV-A496-01	10	0	days	TCGA-FV-A496	10	0	days	10	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	84	3.8	2.8	5.0		TCGA-FV-A496	TCGA-FV-A496-01A	0.3	0.9	3		0.9	1.1	1.0	-30950	51		0	10				0	8	67	0 - No Fibrosis		2013-2-21	FEMALE	162	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	70	0.9	1.1	NO		G2						NO		false	No	M0	NX	T1	Stage I	TCGA-FV-A496.358A0018-5731-45D3-97B8-502A3BF95FA8.pdf	A496	TUMOR FREE	167	140	440			1.0		YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	FV	1.9	Liver	None	A		LIVING	54	2012	TCGA-FV-A496-01A-11D-A25U-01	TCGA-FV-A496-01A-11D-A25U-01	TCGA-FV-A496-01A-11D-A25V-10	TCGA-FV-A496-01	TCGA-FV-A496-01	DD8FB046-5CCE-442F-AEB9-748965BFD520	5c6d857a-55c1-4365-b8de-bde7e769ce77	TCGA-FV-A496-01A-11D-A25V-10	TCGA-FV-A496-01	TCGA-FV-A496-01	5c6d857a-55c1-4365-b8de-bde7e769ce77	TCGA-FV-A496-01A-11D-A25V-10	5c6d857a-55c1-4365-b8de-bde7e769ce77	5c6d857a-55c1-4365-b8de-bde7e769ce77	TCGA-FV-A496-01A-11D-A25V-10	TCGA-FV-A496-01A-11D-A264-05
TCGA-FV-A4ZP-01	1	TCGA-FV-A4ZP-01	2486	1	days	TCGA-FV-A4ZP			days	2486	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		78				TCGA-FV-A4ZP-F64063	TCGA-FV-A4ZP	TCGA-FV-A4ZP-01A								-28771	2519	2486	0	1836						20326			2014-8-25	MALE	168	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	210			NO	NO	G2	Other, specify	Extrahepatic Recurrence	Adrenal Gland	No	YES	YES	No	false	Yes	M0	NX	T3	Stage IIIA	TCGA-FV-A4ZP.B6B41E65-9EFD-4F60-A4F0-68270AC39D15.pdf	A4ZP	TUMOR FREE				NO	NO		NO		RX	R1	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	FV		Liver	Micro	A		DECEASED	69	2005	TCGA-FV-A4ZP-01A-12D-A25U-01	TCGA-FV-A4ZP-01A-12D-A25U-01	TCGA-FV-A4ZP-01A-12D-A25V-10	TCGA-FV-A4ZP-01	TCGA-FV-A4ZP-01	CC0156B0-2373-4CE8-83DC-B84FF14E29D9	36bb7b6e-9a6f-4215-b362-93b6db73c819	TCGA-FV-A4ZP-01A-12D-A25V-10	TCGA-FV-A4ZP-01	TCGA-FV-A4ZP-01	36bb7b6e-9a6f-4215-b362-93b6db73c819	TCGA-FV-A4ZP-01A-12D-A25V-10	36bb7b6e-9a6f-4215-b362-93b6db73c819	36bb7b6e-9a6f-4215-b362-93b6db73c819	TCGA-FV-A4ZP-01A-12D-A25V-10	TCGA-FV-A4ZP-01A-12D-A264-05
TCGA-FV-A4ZQ-01	0	TCGA-FV-A4ZQ-01	12	0	days	TCGA-FV-A4ZQ	12	0	days	12	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				52	3.8	2.4	5.0		TCGA-FV-A4ZQ	TCGA-FV-A4ZQ-01A	0.2	1.8			0.7	1.0	1.0	-19090	224		0	12									2013-3-15	MALE		Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	160	2.0	3.0	NO		G2						NO		false	No	M0	NX	T1	Stage I	TCGA-FV-A4ZQ.C0B03F38-09C0-4B87-94BC-E2E8D9F7F922.pdf	A4ZQ	TUMOR FREE						1.1				R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	FV	1.2	Liver	None	A	Hepatitis C Virus R	LIVING		2012	TCGA-FV-A4ZQ-01A-11D-A25U-01	TCGA-FV-A4ZQ-01A-11D-A25U-01	TCGA-FV-A4ZQ-01A-11D-A25V-10	TCGA-FV-A4ZQ-01	TCGA-FV-A4ZQ-01	DFBDE418-4B11-4B96-A6AD-3A6A54F3D96D	43a21e6a-8b4e-4589-9236-0835dd7d7a00	TCGA-FV-A4ZQ-01A-11D-A25V-10	TCGA-FV-A4ZQ-01	TCGA-FV-A4ZQ-01	43a21e6a-8b4e-4589-9236-0835dd7d7a00	TCGA-FV-A4ZQ-01A-11D-A25V-10	43a21e6a-8b4e-4589-9236-0835dd7d7a00	43a21e6a-8b4e-4589-9236-0835dd7d7a00	TCGA-FV-A4ZQ-01A-11D-A25V-10	TCGA-FV-A4ZQ-01A-11D-A264-05
TCGA-G3-A25S-01	1	TCGA-G3-A25S-01	416	1	days	TCGA-G3-A25S	37	1	days	416	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	YES	Mild	64	0.3	0.4	0.5	TCGA-G3-A25S-F33638	TCGA-G3-A25S	TCGA-G3-A25S-01A	0	1.2	0	A	0.6	1.4	1.0	-23571	707	416	0	37		37	1	0	10	281	6 - Established Cirrhosis	Scheduled Follow-up Submission	2012-7-11	MALE	166	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	480	0.9	1.1	NO		G2	Other, specify	Extrahepatic Recurrence	Bone and Lung		NO	YES		true	No	M0	N0	T1	Stage I	TCGA-G3-A25S.F4DAEF13-D4B0-4C12-9617-04878D3FC98D.pdf	A25S	WITH TUMOR	313	150	400	NO	NO	1.0	NO	NO		R1	Primary Tumor	01	Extended Lobectomy	6th	NO	YES	G3	1.4	Liver	Micro	A		DECEASED	73	2009	TCGA-G3-A25S-01A-11D-A16U-01	TCGA-G3-A25S-01A-11D-A16U-01	TCGA-G3-A25S-01A-11D-A16V-10	TCGA-G3-A25S-01	TCGA-G3-A25S-01	F0CB0DB4-1B18-4DC9-A779-F144ACE7265E	4fd1e10d-c21a-49f8-9d77-a5aa7850d883	TCGA-G3-A25S-01A-11D-A16V-10	TCGA-G3-A25S-01	TCGA-G3-A25S-01	4fd1e10d-c21a-49f8-9d77-a5aa7850d883	TCGA-G3-A25S-01A-11D-A16V-10	4fd1e10d-c21a-49f8-9d77-a5aa7850d883	4fd1e10d-c21a-49f8-9d77-a5aa7850d883	TCGA-G3-A25S-01A-11D-A16V-10	TCGA-G3-A25S-01A-11D-A16X-05
TCGA-G3-A25T-01	0	TCGA-G3-A25T-01	1553	0	days	TCGA-G3-A25T	452	1	days	1553	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	45	0.3	0.4	0.5	TCGA-G3-A25T-F33639	TCGA-G3-A25T		0	2.0		A	0.4	1.4	0.7	-16461			0	1553	452	452	0	0	10	7	0 - No Fibrosis	Scheduled Follow-up Submission	2012-7-11	FEMALE	167	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.9	1.1			G2	Liver	Intrahepatic Recurrence		No	YES	YES	No		No	M0	N0	T3	Stage IIIA		A25T	WITH TUMOR	306	150	400	NO	NO	1.1	NO	NO	R0	R0	Primary Tumor	01	Lobectomy	6th	NO	YES	G3	1.4	Liver	None			LIVING	64	2007	TCGA-G3-A25T-01A-11D-A16U-01	TCGA-G3-A25T-01A-11D-A16U-01	TCGA-G3-A25T-01A-11D-A16V-10	TCGA-G3-A25T-01	TCGA-G3-A25T-01		e54a0934-1fc9-4a54-98a1-63063dc61a1b	TCGA-G3-A25T-01A-11D-A16V-10	TCGA-G3-A25T-01	TCGA-G3-A25T-01	e54a0934-1fc9-4a54-98a1-63063dc61a1b	TCGA-G3-A25T-01A-11D-A16V-10	e54a0934-1fc9-4a54-98a1-63063dc61a1b	e54a0934-1fc9-4a54-98a1-63063dc61a1b	TCGA-G3-A25T-01A-11D-A16V-10	TCGA-G3-A25T-01A-11D-A16X-05
TCGA-G3-A25U-01	0	TCGA-G3-A25U-01	1636	0	days	TCGA-G3-A25U	1636	0	days	1636	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	63	0.3	0.3	0.5	TCGA-G3-A25U-F33636	TCGA-G3-A25U	TCGA-G3-A25U-01A	0	0.3		A	0.4	1.1	0.5	-23207	1281		0	1636			0	0	10	10	0 - No Fibrosis	Scheduled Follow-up Submission	2012-7-11	FEMALE	153	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	350	0.9	1.1	NO		G3						NO		true	No	M0	N0	T1	Stage I	TCGA-G3-A25U.2781ABF5-FC79-4973-BE15-037BC685FAFC.pdf	A25U	TUMOR FREE	113	150	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	G3	1.2	Liver	None	A		LIVING	47	2007	TCGA-G3-A25U-01A-11D-A16U-01	TCGA-G3-A25U-01A-11D-A16U-01	TCGA-G3-A25U-01A-11D-A16V-10	TCGA-G3-A25U-01	TCGA-G3-A25U-01	67D384C8-9C42-4304-BFB3-1930B4422EAC	9d462109-5858-4282-abc2-81282089bc6a	TCGA-G3-A25U-01A-11D-A16V-10	TCGA-G3-A25U-01	TCGA-G3-A25U-01	9d462109-5858-4282-abc2-81282089bc6a	TCGA-G3-A25U-01A-11D-A16V-10	9d462109-5858-4282-abc2-81282089bc6a	9d462109-5858-4282-abc2-81282089bc6a	TCGA-G3-A25U-01A-11D-A16V-10	TCGA-G3-A25U-01A-11D-A16X-05
TCGA-G3-A25V-01	0	TCGA-G3-A25V-01	860	0	days	TCGA-G3-A25V	489	1	days	860	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	68	0.3	0.4	0.5	TCGA-G3-A25V-F40088	TCGA-G3-A25V	TCGA-G3-A25V-01A	0	0.6	0	A	0.6	1.4	0.7	-25144	223		0	860		489	2	0	10	15	6 - Established Cirrhosis		2013-2-12	MALE	187	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	100	0.9	1.1	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	false	No	M0	N0	T1	Stage I	TCGA-G3-A25V.F52224B9-1FAF-4F71-B017-22AAEBA8F75D.pdf	A25V	WITH TUMOR	139	150	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	G3	1.4	Liver	None	A		LIVING	90	2010	TCGA-G3-A25V-01A-11D-A16U-01	TCGA-G3-A25V-01A-11D-A16U-01	TCGA-G3-A25V-01A-11D-A16V-10	TCGA-G3-A25V-01	TCGA-G3-A25V-01	43C544E8-3188-4140-BCAF-74B978F13CEF	b3cf1b9e-aa69-452a-a9cc-f463ab4885be	TCGA-G3-A25V-01A-11D-A16V-10	TCGA-G3-A25V-01	TCGA-G3-A25V-01	b3cf1b9e-aa69-452a-a9cc-f463ab4885be	TCGA-G3-A25V-01A-11D-A16V-10	b3cf1b9e-aa69-452a-a9cc-f463ab4885be	b3cf1b9e-aa69-452a-a9cc-f463ab4885be	TCGA-G3-A25V-01A-11D-A16V-10	TCGA-G3-A25V-01A-11D-A16X-05
TCGA-G3-A25W-01	0	TCGA-G3-A25W-01	935	0	days	TCGA-G3-A25W	935	0	days	935	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	79	0.3	0.4	0.5	TCGA-G3-A25W-F40230	TCGA-G3-A25W	TCGA-G3-A25W-01A	0	0.3	3	A	0.4	1.1	1.5	-29018	419		0	935			0	0	9	6	0 - No Fibrosis		2013-2-14	FEMALE	157	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	260	0.8	1.2	NO	NO	G2						NO		true	Yes	M0	N0	T3b	Stage IIIB	TCGA-G3-A25W.F92FE7A0-15D4-45FD-BB39-E3022E30EB77.pdf	A25W	TUMOR FREE	308	150	400	NO	NO	0.9	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	G3	1.2	Liver	Macro	A		LIVING	48	2010	TCGA-G3-A25W-01A-11D-A16U-01	TCGA-G3-A25W-01A-11D-A16U-01	TCGA-G3-A25W-01A-11D-A16V-10	TCGA-G3-A25W-01		EBBA3C7B-D8A5-46DF-B278-39B1A8A8F25C		TCGA-G3-A25W-01A-11D-A16V-10	TCGA-G3-A25W-01			TCGA-G3-A25W-01A-11D-A16V-10			TCGA-G3-A25W-01A-11D-A16V-10	TCGA-G3-A25W-01A-11D-A16X-05
TCGA-G3-A25W-11	0	TCGA-G3-A25W-11	935	0	days	TCGA-G3-A25W	935	0	days	935	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	79	0.3	0.4	0.5	TCGA-G3-A25W-F40230	TCGA-G3-A25W	TCGA-G3-A25W-11A	0	0.3	3	A	0.4	1.1	1.5	-29018	419		0	935			0	0	9	6	0 - No Fibrosis		2013-2-14	FEMALE	157	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	440	0.8	1.2	NO	NO	G2						NO		true	Yes	M0	N0	T3b	Stage IIIB		A25W	TUMOR FREE	308	150	400	NO	NO	0.9	NO	YES		R0	Solid Tissue Normal	11	Segmentectomy, Single	7th	NO	YES	G3	1.2	Liver	Macro	A		LIVING	48	2010																TCGA-G3-A25W-11A-12D-A16X-05
TCGA-G3-A25X-01	0	TCGA-G3-A25X-01	1779	0	days	TCGA-G3-A25X	1779	0	days	1779	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	73	0.3	0.4	0.5	TCGA-G3-A25X-F33634	TCGA-G3-A25X	TCGA-G3-A25X-01A	0.0	1.1		A	0.4	1.4	0.8	-26988	1346		0	1779			0	0	10	11	1,2 - Portal Fibrosis	Scheduled Follow-up Submission	2012-7-11	MALE	165	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	160	0.9	1.1	NO		G3						NO		true	No	M0	N0	T2	Stage II	TCGA-G3-A25X.7DF1A9E2-3A8F-4A9B-B918-4133D60E4F0A.pdf	A25X	TUMOR FREE	102	150	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	6th	NO	YES	G3	1.4	Liver	None	A		LIVING	65	2007	TCGA-G3-A25X-01A-11D-A16U-01	TCGA-G3-A25X-01A-11D-A16U-01		TCGA-G3-A25X-01	TCGA-G3-A25X-01	35B0DFC0-56DE-4318-AD0F-3FA0745DB6D9	11cbdb5a-82fd-471a-9b33-c5c1b9393716		TCGA-G3-A25X-01	TCGA-G3-A25X-01	11cbdb5a-82fd-471a-9b33-c5c1b9393716		11cbdb5a-82fd-471a-9b33-c5c1b9393716	11cbdb5a-82fd-471a-9b33-c5c1b9393716		TCGA-G3-A25X-01A-11D-A16X-05
TCGA-G3-A25X-11	0	TCGA-G3-A25X-11	1779	0	days	TCGA-G3-A25X	1779	0	days	1779	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	73	0.3	0.4	0.5	TCGA-G3-A25X-F33634	TCGA-G3-A25X	TCGA-G3-A25X-11A	0.0	1.1		A	0.4	1.4	0.8	-26988	1346		0	1779			0	0	10	11	1,2 - Portal Fibrosis	Scheduled Follow-up Submission	2012-7-11	MALE	165	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	220	0.9	1.1	NO		G3						NO		true	No	M0	N0	T2	Stage II		A25X	TUMOR FREE	102	150	400	NO	NO	1.0	NO	NO		R0	Solid Tissue Normal	11	Segmentectomy, Single	6th	NO	YES	G3	1.4	Liver	None	A		LIVING	65	2007																TCGA-G3-A25X-11A-11D-A16X-05
TCGA-G3-A25Y-01	1	TCGA-G3-A25Y-01	452	1	days	TCGA-G3-A25Y	355	1	days	452	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	52	0.3	0.4	0.5	TCGA-G3-A25Y-F40098	TCGA-G3-A25Y	TCGA-G3-A25Y-01A	0.0	0.7		A	0.4	1.1	0.6	-19055	1595	452	0			355	0	0	10	35	3,4 - Fibrous Speta		2013-2-12	FEMALE	158	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	440	0.9	1.1	NO	NO	G3	Liver	Locoregional Recurrence		No	NO	YES	No	true	No	M0	N0	T1	Stage I	TCGA-G3-A25Y.5AEEF060-BA18-416A-BE3F-604891A9A6D2.pdf	A25Y	WITH TUMOR	166	150	400	NO	NO	1.1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	6th	NO	YES	G3	1.2	Liver	None	A		DECEASED	57	2006	TCGA-G3-A25Y-01A-11D-A16U-01	TCGA-G3-A25Y-01A-11D-A16U-01	TCGA-G3-A25Y-01A-11D-A16V-10	TCGA-G3-A25Y-01	TCGA-G3-A25Y-01	9929B349-9D83-4C81-BA8A-D48236C70505	ca7f7d18-3f39-4454-8f72-eb432b800103	TCGA-G3-A25Y-01A-11D-A16V-10	TCGA-G3-A25Y-01	TCGA-G3-A25Y-01	ca7f7d18-3f39-4454-8f72-eb432b800103	TCGA-G3-A25Y-01A-11D-A16V-10	ca7f7d18-3f39-4454-8f72-eb432b800103	ca7f7d18-3f39-4454-8f72-eb432b800103	TCGA-G3-A25Y-01A-11D-A16V-10	TCGA-G3-A25Y-01A-11D-A16X-05
TCGA-G3-A25Z-01	0	TCGA-G3-A25Z-01	655	0	days	TCGA-G3-A25Z	655	0	days	655	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	58	0.3	0.4	0.5	TCGA-G3-A25Z-F33635	TCGA-G3-A25Z	TCGA-G3-A25Z-01A	0	0.9	1	A	0.6	1.4	1.1	-21509	233		0	655			0	0	15	44	5 - Nodular Formation and Incomplete Cirrhosis	Scheduled Follow-up Submission	2012-7-11	MALE	173	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	300	0.9	1.1	NO		G2						NO		true	No	M0	N0	T1	Stage I	TCGA-G3-A25Z.001A2553-3F5F-4A74-88E6-03B42C061E6D.pdf	A25Z	TUMOR FREE	115	150	400	NO	NO	1.0	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	G3	1.4	Liver	None	A		LIVING	69	2010	TCGA-G3-A25Z-01A-11D-A16U-01	TCGA-G3-A25Z-01A-11D-A16U-01	TCGA-G3-A25Z-01A-11D-A16V-10	TCGA-G3-A25Z-01	TCGA-G3-A25Z-01	EA21A265-56D5-4C72-8665-00BF82A67B7D	859fc4fb-40f5-40ce-8784-13eae0fa446a	TCGA-G3-A25Z-01A-11D-A16V-10	TCGA-G3-A25Z-01	TCGA-G3-A25Z-01	859fc4fb-40f5-40ce-8784-13eae0fa446a	TCGA-G3-A25Z-01A-11D-A16V-10	859fc4fb-40f5-40ce-8784-13eae0fa446a	859fc4fb-40f5-40ce-8784-13eae0fa446a	TCGA-G3-A25Z-01A-11D-A16V-10	TCGA-G3-A25Z-01A-11D-A16X-05
TCGA-G3-A3CG-01	0	TCGA-G3-A3CG-01	673	0	days	TCGA-G3-A3CG	329	1	days	673	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	Severe	80	0.3	0.4	0.5	TCGA-G3-A3CG-F40228	TCGA-G3-A3CG	TCGA-G3-A3CG-01A	0.3	0.3		A	0.6	1.4	0.9	-29432	261		0	673		329	1	0	10	67	6 - Established Cirrhosis		2013-2-14	MALE	168	Hepatitis C		Hepatocellular Carcinoma	Yes	C22.0	8170/3	C22.0	YES	270	0.9	1.1	NO	NO	G2	Liver	Intrahepatic Recurrence		No	NO	YES	No	false	Yes	M0	N0	T1	Stage I	TCGA-G3-A3CG.6E2F9CE1-6D48-42DF-8737-64ED53BF8646.pdf	A3CG	WITH TUMOR	131	150	400	NO	NO	1.1	NO	NO		R1	Primary Tumor	01	Lobectomy	7th	NO	YES	G3	1.4	Liver	Micro	A		LIVING	93	2011	TCGA-G3-A3CG-01A-11D-A20V-01	TCGA-G3-A3CG-01A-11D-A20V-01	TCGA-G3-A3CG-01A-11D-A20W-10		TCGA-G3-A3CG-01	203A6526-64B9-4978-8D9F-884898C1E79D	b29ea742-8e19-4cdb-b237-5a7934f01381	TCGA-G3-A3CG-01A-11D-A20W-10		TCGA-G3-A3CG-01	b29ea742-8e19-4cdb-b237-5a7934f01381	TCGA-G3-A3CG-01A-11D-A20W-10	b29ea742-8e19-4cdb-b237-5a7934f01381	b29ea742-8e19-4cdb-b237-5a7934f01381	TCGA-G3-A3CG-01A-11D-A20W-10	TCGA-G3-A3CG-01A-11D-A20Z-05
TCGA-G3-A3CH-01	0	TCGA-G3-A3CH-01	780	0	days	TCGA-G3-A3CH	116	1	days	780	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Severe	53	0.3	0.3	0.5	TCGA-G3-A3CH-F40093	TCGA-G3-A3CH	TCGA-G3-A3CH-01A	0	0.7		A	0.6	1.4	0.9	-19473	296		0	780	180	116	0	0	10	41	6 - Established Cirrhosis		2013-2-12	MALE	178	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	120	0.9	1.1	NO	NO	G2	Liver	Intrahepatic Recurrence		No	YES	YES	No	false	No	M0	N0	T3a	Stage IIIA	TCGA-G3-A3CH.735AAE4A-21E1-4481-9D86-385CCE5712D1.pdf	A3CH	WITH TUMOR	142	150	400	NO	NO	1.2	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	G3	1.4	Liver	None	A		LIVING	74	2010	TCGA-G3-A3CH-01A-11D-A22E-01	TCGA-G3-A3CH-01A-11D-A22E-01	TCGA-G3-A3CH-01A-11D-A22F-10	TCGA-G3-A3CH-01	TCGA-G3-A3CH-01	FB66ADBF-865D-44FD-8ACB-4362226607ED	7e48e392-4196-4188-bb39-bba65e88c2d5	TCGA-G3-A3CH-01A-11D-A22F-10	TCGA-G3-A3CH-01	TCGA-G3-A3CH-01	7e48e392-4196-4188-bb39-bba65e88c2d5	TCGA-G3-A3CH-01A-11D-A22F-10	7e48e392-4196-4188-bb39-bba65e88c2d5	7e48e392-4196-4188-bb39-bba65e88c2d5	TCGA-G3-A3CH-01A-11D-A22F-10	TCGA-G3-A3CH-01A-11D-A22H-05
TCGA-G3-A3CH-11	0	TCGA-G3-A3CH-11	780	0	days	TCGA-G3-A3CH	116	1	days	780	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Severe	53	0.3	0.3	0.5	TCGA-G3-A3CH-F40093	TCGA-G3-A3CH		0	0.7		A	0.6	1.4	0.9	-19473			0	780	180	116	0	0	10	41	6 - Established Cirrhosis		2013-2-12	MALE	178	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.9	1.1		NO	G2	Liver	Intrahepatic Recurrence		No	YES	YES	No		No	M0	N0	T3a	Stage IIIA		A3CH	WITH TUMOR	142	150	400	NO	NO	1.2	NO	NO		R0	Solid Tissue Normal	11	Segmentectomy, Multiple	7th	NO	YES	G3	1.4	Liver	None			LIVING	74	2010				TCGA-G3-A3CH-11			c8de0c98-c69a-44a1-bdf7-e6c731359aac		TCGA-G3-A3CH-11		c8de0c98-c69a-44a1-bdf7-e6c731359aac		c8de0c98-c69a-44a1-bdf7-e6c731359aac	c8de0c98-c69a-44a1-bdf7-e6c731359aac		
TCGA-G3-A3CI-01	0	TCGA-G3-A3CI-01	180	0	days	TCGA-G3-A3CI			days	180	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	71	0.3	0.4	0.5	TCGA-G3-A3CI-F40231	TCGA-G3-A3CI	TCGA-G3-A3CI-01A	0	0.3		A	0.6	1.4	0.9	-26224	258		0	180			1	0	10	2	0 - No Fibrosis		2013-2-14	MALE	167	Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	370	0.9	1.1	NO	YES	G2								false	No	M0	N0	T1	Stage I	TCGA-G3-A3CI.42613B77-F014-4AE9-AEF8-C5E632125EFA.pdf	A3CI	TUMOR FREE	186	150	400			1.3		NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	G3	0.8	Liver	None	A		LIVING	98	2011	TCGA-G3-A3CI-01A-11D-A20V-01	TCGA-G3-A3CI-01A-11D-A20V-01	TCGA-G3-A3CI-01A-11D-A20W-10	TCGA-G3-A3CI-01	TCGA-G3-A3CI-01	BC4F74DA-B45D-4D4B-AF29-E458B09200A6	b1ad5501-06e7-48c7-9fa9-f76527ae39f1	TCGA-G3-A3CI-01A-11D-A20W-10	TCGA-G3-A3CI-01	TCGA-G3-A3CI-01	b1ad5501-06e7-48c7-9fa9-f76527ae39f1	TCGA-G3-A3CI-01A-11D-A20W-10	b1ad5501-06e7-48c7-9fa9-f76527ae39f1	b1ad5501-06e7-48c7-9fa9-f76527ae39f1	TCGA-G3-A3CI-01A-11D-A20W-10	TCGA-G3-A3CI-01A-11D-A20Z-05
TCGA-G3-A3CJ-01	0	TCGA-G3-A3CJ-01	594	0	days	TCGA-G3-A3CJ	296	1	days	594	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	Severe	52	0.3	0.4	0.5	TCGA-G3-A3CJ-F40234	TCGA-G3-A3CJ	TCGA-G3-A3CJ-01A	0	1.0		A	0.5	1.4	0.8	-19305	113		0	594		296	0	0	10	3	5 - Nodular Formation and Incomplete Cirrhosis		2013-2-14	MALE	174	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	0.9	1.1	NO	NO	G2	Lung	Extrahepatic Recurrence		No	NO	YES	No	false	No	M0	N0	T2	Stage II	TCGA-G3-A3CJ.191868C4-3299-4E65-9DB2-C8C43CB83963.pdf	A3CJ	WITH TUMOR	185	150	400	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	G3	1.4	Liver	Micro	A		LIVING	72	2011	TCGA-G3-A3CJ-01A-11D-A20V-01	TCGA-G3-A3CJ-01A-11D-A20V-01	TCGA-G3-A3CJ-01A-11D-A20W-10	TCGA-G3-A3CJ-01	TCGA-G3-A3CJ-01		699fc209-b99a-48f4-a8c5-ace6ca7e30a6	TCGA-G3-A3CJ-01A-11D-A20W-10	TCGA-G3-A3CJ-01	TCGA-G3-A3CJ-01	699fc209-b99a-48f4-a8c5-ace6ca7e30a6	TCGA-G3-A3CJ-01A-11D-A20W-10	699fc209-b99a-48f4-a8c5-ace6ca7e30a6	699fc209-b99a-48f4-a8c5-ace6ca7e30a6	TCGA-G3-A3CJ-01A-11D-A20W-10	TCGA-G3-A3CJ-01A-11D-A20Z-05
TCGA-G3-A3CK-01	0	TCGA-G3-A3CK-01	585	0	days	TCGA-G3-A3CK	585	0	days	585	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	61	0.3	0.2	0.5	TCGA-G3-A3CK-F40227	TCGA-G3-A3CK	TCGA-G3-A3CK-01A	0	0.8	1	A	0.6	1.4	1.1	-22462	132		0	585			0	0	10	3	6 - Established Cirrhosis		2013-2-14	MALE	170	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	520	0.9	1.1	NO	NO	G2						NO		true	No	M0	N0	T1	Stage I	TCGA-G3-A3CK.ED5E5458-1E88-4126-B46B-96297F5A0FFF.pdf	A3CK	TUMOR FREE	143	150	400	NO	NO	1.0	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	G3	1.4	Liver	None	A		LIVING	67	2011	TCGA-G3-A3CK-01A-11D-A20V-01	TCGA-G3-A3CK-01A-11D-A20V-01	TCGA-G3-A3CK-01A-11D-A20W-10	TCGA-G3-A3CK-01	TCGA-G3-A3CK-01	5987458A-335D-4EC2-ABCC-48F89ED707B0	33da53e2-4fc2-4689-a651-1c596481af74	TCGA-G3-A3CK-01A-11D-A20W-10	TCGA-G3-A3CK-01	TCGA-G3-A3CK-01	33da53e2-4fc2-4689-a651-1c596481af74	TCGA-G3-A3CK-01A-11D-A20W-10	33da53e2-4fc2-4689-a651-1c596481af74	33da53e2-4fc2-4689-a651-1c596481af74	TCGA-G3-A3CK-01A-11D-A20W-10	TCGA-G3-A3CK-01A-11D-A20Z-05
TCGA-G3-A5SI-01	1	TCGA-G3-A5SI-01	768	1	days	TCGA-G3-A5SI	768	0	days	768	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	44	3.3	2.8	4.8	TCGA-G3-A5SI-F59276	TCGA-G3-A5SI		0	0.7		A	0.6	1.4	0.4	-16126		768	0	447			1	0	10	9	6 - Established Cirrhosis		2014-5-7	MALE	177	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.9	1.1		NO	G2						NO			No	M0	N0	T2	Stage II		A5SI	WITH TUMOR	145	150	400	NO	NO	1.4	NO			R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	G3	1.4	Liver	None			DECEASED	74	2011	TCGA-G3-A5SI-01A-31D-A27H-01	TCGA-G3-A5SI-01A-31D-A27H-01	TCGA-G3-A5SI-01A-31D-A27I-10	TCGA-G3-A5SI-01	TCGA-G3-A5SI-01		ddb29159-cbe9-4b6d-a86f-8115b859b2bb	TCGA-G3-A5SI-01A-31D-A27I-10	TCGA-G3-A5SI-01	TCGA-G3-A5SI-01	ddb29159-cbe9-4b6d-a86f-8115b859b2bb	TCGA-G3-A5SI-01A-31D-A27I-10	ddb29159-cbe9-4b6d-a86f-8115b859b2bb	ddb29159-cbe9-4b6d-a86f-8115b859b2bb	TCGA-G3-A5SI-01A-31D-A27I-10	TCGA-G3-A5SI-01A-31D-A27W-05
TCGA-G3-A5SJ-01	0	TCGA-G3-A5SJ-01	698	0	days	TCGA-G3-A5SJ	698	0	days	698	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	59	3.3	4.1	4.8	TCGA-G3-A5SJ-F62744	TCGA-G3-A5SJ	TCGA-G3-A5SJ-01A	0	0.5		B	0.6	1.4	1.3	-21848	285		0	698			0	0	10	3	6 - Established Cirrhosis		2014-7-24	MALE	171	Alcohol consumption|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	290	0.9	1.1	NO	NO	G2						NO		true	No	M0	NX	T1	Stage I	TCGA-G3-A5SJ.5237C744-2C11-4340-BC70-9AD10238F1E6.pdf	A5SJ	TUMOR FREE	136	150	400	NO	NO	1	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	G3	1.4	Liver	None	A		LIVING	87	2012	TCGA-G3-A5SJ-01A-11D-A27H-01	TCGA-G3-A5SJ-01A-11D-A27H-01	TCGA-G3-A5SJ-01A-11D-A27I-10	TCGA-G3-A5SJ-01	TCGA-G3-A5SJ-01	5AB22DCE-8485-42C1-A2E0-99B19FCD6E1A	9fc02f84-548e-42a4-8857-717cd8426575	TCGA-G3-A5SJ-01A-11D-A27I-10	TCGA-G3-A5SJ-01	TCGA-G3-A5SJ-01	9fc02f84-548e-42a4-8857-717cd8426575	TCGA-G3-A5SJ-01A-11D-A27I-10	9fc02f84-548e-42a4-8857-717cd8426575	9fc02f84-548e-42a4-8857-717cd8426575	TCGA-G3-A5SJ-01A-11D-A27I-10	TCGA-G3-A5SJ-01A-11D-A27W-05
TCGA-G3-A5SK-01	0	TCGA-G3-A5SK-01	744	0	days	TCGA-G3-A5SK	483	1	days	744	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	58	3.3	3.3	4.8	TCGA-G3-A5SK-F62745	TCGA-G3-A5SK	TCGA-G3-A5SK-01A				A	0.6	1.4	0.6	-21320	251		0	744		483	0				6 - Established Cirrhosis		2014-7-24	MALE	169	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	650	0.9	1.1	NO	NO	G1	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	NX	T1	Stage I	TCGA-G3-A5SK.6FB76663-58FA-48DD-A0F8-136C975FE067.pdf	A5SK	WITH TUMOR	106	150	400	YES	NO	1.1	NO			R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	G3		Liver		A		LIVING	67	2012			TCGA-G3-A5SK-01A-11D-A27I-10	TCGA-G3-A5SK-01	TCGA-G3-A5SK-01	3B1F0D3C-CBF1-4992-A25B-FFBC4480E5A0	602123eb-3790-4882-b8b1-f118838d3027	TCGA-G3-A5SK-01A-11D-A27I-10	TCGA-G3-A5SK-01		602123eb-3790-4882-b8b1-f118838d3027	TCGA-G3-A5SK-01A-11D-A27I-10	602123eb-3790-4882-b8b1-f118838d3027	602123eb-3790-4882-b8b1-f118838d3027	TCGA-G3-A5SK-01A-11D-A27I-10	TCGA-G3-A5SK-01A-11D-A27W-05
TCGA-G3-A5SL-01	0	TCGA-G3-A5SL-01	621	0	days	TCGA-G3-A5SL	621	0	days	621	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	70	3.1	4.2	4.7	TCGA-G3-A5SL-F62747	TCGA-G3-A5SL	TCGA-G3-A5SL-01A	0	0.8			0.6	1.4	1	-25671	236		0	621			0	0	10	4	0 - No Fibrosis		2014-7-24	MALE	180	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	220	0.9	1.3	NO	NO	G2						NO		true	No	M0	NX	T2	Stage II	TCGA-G3-A5SL.7DB1AFB2-69C9-4277-904E-4CF9CBAE8360.pdf	A5SL	TUMOR FREE	295	150	400	NO	NO	1	NO	NO		R0	Primary Tumor	01	Other (specify)	7th	YES	NO	G3	1.40	Liver	Micro	A		LIVING	88	2012	TCGA-G3-A5SL-01A-11D-A27H-01	TCGA-G3-A5SL-01A-11D-A27H-01	TCGA-G3-A5SL-01A-11D-A27I-10	TCGA-G3-A5SL-01	TCGA-G3-A5SL-01	37EB6B47-7ECB-45C7-9519-307452A2FC72	0856a2e8-f139-4809-a7c6-29546080c333	TCGA-G3-A5SL-01A-11D-A27I-10	TCGA-G3-A5SL-01	TCGA-G3-A5SL-01	0856a2e8-f139-4809-a7c6-29546080c333	TCGA-G3-A5SL-01A-11D-A27I-10	0856a2e8-f139-4809-a7c6-29546080c333	0856a2e8-f139-4809-a7c6-29546080c333	TCGA-G3-A5SL-01A-11D-A27I-10	TCGA-G3-A5SL-01A-11D-A27W-05
TCGA-G3-A5SM-01	0	TCGA-G3-A5SM-01	520	0	days	TCGA-G3-A5SM	252	1	days	520	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		58	3.3	3.2	4.8	TCGA-G3-A5SM-F62748	TCGA-G3-A5SM	TCGA-G3-A5SM-01A	0	0.6		A	0.5	1.4	0.5	-21236	111		0	520		252	1	0	10	12	6 - Established Cirrhosis		2014-7-24	MALE	184	Alcohol consumption|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	160	0.9	1.1	NO	NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	M0	NX	T2	Stage II	TCGA-G3-A5SM.791E29AD-22A6-402E-978C-69407C6B748F.pdf	A5SM	TUMOR FREE	260	150	400	YES	NO	0.9	NO	NO		R0	Primary Tumor	01	Other (specify)	7th	YES	NO	G3	1.4	Liver	None	A		LIVING	106	2012	TCGA-G3-A5SM-01A-12D-A28W-01	TCGA-G3-A5SM-01A-12D-A28W-01	TCGA-G3-A5SM-01A-12D-A28X-10	TCGA-G3-A5SM-01	TCGA-G3-A5SM-01	506FD114-C312-4ADC-8DB8-3D004F3A72C1	cccf48e7-af9d-4039-9ed1-ae859f692678	TCGA-G3-A5SM-01A-12D-A28X-10	TCGA-G3-A5SM-01	TCGA-G3-A5SM-01	cccf48e7-af9d-4039-9ed1-ae859f692678	TCGA-G3-A5SM-01A-12D-A28X-10	cccf48e7-af9d-4039-9ed1-ae859f692678	cccf48e7-af9d-4039-9ed1-ae859f692678	TCGA-G3-A5SM-01A-12D-A28X-10	TCGA-G3-A5SM-01A-12D-A28Y-05
TCGA-G3-A6UC-01	0	TCGA-G3-A6UC-01	671	0	days	TCGA-G3-A6UC	639	1	days	671	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	65	3.3	4.6	4.8	TCGA-G3-A6UC-F64551	TCGA-G3-A6UC	TCGA-G3-A6UC-01A	0	1.0		A	0.6	1.4	0.9	-23793	266		0	671		639	0	0	10	4	6 - Established Cirrhosis		2014-9-4	MALE	182	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	410	0.9	1.1	NO	NO	G2	Liver	Intrahepatic Recurrence		No	NO	YES	No	true	Yes	M0	N0	T3b	Stage IIIB	TCGA-G3-A6UC.08415C4C-C645-4911-BA53-6E562E562FD4.pdf	A6UC	WITH TUMOR	257	150	400	NO	NO	1.1	NO			R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	G3	1.4	Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody	LIVING	91	2012	TCGA-G3-A6UC-01A-21D-A33B-01	TCGA-G3-A6UC-01A-21D-A33B-01	TCGA-G3-A6UC-01A-21D-A33K-10	TCGA-G3-A6UC-01	TCGA-G3-A6UC-01		914e6f58-48b5-40aa-9336-69166bd6970b	TCGA-G3-A6UC-01A-21D-A33K-10	TCGA-G3-A6UC-01	TCGA-G3-A6UC-01	914e6f58-48b5-40aa-9336-69166bd6970b	TCGA-G3-A6UC-01A-21D-A33K-10	914e6f58-48b5-40aa-9336-69166bd6970b	914e6f58-48b5-40aa-9336-69166bd6970b	TCGA-G3-A6UC-01A-21D-A33K-10	TCGA-G3-A6UC-01A-21D-A33L-05
TCGA-G3-A7M5-01	0	TCGA-G3-A7M5-01	447	0	days	TCGA-G3-A7M5	447	0	days	447	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	76	3.3	4.1	4.8	TCGA-G3-A7M5-F65810	TCGA-G3-A7M5	TCGA-G3-A7M5-01A	0	0.5		A	0.6	1.4	1.9	-27963	217		0	447			0	0	10	6	0 - No Fibrosis		2014-9-30	MALE	164	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	720	0.9	1.1	NO	NO	G2						NO		true	No	MX	NX	T1	Stage I	TCGA-G3-A7M5.9441C376-F0CE-4A84-A9C0-5FB1917216F2.pdf	A7M5	TUMOR FREE	181	150	400	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	G3	1.4	Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody	LIVING	68	2013	TCGA-G3-A7M5-01A-11D-A33P-01	TCGA-G3-A7M5-01A-11D-A33P-01	TCGA-G3-A7M5-01A-11D-A33Q-10	TCGA-G3-A7M5-01	TCGA-G3-A7M5-01	1EB5B0C8-DBD5-4380-9721-A1FDA5225BFA	a439fc68-c013-4f3a-9be7-2e3243938e12	TCGA-G3-A7M5-01A-11D-A33Q-10	TCGA-G3-A7M5-01	TCGA-G3-A7M5-01	a439fc68-c013-4f3a-9be7-2e3243938e12	TCGA-G3-A7M5-01A-11D-A33Q-10	a439fc68-c013-4f3a-9be7-2e3243938e12	a439fc68-c013-4f3a-9be7-2e3243938e12	TCGA-G3-A7M5-01A-11D-A33Q-10	TCGA-G3-A7M5-01A-11D-A341-05
TCGA-G3-A7M6-01	0	TCGA-G3-A7M6-01	632	0	days	TCGA-G3-A7M6	584	1	days	632	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	60	3.3	3.6	4.8	TCGA-G3-A7M6-F67241	TCGA-G3-A7M6	TCGA-G3-A7M6-01A	0	0.5		A	0.4	1.1	0.6	-22205	212		0	632		584	0	0	10	24	1,2 - Portal Fibrosis		2014-11-3	FEMALE	158	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	680	0.9	1.1	NO	NO	G3	Liver	Locoregional Recurrence		No	NO	YES	No	true	No	MX	NX	T1	Stage I	TCGA-G3-A7M6.BE9902BC-2818-4A37-AF40-768208EA15B9.pdf	A7M6	WITH TUMOR	273	150	400	NO	NO	0.9	NO			R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	G3	1.2	Liver	None	A		LIVING	77	2013	TCGA-G3-A7M6-01A-11D-A33P-01	TCGA-G3-A7M6-01A-11D-A33P-01	TCGA-G3-A7M6-01A-11D-A33Q-10	TCGA-G3-A7M6-01	TCGA-G3-A7M6-01	F9487472-3D9B-4E48-AF59-20F5268794EC	b23af964-65f4-4f37-a750-16a7d460fb38	TCGA-G3-A7M6-01A-11D-A33Q-10	TCGA-G3-A7M6-01	TCGA-G3-A7M6-01	b23af964-65f4-4f37-a750-16a7d460fb38	TCGA-G3-A7M6-01A-11D-A33Q-10	b23af964-65f4-4f37-a750-16a7d460fb38	b23af964-65f4-4f37-a750-16a7d460fb38	TCGA-G3-A7M6-01A-11D-A33Q-10	TCGA-G3-A7M6-01A-11D-A341-05
TCGA-G3-A7M7-01	0	TCGA-G3-A7M7-01	361	0	days	TCGA-G3-A7M7	361	0	days	361	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Severe	65	3.2	3.5	4.6	TCGA-G3-A7M7-F67243	TCGA-G3-A7M7	TCGA-G3-A7M7-01A	0	0.5		A	0.7	1.2	0.6	-24002	112		0	361			0	0	7	4	3,4 - Fibrous Speta		2014-11-3	MALE	181	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	750	0.9	1.1	NO	NO	G1						NO		true	No	MX	NX	T1	Stage I	TCGA-G3-A7M7.9EC72408-F4C7-4D95-ACE3-3BF44E10FF8C.pdf	A7M7	TUMOR FREE	145	150	450	NO	NO	1.1	NO			R0	Primary Tumor	01	Lobectomy	7th	YES	NO	G3	1.2	Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	77	2013	TCGA-G3-A7M7-01A-12D-A34Y-01	TCGA-G3-A7M7-01A-12D-A34Y-01	TCGA-G3-A7M7-01A-12D-A34Z-10	TCGA-G3-A7M7-01	TCGA-G3-A7M7-01	2495B0BD-2941-4F5F-9C7D-2CE9F4075927	0c31e1a3-2920-48f3-8609-f2e7ecd5ec51	TCGA-G3-A7M7-01A-12D-A34Z-10	TCGA-G3-A7M7-01	TCGA-G3-A7M7-01	0c31e1a3-2920-48f3-8609-f2e7ecd5ec51	TCGA-G3-A7M7-01A-12D-A34Z-10	0c31e1a3-2920-48f3-8609-f2e7ecd5ec51	0c31e1a3-2920-48f3-8609-f2e7ecd5ec51	TCGA-G3-A7M7-01A-12D-A34Z-10	TCGA-G3-A7M7-01A-12D-A356-05
TCGA-G3-A7M8-01	0	TCGA-G3-A7M8-01	430	0	days	TCGA-G3-A7M8	430	0	days	430	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				31	3.3	3.5	4.8	TCGA-G3-A7M8-F65814	TCGA-G3-A7M8	TCGA-G3-A7M8-01A	0	1.8		A	0.6	1.4	0.7	-11527	97		0	430			0	0	10	5	6 - Established Cirrhosis		2014-9-30	MALE		Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	180	0.9	1.1	NO	NO	G1						NO		true	No	MX	NX	T1	Stage I	TCGA-G3-A7M8.77483096-0271-4EBD-BC39-2232A3DEFF69.pdf	A7M8	TUMOR FREE	136	150	400	NO	NO	1.1	NO			RX	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	G3	1.2	Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody	LIVING		2013	TCGA-G3-A7M8-01A-11D-A33P-01	TCGA-G3-A7M8-01A-11D-A33P-01	TCGA-G3-A7M8-01A-11D-A33Q-10	TCGA-G3-A7M8-01	TCGA-G3-A7M8-01	E72366C0-4D1A-4197-B39D-BFA404F70675	26e8978a-77bb-459f-b727-51d3fc361670	TCGA-G3-A7M8-01A-11D-A33Q-10	TCGA-G3-A7M8-01	TCGA-G3-A7M8-01	26e8978a-77bb-459f-b727-51d3fc361670	TCGA-G3-A7M8-01A-11D-A33Q-10	26e8978a-77bb-459f-b727-51d3fc361670	26e8978a-77bb-459f-b727-51d3fc361670	TCGA-G3-A7M8-01A-11D-A33Q-10	TCGA-G3-A7M8-01A-11D-A341-05
TCGA-G3-A7M9-01	1	TCGA-G3-A7M9-01	56	1	days	TCGA-G3-A7M9	56	0	days	56	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	70	3.3	3.3	4.8	TCGA-G3-A7M9-F65815	TCGA-G3-A7M9	TCGA-G3-A7M9-01A	0	0.4		A	0.6	1.4	1	-25588	86	56	0				0	0	10	22868	6 - Established Cirrhosis		2014-9-30	MALE	170	Hemochromatosis		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1500	0.9	1.1	NO	NO	G2						NO		true	Yes	MX	NX	T3b	Stage IIIB	TCGA-G3-A7M9.0759EEFA-E337-43A5-A6B8-7FDB5FE579EB.pdf	A7M9		187	150	400	NO	NO	1.1	NO			R0	Primary Tumor	01	Lobectomy	7th	YES	NO	G3	1.4	Liver	Macro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody	DECEASED	73	2013	TCGA-G3-A7M9-01A-23D-A34Y-01	TCGA-G3-A7M9-01A-23D-A34Y-01	TCGA-G3-A7M9-01A-23D-A34Z-10	TCGA-G3-A7M9-01	TCGA-G3-A7M9-01	E22249BF-0815-4034-B171-A69670314312	8bc6822e-7701-4719-a42a-3b7916cde80b	TCGA-G3-A7M9-01A-23D-A34Z-10	TCGA-G3-A7M9-01	TCGA-G3-A7M9-01	8bc6822e-7701-4719-a42a-3b7916cde80b	TCGA-G3-A7M9-01A-23D-A34Z-10	8bc6822e-7701-4719-a42a-3b7916cde80b	8bc6822e-7701-4719-a42a-3b7916cde80b	TCGA-G3-A7M9-01A-23D-A34Z-10	TCGA-G3-A7M9-01A-23D-A356-05
TCGA-G3-AAUZ-01	0	TCGA-G3-AAUZ-01	480	0	days	TCGA-G3-AAUZ	480	0	days	480	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Severe	48	3.3	3.8	4.8	TCGA-G3-AAUZ-F67244	TCGA-G3-AAUZ		0	0.3		A	0.6	1.4	0.8	-17760			0	480			0	0	10	3	1,2 - Portal Fibrosis		2014-11-3	MALE	160	Hepatitis B|Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.9	1.1		NO	G2						NO			No	M0	N0	T1	Stage I		AAUZ	TUMOR FREE	214	150	400	NO	NO	1	NO			R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	G3	1.4	Liver	None		Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV D	LIVING	77	2013	TCGA-G3-AAUZ-01A-11D-A381-01	TCGA-G3-AAUZ-01A-11D-A381-01	TCGA-G3-AAUZ-01A-11D-A382-10	TCGA-G3-AAUZ-01	TCGA-G3-AAUZ-01		fe0ae39e-cbfd-416c-9485-036d0f77531f		TCGA-G3-AAUZ-01	TCGA-G3-AAUZ-01	fe0ae39e-cbfd-416c-9485-036d0f77531f		fe0ae39e-cbfd-416c-9485-036d0f77531f	fe0ae39e-cbfd-416c-9485-036d0f77531f		TCGA-G3-AAUZ-01A-11D-A383-05
TCGA-G3-AAV0-01	0	TCGA-G3-AAV0-01	476	0	days	TCGA-G3-AAV0	476	0	days	476	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	58	3.3	4.2	4.8	TCGA-G3-AAV0-F67245	TCGA-G3-AAV0		0	0.6		A	0.6	1.4	0.9	-21249			0	476			0	0	10	4	0 - No Fibrosis		2014-11-3	MALE	158	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.9	1.1		NO	G2						NO			No	M0	N0	T1	Stage I		AAV0	TUMOR FREE	193	150	400	NO	NO	0.9	NO			R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	G3	1.4	Liver	None		Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody	LIVING	58	2013	TCGA-G3-AAV0-01A-11D-A36W-01	TCGA-G3-AAV0-01A-11D-A36W-01	TCGA-G3-AAV0-01A-11D-A36X-10	TCGA-G3-AAV0-01	TCGA-G3-AAV0-01		cc064dfb-026a-45a9-bf02-f57f473f21a0		TCGA-G3-AAV0-01	TCGA-G3-AAV0-01	cc064dfb-026a-45a9-bf02-f57f473f21a0		cc064dfb-026a-45a9-bf02-f57f473f21a0	cc064dfb-026a-45a9-bf02-f57f473f21a0		TCGA-G3-AAV0-01A-11D-A36Y-05
TCGA-G3-AAV1-01	1	TCGA-G3-AAV1-01	359	1	days	TCGA-G3-AAV1	49	1	days	359	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Severe	51	3.3	3.2	4.8	TCGA-G3-AAV1-F65936	TCGA-G3-AAV1		0	0.7		B	0.6	1.4	0.7	-18973		359	0			49	1	0	10	8	6 - Established Cirrhosis		2014-10-1	MALE	181	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.9	1.1		NO	G3	Liver	Locoregional Recurrence		Yes	NO	YES	No		No	M0	N0	T4	Stage IIIC		AAV1	WITH TUMOR	115	150	400	NO	NO	1.2	NO			R0	Primary Tumor	01	Lobectomy	7th	YES	NO	G3	1.4	Liver	Micro		Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV D	DECEASED	99	2013	TCGA-G3-AAV1-01A-11D-A381-01	TCGA-G3-AAV1-01A-11D-A381-01	TCGA-G3-AAV1-01A-11D-A382-10	TCGA-G3-AAV1-01	TCGA-G3-AAV1-01		b7999182-43bb-4c38-a543-a0bc4dd5a3e3		TCGA-G3-AAV1-01	TCGA-G3-AAV1-01	b7999182-43bb-4c38-a543-a0bc4dd5a3e3		b7999182-43bb-4c38-a543-a0bc4dd5a3e3	b7999182-43bb-4c38-a543-a0bc4dd5a3e3		TCGA-G3-AAV1-01A-11D-A383-05
TCGA-G3-AAV2-01	0	TCGA-G3-AAV2-01	372	0	days	TCGA-G3-AAV2	372	0	days	372	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				50	3.3	4.2	4.8	TCGA-G3-AAV2-F67246	TCGA-G3-AAV2	TCGA-G3-AAV2-01A	0	0.7		A	0.6	1.4	1	-18363	136		0	372			0	0	10	4	6 - Established Cirrhosis		2014-11-3	MALE		Alcohol consumption|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	500	0.9	1.1	NO	NO	G1						NO		true	No	M0	N0	T1	Stage I	TCGA-G3-AAV2.A323CDD5-4022-486C-B77E-F0552FB9076B.pdf	AAV2	TUMOR FREE	110	150	400	NO	NO	1	NO			R0	Primary Tumor	01	Lobectomy	7th	YES	NO	G3	1.4	Liver	None	A	Hepatitis  C Antibody|Hepatitis C Virus R|Hepatitis B Surface Antigen|HBV Surface Antibody	LIVING		2013	TCGA-G3-AAV2-01A-11D-A36W-01	TCGA-G3-AAV2-01A-11D-A36W-01	TCGA-G3-AAV2-01A-11D-A36X-10	TCGA-G3-AAV2-01	TCGA-G3-AAV2-01		5d587eff-228f-49e0-a132-da031a81ad0b		TCGA-G3-AAV2-01	TCGA-G3-AAV2-01	5d587eff-228f-49e0-a132-da031a81ad0b		5d587eff-228f-49e0-a132-da031a81ad0b	5d587eff-228f-49e0-a132-da031a81ad0b		TCGA-G3-AAV2-01A-11D-A36Y-05
TCGA-G3-AAV3-01	0	TCGA-G3-AAV3-01	412	0	days	TCGA-G3-AAV3	412	0	days	412	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Severe	58	3.4	4.4	4.8	TCGA-G3-AAV3-F67247	TCGA-G3-AAV3	TCGA-G3-AAV3-01A	0	0.6	1	A	0.5	0.9	0.6	-21449	98		0	412			1	0	7	5	6 - Established Cirrhosis		2014-11-3	FEMALE	168	Alcohol consumption|Hepatitis C|Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	150	0.9	1.1	NO	NO	G2						NO		true	No	M0	N0	T2	Stage II	TCGA-G3-AAV3.275E9EDA-413F-40BE-943C-9521F8CC297A.pdf	AAV3	TUMOR FREE	113	150	450	NO	NO	1.1	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	G3	1.4	Liver	None	A		LIVING	85	2013	TCGA-G3-AAV3-01A-11D-A36W-01	TCGA-G3-AAV3-01A-11D-A36W-01	TCGA-G3-AAV3-01A-11D-A36X-10	TCGA-G3-AAV3-01	TCGA-G3-AAV3-01		25225fb1-c5ff-4edf-9895-11a7aa21d390		TCGA-G3-AAV3-01	TCGA-G3-AAV3-01	25225fb1-c5ff-4edf-9895-11a7aa21d390		25225fb1-c5ff-4edf-9895-11a7aa21d390	25225fb1-c5ff-4edf-9895-11a7aa21d390		TCGA-G3-AAV3-01A-11D-A36Y-05
TCGA-G3-AAV4-01	1	TCGA-G3-AAV4-01	27	1	days	TCGA-G3-AAV4	27	0	days	27	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				83	3.3	2.7	4.8	TCGA-G3-AAV4-F65940	TCGA-G3-AAV4	TCGA-G3-AAV4-01A	0	0.8	2	A	0.4	1.1	1.1	-30466	423	27	0				0	0	10	4	3,4 - Fibrous Speta		2014-10-1	FEMALE	156	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	470	0.9	1.1	NO	NO	G1						NO		true	No	M0	N0	T1	Stage I	TCGA-G3-AAV4.85CCE331-652C-4D5B-9ED6-ECA8B57AE1AF.pdf	AAV4	TUMOR FREE	79	150	400	NO	NO	1.2	NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	G3	1.2	Liver	None	A		DECEASED	56	2012	TCGA-G3-AAV4-01A-11D-A381-01	TCGA-G3-AAV4-01A-11D-A381-01	TCGA-G3-AAV4-01A-11D-A382-10	TCGA-G3-AAV4-01	TCGA-G3-AAV4-01		30325cae-b955-45a1-9803-84a42c37d130		TCGA-G3-AAV4-01	TCGA-G3-AAV4-01	30325cae-b955-45a1-9803-84a42c37d130		30325cae-b955-45a1-9803-84a42c37d130	30325cae-b955-45a1-9803-84a42c37d130		TCGA-G3-AAV4-01A-11D-A383-05
TCGA-G3-AAV5-01	0	TCGA-G3-AAV5-01	354	0	days	TCGA-G3-AAV5	117	1	days	354	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO		67	3.3	4.2	4.8	TCGA-G3-AAV5-F65955	TCGA-G3-AAV5		0	0.4		A	0.6	1.4	0.8	-24655			0	354		117	1				6 - Established Cirrhosis		2014-10-1	MALE	165	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.9	1.1		NO	G2	Liver	Locoregional Recurrence		Yes	NO	YES	No		No	M0	N0	T2	Stage II		AAV5	WITH TUMOR	326	150	400	YES	YES	1	[Discrepancy]			R0	Primary Tumor	01	Lobectomy	7th	YES	NO	G3	1.4	Liver	Macro		Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody|HBV Core Antibody	LIVING	88	2013	TCGA-G3-AAV5-01A-11D-A36W-01	TCGA-G3-AAV5-01A-11D-A36W-01	TCGA-G3-AAV5-01A-11D-A36X-10	TCGA-G3-AAV5-01	TCGA-G3-AAV5-01		e155a2ba-8842-417b-ab5a-e49339136236		TCGA-G3-AAV5-01	TCGA-G3-AAV5-01	e155a2ba-8842-417b-ab5a-e49339136236		e155a2ba-8842-417b-ab5a-e49339136236	e155a2ba-8842-417b-ab5a-e49339136236		TCGA-G3-AAV5-01A-11D-A36Y-05
TCGA-G3-AAV6-01	1	TCGA-G3-AAV6-01	65	1	days	TCGA-G3-AAV6	44	1	days	65	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Severe	53	3.4	3.9	5.2	TCGA-G3-AAV6-F65959	TCGA-G3-AAV6		0	1.6		A	0.6	1.4	0.9	-19556		65	0			44	0	0	10	57875	0 - No Fibrosis		2014-10-1	FEMALE	165	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.8	1.2		NO	G3	Liver	Intrahepatic Recurrence		No	NO	YES	No		No	M0	N0	T3a	Stage IIIA		AAV6	WITH TUMOR	303	150	400	NO	NO	1	NO			R0	Primary Tumor	01	Extended Lobectomy	7th	YES	NO	G3	1.2	Liver	Micro		Hepatitis B Surface Antigen	DECEASED	78	2013	TCGA-G3-AAV6-01A-21D-A36W-01	TCGA-G3-AAV6-01A-21D-A36W-01	TCGA-G3-AAV6-01A-21D-A36X-10	TCGA-G3-AAV6-01	TCGA-G3-AAV6-01		ebb77266-2b85-4413-b433-4c8db194467a		TCGA-G3-AAV6-01	TCGA-G3-AAV6-01	ebb77266-2b85-4413-b433-4c8db194467a		ebb77266-2b85-4413-b433-4c8db194467a	ebb77266-2b85-4413-b433-4c8db194467a		TCGA-G3-AAV6-01A-21D-A36Y-05
TCGA-G3-AAV7-01	0	TCGA-G3-AAV7-01	361	0	days	TCGA-G3-AAV7	361	0	days	361	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	38	3.3	4	4.8	TCGA-G3-AAV7-F67249	TCGA-G3-AAV7	TCGA-G3-AAV7-01A	0	0.9		A	0.6	1.4	1.1	-14229	52		0	361			0	0	10	3	5 - Nodular Formation and Incomplete Cirrhosis		2014-11-3	MALE	165	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	120	0.9	1.1	NO	NO	G2						NO		true	No	M0	N0	T2	Stage II	TCGA-G3-AAV7.0F368084-04F6-4DCE-9ADF-6B3B94D274AB.pdf	AAV7	TUMOR FREE	179	150	400	NO	NO	1	NO			R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	G3	1.4	Liver	Micro	A	Hepatitis B Surface Antigen|HBV Surface Antibody|HBV D	LIVING	58	2013	TCGA-G3-AAV7-01A-11D-A381-01	TCGA-G3-AAV7-01A-11D-A381-01	TCGA-G3-AAV7-01A-11D-A382-10	TCGA-G3-AAV7-01	TCGA-G3-AAV7-01		33a8bccc-6989-4882-828b-1d8c0b5aa91a		TCGA-G3-AAV7-01	TCGA-G3-AAV7-01	33a8bccc-6989-4882-828b-1d8c0b5aa91a		33a8bccc-6989-4882-828b-1d8c0b5aa91a	33a8bccc-6989-4882-828b-1d8c0b5aa91a		TCGA-G3-AAV7-01A-11D-A383-05
TCGA-GJ-A3OU-01	0	TCGA-GJ-A3OU-01	879	0	days	TCGA-GJ-A3OU	879	1	days	879	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				59	3.5	3.2	5.0	TCGA-GJ-A3OU-F70294	TCGA-GJ-A3OU	TCGA-GJ-A3OU-01A	0.0	0.9	1		0.6	1.4	0.6	-21671	69		0	879		879		0	25	8			2015-3-27	MALE	167	Alcohol consumption|Non-Alcoholic Fatty Liver Disease|Other	hepatic cirrhosis	Hepatocellular Carcinoma	No	C22.0	8174/3	C22.0	YES	130	0.8	1.2	NO	NO	G2	Liver	Intrahepatic Recurrence			NO	YES	No	false	No	MX	NX	T1	Stage I	TCGA-GJ-A3OU.4ABC92BD-6D5C-462D-8DDC-2A3CEE065C13.pdf	A3OU	[Discrepancy]	178	150	450	NO	NO	1.1	NO	YES		RX	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	GJ	1.0	Liver	None	A	Hepatitis  C Antibody	LIVING	172	2011	TCGA-GJ-A3OU-01A-31D-A381-01	TCGA-GJ-A3OU-01A-31D-A381-01	TCGA-GJ-A3OU-01A-31D-A382-10	TCGA-GJ-A3OU-01	TCGA-GJ-A3OU-01		5eeb70ae-b09e-4b6d-80f1-23ed3e20b33c		TCGA-GJ-A3OU-01	TCGA-GJ-A3OU-01	5eeb70ae-b09e-4b6d-80f1-23ed3e20b33c		5eeb70ae-b09e-4b6d-80f1-23ed3e20b33c	5eeb70ae-b09e-4b6d-80f1-23ed3e20b33c		TCGA-GJ-A3OU-01A-31D-A383-05
TCGA-GJ-A6C0-01	1	TCGA-GJ-A6C0-01	31	1	days	TCGA-GJ-A6C0	31	0	days	31	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				75					TCGA-GJ-A6C0	TCGA-GJ-A6C0-01A			1					-27626	310	31	0										2013-11-27	FEMALE	160	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	170			NO		G2						NO		false	No	MX	NX	T2	Stage II	TCGA-GJ-A6C0.D9F106D7-C163-46C5-8DDC-FF60ED1CF17B.pdf	A6C0					NO	NO		NO	YES		RX	Primary Tumor	01	Other (specify)	7th	YES	NO	GJ		Liver	Micro	A		DECEASED	90	2012	TCGA-GJ-A6C0-01A-12D-A30U-01	TCGA-GJ-A6C0-01A-12D-A30U-01	TCGA-GJ-A6C0-01A-12D-A30V-10	TCGA-GJ-A6C0-01	TCGA-GJ-A6C0-01	FB0BE047-479A-4F5D-80F6-4654E627B05F	896ab3e0-3ea4-4459-b0bf-9ccd6b74578c	TCGA-GJ-A6C0-01A-12D-A30V-10	TCGA-GJ-A6C0-01	TCGA-GJ-A6C0-01	896ab3e0-3ea4-4459-b0bf-9ccd6b74578c	TCGA-GJ-A6C0-01A-12D-A30V-10	896ab3e0-3ea4-4459-b0bf-9ccd6b74578c	896ab3e0-3ea4-4459-b0bf-9ccd6b74578c	TCGA-GJ-A6C0-01A-12D-A30V-10	TCGA-GJ-A6C0-01A-12D-A30Y-05
TCGA-GJ-A9DB-01	1	TCGA-GJ-A9DB-01	67	1	days	TCGA-GJ-A9DB	67	0	days	67	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				68	3.5	4.5	5		TCGA-GJ-A9DB	TCGA-GJ-A9DB-01A	0.0	0.5	1		0.8	1.4	1.1	-25020	132	67	0										2014-5-7	MALE	187	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	540	0.7	1.2	NO		G2						NO		false	No	MX	N0	T1	Stage I	TCGA-GJ-A9DB.8B2D3FA5-D673-4B70-B153-7EACE17A50E0.pdf	A9DB		144	150	450	NO	NO	0.9	NO	YES		R0	Primary Tumor	01	Other (specify)	7th	YES	NO	GJ	1.0	Liver	None	A		DECEASED	96	2013	TCGA-GJ-A9DB-01A-11D-A36W-01	TCGA-GJ-A9DB-01A-11D-A36W-01	TCGA-GJ-A9DB-01A-11D-A36X-10	TCGA-GJ-A9DB-01	TCGA-GJ-A9DB-01	6C5CDCF6-58BB-4CD3-BFA5-1F07E29A8E1C	60f5dada-7b3d-49b8-8a96-f2143e1d4c71		TCGA-GJ-A9DB-01	TCGA-GJ-A9DB-01	60f5dada-7b3d-49b8-8a96-f2143e1d4c71		60f5dada-7b3d-49b8-8a96-f2143e1d4c71	60f5dada-7b3d-49b8-8a96-f2143e1d4c71		TCGA-GJ-A9DB-01A-11D-A36Y-05
TCGA-HP-A5MZ-01	1	TCGA-HP-A5MZ-01	91	1	days	TCGA-HP-A5MZ	91	0	days	91	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				78				TCGA-HP-A5MZ-F64772	TCGA-HP-A5MZ	TCGA-HP-A5MZ-01A					62	120	124	-22702		91	0										2014-9-11	MALE	185	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	160	0.9	1.1	NO	NO	G2						NO		false	No	M0	NX	T1	Stage I	TCGA-HP-A5MZ.BD5F2C9B-16EE-42B2-B09B-F9BE4FCB2F75.pdf	A5MZ	TUMOR FREE	231	150	400	NO	NO	1.0	NO			R0	Primary Tumor	01	Lobectomy	6th	NO	YES	HP		Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody	DECEASED	82		TCGA-HP-A5MZ-01A-21D-A27H-01	TCGA-HP-A5MZ-01A-21D-A27H-01	TCGA-HP-A5MZ-01A-21D-A27I-10	TCGA-HP-A5MZ-01	TCGA-HP-A5MZ-01	EE037571-4D80-4766-81A9-7E1214F43496	c3d40f5f-e3df-4bf7-867d-7d17fa8fc3ad	TCGA-HP-A5MZ-01A-21D-A27I-10	TCGA-HP-A5MZ-01	TCGA-HP-A5MZ-01	c3d40f5f-e3df-4bf7-867d-7d17fa8fc3ad	TCGA-HP-A5MZ-01A-21D-A27I-10	c3d40f5f-e3df-4bf7-867d-7d17fa8fc3ad	c3d40f5f-e3df-4bf7-867d-7d17fa8fc3ad	TCGA-HP-A5MZ-01A-21D-A27I-10	TCGA-HP-A5MZ-01A-21D-A27W-05
TCGA-HP-A5N0-01	1	TCGA-HP-A5N0-01	1147	1	days	TCGA-HP-A5N0	179	1	days	1147	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	90	3.5	2.6	4.8	TCGA-HP-A5N0-F70727	TCGA-HP-A5N0	TCGA-HP-A5N0-01A			3		0	0.9	0.5	-32120		1147	0			179	0				0 - No Fibrosis		2015-3-2	FEMALE	156	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8174/3	C22.0	YES	350	0.9	1.2	NO	NO		Liver	Locoregional Recurrence		No	NO	YES	No	false	No	M0	NX	TX		TCGA-HP-A5N0.0221A6F3-34F5-407E-8548-B62F27F66FCE.pdf	A5N0	WITH TUMOR				NO	NO	1.2	NO	YES		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	HP		Liver		A		DECEASED	65		TCGA-HP-A5N0-01A-11D-A28W-01	TCGA-HP-A5N0-01A-11D-A28W-01	TCGA-HP-A5N0-01A-11D-A28X-10	TCGA-HP-A5N0-01	TCGA-HP-A5N0-01	3630E5F3-9CEF-49D8-BFE5-2B3EDC4E200D	10285abf-91af-443f-8e5e-61b87c003165	TCGA-HP-A5N0-01A-11D-A28X-10	TCGA-HP-A5N0-01	TCGA-HP-A5N0-01	10285abf-91af-443f-8e5e-61b87c003165	TCGA-HP-A5N0-01A-11D-A28X-10	10285abf-91af-443f-8e5e-61b87c003165	10285abf-91af-443f-8e5e-61b87c003165	TCGA-HP-A5N0-01A-11D-A28X-10	TCGA-HP-A5N0-01A-11D-A28Y-05
TCGA-K7-A5RF-01	0	TCGA-K7-A5RF-01	631	0	days	TCGA-K7-A5RF	631	0	days	631	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				64				TCGA-K7-A5RF-F64037	TCGA-K7-A5RF	TCGA-K7-A5RF-01A								-23557	102		0	631						5			2014-8-25	MALE	177	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1350			NO	NO	G1						NO		true	No	MX	NX	T1	Stage I	TCGA-K7-A5RF.04C26B7B-66EE-4F20-A059-52E19557C268.pdf	A5RF	TUMOR FREE				YES	NO		NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	K7		Liver		A	Hepatitis C Virus R	LIVING	75	2012	TCGA-K7-A5RF-01A-11D-A28W-01	TCGA-K7-A5RF-01A-11D-A28W-01	TCGA-K7-A5RF-01A-11D-A28X-10	TCGA-K7-A5RF-01	TCGA-K7-A5RF-01	6DBDC9AF-E565-46A3-BA78-14CE7C982DBF	af1ae913-a82c-4d3f-9705-b45685a434ab	TCGA-K7-A5RF-01A-11D-A28X-10	TCGA-K7-A5RF-01	TCGA-K7-A5RF-01	af1ae913-a82c-4d3f-9705-b45685a434ab	TCGA-K7-A5RF-01A-11D-A28X-10	af1ae913-a82c-4d3f-9705-b45685a434ab	af1ae913-a82c-4d3f-9705-b45685a434ab	TCGA-K7-A5RF-01A-11D-A28X-10	TCGA-K7-A5RF-01A-11D-A28Y-05
TCGA-K7-A5RG-01	0	TCGA-K7-A5RG-01	519	0	days	TCGA-K7-A5RG	519	0	days	519	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				66				TCGA-K7-A5RG-F64039	TCGA-K7-A5RG	TCGA-K7-A5RG-01A			1					-24218	100		0	519						19			2014-8-25	MALE	173	Alcohol consumption|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	630			NO	NO	G1						NO		true	No	MX	NX	T1	Stage I	TCGA-K7-A5RG.AADEAE33-3867-4F77-AAA6-072471B5A397.pdf	A5RG	TUMOR FREE				NO	NO		NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	K7		Liver	None	A	HCV Genotype	LIVING	123	2012	TCGA-K7-A5RG-01A-11D-A28W-01	TCGA-K7-A5RG-01A-11D-A28W-01	TCGA-K7-A5RG-01A-11D-A28X-10	TCGA-K7-A5RG-01	TCGA-K7-A5RG-01	5046E74A-24C1-4365-A29E-1E5D89869E92	a8a41ad6-263c-4c76-987f-2f8a7dffefa1	TCGA-K7-A5RG-01A-11D-A28X-10	TCGA-K7-A5RG-01	TCGA-K7-A5RG-01	a8a41ad6-263c-4c76-987f-2f8a7dffefa1	TCGA-K7-A5RG-01A-11D-A28X-10	a8a41ad6-263c-4c76-987f-2f8a7dffefa1	a8a41ad6-263c-4c76-987f-2f8a7dffefa1	TCGA-K7-A5RG-01A-11D-A28X-10	TCGA-K7-A5RG-01A-11D-A28Y-05
TCGA-K7-A6G5-01	0	TCGA-K7-A6G5-01	512	0	days	TCGA-K7-A6G5	512	0	days	512	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				66				TCGA-K7-A6G5-F64040	TCGA-K7-A6G5	TCGA-K7-A6G5-01A								-24233	31		0	512			0						2014-8-25	MALE	184	Alcohol consumption|Hepatitis B|Hepatitis C|Hemochromatosis		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	60			NO	NO	G2						NO		true	No	MX	N0	T1	Stage I	TCGA-K7-A6G5.BA14915C-0D72-4A11-AAFA-DD51FC6309B2.pdf	A6G5	TUMOR FREE				NO	NO		NO			RX	Primary Tumor	01	Lobectomy	7th	YES	NO	K7		Liver	None	A	HCV Genotype	LIVING	80	2013	TCGA-K7-A6G5-01A-11D-A30U-01	TCGA-K7-A6G5-01A-11D-A30U-01	TCGA-K7-A6G5-01A-11D-A30V-10	TCGA-K7-A6G5-01	TCGA-K7-A6G5-01		42e83563-54b2-4848-b657-6367e71eac65	TCGA-K7-A6G5-01A-11D-A30V-10	TCGA-K7-A6G5-01	TCGA-K7-A6G5-01	42e83563-54b2-4848-b657-6367e71eac65	TCGA-K7-A6G5-01A-11D-A30V-10	42e83563-54b2-4848-b657-6367e71eac65	42e83563-54b2-4848-b657-6367e71eac65	TCGA-K7-A6G5-01A-11D-A30V-10	TCGA-K7-A6G5-01A-11D-A30Y-05
TCGA-K7-AAU7-01	0	TCGA-K7-AAU7-01	359	0	days	TCGA-K7-AAU7	58	1	days	359	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				61				TCGA-K7-AAU7-F70895	TCGA-K7-AAU7				2	A				-22476			0	359		58	0	0	10	290			2015-3-10	MALE		Hepatitis C|Hemochromatosis		Hepatocholangiocarcinoma (Mixed)	No	C22.0	8180/3	C22.0	YES		0	1.9		NO	G2	Liver	Intrahepatic Recurrence				YES			No	MX	NX	T2a	Stage II		AAU7	WITH TUMOR	87	150	450	NO	YES	0.9	NO	YES		RX	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	K7		Liver	Micro			LIVING		2013	TCGA-K7-AAU7-01A-11D-A381-01	TCGA-K7-AAU7-01A-11D-A381-01	TCGA-K7-AAU7-01A-11D-A382-10	TCGA-K7-AAU7-01	TCGA-K7-AAU7-01		e9f1e235-52ff-45fd-84ad-52135124cec9		TCGA-K7-AAU7-01	TCGA-K7-AAU7-01	e9f1e235-52ff-45fd-84ad-52135124cec9		e9f1e235-52ff-45fd-84ad-52135124cec9	e9f1e235-52ff-45fd-84ad-52135124cec9		TCGA-K7-AAU7-01A-11D-A383-05
TCGA-KR-A7K0-01	1	TCGA-KR-A7K0-01	65	1	days	TCGA-KR-A7K0	65	0	days	65	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				65	3.5	2.8	4.9		TCGA-KR-A7K0		0.2	1.3			0.7	1.3	0.7	-23974		65	0					0	8	11			2014-5-28	MALE	174	Alcohol consumption|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES						G1						NO			Yes	M0	N0	T1	Stage I		A7K0	TUMOR FREE	102	150	400	NO	NO	1.4	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	KR	1.2	Liver	None		Hepatitis  C Antibody	DECEASED	66	2013	TCGA-KR-A7K0-01A-12D-A33P-01	TCGA-KR-A7K0-01A-12D-A33P-01	TCGA-KR-A7K0-01A-12D-A33Q-10	TCGA-KR-A7K0-01	TCGA-KR-A7K0-01		e926e7f1-c849-47b4-b466-b1c2d187fdd2	TCGA-KR-A7K0-01A-12D-A33Q-10	TCGA-KR-A7K0-01	TCGA-KR-A7K0-01	e926e7f1-c849-47b4-b466-b1c2d187fdd2	TCGA-KR-A7K0-01A-12D-A33Q-10	e926e7f1-c849-47b4-b466-b1c2d187fdd2	e926e7f1-c849-47b4-b466-b1c2d187fdd2	TCGA-KR-A7K0-01A-12D-A33Q-10	TCGA-KR-A7K0-01A-12D-A341-05
TCGA-KR-A7K2-01	0	TCGA-KR-A7K2-01	829	0	days	TCGA-KR-A7K2	829	0	days	829	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				64	3.5	3.3	4.9	TCGA-KR-A7K2-F72748	TCGA-KR-A7K2	TCGA-KR-A7K2-01A	0.2	1.5			0.7	1.3	1.1	-23699	85		0	829				0	8	14			2015-11-24	MALE	166	Hepatitis C		Hepatocholangiocarcinoma (Mixed)	No	C22.0	8180/3	C22.0	YES	70			NO	NO	G1						NO		false	No	M0	N0	T1	Stage I	TCGA-KR-A7K2.5121C5D6-3BCB-4A0F-B18A-51BA4E87778B.pdf	A7K2	TUMOR FREE	178	150	400	NO	NO	1	NO			R0	Primary Tumor	01	Other (specify)	7th	NO	YES	KR	1.2	Liver	None	A	HCV Genotype	LIVING	79	2013	TCGA-KR-A7K2-01A-12D-A33P-01	TCGA-KR-A7K2-01A-12D-A33P-01	TCGA-KR-A7K2-01A-12D-A33Q-10	TCGA-KR-A7K2-01	TCGA-KR-A7K2-01		2242b367-081f-4369-9761-bcd225c05124	TCGA-KR-A7K2-01A-12D-A33Q-10	TCGA-KR-A7K2-01	TCGA-KR-A7K2-01	2242b367-081f-4369-9761-bcd225c05124	TCGA-KR-A7K2-01A-12D-A33Q-10	2242b367-081f-4369-9761-bcd225c05124	2242b367-081f-4369-9761-bcd225c05124	TCGA-KR-A7K2-01A-12D-A33Q-10	TCGA-KR-A7K2-01A-12D-A341-05
TCGA-KR-A7K7-01	0	TCGA-KR-A7K7-01	951	0	days	TCGA-KR-A7K7	239	1	days	951	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO		61	3.5	3.4	4.9	TCGA-KR-A7K7-F71440	TCGA-KR-A7K7	TCGA-KR-A7K7-01A	0.2	1.4			0.5	1.0	0.8	-22587	461		0	951		239		0	8	308836			2015-3-25	FEMALE	168	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	140			NO	NO	G1	Other, specify	Extrahepatic Recurrence	Adrenal	No	NO	YES	No	false	Yes	M0	N0	T2	Stage II	TCGA-KR-A7K7.8CE97410-9210-4B15-97FE-E61722535975.pdf	A7K7	WITH TUMOR	130	150	400	NO	NO	1.0	NO			R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	KR	1.2	Liver	Micro	A		LIVING	125	2012	TCGA-KR-A7K7-01A-11D-A33B-01	TCGA-KR-A7K7-01A-11D-A33B-01	TCGA-KR-A7K7-01A-11D-A33K-10	TCGA-KR-A7K7-01	TCGA-KR-A7K7-01	351556A0-38B2-41BD-8B08-8532588F0A8F	c926906f-e63c-41e4-b117-87cf91206132	TCGA-KR-A7K7-01A-11D-A33K-10	TCGA-KR-A7K7-01	TCGA-KR-A7K7-01	c926906f-e63c-41e4-b117-87cf91206132	TCGA-KR-A7K7-01A-11D-A33K-10	c926906f-e63c-41e4-b117-87cf91206132	c926906f-e63c-41e4-b117-87cf91206132	TCGA-KR-A7K7-01A-11D-A33K-10	TCGA-KR-A7K7-01A-11D-A33L-05
TCGA-KR-A7K8-01	0	TCGA-KR-A7K8-01	906	0	days	TCGA-KR-A7K8	906	0	days	906	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	57	3.5	3.3	4.9	TCGA-KR-A7K8-F71274	TCGA-KR-A7K8	TCGA-KR-A7K8-01A	0.2	1.9	1		0.7	1.3	1.1	-20914	435		0	906				0	8	154			2015-3-24	MALE	170	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	80			NO	NO	G1						NO		false	No	M0	N0	T1	Stage I	TCGA-KR-A7K8.9B449A83-1172-4EE0-9337-27BD5D3ECF4D.pdf	A7K8	TUMOR FREE	103	150	400	NO	NO	1.3	NO	YES		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	KR	1.2	Liver	None	A		LIVING	109	2012	TCGA-KR-A7K8-01A-11D-A33B-01	TCGA-KR-A7K8-01A-11D-A33B-01	TCGA-KR-A7K8-01A-11D-A33K-10	TCGA-KR-A7K8-01	TCGA-KR-A7K8-01		1fbb2486-5c98-42af-a8b7-3c771a30702c	TCGA-KR-A7K8-01A-11D-A33K-10	TCGA-KR-A7K8-01	TCGA-KR-A7K8-01	1fbb2486-5c98-42af-a8b7-3c771a30702c	TCGA-KR-A7K8-01A-11D-A33K-10	1fbb2486-5c98-42af-a8b7-3c771a30702c	1fbb2486-5c98-42af-a8b7-3c771a30702c	TCGA-KR-A7K8-01A-11D-A33K-10	TCGA-KR-A7K8-01A-11D-A33L-05
TCGA-LG-A6GG-01	0	TCGA-LG-A6GG-01	387	0	days	TCGA-LG-A6GG	387	0	days	387	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	79	3.4	3.7	4.8	TCGA-LG-A6GG-F59890	TCGA-LG-A6GG	TCGA-LG-A6GG-01A	0.2	0.8		A	0.4	1.1	0.6	-28871	35		0	387			0						2014-5-22	FEMALE	158	Other	Cryptogenic Cirrhosis	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1140	9.4	12.2	NO	NO	G2						NO		true	Yes	M0	NX	T2	Stage II	TCGA-LG-A6GG.A7F1EA5C-5797-42D1-AD35-E2E529B26409.pdf	A6GG	TUMOR FREE	93	150	450	NO	NO	12.2	NO			R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	LG	1.0	Liver	Micro	A		LIVING	65	2013	TCGA-LG-A6GG-01A-11D-A30U-01	TCGA-LG-A6GG-01A-11D-A30U-01	TCGA-LG-A6GG-01A-11D-A30V-10	TCGA-LG-A6GG-01	TCGA-LG-A6GG-01	471985D8-4D5A-44A6-9659-B1B3F286BCA5	dc1a8da9-58bf-4394-a9f8-8e14da005ba7	TCGA-LG-A6GG-01A-11D-A30V-10	TCGA-LG-A6GG-01	TCGA-LG-A6GG-01	dc1a8da9-58bf-4394-a9f8-8e14da005ba7	TCGA-LG-A6GG-01A-11D-A30V-10	dc1a8da9-58bf-4394-a9f8-8e14da005ba7	dc1a8da9-58bf-4394-a9f8-8e14da005ba7	TCGA-LG-A6GG-01A-11D-A30V-10	TCGA-LG-A6GG-01A-11D-A30Y-05
TCGA-LG-A9QC-01	0	TCGA-LG-A9QC-01	425	0	days	TCGA-LG-A9QC	425	0	days	425	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	48	3.5	4.7	5.0	TCGA-LG-A9QC-F69223	TCGA-LG-A9QC	TCGA-LG-A9QC-01A	0.2	2.8	1		0.5	1.3	0.8	-17842	62		0	425									2014-12-30	MALE	188	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1080	9.4	12.2	NO	NO	G2						NO		true	No	M0	NX	T1	Stage I	TCGA-LG-A9QC.AD8045A1-61EA-4713-9C8D-9AF200DB1424.pdf	A9QC	TUMOR FREE	275	150	450	NO	NO	12.1	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	LG	1.0	Liver	Micro	A		LIVING	103	2013	TCGA-LG-A9QC-01A-11D-A36W-01	TCGA-LG-A9QC-01A-11D-A36W-01	TCGA-LG-A9QC-01A-11D-A36X-10	TCGA-LG-A9QC-01	TCGA-LG-A9QC-01		84c348d8-a1a8-4ffe-938d-3a6789004e7a		TCGA-LG-A9QC-01	TCGA-LG-A9QC-01	84c348d8-a1a8-4ffe-938d-3a6789004e7a		84c348d8-a1a8-4ffe-938d-3a6789004e7a	84c348d8-a1a8-4ffe-938d-3a6789004e7a		TCGA-LG-A9QC-01A-11D-A36Y-05
TCGA-LG-A9QD-01	0	TCGA-LG-A9QD-01	366	0	days	TCGA-LG-A9QD	366	0	days	366	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	68	3.4	2.9	4.8	TCGA-LG-A9QD-F69200	TCGA-LG-A9QD	TCGA-LG-A9QD-01A	0.0	0.5	3		0.7	1.5	0.9	-24969	28		0	366									2014-12-30	MALE	168	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	1580			NO	NO	G2						NO		true	No	M0	N0	T3a	Stage IIIA	TCGA-LG-A9QD.D5BAD949-7001-4FAC-A7B4-E9B426A53A76.pdf	A9QD	WITH TUMOR	320	150	450	NO	YES		NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	LG	1.2	Liver	None	A		LIVING	74	2013	TCGA-LG-A9QD-01A-11D-A381-01	TCGA-LG-A9QD-01A-11D-A381-01	TCGA-LG-A9QD-01A-11D-A382-10	TCGA-LG-A9QD-01	TCGA-LG-A9QD-01		42f6b380-6c70-41ec-bac2-54fec52b4a49		TCGA-LG-A9QD-01	TCGA-LG-A9QD-01	42f6b380-6c70-41ec-bac2-54fec52b4a49		42f6b380-6c70-41ec-bac2-54fec52b4a49	42f6b380-6c70-41ec-bac2-54fec52b4a49		TCGA-LG-A9QD-01A-11D-A383-05
TCGA-MI-A75C-01	0	TCGA-MI-A75C-01	291	0	days	TCGA-MI-A75C	291	0	days	291	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				64	3.5	4.0	4.9	TCGA-MI-A75C-F62894	TCGA-MI-A75C		0.2	1.1		A	0.6	1.3	1.0	-23441			0	291			1	0	9	4			2014-7-28	MALE	175	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES					YES	G3						NO			No	M0	N0	T1	Stage I		A75C	TUMOR FREE	243	150	450	NO	NO		NO			R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	MI	1.2	Liver	None		HBV Surface Antibody	LIVING	84	2012	TCGA-MI-A75C-01A-11D-A32F-01	TCGA-MI-A75C-01A-11D-A32F-01	TCGA-MI-A75C-01A-11D-A32G-10	TCGA-MI-A75C-01	TCGA-MI-A75C-01		fe4a54d5-3270-4b53-a813-159b68764037	TCGA-MI-A75C-01A-11D-A32G-10	TCGA-MI-A75C-01	TCGA-MI-A75C-01	fe4a54d5-3270-4b53-a813-159b68764037	TCGA-MI-A75C-01A-11D-A32G-10	fe4a54d5-3270-4b53-a813-159b68764037	fe4a54d5-3270-4b53-a813-159b68764037	TCGA-MI-A75C-01A-11D-A32G-10	TCGA-MI-A75C-01A-11D-A32R-05
TCGA-MI-A75E-01	0	TCGA-MI-A75E-01	507	0	days	TCGA-MI-A75E	507	0	days	507	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				61	3.5	3.0	4.9	TCGA-MI-A75E-F62895	TCGA-MI-A75E	TCGA-MI-A75E-01A	0.2	1.1	1	A	0.6	1.3		-22457	157		0	507			1	0	9	5	1,2 - Portal Fibrosis		2014-7-28	MALE	175	Alcohol consumption|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	80			NO	NO	G2						NO		true	No	M0	N0	T4	Stage IIIC	TCGA-MI-A75E.F88435AB-695B-4481-BE6C-93FEE7954465.pdf	A75E	TUMOR FREE	158	150	450	NO	NO		NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	MI	1.2	Liver	Micro	A	HCV Genotype	LIVING	103	2013	TCGA-MI-A75E-01A-11D-A32F-01	TCGA-MI-A75E-01A-11D-A32F-01	TCGA-MI-A75E-01A-11D-A32G-10	TCGA-MI-A75E-01	TCGA-MI-A75E-01		1be67822-b74f-4321-b7b9-2d85032d3ce6	TCGA-MI-A75E-01A-11D-A32G-10	TCGA-MI-A75E-01	TCGA-MI-A75E-01	1be67822-b74f-4321-b7b9-2d85032d3ce6	TCGA-MI-A75E-01A-11D-A32G-10	1be67822-b74f-4321-b7b9-2d85032d3ce6	1be67822-b74f-4321-b7b9-2d85032d3ce6	TCGA-MI-A75E-01A-11D-A32G-10	TCGA-MI-A75E-01A-11D-A32R-05
TCGA-MI-A75G-01	0	TCGA-MI-A75G-01	698	0	days	TCGA-MI-A75G	698	0	days	698	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				63	3.5	2.3	4.9	TCGA-MI-A75G-F58603	TCGA-MI-A75G	TCGA-MI-A75G-01A	0.2	1.7	1	B	0.6	1.3	0.5	-23284	427		0	698			1	0	9	6	6 - Established Cirrhosis		2014-7-28	MALE	178	Alcohol consumption|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	80			NO	YES	G2						NO		true	No	M0	N0	T2	Stage II	TCGA-MI-A75G.30FAEBBF-0EEE-40F5-9463-50FDDE258D4B.pdf	A75G	TUMOR FREE	160	150	450	NO	NO		NO	YES		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	MI	1.2	Liver	None	A	HCV Genotype	LIVING	69	2012	TCGA-MI-A75G-01A-11D-A32F-01	TCGA-MI-A75G-01A-11D-A32F-01	TCGA-MI-A75G-01A-11D-A32G-10	TCGA-MI-A75G-01	TCGA-MI-A75G-01		5d93dde1-846e-4ba9-b27e-107a9570deed	TCGA-MI-A75G-01A-11D-A32G-10	TCGA-MI-A75G-01	TCGA-MI-A75G-01	5d93dde1-846e-4ba9-b27e-107a9570deed	TCGA-MI-A75G-01A-11D-A32G-10	5d93dde1-846e-4ba9-b27e-107a9570deed	5d93dde1-846e-4ba9-b27e-107a9570deed	TCGA-MI-A75G-01A-11D-A32G-10	TCGA-MI-A75G-01A-11D-A32R-05
TCGA-MI-A75H-01	0	TCGA-MI-A75H-01	747	0	days	TCGA-MI-A75H	307	1	days	747	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		77	3.5	3.3	4.9	TCGA-MI-A75H-F68684	TCGA-MI-A75H	TCGA-MI-A75H-01A	0.2	2.3		B	0.6	1.3		-28371	287		0	747		307	1	0	9	11	6 - Established Cirrhosis		2015-1-9	MALE	173	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	30			NO	NO		Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	Yes	MX	NX			TCGA-MI-A75H.57959509-A138-4131-BE87-9A77ED365702.pdf	A75H	WITH TUMOR	138	150	450	YES	NO	1.1	NO		R0	R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	MI	1.2	Liver	Micro	A	HCV Genotype	LIVING	84	2012	TCGA-MI-A75H-01A-11D-A32F-01	TCGA-MI-A75H-01A-11D-A32F-01	TCGA-MI-A75H-01A-11D-A32G-10	TCGA-MI-A75H-01	TCGA-MI-A75H-01		5abe35ae-90bf-411e-b96f-b92c00718696	TCGA-MI-A75H-01A-11D-A32G-10	TCGA-MI-A75H-01	TCGA-MI-A75H-01	5abe35ae-90bf-411e-b96f-b92c00718696	TCGA-MI-A75H-01A-11D-A32G-10	5abe35ae-90bf-411e-b96f-b92c00718696	5abe35ae-90bf-411e-b96f-b92c00718696	TCGA-MI-A75H-01A-11D-A32G-10	TCGA-MI-A75H-01A-11D-A32R-05
TCGA-MI-A75I-01	0	TCGA-MI-A75I-01	630	0	days	TCGA-MI-A75I	265	1	days	630	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				61				TCGA-MI-A75I-F62897	TCGA-MI-A75I	TCGA-MI-A75I-01A			3	A				-22341	665		0	630		265	1						2014-7-28	MALE	188	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	50			NO	NO	G1	Liver					YES		true	No	MX	NX	T2		TCGA-MI-A75I.4630A897-45DC-4122-BB86-A2943FE27CEA.pdf	A75I		153	150	450	NO	NO		NO	YES		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	MI		Liver		A		LIVING	100	2011	TCGA-MI-A75I-01A-11D-A32F-01	TCGA-MI-A75I-01A-11D-A32F-01	TCGA-MI-A75I-01A-11D-A32G-10	TCGA-MI-A75I-01	TCGA-MI-A75I-01		4b2926c2-e50c-43ed-93df-a85901fcf0a2	TCGA-MI-A75I-01A-11D-A32G-10	TCGA-MI-A75I-01	TCGA-MI-A75I-01	4b2926c2-e50c-43ed-93df-a85901fcf0a2	TCGA-MI-A75I-01A-11D-A32G-10	4b2926c2-e50c-43ed-93df-a85901fcf0a2	4b2926c2-e50c-43ed-93df-a85901fcf0a2	TCGA-MI-A75I-01A-11D-A32G-10	TCGA-MI-A75I-01A-11D-A32R-05
TCGA-MR-A520-01	0	TCGA-MR-A520-01	229	0	days	TCGA-MR-A520	229	0	days	229	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				58				TCGA-MR-A520-F48052	TCGA-MR-A520	TCGA-MR-A520-01A								-21398	106		0	229									2012-9-14	MALE	179	Other	Moderate alcohol consumption, anti TB drug used for TB positive testing	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	270			NO	NO	G1						NO		true	No	MX	NX	T1	Stage I	TCGA-MR-A520.FA4ACC09-F22B-4253-8667-6C04369E5DCA.pdf	A520	TUMOR FREE				NO	NO		NO				Primary Tumor	01	Lobectomy	7th	YES	NO	MR		Liver		A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody	LIVING	104	2012	TCGA-MR-A520-01A-11D-A25U-01	TCGA-MR-A520-01A-11D-A25U-01	TCGA-MR-A520-01A-11D-A25V-10	TCGA-MR-A520-01	TCGA-MR-A520-01	997F554C-50F9-482F-B08B-6AD76043FCA4	ee0b8b56-4246-45c7-800c-e8d37c8d6c4d	TCGA-MR-A520-01A-11D-A25V-10	TCGA-MR-A520-01	TCGA-MR-A520-01	ee0b8b56-4246-45c7-800c-e8d37c8d6c4d	TCGA-MR-A520-01A-11D-A25V-10	ee0b8b56-4246-45c7-800c-e8d37c8d6c4d	ee0b8b56-4246-45c7-800c-e8d37c8d6c4d	TCGA-MR-A520-01A-11D-A25V-10	TCGA-MR-A520-01A-11D-A264-05
TCGA-MR-A8JO-01	0	TCGA-MR-A8JO-01	330	0	days	TCGA-MR-A8JO	330	0	days	330	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				34	3.9	4.1	5.1	TCGA-MR-A8JO-F58923	TCGA-MR-A8JO	TCGA-MR-A8JO-01A	0.2	0.8						-12669	184		0	330						2			2014-4-28	MALE	196	Alcohol consumption		Fibrolamellar Carcinoma	No	C22.0	8171/3	C22.0	YES	350			NO	NO	G3						NO		true	No	MX	N0	T1	Stage I	TCGA-MR-A8JO.DA03F6F5-2579-45B7-954B-8C0F8EFD0F75.pdf	A8JO	TUMOR FREE	162	150	450	NO	NO		NO	NO		RX	Primary Tumor	01	Lobectomy	7th	YES	NO	MR	1.3	Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody	LIVING	90	2013	TCGA-MR-A8JO-01A-12D-A35Y-01	TCGA-MR-A8JO-01A-12D-A35Y-01	TCGA-MR-A8JO-01A-12D-A35Z-10	TCGA-MR-A8JO-01	TCGA-MR-A8JO-01	B029C2F8-1F50-49BF-B2F1-84B6D973AE0E	c43df6db-5556-449c-bbc6-a337873c588b		TCGA-MR-A8JO-01	TCGA-MR-A8JO-01	c43df6db-5556-449c-bbc6-a337873c588b		c43df6db-5556-449c-bbc6-a337873c588b	c43df6db-5556-449c-bbc6-a337873c588b		TCGA-MR-A8JO-01A-12D-A369-05
TCGA-NI-A4U2-01	1	TCGA-NI-A4U2-01	1791	1	days	TCGA-NI-A4U2			days	1791	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	71					TCGA-NI-A4U2	TCGA-NI-A4U2-01A			3				0.8	-26011	2802	1791	0				0			5	1,2 - Portal Fibrosis		2013-6-28	MALE	171	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	320			NO		G1						YES		false	No	MX	NX	T3	Stage IIIA	TCGA-NI-A4U2.3AC56788-7CF9-4E6E-B1B8-7620A33E32A0.pdf	A4U2	WITH TUMOR	299			NO	NO	1.0	NO	YES		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	NI		Liver	None	A		DECEASED	82	2005	TCGA-NI-A4U2-01A-11D-A28W-01	TCGA-NI-A4U2-01A-11D-A28W-01	TCGA-NI-A4U2-01A-11D-A28X-10	TCGA-NI-A4U2-01	TCGA-NI-A4U2-01	5CFD632E-6487-4356-AF69-2AB9F0CDA1A9	16336ca0-8d66-4a19-8a1a-3778aac6f291	TCGA-NI-A4U2-01A-11D-A28X-10	TCGA-NI-A4U2-01	TCGA-NI-A4U2-01	16336ca0-8d66-4a19-8a1a-3778aac6f291	TCGA-NI-A4U2-01A-11D-A28X-10	16336ca0-8d66-4a19-8a1a-3778aac6f291	16336ca0-8d66-4a19-8a1a-3778aac6f291	TCGA-NI-A4U2-01A-11D-A28X-10	TCGA-NI-A4U2-01A-11D-A28Y-05
TCGA-NI-A8LF-01	0	TCGA-NI-A8LF-01	799	0	days	TCGA-NI-A8LF	799	0	days	799	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	74		1.2		TCGA-NI-A8LF-F69826	TCGA-NI-A8LF	TCGA-NI-A8LF-01A		0.6	1				15	-27162	422		0	799			1						2015-1-21	MALE	171	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	240			NO	NO	G3						NO		true	No	MX	NX	T1	Stage I	TCGA-NI-A8LF.5B4751DF-719F-4F2B-8D27-D69E480F6881.pdf	A8LF	TUMOR FREE	132			NO	NO		NO	YES		R0	Primary Tumor	01	Other (specify)	7th	NO	YES	NI		Liver	None	A		LIVING	104	2012	TCGA-NI-A8LF-01A-11D-A35Y-01	TCGA-NI-A8LF-01A-11D-A35Y-01	TCGA-NI-A8LF-01A-11D-A35Z-10	TCGA-NI-A8LF-01	TCGA-NI-A8LF-01	BFC51C69-BAF3-4872-A2F5-EDC4BC83FAF4	137c4106-77b9-4834-a060-6bf0af71ae08		TCGA-NI-A8LF-01	TCGA-NI-A8LF-01	137c4106-77b9-4834-a060-6bf0af71ae08		137c4106-77b9-4834-a060-6bf0af71ae08	137c4106-77b9-4834-a060-6bf0af71ae08		TCGA-NI-A8LF-01A-11D-A369-05
TCGA-O8-A75V-01	0	TCGA-O8-A75V-01	538	0	days	TCGA-O8-A75V	538	0	days	538	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	54	2.9	3.8	4.4	TCGA-O8-A75V-F66431	TCGA-O8-A75V	TCGA-O8-A75V-01A	0.3	1.9	1	A	0.50	1.50	1	-19850	142		0	538				0	7	7	6 - Established Cirrhosis		2014-10-16	MALE	180	Alcohol consumption|Hepatitis B|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	270	9.3	13.1	NO	NO	G2						NO		true	No	MX	NX	T1	Stage I	TCGA-O8-A75V.F3642560-1DE2-43D1-A8B5-06308AFF325E.pdf	A75V	TUMOR FREE	211	140	450	NO	NO	9.1	NO	YES		R1	Primary Tumor	01	Other (specify)	7th	YES	NO	O8	1.2	Liver	None	A		LIVING	92	2013	TCGA-O8-A75V-01A-11D-A32F-01	TCGA-O8-A75V-01A-11D-A32F-01	TCGA-O8-A75V-01A-11D-A32G-10	TCGA-O8-A75V-01	TCGA-O8-A75V-01	AB81048A-7344-493B-85D3-CDAC61D6D6AB	a76c84d3-7243-465b-bbfe-087dbfba4b24	TCGA-O8-A75V-01A-11D-A32G-10	TCGA-O8-A75V-01	TCGA-O8-A75V-01	a76c84d3-7243-465b-bbfe-087dbfba4b24	TCGA-O8-A75V-01A-11D-A32G-10	a76c84d3-7243-465b-bbfe-087dbfba4b24	a76c84d3-7243-465b-bbfe-087dbfba4b24	TCGA-O8-A75V-01A-11D-A32G-10	TCGA-O8-A75V-01A-11D-A32R-05
TCGA-PD-A5DF-01	1	TCGA-PD-A5DF-01	639	1	days	TCGA-PD-A5DF	639	0	days	639	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				58					TCGA-PD-A5DF	TCGA-PD-A5DF-01A								-21414	1906	639	0										2013-4-30	FEMALE	167	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	140			NO		G2						NO		true	No	M0	N0	T4	Stage IIIB	TCGA-PD-A5DF.8D63D119-DC81-45FE-9F02-8228A7160C55.pdf	A5DF	WITH TUMOR				NO	YES		NO	YES			Primary Tumor	01		6th	NO	YES	PD		Liver		A		DECEASED	72	2007	TCGA-PD-A5DF-01A-11D-A27H-01	TCGA-PD-A5DF-01A-11D-A27H-01	TCGA-PD-A5DF-01A-11D-A27I-10	TCGA-PD-A5DF-01	TCGA-PD-A5DF-01	0137FBC4-317A-4E7E-9D21-66DDB73097A7	41d56421-a998-43b9-b319-18535315c820	TCGA-PD-A5DF-01A-11D-A27I-10	TCGA-PD-A5DF-01	TCGA-PD-A5DF-01	41d56421-a998-43b9-b319-18535315c820	TCGA-PD-A5DF-01A-11D-A27I-10	41d56421-a998-43b9-b319-18535315c820	41d56421-a998-43b9-b319-18535315c820	TCGA-PD-A5DF-01A-11D-A27I-10	TCGA-PD-A5DF-01A-11D-A27W-05
TCGA-QA-A7B7-01	0	TCGA-QA-A7B7-01	94	0	days	TCGA-QA-A7B7	88	1	days	94	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver		NO	Mild	48	3.5	4.2	4.8	TCGA-QA-A7B7-F65031	TCGA-QA-A7B7		0.3	1.0		A	0.7	1.2	1	-17636			0	94		88	1	0	8	1751	0 - No Fibrosis		2014-10-30	MALE	180	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		10.4	13.1		NO	G2	Liver	Locoregional Recurrence		No	NO	YES	No		No	MX	NX	T2	Stage II		A7B7	WITH TUMOR	218	150	400	NO	NO	11.5	NO	NO		RX	Primary Tumor	01	Other (specify)	7th	YES	NO	QA	1.2	Liver	Micro			LIVING	108	2013	TCGA-QA-A7B7-01A-11D-A32F-01	TCGA-QA-A7B7-01A-11D-A32F-01	TCGA-QA-A7B7-01A-11D-A32G-10	TCGA-QA-A7B7-01	TCGA-QA-A7B7-01		c30c0452-81d2-453d-91e2-2be1a07d02c7	TCGA-QA-A7B7-01A-11D-A32G-10	TCGA-QA-A7B7-01	TCGA-QA-A7B7-01	c30c0452-81d2-453d-91e2-2be1a07d02c7	TCGA-QA-A7B7-01A-11D-A32G-10	c30c0452-81d2-453d-91e2-2be1a07d02c7	c30c0452-81d2-453d-91e2-2be1a07d02c7	TCGA-QA-A7B7-01A-11D-A32G-10	TCGA-QA-A7B7-01A-11D-A32R-05
TCGA-RC-A6M3-01		TCGA-RC-A6M3-01			days	TCGA-RC-A6M3			days		days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				24					TCGA-RC-A6M3									-8899			0	0									2015-7-9	MALE	175			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES						G3									No	M0	N0	T2	Stage II		A6M3					NO				NO		R0	Primary Tumor	01	Lobectomy	6th	NO	YES	RC		Liver	Micro			LIVING		2009	TCGA-RC-A6M3-01A-11D-A32F-01	TCGA-RC-A6M3-01A-11D-A32F-01	TCGA-RC-A6M3-01A-11D-A32G-10	TCGA-RC-A6M3-01	TCGA-RC-A6M3-01		e4fcb1f0-4637-49c4-ba32-3d037ccc25f2	TCGA-RC-A6M3-01A-11D-A32G-10	TCGA-RC-A6M3-01	TCGA-RC-A6M3-01	e4fcb1f0-4637-49c4-ba32-3d037ccc25f2	TCGA-RC-A6M3-01A-11D-A32G-10	e4fcb1f0-4637-49c4-ba32-3d037ccc25f2	e4fcb1f0-4637-49c4-ba32-3d037ccc25f2	TCGA-RC-A6M3-01A-11D-A32G-10	TCGA-RC-A6M3-01A-11D-A32R-05
TCGA-RC-A6M4-01	0	TCGA-RC-A6M4-01	22	0	days	TCGA-RC-A6M4			days	22	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				74	3.5	2.3	4.8		TCGA-RC-A6M4		0.2	0.6	2	A	0.8	1.3	0.9	-27327			0	22			1	0	44	5			2015-7-9	FEMALE		No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES						G2									No	MX	NX	T3	Stage IIIA		A6M4					NO				YES		R1	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	RC	1.3	Liver	None			LIVING	87	2010	TCGA-RC-A6M4-01A-11D-A32F-01	TCGA-RC-A6M4-01A-11D-A32F-01	TCGA-RC-A6M4-01A-11D-A32G-10	TCGA-RC-A6M4-01	TCGA-RC-A6M4-01		e447c057-5e90-4fef-a916-6ab71092fcb5	TCGA-RC-A6M4-01A-11D-A32G-10	TCGA-RC-A6M4-01	TCGA-RC-A6M4-01	e447c057-5e90-4fef-a916-6ab71092fcb5	TCGA-RC-A6M4-01A-11D-A32G-10	e447c057-5e90-4fef-a916-6ab71092fcb5	e447c057-5e90-4fef-a916-6ab71092fcb5	TCGA-RC-A6M4-01A-11D-A32G-10	TCGA-RC-A6M4-01A-11D-A32R-05
TCGA-RC-A6M5-01	0	TCGA-RC-A6M5-01	15	0	days	TCGA-RC-A6M5			days	15	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				20	3.5	3.9	4.8		TCGA-RC-A6M5	TCGA-RC-A6M5-01A	0.2	0.5		A	0.8	1.3	0.4	-7634	484		0	15									2015-7-9	FEMALE		No History of Primary Risk Factors		Fibrolamellar Carcinoma	No	C22.0	8171/3	C22.0	YES	50	0.9	1.2	NO		G2								true	No	M0	N1	T1	Stage IVA	TCGA-RC-A6M5.CFE4CEBF-2B23-4ABD-8F50-2B7C4A432AA6.pdf	A6M5		317000	150000	400000	NO		1.2		NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	RC	1.3	Liver	None	A		LIVING		2012	TCGA-RC-A6M5-01A-11D-A32F-01	TCGA-RC-A6M5-01A-11D-A32F-01	TCGA-RC-A6M5-01A-11D-A32G-10	TCGA-RC-A6M5-01	TCGA-RC-A6M5-01		05246bfa-faf4-4d63-9890-88bb6f7a6546	TCGA-RC-A6M5-01A-11D-A32G-10	TCGA-RC-A6M5-01	TCGA-RC-A6M5-01	05246bfa-faf4-4d63-9890-88bb6f7a6546	TCGA-RC-A6M5-01A-11D-A32G-10	05246bfa-faf4-4d63-9890-88bb6f7a6546	05246bfa-faf4-4d63-9890-88bb6f7a6546	TCGA-RC-A6M5-01A-11D-A32G-10	TCGA-RC-A6M5-01A-11D-A32R-05
TCGA-RC-A6M6-01	0	TCGA-RC-A6M6-01	9	0	days	TCGA-RC-A6M6			days	9	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				75	3.5	2.8	4.8		TCGA-RC-A6M6	TCGA-RC-A6M6-01A	0.2	2.3		B	0.8	1.3	0.8	-27649	748		0	9				0	44	12986			2015-7-9	MALE		Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	110	0.9	1.2	NO		G3								true	No	M0	NX	T2	Stage II	TCGA-RC-A6M6.210AAA2E-0B18-4C08-815D-BC523FF2A7D5.pdf	A6M6		235000	150000	400000	NO		1.3				R1	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	RC	1.3	Liver	None	A		LIVING		2011	TCGA-RC-A6M6-01A-11D-A32F-01	TCGA-RC-A6M6-01A-11D-A32F-01	TCGA-RC-A6M6-01A-11D-A32G-10	TCGA-RC-A6M6-01	TCGA-RC-A6M6-01	2D8C0C39-04E8-4B11-9CFE-E0650D8C090A	8cb97760-f404-486a-9957-f90d1026bc08	TCGA-RC-A6M6-01A-11D-A32G-10	TCGA-RC-A6M6-01	TCGA-RC-A6M6-01	8cb97760-f404-486a-9957-f90d1026bc08	TCGA-RC-A6M6-01A-11D-A32G-10	8cb97760-f404-486a-9957-f90d1026bc08	8cb97760-f404-486a-9957-f90d1026bc08	TCGA-RC-A6M6-01A-11D-A32G-10	TCGA-RC-A6M6-01A-11D-A32R-05
TCGA-RC-A7S9-01	0	TCGA-RC-A7S9-01	640	0	days	TCGA-RC-A7S9	640	0	days	640	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	47	3.1	4.3	5.2		TCGA-RC-A7S9	TCGA-RC-A7S9-01A	0.1	0.8		A	0.3	1.20	0.7	-17403	383		0	640			0	0	20	10	6 - Established Cirrhosis		2014-7-21	FEMALE	161	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	0.8	1.30	NO		G3						NO		true	No	M0	N0	T1	Stage I	TCGA-RC-A7S9.A537996A-E747-4906-B488-43181F3C7E17.pdf	A7S9	TUMOR FREE	178000	150000	400000	NO	NO	1.1	NO			R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	RC	1.3	Liver	None	A		LIVING	58	2012	TCGA-RC-A7S9-01A-11D-A33P-01	TCGA-RC-A7S9-01A-11D-A33P-01	TCGA-RC-A7S9-01A-11D-A33Q-10	TCGA-RC-A7S9-01	TCGA-RC-A7S9-01		811d94b6-2802-44ff-915f-7344886d93bb	TCGA-RC-A7S9-01A-11D-A33Q-10	TCGA-RC-A7S9-01	TCGA-RC-A7S9-01	811d94b6-2802-44ff-915f-7344886d93bb	TCGA-RC-A7S9-01A-11D-A33Q-10	811d94b6-2802-44ff-915f-7344886d93bb	811d94b6-2802-44ff-915f-7344886d93bb	TCGA-RC-A7S9-01A-11D-A33Q-10	TCGA-RC-A7S9-01A-11D-A341-05
TCGA-RC-A7SB-01	0	TCGA-RC-A7SB-01	588	0	days	TCGA-RC-A7SB	588	0	days	588	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	53	3.1	4.8	5.2		TCGA-RC-A7SB		0.1	3.7		B	0.3	1.20	1.1	-19698			0	588			0	0	20	3	0 - No Fibrosis		2014-7-21	MALE	166	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.8	1.30			G2						NO			No	M0	N0	T2	Stage II		A7SB	TUMOR FREE	196000	150000	400000	NO	NO	1	NO			R0	Primary Tumor	01	Lobectomy	7th	YES	NO	RC	1.3	Liver	None			LIVING	61	2012	TCGA-RC-A7SB-01A-21D-A34Y-01	TCGA-RC-A7SB-01A-21D-A34Y-01	TCGA-RC-A7SB-01A-21D-A34Z-10	TCGA-RC-A7SB-01	TCGA-RC-A7SB-01		d1d1393b-5eda-4484-8254-a6bf11a19908	TCGA-RC-A7SB-01A-21D-A34Z-10	TCGA-RC-A7SB-01	TCGA-RC-A7SB-01	d1d1393b-5eda-4484-8254-a6bf11a19908	TCGA-RC-A7SB-01A-21D-A34Z-10	d1d1393b-5eda-4484-8254-a6bf11a19908	d1d1393b-5eda-4484-8254-a6bf11a19908	TCGA-RC-A7SB-01A-21D-A34Z-10	TCGA-RC-A7SB-01A-21D-A356-05
TCGA-RC-A7SF-01	0	TCGA-RC-A7SF-01	579	0	days	TCGA-RC-A7SF			days	579	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	66	3.1	4.4	5.2		TCGA-RC-A7SF	TCGA-RC-A7SF-01A	0.1	0.8		A	0.3	1.20	1.0	-24432	285		0	579			0	0	20	87	3,4 - Fibrous Speta		2014-7-21	MALE	170	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	0.8	1.30	NO		G2						YES		true	No	M0	N0	T1	Stage I	TCGA-RC-A7SF.D4F398CC-0003-4C08-989F-3C60762B100F.pdf	A7SF	WITH TUMOR	209000	150000	400000	NO	NO	0.9	NO			R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	RC	1.3	Liver	None	A		LIVING	76	2012	TCGA-RC-A7SF-01A-11D-A34Y-01	TCGA-RC-A7SF-01A-11D-A34Y-01	TCGA-RC-A7SF-01A-11D-A34Z-10	TCGA-RC-A7SF-01	TCGA-RC-A7SF-01		136abc20-19ec-4049-96f9-7fe8dcda7029	TCGA-RC-A7SF-01A-11D-A34Z-10	TCGA-RC-A7SF-01	TCGA-RC-A7SF-01	136abc20-19ec-4049-96f9-7fe8dcda7029	TCGA-RC-A7SF-01A-11D-A34Z-10	136abc20-19ec-4049-96f9-7fe8dcda7029	136abc20-19ec-4049-96f9-7fe8dcda7029	TCGA-RC-A7SF-01A-11D-A34Z-10	TCGA-RC-A7SF-01A-11D-A356-05
TCGA-RC-A7SH-01	0	TCGA-RC-A7SH-01	468	0	days	TCGA-RC-A7SH			days	468	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	42	3.1	4.1	5.2		TCGA-RC-A7SH	TCGA-RC-A7SH-01A	0.1	0.5		A	0.3	1.20	0.8	-15560	271		0	468			1	0	20	2466	3,4 - Fibrous Speta		2014-7-21	MALE	174	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8174/3	C22.0	YES	10	0.8	1.30	NO		G3						YES		true	No	M0	N0	T2	Stage II	TCGA-RC-A7SH.F862582D-03E2-41AB-85C8-B637C2573E74.pdf	A7SH	WITH TUMOR	225	150000	400000	NO	NO	1.0	NO			R0	Primary Tumor	01	Lobectomy	7th	YES	NO	RC	1.3	Liver	Micro	A		LIVING	68	2012	TCGA-RC-A7SH-01A-11D-A381-01	TCGA-RC-A7SH-01A-11D-A381-01	TCGA-RC-A7SH-01A-11D-A382-10	TCGA-RC-A7SH-01	TCGA-RC-A7SH-01		6bda7fe9-c8e8-4f79-8e4b-015ca56760b0		TCGA-RC-A7SH-01	TCGA-RC-A7SH-01	6bda7fe9-c8e8-4f79-8e4b-015ca56760b0		6bda7fe9-c8e8-4f79-8e4b-015ca56760b0	6bda7fe9-c8e8-4f79-8e4b-015ca56760b0		TCGA-RC-A7SH-01A-11D-A383-05
TCGA-RC-A7SK-01	0	TCGA-RC-A7SK-01	472	0	days	TCGA-RC-A7SK			days	472	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	59	3.1	4.3	5.2		TCGA-RC-A7SK	TCGA-RC-A7SK-01A	0.1	0.6		A	0.3	1.20	1	-21814	232		0	472			0	0	20	25	1,2 - Portal Fibrosis		2014-7-21	MALE	169	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	40	0.8	1.30	NO		G3						YES		true	No	M0	N0	T1	Stage I	TCGA-RC-A7SK.5C08444C-DD26-44C1-BDF3-E6E581126F38.pdf	A7SK	TUMOR FREE	138000	150000	400000	NO	NO	1	NO			R0	Primary Tumor	01	Lobectomy	7th	YES	NO	RC	1.3	Liver	Micro	A		LIVING	60	2013	TCGA-RC-A7SK-01A-11D-A34Y-01	TCGA-RC-A7SK-01A-11D-A34Y-01	TCGA-RC-A7SK-01A-11D-A34Z-10	TCGA-RC-A7SK-01	TCGA-RC-A7SK-01		34982e2a-db69-4bc1-ac82-39ea181190d2	TCGA-RC-A7SK-01A-11D-A34Z-10	TCGA-RC-A7SK-01	TCGA-RC-A7SK-01	34982e2a-db69-4bc1-ac82-39ea181190d2	TCGA-RC-A7SK-01A-11D-A34Z-10	34982e2a-db69-4bc1-ac82-39ea181190d2	34982e2a-db69-4bc1-ac82-39ea181190d2	TCGA-RC-A7SK-01A-11D-A34Z-10	TCGA-RC-A7SK-01A-11D-A356-05
TCGA-RG-A7D4-01	0	TCGA-RG-A7D4-01	1098	0	days	TCGA-RG-A7D4	1098	0	days	1098	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				69	3	3	5	TCGA-RG-A7D4-F71159	TCGA-RG-A7D4	TCGA-RG-A7D4-01A	1	1	2	A	1	2	1	-25302	530		0	1098				0	9	5650			2015-3-19	MALE	172	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	250	1	2	NO	NO	G2						NO		true	No	M0	N0	T2	Stage II	TCGA-RG-A7D4.C8724B8E-5FC3-419B-9CC8-E6046D671D96.pdf	A7D4	TUMOR FREE	175	150	400	NO	NO	1	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	RG	2	Liver		A	Hepatitis  C Antibody	LIVING	87	2012	TCGA-RG-A7D4-01A-12D-A33P-01	TCGA-RG-A7D4-01A-12D-A33P-01	TCGA-RG-A7D4-01A-12D-A33Q-10	TCGA-RG-A7D4-01	TCGA-RG-A7D4-01	DFF361AE-94B2-4034-BFC1-B8BD4CE3A9A0	7796772d-d52f-4909-ae88-e961e827c962	TCGA-RG-A7D4-01A-12D-A33Q-10	TCGA-RG-A7D4-01	TCGA-RG-A7D4-01	7796772d-d52f-4909-ae88-e961e827c962	TCGA-RG-A7D4-01A-12D-A33Q-10	7796772d-d52f-4909-ae88-e961e827c962	7796772d-d52f-4909-ae88-e961e827c962	TCGA-RG-A7D4-01A-12D-A33Q-10	TCGA-RG-A7D4-01A-12D-A341-05
TCGA-T1-A6J8-01	0	TCGA-T1-A6J8-01	23	0	days	TCGA-T1-A6J8			days	23	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				68				TCGA-T1-A6J8-F68334	TCGA-T1-A6J8	TCGA-T1-A6J8-01A								-24853	77		0	23									2014-11-14	MALE	188	Alcohol consumption		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	340			NO	YES	G2								true	Yes	M0	NX	T1		TCGA-T1-A6J8.CEAA3A97-FE48-4408-9DCA-21D924287CAC.pdf	A6J8	TUMOR FREE										RX	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	T1		Liver	None	A		LIVING	65	2013	TCGA-T1-A6J8-01A-11D-A32F-01	TCGA-T1-A6J8-01A-11D-A32F-01	TCGA-T1-A6J8-01A-11D-A32G-10		TCGA-T1-A6J8-01	6CF069EB-CE3B-4706-AC56-8E556CDCE42C	366c514e-877d-4aa6-bb14-610c8a93191b	TCGA-T1-A6J8-01A-11D-A32G-10		TCGA-T1-A6J8-01	366c514e-877d-4aa6-bb14-610c8a93191b	TCGA-T1-A6J8-01A-11D-A32G-10	366c514e-877d-4aa6-bb14-610c8a93191b	366c514e-877d-4aa6-bb14-610c8a93191b	TCGA-T1-A6J8-01A-11D-A32G-10	TCGA-T1-A6J8-01A-11D-A32R-05
TCGA-UB-A7MA-01	0	TCGA-UB-A7MA-01	848	0	days	TCGA-UB-A7MA	478	1	days	848	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	62	3.4	4.0	5.0	TCGA-UB-A7MA-F67133	TCGA-UB-A7MA	TCGA-UB-A7MA-01A	0	1.2		A	0.4	0.90	0.7	-22843	109		0	848		478	0	0	8	2008	0 - No Fibrosis		2015-11-24	FEMALE	165	No History of Primary Risk Factors		Hepatocholangiocarcinoma (Mixed)	No	C22.0	8180/3	C22.0	YES	500	0.9	1.2	NO	NO	G2	Liver	Intrahepatic Recurrence		No	NO	YES	No	true	No	M0	N0	T2b	Stage II	TCGA-UB-A7MA.82349CD5-39AA-42F8-80A1-B438B2300D09.pdf	A7MA	WITH TUMOR	600	140	450	NO	YES	0.9	NO	NO		R1	Primary Tumor	01	Extended Lobectomy	7th	YES	NO	UB	1.0	Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody	LIVING	85	2013	TCGA-UB-A7MA-01A-11D-A33P-01	TCGA-UB-A7MA-01A-11D-A33P-01	TCGA-UB-A7MA-01A-11D-A33Q-10	TCGA-UB-A7MA-01	TCGA-UB-A7MA-01	79D472C1-7A6A-4AAE-8252-CE0DA5ED5FDC	a23fd611-d413-4ea7-9061-8caeba4b39ff	TCGA-UB-A7MA-01A-11D-A33Q-10	TCGA-UB-A7MA-01	TCGA-UB-A7MA-01	a23fd611-d413-4ea7-9061-8caeba4b39ff	TCGA-UB-A7MA-01A-11D-A33Q-10	a23fd611-d413-4ea7-9061-8caeba4b39ff	a23fd611-d413-4ea7-9061-8caeba4b39ff	TCGA-UB-A7MA-01A-11D-A33Q-10	TCGA-UB-A7MA-01A-11D-A341-05
TCGA-UB-A7MB-01	0	TCGA-UB-A7MB-01	601	0	days	TCGA-UB-A7MB	48	1	days	601	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	24	3.5	3.1	4.8	TCGA-UB-A7MB-F67159	TCGA-UB-A7MB	TCGA-UB-A7MB-01A	0.2	0.4		A	0.7	1.2	0.4	-8951	176		0	601		48	0	0	8	1865	0 - No Fibrosis		2014-10-31	MALE	180	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	140	0.9	1.2	NO	NO	G3	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	MX	NX	T2	Stage II	TCGA-UB-A7MB.8B239487-4D0E-45EF-84EB-F61B23C42FE7.pdf	A7MB	WITH TUMOR	583	140	450	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	UB	1.3	Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody	LIVING	62	2013	TCGA-UB-A7MB-01A-11D-A33P-01	TCGA-UB-A7MB-01A-11D-A33P-01	TCGA-UB-A7MB-01A-11D-A33Q-10	TCGA-UB-A7MB-01	TCGA-UB-A7MB-01	4E09D005-7D96-4F25-8386-F2E64E95B561	a18a49c7-e3e8-422a-b8e5-e5632604191a	TCGA-UB-A7MB-01A-11D-A33Q-10	TCGA-UB-A7MB-01	TCGA-UB-A7MB-01	a18a49c7-e3e8-422a-b8e5-e5632604191a	TCGA-UB-A7MB-01A-11D-A33Q-10	a18a49c7-e3e8-422a-b8e5-e5632604191a	a18a49c7-e3e8-422a-b8e5-e5632604191a	TCGA-UB-A7MB-01A-11D-A33Q-10	TCGA-UB-A7MB-01A-11D-A341-05
TCGA-UB-A7MC-01	0	TCGA-UB-A7MC-01	500	0	days	TCGA-UB-A7MC	359	1	days	500	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	YES	Mild	59	3.5	3.9	4.8	TCGA-UB-A7MC-F67161	TCGA-UB-A7MC	TCGA-UB-A7MC-01A	0.2	1.5		A	0.7	1.2	0.7	-21733	88		0	500		359	0	0	8	126	1,2 - Portal Fibrosis		2014-10-31	MALE	176	Alcohol consumption|Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	540	0.9	1.2	NO	NO	G3	Other, specify	Extrahepatic Recurrence	Adrenal glands	Yes	NO	YES	No	true	No	MX	N0	T3a	Stage IIIA	TCGA-UB-A7MC.B391B6EA-425D-411D-AA4C-EE43B861E807.pdf	A7MC	WITH TUMOR	200	140	450	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Lobectomy	7th	YES	NO	UB	1.3	Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV D	LIVING	78	2013	TCGA-UB-A7MC-01A-11D-A33P-01	TCGA-UB-A7MC-01A-11D-A33P-01	TCGA-UB-A7MC-01A-11D-A33Q-10	TCGA-UB-A7MC-01	TCGA-UB-A7MC-01	85185E12-7503-412A-BDE8-972CF9657638	86eb0a1e-45f3-4bc1-a2f8-6e369292b113	TCGA-UB-A7MC-01A-11D-A33Q-10	TCGA-UB-A7MC-01	TCGA-UB-A7MC-01	86eb0a1e-45f3-4bc1-a2f8-6e369292b113	TCGA-UB-A7MC-01A-11D-A33Q-10	86eb0a1e-45f3-4bc1-a2f8-6e369292b113	86eb0a1e-45f3-4bc1-a2f8-6e369292b113	TCGA-UB-A7MC-01A-11D-A33Q-10	TCGA-UB-A7MC-01A-11D-A341-05
TCGA-UB-A7MD-01	1	TCGA-UB-A7MD-01	52	1	days	TCGA-UB-A7MD	52	0	days	52	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				67	3.5	3.5	4.8	TCGA-UB-A7MD-F63729	TCGA-UB-A7MD	TCGA-UB-A7MD-01A	0.2	0.8		A	0.7	1.2	1.0	-24717	128	52	0				0	0	8	23	6 - Established Cirrhosis		2014-8-15	MALE	175	Alcohol consumption|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	140	0.9	1.2	NO	NO	G3						NO		true	No	MX	N0	T1	Stage I	TCGA-UB-A7MD.DF3145A4-6311-4DCD-914F-3B3AABE4DAE7.pdf	A7MD	TUMOR FREE	201	140	450	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	YES	NO	UB	1.3	Liver	Micro	A	Hepatitis  C Antibody|Hepatitis C Virus R|HCV Genotype|Hepatitis B Surface Antigen	DECEASED	57	2013	TCGA-UB-A7MD-01A-12D-A34Y-01	TCGA-UB-A7MD-01A-12D-A34Y-01	TCGA-UB-A7MD-01A-12D-A34Z-10	TCGA-UB-A7MD-01	TCGA-UB-A7MD-01	3C88AF72-B1F7-4099-B99B-67ECD6F24E6C	8a1c649e-43ae-4024-83d5-7ec8da50667f	TCGA-UB-A7MD-01A-12D-A34Z-10	TCGA-UB-A7MD-01	TCGA-UB-A7MD-01	8a1c649e-43ae-4024-83d5-7ec8da50667f	TCGA-UB-A7MD-01A-12D-A34Z-10	8a1c649e-43ae-4024-83d5-7ec8da50667f	8a1c649e-43ae-4024-83d5-7ec8da50667f	TCGA-UB-A7MD-01A-12D-A34Z-10	TCGA-UB-A7MD-01A-12D-A356-05
TCGA-UB-A7ME-01	0	TCGA-UB-A7ME-01	486	0	days	TCGA-UB-A7ME	486	0	days	486	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	51	3.5	4.2	4.8	TCGA-UB-A7ME-F67165	TCGA-UB-A7ME		0.2	0.6		B	0.7	1.2	1.1	-18846			0	486			0	0	8	1388	1,2 - Portal Fibrosis		2014-10-31	MALE	165	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.9	1.2		NO	G2						NO			No	MX	NX	T1	Stage I		A7ME	TUMOR FREE	181	140	450	NO	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	UB	1.3	Liver	None		Hepatitis B Surface Antigen|HBV Core Antibody|HBV D	LIVING	75	2013	TCGA-UB-A7ME-01A-11D-A33B-01	TCGA-UB-A7ME-01A-11D-A33B-01	TCGA-UB-A7ME-01A-11D-A33K-10	TCGA-UB-A7ME-01	TCGA-UB-A7ME-01		c9e807fc-4988-461d-a918-bff25f639bac	TCGA-UB-A7ME-01A-11D-A33K-10	TCGA-UB-A7ME-01	TCGA-UB-A7ME-01	c9e807fc-4988-461d-a918-bff25f639bac	TCGA-UB-A7ME-01A-11D-A33K-10	c9e807fc-4988-461d-a918-bff25f639bac	c9e807fc-4988-461d-a918-bff25f639bac	TCGA-UB-A7ME-01A-11D-A33K-10	TCGA-UB-A7ME-01A-11D-A33L-05
TCGA-UB-A7MF-01	1	TCGA-UB-A7MF-01	214	1	days	TCGA-UB-A7MF			days	214	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				56	3.5	3.6	4.8		TCGA-UB-A7MF	TCGA-UB-A7MF-01A	0.2	1.1	1	A	0.7	1.2	0.9	-20815	240	214	0					0	8	2505	6 - Established Cirrhosis		2014-8-16	MALE	195	Hepatitis B|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	380	0.9	1.2	NO		G2						YES		true	Yes	MX	NX	T3a	Stage IIIA	TCGA-UB-A7MF.7A3E5345-5272-4D82-8E97-40CCE9BAF330.pdf	A7MF	WITH TUMOR	130	140	450	NO	NO	1.0	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	UB	1.3	Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody|HBV D	DECEASED	95	2013	TCGA-UB-A7MF-01A-11D-A33B-01	TCGA-UB-A7MF-01A-11D-A33B-01	TCGA-UB-A7MF-01A-11D-A33K-10	TCGA-UB-A7MF-01	TCGA-UB-A7MF-01	98F4D8EA-6240-4134-A6C1-6E1D60DDF427	0fd5e345-f535-42ef-9cf5-0db512d2ad73	TCGA-UB-A7MF-01A-11D-A33K-10	TCGA-UB-A7MF-01	TCGA-UB-A7MF-01	0fd5e345-f535-42ef-9cf5-0db512d2ad73	TCGA-UB-A7MF-01A-11D-A33K-10	0fd5e345-f535-42ef-9cf5-0db512d2ad73	0fd5e345-f535-42ef-9cf5-0db512d2ad73	TCGA-UB-A7MF-01A-11D-A33K-10	TCGA-UB-A7MF-01A-11D-A33L-05
TCGA-UB-AA0U-01	0	TCGA-UB-AA0U-01	327	0	days	TCGA-UB-AA0U	106	1	days	327	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	YES	Mild	60	3.5	3.9	4.8	TCGA-UB-AA0U-F67166	TCGA-UB-AA0U	TCGA-UB-AA0U-01A	0.2	0.7	2	A	0.7	1.2	0.6	-21985	18		0	327		106	0	0	8	26	0 - No Fibrosis		2014-10-31	MALE	178	Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	730	0.9	1.2	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	No	true	No	MX	NX	T2	Stage II	TCGA-UB-AA0U.00C0CD33-615E-47A6-8CEF-EE3A67F277D3.pdf	AA0U	TUMOR FREE	227	140	450	NO	NO	1.1	NO	YES		R1	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	UB	1.3	Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody	LIVING	93	2013	TCGA-UB-AA0U-01A-11D-A381-01	TCGA-UB-AA0U-01A-11D-A381-01	TCGA-UB-AA0U-01A-11D-A382-10	TCGA-UB-AA0U-01	TCGA-UB-AA0U-01		5055524c-95b9-40d3-a373-401ce12ec223		TCGA-UB-AA0U-01	TCGA-UB-AA0U-01	5055524c-95b9-40d3-a373-401ce12ec223		5055524c-95b9-40d3-a373-401ce12ec223	5055524c-95b9-40d3-a373-401ce12ec223		TCGA-UB-AA0U-01A-11D-A383-05
TCGA-UB-AA0V-01	0	TCGA-UB-AA0V-01	314	0	days	TCGA-UB-AA0V	314	0	days	314	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	69	3.5	3.8	4.8	TCGA-UB-AA0V-F67169	TCGA-UB-AA0V	TCGA-UB-AA0V-01A	0.2	1.0	1	A	0.5	1.0	0.7	-25340	7		0	314			0	0	8	3	0 - No Fibrosis		2014-10-31	FEMALE	175	Hemochromatosis		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	110	0.9	1.2	NO	NO	G1						NO		true	Yes	MX	NX	[Discrepancy]	Stage I	TCGA-UB-AA0V.0BEA5A64-9DDE-45A8-A788-5EE2CEC6F6E4.pdf	AA0V	TUMOR FREE	273	140	450	NO	NO	0.9	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	UB	1.3	Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Core Antibody	LIVING	57	2013	TCGA-UB-AA0V-01A-11D-A381-01	TCGA-UB-AA0V-01A-11D-A381-01	TCGA-UB-AA0V-01A-11D-A382-10	TCGA-UB-AA0V-01	TCGA-UB-AA0V-01		9e1bd81b-74bb-4909-ba0d-1e6bdf98b066		TCGA-UB-AA0V-01	TCGA-UB-AA0V-01	9e1bd81b-74bb-4909-ba0d-1e6bdf98b066		9e1bd81b-74bb-4909-ba0d-1e6bdf98b066	9e1bd81b-74bb-4909-ba0d-1e6bdf98b066		TCGA-UB-AA0V-01A-11D-A383-05
TCGA-WJ-A86L-01	0	TCGA-WJ-A86L-01	345	0	days	TCGA-WJ-A86L	345	0	days	345	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	68	3.4	4.2	4.8	TCGA-WJ-A86L-F65568	TCGA-WJ-A86L	TCGA-WJ-A86L-01A	0.1	0.5		A	0.5	1.1	0.9	-25018	95		0	345			1		6	16	0 - No Fibrosis		2014-9-26	FEMALE	159	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8310/3	C22.0	YES	270	2.0	3.0	NO	NO	G2						NO		false	No	MX	NX	T1	Stage I	TCGA-WJ-A86L.2C93F65E-88FD-405F-86F1-0E35C7F46DC2.pdf	A86L	TUMOR FREE	257000	125000	415000	NO	NO	0.9	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	YES	NO	WJ	1.2	Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen|HBV Surface Antibody	LIVING	56	2013	TCGA-WJ-A86L-01A-12D-A38W-01	TCGA-WJ-A86L-01A-12D-A38W-01	TCGA-WJ-A86L-01A-12D-A45V-10	TCGA-WJ-A86L-01	TCGA-WJ-A86L-01		24863244-1cee-4da9-b730-742a0269ee58		TCGA-WJ-A86L-01	TCGA-WJ-A86L-01	24863244-1cee-4da9-b730-742a0269ee58		24863244-1cee-4da9-b730-742a0269ee58	24863244-1cee-4da9-b730-742a0269ee58		TCGA-WJ-A86L-01A-12D-A39G-05
TCGA-WQ-A9G7-01	0	TCGA-WQ-A9G7-01	30	0	days	TCGA-WQ-A9G7	30	0	days	30	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				71	3.5	3.5	5	TCGA-WQ-A9G7-F66632	TCGA-WQ-A9G7	TCGA-WQ-A9G7-01A	0.3	0.7			0.4	1	0.4		165		0	30									2014-10-21	FEMALE	157	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	160	0.8	1.2	NO	NO	G3						NO		false	No	M0	NX	T3a		TCGA-WQ-A9G7.211B2C4B-7DEB-4031-A3D2-5464A7386245.pdf	A9G7	TUMOR FREE	266	150	400	NO	NO	1.3	NO	NO		R0	Primary Tumor	01	Other (specify)	7th	NO	YES	WQ	1.2	Liver	None	A		LIVING	69	2013	TCGA-WQ-A9G7-01A-11D-A36W-01	TCGA-WQ-A9G7-01A-11D-A36W-01	TCGA-WQ-A9G7-01A-11D-A36X-10	TCGA-WQ-A9G7-01	TCGA-WQ-A9G7-01	0EF14962-BDC1-4ECB-9947-3E8A600899EA	a27a9d35-4804-4b24-8889-4128e4434487		TCGA-WQ-A9G7-01	TCGA-WQ-A9G7-01	a27a9d35-4804-4b24-8889-4128e4434487		a27a9d35-4804-4b24-8889-4128e4434487	a27a9d35-4804-4b24-8889-4128e4434487		TCGA-WQ-A9G7-01A-11D-A36Y-05
TCGA-WQ-AB4B-01	0	TCGA-WQ-AB4B-01	395	0	days	TCGA-WQ-AB4B	273	1	days	395	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO		62	3.5	3.3	5	TCGA-WQ-AB4B-F66633	TCGA-WQ-AB4B		0.3	1.7		A	0.4	1.2	1.1	-22769			0	395		273		0	15	5			2014-10-21	MALE	175	Alcohol consumption|Non-Alcoholic Fatty Liver Disease|Other	Hepatic Encephalopathy	Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		0.8	1.2		NO	G2		Intrahepatic Recurrence		No		YES	No		No	M0	NX	T2	Stage II		AB4B	WITH TUMOR				NO	NO	1.3	NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	WQ	1.2	Liver	Micro			LIVING	122	2013	TCGA-WQ-AB4B-01A-11D-A40O-01	TCGA-WQ-AB4B-01A-11D-A40O-01	TCGA-WQ-AB4B-01A-11D-A40P-10	TCGA-WQ-AB4B-01	TCGA-WQ-AB4B-01		a2dee72c-85ab-44fc-b37f-bb8c82ced8a2		TCGA-WQ-AB4B-01	TCGA-WQ-AB4B-01	a2dee72c-85ab-44fc-b37f-bb8c82ced8a2		a2dee72c-85ab-44fc-b37f-bb8c82ced8a2	a2dee72c-85ab-44fc-b37f-bb8c82ced8a2		TCGA-WQ-AB4B-01A-11D-A40X-05
TCGA-WX-AA44-01	0	TCGA-WX-AA44-01	615	0	days	TCGA-WX-AA44			days	615	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	64	3.5	4.4	5.0	TCGA-WX-AA44-F68251	TCGA-WX-AA44	TCGA-WX-AA44-01A	0	0.5		A	0.5	1.2	0.6	-23654	924		0	615			1	0	6	48	6 - Established Cirrhosis		2014-11-14	FEMALE	152	Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	90	0.9	1.2	NO	YES	G3						YES		true	No	MX	NX	T1	Stage I	TCGA-WX-AA44.759F0B44-92DC-4E47-BA10-7B19C4272485.pdf	AA44	WITH TUMOR	215	150	350	YES	YES	0.9	YES	NO		RX	Primary Tumor	01	Other (specify)	7th	YES	NO	WX	1.20	Liver	None	A	Hepatitis  C Antibody	LIVING	61	2011	TCGA-WX-AA44-01A-11D-A38W-01	TCGA-WX-AA44-01A-11D-A38W-01	TCGA-WX-AA44-01A-11D-A38X-10	TCGA-WX-AA44-01	TCGA-WX-AA44-01		8f0b105f-e2de-4433-bd6a-dd81cb6c0c93		TCGA-WX-AA44-01	TCGA-WX-AA44-01	8f0b105f-e2de-4433-bd6a-dd81cb6c0c93		8f0b105f-e2de-4433-bd6a-dd81cb6c0c93	8f0b105f-e2de-4433-bd6a-dd81cb6c0c93		TCGA-WX-AA44-01A-11D-A39G-05
TCGA-WX-AA46-01	0	TCGA-WX-AA46-01	756	0	days	TCGA-WX-AA46	756	0	days	756	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			None	61	3.5	4.6	5.0	TCGA-WX-AA46-F68250	TCGA-WX-AA46	TCGA-WX-AA46-01A	0	1.3	3	A	0.5	1.2	1.2	-22639	456		0	756			0	0	6	1	0 - No Fibrosis		2014-11-14	MALE	156	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	80	0.8	1.1	NO	NO	G1						NO		true	No	MX	NX	T2	Stage II	TCGA-WX-AA46.A767B73F-5C51-47E8-A569-E112DBB987FF.pdf	AA46	TUMOR FREE	205	150	350	NO	NO	1.0	NO	YES		R0	Primary Tumor	01	Other (specify)	7th	NO	YES	WX	1.2	Liver	Macro	A	Hepatitis  C Antibody	LIVING	75	2012	TCGA-WX-AA46-01A-11D-A38W-01	TCGA-WX-AA46-01A-11D-A38W-01	TCGA-WX-AA46-01A-11D-A38X-10	TCGA-WX-AA46-01	TCGA-WX-AA46-01		1c666252-0438-4c4d-bbb8-99a06b90ab76		TCGA-WX-AA46-01	TCGA-WX-AA46-01	1c666252-0438-4c4d-bbb8-99a06b90ab76		1c666252-0438-4c4d-bbb8-99a06b90ab76	1c666252-0438-4c4d-bbb8-99a06b90ab76		TCGA-WX-AA46-01A-11D-A39G-05
TCGA-WX-AA47-01	1	TCGA-WX-AA47-01	556	1	days	TCGA-WX-AA47			days	556	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	33	3.5	2.8	5.0		TCGA-WX-AA47	TCGA-WX-AA47-01A		0.2		A	0.5	1.2	0.6	-12056	626	556	0				2	0	6	1	0 - No Fibrosis		2014-6-10	FEMALE	168	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	60	0.8	1.1	NO		G2						YES		true	No	MX	NX	T3a	Stage IIIA	TCGA-WX-AA47.473868C8-CFDF-42E6-B6DC-48A737697D07.pdf	AA47	WITH TUMOR	423	150	350	NO	YES	0.9	YES	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	WX	1.2	Liver	Macro	A	Hepatitis  C Antibody	DECEASED	63	2012	TCGA-WX-AA47-01A-11D-A38W-01	TCGA-WX-AA47-01A-11D-A38W-01	TCGA-WX-AA47-01A-11D-A38X-10	TCGA-WX-AA47-01	TCGA-WX-AA47-01		676d126f-b0c7-4c79-b4b6-852207b31437		TCGA-WX-AA47-01	TCGA-WX-AA47-01	676d126f-b0c7-4c79-b4b6-852207b31437		676d126f-b0c7-4c79-b4b6-852207b31437	676d126f-b0c7-4c79-b4b6-852207b31437		TCGA-WX-AA47-01A-11D-A39G-05
TCGA-XR-A8TC-01	0	TCGA-XR-A8TC-01	1339	0	days	TCGA-XR-A8TC	1339	0	days	1339	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	43	3.5	3.9	4.8	TCGA-XR-A8TC-F72317	TCGA-XR-A8TC	TCGA-XR-A8TC-01A	0.2	0.2		A	0.7	1.5	0.7	-15817	908		0	1339			0	6	6	47	6 - Established Cirrhosis		2015-5-20	FEMALE	155	Hepatitis B		Hepatocellular Carcinoma	Yes	C22.0	8170/3	C22.0	YES	110	1.3	1.3	NO	NO	G2						NO		true	Yes	MX	NX	T1	Stage I	TCGA-XR-A8TC.681B14A0-98E6-4F74-89B0-3DFB3A97C0E1.pdf	A8TC	WITH TUMOR	318000	150000	450000	YES	NO	1.0	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	XR	1.2	Liver	None	A		LIVING	52	2011			TCGA-XR-A8TC-01A-11D-A35Z-10	TCGA-XR-A8TC-01	TCGA-XR-A8TC-01	81166064-A9F8-462A-9563-F72A39C24E59	7e61e7f1-2c5e-45e4-a0cc-b0ab27c29bc3		TCGA-XR-A8TC-01		7e61e7f1-2c5e-45e4-a0cc-b0ab27c29bc3		7e61e7f1-2c5e-45e4-a0cc-b0ab27c29bc3	7e61e7f1-2c5e-45e4-a0cc-b0ab27c29bc3		TCGA-XR-A8TC-01A-11D-A369-05
TCGA-XR-A8TD-01	0	TCGA-XR-A8TD-01	1030	0	days	TCGA-XR-A8TD	1030	0	days	1030	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	49	3.5	3.8	4.8	TCGA-XR-A8TD-F72319	TCGA-XR-A8TD		0.2	0.7		A	0.7	1.5	0.5	-17908			0	1030			1	6	6	188	0 - No Fibrosis		2015-5-20	FEMALE	156	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8174/3	C22.0	YES		0	1.3		NO	G3				No	NO	NO	No		No	M0	N0	T3	Stage IIIB		A8TD	TUMOR FREE	334000	150000	450000	NO	NO	1.1	NO			R0	Primary Tumor	01	Extended Lobectomy	7th	NO	YES	XR	1.2	Liver	None			LIVING	69	2012	TCGA-XR-A8TD-01A-12D-A38W-01	TCGA-XR-A8TD-01A-12D-A38W-01	TCGA-XR-A8TD-01A-12D-A38X-10	TCGA-XR-A8TD-01	TCGA-XR-A8TD-01		ed43b946-0700-4e19-8a04-d2a5720a7cdb		TCGA-XR-A8TD-01	TCGA-XR-A8TD-01	ed43b946-0700-4e19-8a04-d2a5720a7cdb		ed43b946-0700-4e19-8a04-d2a5720a7cdb	ed43b946-0700-4e19-8a04-d2a5720a7cdb		TCGA-XR-A8TD-01A-12D-A39G-05
TCGA-XR-A8TE-01	0	TCGA-XR-A8TE-01	925	0	days	TCGA-XR-A8TE	210	1	days	925	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	YES	NO	None	16	3.2	3.9	4.5	TCGA-XR-A8TE-F72321	TCGA-XR-A8TE						0.7	1.5	0.4	-5862			0	925	244	210	0	6	6	809	0 - No Fibrosis		2015-5-20	MALE	157	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		1.3	1.3		NO	G1	Liver	Intrahepatic Recurrence		No	YES	YES	No		No	MX	N0	T3	Stage IIIA		A8TE	WITH TUMOR	206000	150000	450000	NO	YES	1.0	NO	NO	R0	R0	Primary Tumor	01	Extended Lobectomy	7th	NO	YES	XR		Liver	None			LIVING	43	2012	TCGA-XR-A8TE-01A-11D-A35Y-01	TCGA-XR-A8TE-01A-11D-A35Y-01	TCGA-XR-A8TE-01A-11D-A35Z-10	TCGA-XR-A8TE-01	TCGA-XR-A8TE-01		b9ddaaef-028b-4db4-ad31-e70931bd8e44		TCGA-XR-A8TE-01	TCGA-XR-A8TE-01	b9ddaaef-028b-4db4-ad31-e70931bd8e44		b9ddaaef-028b-4db4-ad31-e70931bd8e44	b9ddaaef-028b-4db4-ad31-e70931bd8e44		TCGA-XR-A8TE-01A-11D-A369-05
TCGA-XR-A8TF-01	1	TCGA-XR-A8TF-01	693	1	days	TCGA-XR-A8TF	231	1	days	693	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	74	3.5	3.9	4.8	TCGA-XR-A8TF-F72323	TCGA-XR-A8TF	TCGA-XR-A8TF-01A	0.2	0.8		A	0.7	1.5	0.8	-27145	481	693	0		271	231	0	6	6	39	3,4 - Fibrous Speta		2015-5-20	MALE	166	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	250	0	1.3	NO	NO	G1	Liver	Intrahepatic Recurrence		No	YES	YES	No	true	No	MX	NX	T1	Stage I	TCGA-XR-A8TF.A0557F82-3ACC-43E5-9ED3-902BEDD36939.pdf	A8TF	TUMOR FREE	194000	150000	450000	NO	NO	1.1	NO	NO	R1	R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	XR	1.2	Liver	None	A		DECEASED	57	2012	TCGA-XR-A8TF-01A-11D-A35Y-01	TCGA-XR-A8TF-01A-11D-A35Y-01	TCGA-XR-A8TF-01A-11D-A35Z-10	TCGA-XR-A8TF-01	TCGA-XR-A8TF-01	B132756A-0CF8-4DFB-B839-AF3E192AC614	1f676139-c73f-49d7-95c1-f5f955a27669		TCGA-XR-A8TF-01	TCGA-XR-A8TF-01	1f676139-c73f-49d7-95c1-f5f955a27669		1f676139-c73f-49d7-95c1-f5f955a27669	1f676139-c73f-49d7-95c1-f5f955a27669		TCGA-XR-A8TF-01A-11D-A369-05
TCGA-XR-A8TG-01	0	TCGA-XR-A8TG-01	898	0	days	TCGA-XR-A8TG	350	1	days	898	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	58	3.5	4.3	4.8	TCGA-XR-A8TG-F72325	TCGA-XR-A8TG	TCGA-XR-A8TG-01A	0.2	0.5	2		0.7	1.5	0.9	-21544	439		0	898		350	0	6	6	1	6 - Established Cirrhosis		2015-5-20	MALE	184	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	20	0	1.5	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	YES	Yes	true	Yes	M0	NX	T1	Stage I	TCGA-XR-A8TG.B6CBB321-E73F-4A24-8557-E10E94B2B8C6.pdf	A8TG	TUMOR FREE	80000	150000	450000	YES	NO	1.1	YES	YES	R0	R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	XR	1.2	Liver	None	A		LIVING	71	2012	TCGA-XR-A8TG-01A-11D-A35Y-01	TCGA-XR-A8TG-01A-11D-A35Y-01	TCGA-XR-A8TG-01A-11D-A35Z-10	TCGA-XR-A8TG-01	TCGA-XR-A8TG-01		7cbc59c1-c767-4b50-a6fe-fc3e3365b5cf		TCGA-XR-A8TG-01	TCGA-XR-A8TG-01	7cbc59c1-c767-4b50-a6fe-fc3e3365b5cf		7cbc59c1-c767-4b50-a6fe-fc3e3365b5cf	7cbc59c1-c767-4b50-a6fe-fc3e3365b5cf		TCGA-XR-A8TG-01A-11D-A369-05
TCGA-YA-A8S7-01	1	TCGA-YA-A8S7-01	412	1	days	TCGA-YA-A8S7			days	412	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	68	3.5	2.1	5.0		TCGA-YA-A8S7	TCGA-YA-A8S7-01A	0.2	3.8			0.60	1.3	0.7	-25188	383	412	0						8	56			2014-4-8	MALE	164	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	160	0.9	1.2	NO		G3						YES		false	No	MX	N0	T3a	Stage IIIA	TCGA-YA-A8S7.CFF98B7F-C09E-441D-BE5F-48A06036735B.pdf	A8S7	WITH TUMOR				NO	YES	1.2	NO	NO		R0	Primary Tumor	01	Other (specify)	7th	NO	YES	YA	1.0	Liver	None	A		DECEASED	73	2012	TCGA-YA-A8S7-01A-11D-A36W-01	TCGA-YA-A8S7-01A-11D-A36W-01	TCGA-YA-A8S7-01A-11D-A36X-10	TCGA-YA-A8S7-01	TCGA-YA-A8S7-01	F2A3D58A-4976-4B4B-A693-39EC9D7641AB	8f1e9042-ffcf-44b4-9854-7f7be7e92f24		TCGA-YA-A8S7-01	TCGA-YA-A8S7-01	8f1e9042-ffcf-44b4-9854-7f7be7e92f24		8f1e9042-ffcf-44b4-9854-7f7be7e92f24	8f1e9042-ffcf-44b4-9854-7f7be7e92f24		TCGA-YA-A8S7-01A-11D-A36Y-05
TCGA-ZP-A9CV-01	1	TCGA-ZP-A9CV-01	1088	1	days	TCGA-ZP-A9CV	1088	0	days	1088	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Severe	59	3.5	4	5.7	TCGA-ZP-A9CV-F57756	TCGA-ZP-A9CV	TCGA-ZP-A9CV-01A	0.2	0.5		A	0.7	1.3	0.8	-21633	955	1088	0	142			1	0	8	48			2014-3-28	MALE	173	Alcohol consumption|Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	40			NO	NO	G1						NO		false	No	MX	NX	T1		TCGA-ZP-A9CV.382219F6-24AD-49BD-96D1-FC7A9B2CDFDB.pdf	A9CV	WITH TUMOR	114000	163000	369000	NO	NO		NO	NO		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	ZP	1.0	Liver	None	A		DECEASED	59	2011	TCGA-ZP-A9CV-01A-11D-A381-01	TCGA-ZP-A9CV-01A-11D-A381-01	TCGA-ZP-A9CV-01A-11D-A382-10	TCGA-ZP-A9CV-01	TCGA-ZP-A9CV-01		86f6c86d-d218-4721-86fd-1dd70ee454eb		TCGA-ZP-A9CV-01	TCGA-ZP-A9CV-01	86f6c86d-d218-4721-86fd-1dd70ee454eb		86f6c86d-d218-4721-86fd-1dd70ee454eb	86f6c86d-d218-4721-86fd-1dd70ee454eb		TCGA-ZP-A9CV-01A-11D-A383-05
TCGA-ZP-A9CY-01	0	TCGA-ZP-A9CY-01	782	0	days	TCGA-ZP-A9CY	782	0	days	782	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	66	3.5	3.9	5.2	TCGA-ZP-A9CY-F57752	TCGA-ZP-A9CY		0.2	0.9	1	A				-24223			0	782			1				6 - Established Cirrhosis		2014-3-28	FEMALE	152	Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		9.6	12.6		NO	G1						NO			No	MX	NX	T1			A9CY	TUMOR FREE	93000	163000	369000	NO	NO	11	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	ZP	1.2	Liver	None			LIVING	83	2011	TCGA-ZP-A9CY-01A-11D-A381-01	TCGA-ZP-A9CY-01A-11D-A381-01	TCGA-ZP-A9CY-01A-11D-A382-10	TCGA-ZP-A9CY-01	TCGA-ZP-A9CY-01		f3490052-6688-4279-9d92-0aca9fe94382		TCGA-ZP-A9CY-01	TCGA-ZP-A9CY-01	f3490052-6688-4279-9d92-0aca9fe94382		f3490052-6688-4279-9d92-0aca9fe94382	f3490052-6688-4279-9d92-0aca9fe94382		TCGA-ZP-A9CY-01A-11D-A383-05
TCGA-ZP-A9CZ-01	0	TCGA-ZP-A9CZ-01	706	0	days	TCGA-ZP-A9CZ	706	0	days	706	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				72	3.5	4.4	5.2	TCGA-ZP-A9CZ-F57754	TCGA-ZP-A9CZ	TCGA-ZP-A9CZ-01A	0.2	0.5	2	A				-26403	797		0	706			0	0	8	8	3,4 - Fibrous Speta		2014-3-28	MALE	167	Hepatitis B		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	50	9.6	12.6	NO	NO	G1						NO		false	No	MX	NX	T1		TCGA-ZP-A9CZ.C3F4669C-9E5D-4A46-84A8-E78BF2D5EA92.pdf	A9CZ	TUMOR FREE				NO	NO	11.5	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	ZP	1.2	Liver	None	A	Hepatitis B Surface Antigen	LIVING	73	2011	TCGA-ZP-A9CZ-01A-11D-A381-01	TCGA-ZP-A9CZ-01A-11D-A381-01	TCGA-ZP-A9CZ-01A-11D-A382-10	TCGA-ZP-A9CZ-01	TCGA-ZP-A9CZ-01		7d467df3-8ea8-4979-a609-775baef7a680		TCGA-ZP-A9CZ-01	TCGA-ZP-A9CZ-01	7d467df3-8ea8-4979-a609-775baef7a680		7d467df3-8ea8-4979-a609-775baef7a680	7d467df3-8ea8-4979-a609-775baef7a680		TCGA-ZP-A9CZ-01A-11D-A383-05
TCGA-ZP-A9D0-01	0	TCGA-ZP-A9D0-01	1091	0	days	TCGA-ZP-A9D0	1091	0	days	1091	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	67	3.5	4.1	5.2	TCGA-ZP-A9D0-F69077	TCGA-ZP-A9D0	TCGA-ZP-A9D0-01A	0.2	1.4		A	0.5	1.1	0.9	-24525	723		0	1091			0				0 - No Fibrosis		2014-12-29	FEMALE	165	Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	100	9.6	12.6	NO	NO	G1						NO		false	No	MX	NX	T1		TCGA-ZP-A9D0.38325470-AA90-4CA4-A8C0-8BF1A9D595F9.pdf	A9D0	TUMOR FREE	185000	163000	369000	NO	NO	11	NO	NO		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	ZP	1.2	Liver	None	A		LIVING	78	2011	TCGA-ZP-A9D0-01A-11D-A36W-01	TCGA-ZP-A9D0-01A-11D-A36W-01	TCGA-ZP-A9D0-01A-11D-A36X-10	TCGA-ZP-A9D0-01	TCGA-ZP-A9D0-01		78a9c934-1a9a-42a4-95ba-c99565afccd0		TCGA-ZP-A9D0-01	TCGA-ZP-A9D0-01	78a9c934-1a9a-42a4-95ba-c99565afccd0		78a9c934-1a9a-42a4-95ba-c99565afccd0	78a9c934-1a9a-42a4-95ba-c99565afccd0		TCGA-ZP-A9D0-01A-11D-A36Y-05
TCGA-ZP-A9D1-01	0	TCGA-ZP-A9D1-01	21	0	days	TCGA-ZP-A9D1	21	0	days	21	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver				56				TCGA-ZP-A9D1-F57746	TCGA-ZP-A9D1	TCGA-ZP-A9D1-01A			1	A				-20584	699		0	21			0	0	8	8	5 - Nodular Formation and Incomplete Cirrhosis		2014-3-28	FEMALE	170	Non-Alcoholic Fatty Liver Disease		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	70	9.6	12.6	NO	NO	G2						NO		false	Yes	MX	NX	T1		TCGA-ZP-A9D1.2FA60C52-0164-432D-BB08-A8638AAF2C2F.pdf	A9D1	TUMOR FREE				NO	NO	12	NO	YES		R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	ZP		Liver	None	A		LIVING	130	2012	TCGA-ZP-A9D1-01A-11D-A381-01	TCGA-ZP-A9D1-01A-11D-A381-01	TCGA-ZP-A9D1-01A-11D-A382-10	TCGA-ZP-A9D1-01	TCGA-ZP-A9D1-01		8a5804cb-d45f-4a6c-b7a0-af505b4b4237		TCGA-ZP-A9D1-01	TCGA-ZP-A9D1-01	8a5804cb-d45f-4a6c-b7a0-af505b4b4237		8a5804cb-d45f-4a6c-b7a0-af505b4b4237	8a5804cb-d45f-4a6c-b7a0-af505b4b4237		TCGA-ZP-A9D1-01A-11D-A383-05
TCGA-ZP-A9D2-01	1	TCGA-ZP-A9D2-01	765	1	days	TCGA-ZP-A9D2	765	0	days	765	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	Mild	51				TCGA-ZP-A9D2-F57748	TCGA-ZP-A9D2	TCGA-ZP-A9D2-01A			1	A				-18717	654	765	0	743		315	0				1,2 - Portal Fibrosis		2015-1-16	MALE	172	Hepatitis C		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	60			NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	NO	NO	No	false	No	MX	NX	T2		TCGA-ZP-A9D2.260D67D7-9E8C-4A3B-B031-8AB4A05BC688.pdf	A9D2	WITH TUMOR				YES	NO		NO	YES		R0	Primary Tumor	01	Segmentectomy, Multiple	7th	NO	YES	ZP		Liver	Micro	A	Hepatitis C Virus R	DECEASED	74	2012	TCGA-ZP-A9D2-01A-11D-A381-01	TCGA-ZP-A9D2-01A-11D-A381-01	TCGA-ZP-A9D2-01A-11D-A382-10	TCGA-ZP-A9D2-01	TCGA-ZP-A9D2-01		159b00ee-9db8-4de9-bd94-16e65b917502		TCGA-ZP-A9D2-01	TCGA-ZP-A9D2-01	159b00ee-9db8-4de9-bd94-16e65b917502		159b00ee-9db8-4de9-bd94-16e65b917502	159b00ee-9db8-4de9-bd94-16e65b917502		TCGA-ZP-A9D2-01A-11D-A383-05
TCGA-ZP-A9D4-01	0	TCGA-ZP-A9D4-01	395	0	days	TCGA-ZP-A9D4	395	0	days	395	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	64	3.5	4.3	5.2	TCGA-ZP-A9D4-F57750	TCGA-ZP-A9D4		0.2	0.4		A	0.5	1.1	0.6	-23656			0	395			0	0	8	2	0 - No Fibrosis		2014-3-28	FEMALE	155	No History of Primary Risk Factors		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES					NO	G1						NO			No	MX	NX	T1			A9D4	TUMOR FREE	292000	163000	369000	NO	NO		NO	NO		R0	Primary Tumor	01	Lobectomy	7th	NO	YES	ZP	1.2	Liver	None			LIVING	55	2012	TCGA-ZP-A9D4-01A-11D-A36W-01	TCGA-ZP-A9D4-01A-11D-A36W-01	TCGA-ZP-A9D4-01A-11D-A36X-10	TCGA-ZP-A9D4-01	TCGA-ZP-A9D4-01		da0eec5b-54d6-421c-b850-c7d75e0a8a46		TCGA-ZP-A9D4-01	TCGA-ZP-A9D4-01	da0eec5b-54d6-421c-b850-c7d75e0a8a46		da0eec5b-54d6-421c-b850-c7d75e0a8a46	da0eec5b-54d6-421c-b850-c7d75e0a8a46		TCGA-ZP-A9D4-01A-11D-A36Y-05
TCGA-ZS-A9CD-01	1	TCGA-ZS-A9CD-01	1386	1	days	TCGA-ZS-A9CD			days	1386	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	73	36	48	50		TCGA-ZS-A9CD	TCGA-ZS-A9CD-01A	0	8		A	62	106	73	-26915	1268	1386	0				1				5 - Nodular Formation and Incomplete Cirrhosis		2014-4-30	MALE				Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	30	9	12	NO		G2						YES		true	No	MX	NX	T2	Stage II	TCGA-ZS-A9CD.11C6E09D-89C3-43B9-B884-247278242067.pdf	A9CD		198	150	400	NO	NO	11.7	NO			R0	Primary Tumor	01	Lobectomy	7th	NO	YES	ZS	17	Liver	None	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	DECEASED		2010	TCGA-ZS-A9CD-01A-11D-A36W-01	TCGA-ZS-A9CD-01A-11D-A36W-01	TCGA-ZS-A9CD-01A-11D-A36X-10	TCGA-ZS-A9CD-01	TCGA-ZS-A9CD-01		35c7281c-ffe6-4fc4-b3de-da4f6a113397		TCGA-ZS-A9CD-01	TCGA-ZS-A9CD-01	35c7281c-ffe6-4fc4-b3de-da4f6a113397		35c7281c-ffe6-4fc4-b3de-da4f6a113397	35c7281c-ffe6-4fc4-b3de-da4f6a113397		TCGA-ZS-A9CD-01A-11D-A36Y-05
TCGA-ZS-A9CE-01	0	TCGA-ZS-A9CE-01	1241	0	days	TCGA-ZS-A9CE	892	1	days	1241	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	79	36	44	50	TCGA-ZS-A9CE-F68444	TCGA-ZS-A9CE		0	5		A	44	80	78	-29051			0	1241	892	892	0				0 - No Fibrosis		2014-11-18	FEMALE				Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		9	12		NO	G1	Other, specify	New Primary Tumor	Right Temple	No	YES	YES	No		Yes	MX	NX	T2	Stage II		A9CE	TUMOR FREE	310	150	400	NO	NO	36.4	NO		R0	R0	Primary Tumor	01	Segmentectomy, Single	7th	NO	YES	ZS	15	Liver	Micro		Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING		2011	TCGA-ZS-A9CE-01A-11D-A36W-01	TCGA-ZS-A9CE-01A-11D-A36W-01	TCGA-ZS-A9CE-01A-11D-A36X-10	TCGA-ZS-A9CE-01	TCGA-ZS-A9CE-01		d8b053f6-2674-43ec-9c36-ed652fe5ff7e		TCGA-ZS-A9CE-01	TCGA-ZS-A9CE-01	d8b053f6-2674-43ec-9c36-ed652fe5ff7e		d8b053f6-2674-43ec-9c36-ed652fe5ff7e	d8b053f6-2674-43ec-9c36-ed652fe5ff7e		TCGA-ZS-A9CE-01A-11D-A36Y-05
TCGA-ZS-A9CF-01	0	TCGA-ZS-A9CF-01	2412	0	days	TCGA-ZS-A9CF	636	1	days	2412	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	64	36	51	50	TCGA-ZS-A9CF-F68445	TCGA-ZS-A9CF		0	19			62	106	89	-23510			0	2412	700	636	0				0 - No Fibrosis		2014-11-18	MALE		Hemochromatosis		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES		9	12		NO	G2	Liver	Intrahepatic Recurrence		Yes	YES	YES	No		No	MX	NX	T2	Stage II		A9CF	TUMOR FREE	259	150	400	NO	NO	10.2	NO		RX	R0	Primary Tumor	01	Lobectomy	7th	NO	YES	ZS	17	Liver	Micro		Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING		2008	TCGA-ZS-A9CF-01A-11D-A381-01	TCGA-ZS-A9CF-01A-11D-A381-01	TCGA-ZS-A9CF-01A-11D-A382-10	TCGA-ZS-A9CF-01	TCGA-ZS-A9CF-01		b6a5831d-1a97-49f1-8dbc-c833abb60a20		TCGA-ZS-A9CF-01	TCGA-ZS-A9CF-01	b6a5831d-1a97-49f1-8dbc-c833abb60a20		b6a5831d-1a97-49f1-8dbc-c833abb60a20	b6a5831d-1a97-49f1-8dbc-c833abb60a20		TCGA-ZS-A9CF-01A-11D-A383-05
TCGA-ZS-A9CF-02	0	TCGA-ZS-A9CF-02	2412	0	days	TCGA-ZS-A9CF	636	1	days	2412	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver	NO	NO	None	64	36	51	50	TCGA-ZS-A9CF-F68445	TCGA-ZS-A9CF	TCGA-ZS-A9CF-02A	0	19			62	106	89	-23510	2217		0	2412	700	636	0				0 - No Fibrosis		2014-11-18	MALE		Hemochromatosis		Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	30	9	12	NO	NO	G2	Liver	Intrahepatic Recurrence		Yes	YES	YES	No	false	No	MX	NX	T2	Stage II	TCGA-ZS-A9CF.5D79D370-F174-4CCB-AF64-5617EBF352BE.pdf	A9CF	TUMOR FREE	259	150	400	NO	NO	10.2	NO		RX	R0	Recurrent Tumor	02	Lobectomy	7th	NO	YES	ZS	17	Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING		2008				TCGA-ZS-A9CF-02			3c670523-5f34-4518-bf25-cc0d725de814		TCGA-ZS-A9CF-02		3c670523-5f34-4518-bf25-cc0d725de814		3c670523-5f34-4518-bf25-cc0d725de814	3c670523-5f34-4518-bf25-cc0d725de814		TCGA-ZS-A9CF-02A-11D-A383-05
TCGA-ZS-A9CG-01	0	TCGA-ZS-A9CG-01	341	0	days	TCGA-ZS-A9CG	341	0	days	341	days	TCGA Liver Cancer (LIHC)	liver hepatocellular carcinoma	Liver			Mild	55	35	40	50	TCGA-ZS-A9CG-F68446	TCGA-ZS-A9CG	TCGA-ZS-A9CG-01A	0	5		A	62	106	72	-20100	201		0	341			0				0 - No Fibrosis		2014-11-18	MALE	179			Hepatocellular Carcinoma	No	C22.0	8170/3	C22.0	YES	50	9.5	14	NO	NO	G2						NO		true	No	MX	NX	T2	Stage II	TCGA-ZS-A9CG.8A0E7BA8-7262-4832-89DA-61893BE4B458.pdf	A9CG	TUMOR FREE	382	150	400	NO	NO	10.8	NO			R0	Primary Tumor	01	Extended Lobectomy	7th	NO	YES	ZS	21	Liver	Micro	A	Hepatitis  C Antibody|Hepatitis B Surface Antigen	LIVING	94	2013	TCGA-ZS-A9CG-01A-11D-A36W-01	TCGA-ZS-A9CG-01A-11D-A36W-01	TCGA-ZS-A9CG-01A-11D-A36X-10	TCGA-ZS-A9CG-01	TCGA-ZS-A9CG-01		23b47813-7a77-44ca-b650-31a319c1f497		TCGA-ZS-A9CG-01	TCGA-ZS-A9CG-01	23b47813-7a77-44ca-b650-31a319c1f497		23b47813-7a77-44ca-b650-31a319c1f497	23b47813-7a77-44ca-b650-31a319c1f497		TCGA-ZS-A9CG-01A-11D-A36Y-05
